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Abstract 
Introduction 
Liver resection is increasingly being carried out via the laparoscopic approach (keyhole 
surgery) because there is mounting evidence that it benefits patients by reducing pain and 
length of hospitalisation. There are however ongoing concerns about oncological radicality 
(i.e. ability to completely remove cancer) and an inability to control massive haemorrhage. 
These issues can partially be attributed to a loss of sensation such as depth perception, 
tactile feedback and a reduced field of view. Utilisation of optical imaging and computer 
vision may be able to compensate for some of the lost sensory input because these 
modalities can facilitate visualisation of liver tissue and structural anatomy. Their use in 
laparoscopy is attractive because it is easy to adapt or integrate with existing technology. 
The aim of this thesis is to explore to what extent this technology can aid in the detection of 
normal and abnormal liver tissue and structures.  
Methods 
The current state of the art for optical imaging and computer vision in laparoscopic liver 
surgery is assessed in a systematic review. Evaluation of confocal laser endomicroscopy is 
carried out on a murine and porcine model of liver disease. Multispectral near infrared 
imaging is evaluated on ex-vivo liver specimen. Video magnification is assessed on a 
mechanical flow phantom and a porcine model of liver disease. The latter model was also 
employed to develop a computer vision based image guidance system for laparoscopic liver 
surgery. This image guidance system is further evaluated in a clinical feasibility study. 
Where appropriate, experimental findings are substantiated with statistical analysis. 
Results 
Use of confocal laser endomicroscopy enabled discrimination between cancer and normal 
liver tissue with a sub-millimetre precision. This technology also made it possible to verify 
the adequacy of thermal liver ablation. Multispectral imaging, at specific wavelengths was 
shown to have the potential to highlight the presence of colorectal and hepatocellular 
cancer. An image reprocessing algorithm is proposed to simplify visual interpretation of the 
resulting images. It is shown that video magnification can determine the presence of 
pulsatile motion but that it cannot reliably determine the extent of motion. Development and 
performance metrics of an image guidance system for laparoscopic liver surgery are 
outlined. The system was found to improve intraoperative orientation more development 
work is however required to enable reliable prediction of oncological margins.  
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Discussion 
The results in this thesis indicate that confocal laser endomicroscopy and image guidance 
systems have reached a development stage where their intraoperative use may benefit 
surgeons by visualising features of liver anatomy and tissue characteristics. Video 
magnification and multispectral imaging require more development and suggestions are 
made to direct this work. It is also highlighted that it is crucial to standardise assessment 
methods for these technologies which will allow a more direct comparison between the 
outcomes of different groups. Limited imaging depth is a major restriction of these 
technologies but this may be overcome by combining them with preoperatively obtained 
imaging data. Just like laparoscopy, optical imaging and computer vision use functions of 
light, a shared characteristic that makes their combined use complementary. 
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Impact statement 
This thesis focuses on laparoscopic liver surgery which is a form of minimal invasive 
surgery. It benefits patients by reducing surgical trauma which may improve recovery time 
and complication rates. Laparoscopic liver surgery is not widely practised because it is 
technically challenging. Some of these challenges relate to the fact that surgeons cannot 
palpate the liver or visualise it directly. In other words, the sense of touch and vision is 
impaired during laparoscopic surgery.  
The aim of this work is to explore technologies that enhance surgical vision to compensate 
for these shortcomings. The potential benefit of improving surgical sensing is firstly to enable 
the complete removal of liver cancer, which reduces the cancer recurrence rate, and 
secondly to avoid potentially fatal injury to vulnerable liver structures. The potential 
beneficiaries of this work are surgeons and by natural extension their patients.  It also 
benefits researchers who are investigating imaging of liver disease. The results of this work 
are being disseminated through peer reviewed publications and presentations at scientific 
conferences. To maximise public visibility of this research, publication in an open access 
format has been pursued whenever possible.  
Some of the findings of this work and their potential impact are outlined below.  
It has been demonstrated that confocal laser endomicroscopy can discriminate between 
cancerous and non-cancerous liver tissue. This method may enhance intraoperative 
decision making by determining if a liver lesion needs to be excised and how extensive the 
excision needs to be. Avoiding unnecessary excisions can help in reducing surgical 
complications. This methodology is already being applied to the diagnosis of solid cancer in 
other organs and it is hoped that the findings in this work will contribute to ongoing clinical 
research in this field.   
Multispectral imaging is an imaging modality that can utilise alterations in the light absorption 
behaviour to elucidate the biological composition of tissue. In this thesis a novel, remote 
approach to acquire and analyse multispectral images of liver tissue has been developed. 
Subsequently it has been shown that this method can predict the presence of liver cancer. 
Pending further research, this imaging method could also be applied to assess other liver 
pathologies.  
Augmented reality based image guidance utilises 3D organ models that contain a virtual 
representation of patient specific anatomy and tumour locations. These organ models can 
be projected onto the surgical field (e.g. laparoscopic monitor) hence creating an augmented 
reality environment. The development and evaluation of such a system forms part of this 
thesis and highlights the potential of this technology to improve precision and safety of 
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laparoscopic liver surgery. However, before this can be realised, further improvements 
focusing on the accuracy and usability of this imaging modality are required.   
In conclusion the research in this thesis has demonstrated how technologically enhanced 
vision may improve the assessment of liver tissue and guide laparoscopic liver surgery. The 
methods evaluated in this work can be expanded to other organs and therefore the findings 
are generalisable and may therefore benefit research and clinical care in other medical 
specialties. 
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PAI – Photoacoustic imaging 
PP – Pulse present 
PVCP - Polyvinyl chloride plastisol 
PVE – Portal vein embolisation 
RCT – Randomised controlled trial 
RFA – Radiofrequency ablation 
RFU – Relative fluorescence unit 
RGB – Red green blue space 
RMS – Root mean square 
ROC – Receiver operating characteristic 
ROI – Region of interest 
SEM – Standard error of the mean 
SLAM - Simultaneous localization and mapping 
SNR – Signal to noise ratio 
SRC – Spectral response curve 
SSR – Stereoscopic surface reconstruction 
TRE – Target registration error 
Uint8 / 16 – Unsigned integer 8bit or 16bit 
US – Ultrasound 
VM – Eulerian video magnification 
VR – Virtual reality 
 
  
24 
 
Glossary 
 
Absorption spectrum also Spectral response curve  
Fraction of incident radiation absorbed by the material (or tissue) over a range of 
frequencies or simplified how much light is absorbed at certain wavelength. In this thesis the 
tissue absorption is plotted against wavelengths of light. 
 
Augmented reality  
A technology that superimposes a computer-generated image on a user's view of the real 
world, thus providing a composite view. 
 
Band-pass filter 
A band-pass filter is a device that passes frequencies within a certain range and rejects 
(attenuates) frequencies outside that range. In this work it describes devices that filter 
certain wavelengths of light. 
 
Bandwidth 
A range of frequencies within a given band, in particular that used for transmitting a signal. 
 
Codec 
A codec is a device or computer program for encoding or decoding a digital data stream or 
signal. 
 
Confocal laser endomicroscopy 
Probe based variant of confocal laser microscopy imaging. 
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Data smoothing 
Creation of an approximating function that attempts to capture important patterns in the data, 
while leaving out noise. 
 
Fluorophore 
A fluorescent chemical compound. 
 
Gray-level co-occurrence matrix 
A texture based statistical representation of image data. 
 
Gray-level co-occurrence matrix statistics 
Described as Energy, Contrast, Correlation and Homogeneity which are statistics that 
provide information about the texture of an image. 
 
Hepatectomy 
Resection of liver tissue. 
 
Image guided surgery 
General term for using images to guide surgical therapy. In the context of this thesis only 
used for computer navigated surgery i.e. using a 3D organ model to reflect in-vivo anatomy. 
 
Intensity 
In this work used to describe luminous intensity which is a measure of the wavelength-
weighted power emitted by a light source. 
 
Multispectral imaging 
An imaging method that captures image data within specific wavelength ranges across the 
electromagnetic spectrum. 
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Parenchymal sparing resection 
A method of liver resection with the intention of preserving a maximum volume for the future 
liver remnant.  
 
Registration 
In image guided surgery it describes the process of aligning a 3D organ model in an 
anatomically correct position with the corresponding organ of the patient (e.g. liver). 
 
Segmentectomy 
Resection of a functional liver segment. 
 
SmartLiver 
An image guidance system for laparoscopic liver surgery that is being developed by a team 
of surgeons and computer scientists at UCL. 
Steatosis  
Fatty change or degeneration (used in the context of liver steatosis in this work). 
 
Sub-segmentectomy / wedge resection / non-anatomical resection 
Resection of less than a segment of liver. 
 
Tracking 
In laparoscopic image guided surgery it describes the process of following the position of the 
laparoscope or laparoscopic instrument. 
 
Video magnification 
A video processing algorithm that enhances subtle motion or colour variation.  
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Virtual reality 
The computer-generated simulation of a three-dimensional image or environment. 
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1. General introduction  
1.1. Introduction to liver surgery 
1.1.1 Liver function 
The liver is the largest solid organ in the body and weighs between 1200-1500g. It is 
situated in the right upper portion of the abdominal cavity where it is sheltered by the ribs. 
The upper border of the liver lies approximately at the height of the nipples (1). Major organs 
that border onto the liver are the right kidney, stomach, duodenum and colon. 
The liver fulfils many diverse functions and can perhaps be regarded as the body’s “power 
plant and manufacturing site”. It fulfils a variety of roles that include metabolic-, synthetic-, 
excretory-, endocrine- and immunological functions. More specifically the liver plays a 
central role in the metabolism of carbohydrates, fats and proteins (2). It is essential for the 
metabolism and conjugation of many drugs whose excretion depends on a normal liver 
function. The liver accumulates fat soluble vitamins and glycogen which is a storage 
carbohydrate. Proteins that are crucial for coagulation, immune response and transport and 
bloodstream mediated transport are all synthesised in the liver as is bile. The main excretory 
functions involve the excretion of drug metabolites and bile(2). The liver performs an 
important endocrine function by breaking down hormones and activates vitamin D via 
hydroxylation. As a crucial component of the immune system, it removes circulating immune 
complexes, aids in the fetal development of B-lymphocytes, hosts the majority of the bodies 
macrophage population in the form of Kupffer cells and it is one of the main sources for 
cytokine release (3,4). 
Because of this diversity which sets it apart from organs with one main function such as the 
heart (pump) or the kidney (filter) it has so far not been possible to create an artificial liver 
device. In contrast to most other solid organs the liver has a striking capacity for self-
regeneration. In animal models it has been proven that it is possible to remove two-thirds of 
the liver up to 12 times. Hepatocytes have the ability to replenish liver volume but when they 
eventually lose this ability, then so called oval cells, a population of pluripotent stem cells 
that dwell in small bile ducts, can proliferate and differentiate into hepatocytes and biliary 
cells (5). 
1.1.2 Liver anatomy 
1.1.2.1 External liver anatomy 
As described above, most of the liver bulk lies in the right upper abdomen, there is however 
a smaller portion that constitutes about a sixth of the livers volume which protrudes to the left 
of the midline, between the diaphragm and the anterior surface of the stomach. The superior 
portion of the liver is convex and is moulded to the diaphragm. At the front it slopes down 
straight lying against the lower right ribcage and the abdominal wall. At the back it extends 
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down to a posterior surface which is triangular in outline. The liver is invested in peritoneum 
except at the back where the peritoneum reflects onto the diaphragm and thus forms the left 
and right triangular ligaments. These ligaments in conjunction with the falciform ligament 
also provide attachments to the anterior convexity of the diaphragm. The falciform ligament 
is the landmark for the border between the right and left liver lobe. The anterior and posterior 
liver surface meet inferiorly at a sharp angle to form the lower liver border (6). The liver has 
a dual blood supply, the portal vein brings venous blood from the intestines and spleen and 
the hepatic artery carries arterial blood from the coeliac trunk. Both blood vessels enter the 
liver through the porta hepatis which is a fissure in the inferior portion of the right lobe. The 
bile ducts follow the course of the hepatic artery within the liver. With the exception of its left 
main trunk, which has an unusual morphology due to its need to perform different functions 
in the foetus, this is also true of the portal vein. Because the smaller subdivisions of the 
hepatic artery, portal vein and bile ducts run alongside each other, surrounded by a fibrous 
sheath, they are also referred to as portal triad or portal pedicles. Blood drains directly into 
the inferior vena cava (IVC) via three main hepatic veins (right, middle and left) and a 
number of smaller hepatic veins that originate from the posterior surface of the liver where it 
lies adjacent to the IVC.  
1.1.2.2 Functional liver anatomy 
The classical description of the liver anatomy above hides a more intricate internal liver 
anatomy, also sometimes called functional anatomy. The knowledge of this functional 
anatomy which is based on the teachings of Couinaud (7) with a later amendment 
introduced by a consensus conference in 2000 Brisbane classification (8), is essential to 
carry out precise hepatectomies (liver resections). A simplified description of the functional 
liver anatomy is given below (Figure 1.1). This is intended to stress the central role that 
imaging plays in the correct interpretation of liver anatomy.  
Couinaud divided the liver into 2 livers, 4 sectors and 8 segments founded on the distribution 
of the portal vessels and the main hepatic veins. The first division of the proper hepatic 
artery divides the liver into the right and left liver. The course of the three main hepatic veins 
separates the liver into 4 sectors, two each in the right and left liver, respectively. The 
sectors are supplied by the second order division of the hepatic artery (right anterior, right 
posterior, left medial and left lateral section). Each liver segment is supplied by the third 
order division of the hepatic artery. As a simplification it can be said that the course of the 
portal vessel along the horizontal plan subdivides the sectors into cranial and caudal 
segments. Segment 4 is divided by its course into segment 4a and 4b. The caudate lobe 
(segment 1) lies posterior to the liver and embraces the retrohepatic IVC. It is surrounded by 
major vascular structures such as the IVC, left portal vein and the main middle hepatic vein. 
A detailed anatomical description of the caudate lobe goes beyond the scope of this chapter. 
The interested reader is referred to here (6). 
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Knowledge of the functional anatomy is key to describing the location of surgical liver 
pathology and to planning its resection. Because there is little correlation between the livers 
surface anatomy and its functional anatomy it is crucial to employ intraoperative imaging to 
guide surgical resection. 
 
Figure 1.1 Illustration of functional liver anatomy after Couinaud. (reprinted with 
permission from : BodyParts3D, © The Database Center for Life Science licensed under CC 
Attribution-Share Alike 2.1 Japan.") 
 
1.1.3 History of liver surgery  
1.1.3.1 Pre-modern medicine 
A report on gallbladder calculi found in a mummy from Theben (1.500 B.C.) is the only 
evidence of biliary disease that survived from antiquity. Alexander the Great is also thought 
to have succumbed to biliary tract disease culminating in peritonitis in 323 B.C. Translations 
from the works of Hippocrates (5th century B.C.) indicate that he had knowledge of the 
clinical signs of biliary sepsis and malignant obstructive jaundice (9). A few centuries later 
(1st century A.D.), Galen decreed that the liver, alongside the heart and brain, is one of the 
main organs of the body and as such is chiefly involved with governing the nutritive facility. 
Many of his teachings surrounding the balance and imbalance of bodily humours being the 
cause of disease persisted up to the middle of the 17th century. The advent of the 
renaissance saw further advances founded on the autopsies of patients who succumbed to 
the complications of gallstone disease (6). The publication of “Anatomia Hepatis” by Francis 
Glisson, in 1654 was a milestone in the study of liver disease (10). In it he clearly described 
the liver anatomy, in particular its capsule which invests the portal structures and the 
distribution of the bile ducts. He also deduced that the venous blood entering from the portal 
vein traverses through capillaries before entering the vena cava. Some of his illustrations 
bear a striking similarity to those of Couinaud and to modern computer tomography (CT) 
based 3D reconstruction of liver anatomy (6). The liver capsule and fibrous sheath 
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surrounding the portal vessels is named after him. In the 18th century, Morgagni published a 
seminal work which revolutionised the understanding of liver and biliary disease. In it he 
presented symptoms in a logical sequence and combined knowledge of pathology and 
physiology to formulate theories on the causes of disease. From the 18th century onwards 
the theories around humoral imbalances were disproved and modern scientific medicine was 
born (6). 
1.1.3.2 Advent of biliary surgery 
The first surgical interventions for liver disease were all centred on the gallbladder and biliary 
system. This is hardly surprising as the disease burden related to gallstones is vastly greater 
than other liver diseases and in addition it was technically safer to operate on the biliary 
system than on the substance of the liver itself. The first lithotomy, meaning opening of the 
gallbladder and extraction of stones was carried out by Bobbs in 1867. This was an 
incidental procedure as Bobbs was expecting to find an ovarian tumour (6). The first planned 
gallbladder procedures in the modern era were cholecystostomies which were performed by 
Simms, Koch and Tait around the same time. In this historic form of cholecystostomy, the 
gallbladder is opened to extract pus and stones and it is left open, draining onto the skin to 
prevent biliary peritonitis. The first excision of the gallbladder (cholecystectomy) was 
performed by Langenbuch in 1882, who correctly identified that “others busied themselves 
with the product of the disease (gallstones), not with the disease itself”. This was an 
important step as it was observed that gallstones would frequently reoccur (6). Soon after 
the first cholecystectomy, techniques to remove stones from the common bile duct were 
invented. These were initially unpopular because of the risk of biliary peritonitis, until Kehr 
introduced the technique of biliary intubation. Kehr was also credited with performing the first 
hepatico-enteric anastomosis and resection of a hepatic tumour (11). 
1.1.3.3 The role of imaging in the development of hepato-biliary surgery 
Progress in biliary surgery was supported by new developments in imaging, especially in the 
20th century when it became possible to image the gallbladder via oral cholecystography 
(1924) and the bile duct via cholangiography (1932). Much later in the 1970’s ultrasound 
imaging, CT and magnetic resonance imaging (MRI) were added to the imaging 
armamentarium (12,13). The first successful percutaneous interventions on the liver such as 
percutaneous transhepatic cholangiography for the relief of jaundice and the dilatation of 
strictures were also described in this decade. The refinement of selective arteriography led 
to the invention first hepatic artery embolisation for the treatment of liver tumours (14). 
Modern surgeons have seen their world transformed by advancements in imaging and it is 
fair to say that these have enabled the rapid progress in the management of biliary and 
hepatic disease (6). 
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1.1.3.4 Advent of liver surgery 
“...the liver is so friable, so full of gaping vessels and so evidently incapable of being 
sutured that it seems impossible to successfully manage large wounds of its 
substance.”  
JW Elliot 1897 (15) 
 
This description by Elliot, in a case report on liver resection, highlights why liver surgery was 
virtually non-existent, until the middle of the last century. There is the oft cited Greek myth of 
Prometheus who was chained to the Caucasus Mountain as a punishment by Zeus for 
showing humans how to make fire. Every day an eagle descends and eats his liver, which 
miraculously re-grows over night (Figure 1.2). If this myth can be regarded as proof that the 
ancient Greeks knew about the livers regenerative capabilities is uncertain.  
Nevertheless, with the exception of one report form 1716 where part of the liver which was 
protruding from the wound was amputated, no hepatic resections were attempted until the 
advent of anaesthesia. As mentioned above, Langenbuch described the first liver resection 
in 1888 and other surgeons soon followed. At around this time Rex (1888) and later Cantlie 
(1897) further enhanced the understanding of lobar and segmental liver anatomy and 
brought to light the existence of planes within the liver parenchyma that are devoid of major 
vascular and biliary structures. These findings were complemented by studies which 
revealed that blood vessels in the liver parenchym (liver tissue) could be compressed by 
suture ligation if the sutures were passed in sufficient distance from the wound.  
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Figure 1.2 Prometheus depicted in a sculpture by Nicolas-Sébastien Adam, 1762. (from 
https://en.wikipedia.org/wiki/Prometheus#/media/File:Prometheus_Adam_Louvre_MR1745_
edit_atoma.jpg, image rights released) 
 
More adjuncts to control hepatic bleeding were introduced in quick succession. In 1907, 
Garre emphasised the importance of packing for the management of liver injuries and 
indeed even in modern times this approach remains the mainstay of liver trauma 
management. Pringle contributed another milestone in the management of hepatic bleeding 
in 1908 by describing a method of compressing the hepatic inflow vessels. 
The first major hepatectomy was carried out by Wendell (1911) who realised that blood loss 
could be reduced by ligating the portal pedicle that supplied the side of the liver that was to 
be removed. Unfortunately this discovery was lost to the surgical community so that the next 
major hepatectomy was not performed until 1949. As this was not reported in the English 
literature until 1955, another case of major hepatectomy carried out by Lortat-Jacob in 1952 
gained publicity instead. Initially a thoraco-laparotomy incision (opening chest and abdomen) 
was popularised because it allowed good access to vascular structures, although this came 
at the cost of increased morbidity. The introduction of coastal rib retractors made opening of 
the chest unnecessary. A variety of methods for parenchymal transection have been 
advocated such as electrocautery, microwave tissue coagulation, water jet, ultrasonic 
aspiration dissector and the harmonic scalpel to name a few. Many of these remain still in 
use today as does the original method of parenchymal transection, the clamp-crush 
technique. 
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1.1.4 Common indications for liver surgery 
Following is a brief summary of common indications for liver resection. Diseases where only 
part of the biliary system is excised (e.g. cholecystectomy) will not be discussed here 
because it is not relevant for the research proposed in this work. There is a significant 
discrepancy in surgical liver disease patterns between the West (Europe and the Americas) 
and the East (East Asia). A detailed description of global variations in presentation and 
practice however is beyond the scope of this chapter and hence the focus is on western 
practice and in particular the UK. 
1.1.4.1 Primary liver cancer 
The majority of liver resections are carried out for malignant tumours. These can be 
categorised into primary (originating in the liver) and secondary liver cancers (i.e. 
metastatic). More than 90% of primary liver cancers are hepatocellular carcinomas (HCC) 
which is the fifth most common cancer worldwide and the third most common cause of 
cancer related mortality (16). In the majority of cases HCC arises in cirrhotic livers. It 
constitutes the bulk of hepatic cancer resections in the East Asia because of the endemic 
presence of hepatitis B virus (HBV) infection which is one of the globally leading causes for 
liver cirrhosis (17). HCC in the West usually presents late, as a large and/or multifocal 
cancer and hence is often not amenable for surgical resection. The main limitation for 
resection of HCC is liver function, because a removal of even small amounts of liver tissue 
may precipitate liver failure. Another issue is that development of de-novo HCC in cirrhotic 
livers is common after resection. Since the 1990’s liver transplantation has been shown to 
be an effective therapy for small HCC in patients with liver failure (18).  
Cholangiocarcinoma (CCA) accounts for approximately 3% of all GI cancers and is the 
second most common hepatobiliary cancer after HCC (19,20). On the basis of anatomical 
distribution of the involved bile ducts, CCA has been classified as intrahepatic, perihilar or 
distal. Usually only intrahepatic and perihilar CCA are treated with liver resection. There are 
number of risk factors for CCA with primary sclerosing cholangitis being the best known one. 
Most cases of CCA are however sporadic. Intrahepatic CCA is treated with liver resection 
whereas perihilar CCA requires additional excision of the common bile duct and not 
infrequently also of hilar blood vessels that have been invaded by cancer. The 
preponderance of vascular invasion and extensive spread along the bile ducts means that 
most perihilar CCA are unresectable. Some centres have demonstrated good survival rates 
for patients with perihilar CCA who were treated with liver transplantation (20). 
1.1.4.2 Secondary liver cancer 
Colorectal cancer is the commonest gastrointestinal malignancy and causes an estimated 
17,000 cancer deaths in the UK each year. Approximately 25% of patients with colorectal 
cancer present with liver metastasis at the time of diagnosis. A further 40-50% will develop 
colorectal cancer liver metastasis (CRLM) later on (21). The minority of these patients 
(around 20%) present with resectable disease (22). If resection is undertaken approximately 
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40% of patients are alive after 5 years, without surgery it is <1% (23). The definition and 
limits of what is deemed resectable have undergone tremendous evolution over the last two 
decades. The main criteria for resection with curative intent are considered if 1) all disease 
can be cleared 2) the remaining liver volume is adequate to prevent liver failure 3) there is 
no extrahepatic disease that cannot be removed (24,25). In unresectable CRLM, 
preoperative (neoadjuvant) chemotherapy is often employed to reduce the size of the cancer 
in an attempt to make it potentially amenable to resection. If cancer reoccurs in the liver 
without concomitant extrahepatic disease, it can be re-resected with outcomes being 
comparable to the primary resection (23,26). Surgeons in western countries carry out the 
majority of liver resections for metastatic disease (6). 
The success in treating CRLM with hepatic resection has created interested in treating other 
forms of metastatic cancer the same way. In patient with metastatic gastrointestinal 
neuroendocrine tumour, liver resection has been shown to be a viable curative option. If all 
disease can be removed the 5 year survival rates approach 85% (27). In a non-curative 
setting liver resection may be carried out to reduce tumour burden (debulking) which is 
thought to have a beneficial impact on survival (28). Debulking for metastatic ovarian cancer 
may also necessitate hepatectomy to reduce the burden of disease prior to intraperitoneal 
chemotherapy, which has been shown to convey a survival advantage (29). There are some 
reports about the benefit of liver resection in a number of other cancers (e.g. melanoma, 
breast cancer, renal cell cancer), but due to the heterogeneous biology of these cancer 
types more data is needed to establish a clear role for hepatic surgery (30).  
1.1.4.3 Benign indications for liver resection 
There a variety of benign liver tumours, with the most common ones of epithelial origin being 
hepatocellular adenoma and focal nodular hyperplasia whereas the most common tumours 
of mesenchymal origin are haemangiomas and angiomyolipomas. Diagnosis is frequently 
made based on imaging criteria because percutaneous biopsy is only indicated in selected 
cases. If lesions become symptomatic they are usually excised while asymptomatic lesions 
are kept under surveillance. Lesions with an increased risk for malignant transformation (e.g. 
hepatic adenoma >5cm) or lesions that are indeterminate are usually also excised (31). 
Other benign diseases that may require hepatic resection include intrahepatic gallstones, 
intrahepatic biliary strictures and hydatid cysts (6).  
1.1.5 Current state of liver surgery 
Morbidity and mortality associated with liver resection has vastly improved over the last few 
decades. The first ever reported operative mortality from a multicentre series of liver 
resections was 25% (32). Compared to this recent series frequently quote mortality rates of 
2-3% for CRLM and <5% for HCC resection routinely (33,34). The reasons for these 
improvements are multifactorial and include advances in pre- and postoperative diagnostics, 
preoperative planning and patient selection, perioperative care, interventional procedures 
and specialised surgical instruments (6).  
36 
 
The majority of newly developed instruments are dedicated towards the division of liver 
tissue which is also called parenchymal transection. The gold standard for parenchymal 
transection is the Crush-Clamp technique, where a standard surgical metal clamp is used to 
fracture parenchym around bile ducts and blood vessels which subsequently can be divided 
in a controlled fashion (35). The Cavitron Ultrasonic Suction Aspirator (CUSA) is used in a 
similar fashion; the removal of parenchym however is achieved by inducing a cavitation 
effect through tiny oscillating motions. Stapled hepatectomy employs devices that 
simultaneously cut and seal liver tissue via small metallic staples. Finally there are a number 
of energy devices that employ various methods (e.g. radiofrequency ablation, bipolar 
coagulation, ultrasonic vibration) to create heat that divides and seals liver tissue. 
Numerous clinical trials have been conducted to establish the optimal parenchymal 
transection method. Some RCT’s have compared more recently developed transection 
technologies with each other and found some to be more advantageous (36,37). So far 
however there is no evidence that any method has advantages over the traditional clamp-
crush technique. A network analysis found an increased rate of adverse events with use of 
the radiofrequency dissecting sealer compared to clamp-crush transection. The majority of 
novel transection methods however have been shown to be non-inferior or to have no 
significant benefits compared to the gold standard (38,39). 
At present the majority of liver resections are carried out in highly specialised centres that 
have the necessary support network to provide optimal care (40,41). Surgical education has 
evolved alongside these rapid developments and in most countries surgeons require a 
dedicated period of subspecialty training in liver surgery before they can obtain accreditation 
as hepato-biliary surgeons.  
Concomitant with improved patient outcomes the indications for liver surgery have expanded 
significantly. In its early beginnings, liver resection for metastatic disease was contentious 
whereas in current practice in constitutes the bulk of resected liver lesions in western 
countries (1.1.4.) The introduction of novel technologies has expanded the surgical 
armamentarium for parenchymal transection and haemostasis (42,43).  
Thermal ablation of liver tumours, which can be performed via a percutaneous, laparoscopic 
or open (laparotomy) approach, has been shown to be a viable alternative to surgical 
resection. In some case it can be used as a complementary modality alongside resection. 
Ablation is based on the principle of destroying tumour tissue via induced liver necrosis. It 
involves insertion of one or more metal probes into the liver tumour (44,45). During ablation, 
USS, MRI or CT guidance is used for the adequate localization and monitoring of the 
ablation process. At present thermal ablation via radiofrequency or microwave ablation is the 
most widely practised method with the latter, more novel method having the advantage 
achieving higher temperatures in a shorter time frame thus allowing more extensive ablation 
procedures to be carried out (46). 
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An important limitation of ablation is the heatsink effect which cools down tumours that are 
close to larger blood vessels. A reduction in maximum temperature may result in incomplete 
tumour destruction. Furthermore, thermal ablation carried out close to blood vessels or bile 
ducts may damage these vulnerable structures which can lead to complications such as bile 
leak, bile duct strictures, bleeding and thrombosis. To address this limitation, a new 
technology called irreversible electroporation (IRE) has been introduced. IRE employs 
multiple, rapid, high voltage pulses that disrupts cell membranes which ultimately leads to 
loss of homeostasis and cell death (47–49). Ablation of small solitary liver cancers may 
produce comparable results to liver resection with a reduced morbidity and mortality 
(50).The main concern regarding thermal ablation is the high incidence of local recurrence. 
To avoid recurrence it is crucial to destroy not only the cancer harbouring tissue but also a 5-
10mm safety margin to include any local satellite lesions. 
Neoadjuvant chemotherapy is frequently utilised in an attempt to downsize unresectable 
CRLM to such an extent that they become amenable for curative resection. Another 
approach to improve resectability is the use of portal vein embolisation (PVE) which is used 
to block the blood flow to the part of part of the liver (right or left) that carries the majority of 
disease burden. This leads to a decrease in the affected part of the liver and a 
compensatory growth in the contralateral side (51,52). The two-staged hepatectomy 
approach is used in conjunction with PVE or surgical portal vein ligation to improve 
outcomes in bi-lobar disease (affecting right and left liver). The first stage involves localised 
resection (e.g. segmentectomy) of disease from the less affected side of the liver. This is 
followed by PVE or surgical ligation to the contralateral side to induce growth in the side that 
has been rendered disease free. Once sufficient liver regeneration has taken place the 
previously embolised side is resected (53).  
The method of associated liver partition and portal vein ligation for staged hepatectomy 
(ALPPS) has evolved from the two staged hepatectomy recently with the main difference 
being that the liver is transected during the first stage. This induces more rapid regeneration 
but also increases operative morbidity and mortality (54,55). In a recent attempt to improve 
the safety profile of ALPPS, some authors have advocated the less invasive partial -ALPPS 
where liver transection is limited to 50-80% of the whole transection surface. The mini-
ALPPS procedure combines partial transection with a portal vein embolisation instead of 
portal vein ligation. Both modifications of ALPPS have the aim of reducing the complication 
rates during the first stage of ALPPS (e.g. bile leaks, bleeding) (56,57). For liver cancers 
with extensive involvement of vascular structures an ex-vivo dissection approach has been 
first propagated by Pichlmayr (58). Although this has been replicated by other groups its 
applicability remains reserved for a few select cases (59,60). 
Two staged hepatectomy, ALPPS and ex-vivo dissection are aggressive surgical solutions 
for advanced and complex disease. The disadvantage of utilising these techniques is an 
increase in surgical morbidity and mortality (54,59). At the other end of the spectrum novel 
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approaches are being developed with the aim of minimising invasiveness and surgical 
trauma. Parenchyma sparing resections such as segmentectomies have long been 
popularised for HCC in cirrhotic livers but are also now being introduced for CRLM resection 
in the form of sub-segmentectomies. The benefit of parenchyma sparing surgery is that a 
greater future liver remnant can be preserved which reduces the risk of postoperative liver 
failure and enhances the feasibility of carrying out further liver resections should the cancer 
reoccur (23,61,62). Correctly identifying segmental anatomy relies heavily on imaging by 
intraoperative ultrasound whose use and visual interpretation has been accordingly refined 
(63,64). Virtual three dimensional (3D) reconstruction of the liver has been introduced to aid 
in the planning of liver resection and to accurately predict the future liver remnant (FLR) (65). 
More recently 3D organ models have been integrated into image guidance systems that can 
provide intraoperative image guidance in real-time (66,67). Laparoscopic (keyhole) surgery 
was introduced in the early 1990’s into the field of oncological surgery and has since 
undergone a rapid expansion. Minimising the size of abdominal incision has been shown to 
benefit patients by reducing pain, blood loss, length of stay and postoperative complications. 
In certain procedures (e.g. cholecystectomy, anti-reflux surgery) the impact of laparoscopy 
has been so significant that it has become the approach of 1st choice (68,69). In contrast to 
this liver surgeons have been relatively slow to adapt the laparoscopic approach. The 
reasons behind this will be elaborated on in the following section. 
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1.2. Introduction to laparoscopic liver surgery 
1.2.1 The concept of laparoscopy 
The aim of laparoscopic surgery is to reduce the size of the surgical incision and hence the 
associated surgical trauma (Figure 1.3). The semantic origins of “laparoscopy” stems from 
the Greek words ‘lapar’ meaning ‘flank’ or ‘abdomen’ and ‘scop’ meaning ‘see’. It is 
essentially a medical procedure initially developed to look inside the abdomen for diagnostic 
purposes which later on has evolved to enable therapeutic interventions (e.g. organ 
resection) as well. To perform laparoscopy the first step is to distend the abdominal cavity by 
insufflating it with carbon dioxide, which subsequently creates the space required for the 
manoeuvring surgical instruments. The now established pneumoperitoneum is accessed via 
laparoscopic ports. These ports are essentially 5-15mm diameter tubes with an integrated 
air lock that enables introduction of specialised laparoscopic instruments without the loss of 
intraabdominal pressure. The first port is used is to introduce a laparoscopic camera called 
‘laparoscope’. The view of the laparoscope is projected on a screen that is placed in a 
convenient position close to the patient. Depending on the requirements of the intended 
procedure a varying number of additional ports is subsequently introduced (Figure 1.4).  
 
Figure 1.3 Comparison between conventional and laparoscopic scars. 
a) Open liver resection (70) and b) Laparoscopic liver resection (71). (reprinted with 
permission from: a - Wiley copyright 2014, b - CC BY-NC 4.0 from Ingenta Connect) 
 
There are a vast and steadily increasing number of laparoscopic instruments that amongst 
many other things can be utilised to manipulate, cut, coagulate, irrigate and suture tissues. 
Many of these are adaptations of instruments used in open surgery such as laparoscopic 
diathermy, needle holders or staplers. Others instruments have been specifically designed 
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for laparoscopic surgery, tissue graspers for example have been introduced to hold and 
manipulate tissues with the aim of replacing the surgeon’s hands. Laparoscopic surgeons 
are becoming increasingly skilful in substituting the motor function of the hand with tissue 
graspers. The issue is that graspers cannot convey the feel of touch and hence surgeons 
are deprived of their second most important sense, the sense of touch.  
 
Figure 1.4 Laparoscopic port placement.  
The ports (*) allow the insertion of a laparoscopic camera (#) and instruments (72). 
(reprinted with CC BY-NC 4.0 from Intechopen) 
 
1.2.2 Adaptations specific to liver surgery 
The majority of the laparoscopic instruments used for liver resections are also used in other 
laparoscopic procedures. These ‘general purpose’ instruments include graspers for tissue 
manipulation, diathermy or thermal tissue sealing systems for dissection and haemostasis 
(stopping bleeding), scissors for cutting, needle holders for suturing, suction to evacuate 
fluid, laparoscopic staplers to divide and seal structures and to perform an anastomosis 
between two hollow viscus. Laparoscopic retractors either held by hand or fixed to the 
operating table by a pole, can be used to hold the liver in place while a resection is carried 
out. There are many other instruments in use which cannot all be named here.  
  
# 
* * 
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Some instruments however have been developed for specific use in liver surgery. These 
include the argon beam coagulator used for haemostasis, the ultrasonic suction aspirator for 
parenchymal transection and laparoscopic ablation probes for thermal ablation. Although 
also employed by other surgical specialties, laparoscopic ultrasound is an essential tool for 
the visualisation of functional liver anatomy and has therefore found widespread uptake for 
laparoscopic liver resection (73–77).  
1.2.3 Historical development of laparoscopic liver surgery 
The first report of a laparoscopic procedure in the field of hepato-biliary surgery was that of a 
laparoscopic cholecystectomy carried out by Muhe in 1985 (78). This was performed using a 
side-viewing endoscope without video connectivity. In this first report the surgeon visualised 
the abdominal cavity directly without the aid of a video screen. The procedure was soon 
adapted to be used in conjunction with a video-laparoscope that projected its views onto a 
screen, much like it is performed in this day and age (79). It took several years until this 
approach was extended to the resection of a parenchymal liver lesion in order to remove a 
focal nodular hyperplastic nodule (80). The first liver resection for malignancy (CRLM) was 
carried out soon after this report (81). As the international surgical community took note of 
these advances which is reflected by a number of case series of laparoscopic liver resection 
(LLR) that were published in rapid succession (82–85). These studies conducted on different 
continents, populations and pathologies demonstrated the repeatability and safety of this 
new approach. Due to concerns about oncological adequacy of LLR, many groups gained 
experience in benign cases first before embarking on resection of malignancy. Not unlike 
laparoscopic liver surgery today, a variety of methods for parenchymal transection such as 
hydro jet dissector, thermal ablation, clamp crush technique and ultrasonic scalpel were 
proposed in these studies(82,84–88). Many authors advocated the use of laparoscopic 
ultrasound to identify landmarks of functional liver anatomy intraoperatively (85,86,88). In 
this early period very few authors attempted major liver resections (>2 segments) via the 
laparoscopic approach were reported. The first series containing major hepatectomies via 
the laparoscopic approach was published in 1997 and the authors concluded that it was a 
feasible alternative in selected patients (83). 
Several of these pioneers of LLR continued to refine their operative techniques and publish 
them in the literature. Other centres emulated these techniques and started to introduce LLR 
into their repertoire. This process started a standardisation of several laparoscopic 
techniques (e.g. ‘French position’, caudal approach), which are still in use today 
(74,76,83,85,89,90).  
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In parallel with increasing sophistication, the laparoscopic approach was extended to 
technically more demanding and complex procedures such as caudate lobe resection (91) or 
resection of the right posterior liver segments (92). The confidence of some authors in the 
safety of LLR is reflected by the first report of laparoscopic left lateral sectionectomy for the 
purpose of living donor transplantation (93) (harvest of partial liver for liver transplantation). 
In living donor transplantation, donor safety is of the utmost importance and the willingness 
to apply LLR to this patient cohort heralded a big step in the evolution of laparoscopic liver 
surgery. 
With increasing certainty about the technical feasibility and safety of LLR (76,94–96), the 
focus of publications extended to studying the potential benefits of this technique for patient 
outcomes. Outcome parameters that were thought to improve with the minimal invasive 
approach included postoperative pain, length of hospital stay and intraoperative blood loss 
(75,76,97). Over the last decade evidence of a decrease in postoperative complications for 
patients undergoing LLR vs. open liver resection has been accumulating (98,99). However 
due to the paucity of standardised registries, randomised controlled trials (RCT) or a large 
volume meta-analysis, there remained some uncertainty about the exact nature of benefits 
conveyed by the laparoscopic approach (94,100,101). 
In 2008 and 2014 two consensus conferences on the international position on laparoscopic 
liver surgery were held in Louisville and Morioka, respectively. During the Louisville 
conference it was concluded that LLR is safe and effective if performed by surgeons with 
experience in traditional (open) liver- and laparoscopic surgery. A recommendation to 
establish an international registry for LLR was issued (94). The second conference in 
Morioka postulated that minor (i.e. resection of ≤2 segments) LLR has made the transition 
from experimental treatment to standard of care whereas major LLR is still an innovative 
procedure that requires further evaluation (74). 
1.2.4 Current state of the art in laparoscopic liver surgery 
The uptake of LLR has exponentially increased over the last decade. The estimate of 
globally reported procedures has increased from approximately 3000 to over 9000 in the 
span of 6 years (96,102). The majority of laparoscopic liver surgeons are carrying out minor 
LLR such as left lateral sectionectomies or wedge resections; more complex surgery (e.g. 
major hepatectomy, caudate lobe, right posterior sectionectomy) however has not been 
taken up widely so far. Complex LLR are performed in a relatively small number of highly 
specialised centres that have driven the innovation of novel laparoscopic techniques in the 
recent past (74,102). 
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Laparoscopic resection of hilar cholangiocarcinoma for example had not been attempted 
until a few years ago because it required a concomitant reconstruction of biliary drainage 
(hepatico-jejunostomy). Although technically challenging, the feasibility of performing this 
laparoscopically with acceptable outcomes has been demonstrated recently (103). Because 
a significant number of hilar cholangiocarcinomas also require resection and reconstruction 
of blood vessels that have been infiltrated by cancer (20), it is likely that the laparoscopic 
approach will only be applicable for a small cohort of these patients.  
It has been recognised that the difficulty of a laparoscopic resection does not exclusively 
depend on the extent of resected liver tissue but also and perhaps to a greater degree on its 
location. In this context it is particularly difficult to perform a segmentectomy of liver 
segments 7 and 8, on the superior right aspects of the liver. It is simpler to carry out a right 
hepatectomy and remove segment 7 or 8 together with segments 5 and 6. This however has 
the disadvantage of unnecessarily removing healthy parenchyma which can affect 
postoperative liver function in diseased livers (e.g. cirrhosis) and restrict surgical options if a 
cancer recurrence in the liver requires resection at a later stage (23,74). Technical aspects 
to performing parenchyma-sparing segmentectomies throughout segment 1-8 have been 
described previously (73). In this report it was suggested to place laparoscopic ports 
traversing through the chest and diaphragm into the abdominal cavity to access the most 
challenging superior portions of the liver (segment 7&8). A more aggressive trans-
diaphragmatic access facilitated by a thoracoscopic (minimal invasive chest surgery) 
approach that requires incision and repair of the diaphragm, has been advocated by a 
different group. For preoperative planning and simulation a 3D liver model (Figure 1.5) was 
utilised in this report (104). 
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Figure 1.5 A 3D liver model for preoperative simulation. 
The 3D model was used to visualise the position of the liver lesion (arrow). At the 
lower half of the image the hilar vessels can be seen (blue - portal vein; red - hepatic 
artery). The gallbladder is shown as a green structure on the left (105). (Reprinted with 
CC BY-NC 4.0 from Elsevier) 
 
An alternative to hilar dissection and control was suggested by an author who invented the 
‘Glissonian approach’ (106). Instead of controlling hepatic inflow vessels at the hilum, they 
(the hepatic inflow vessels) are transected with a stapler device inside the liver parenchyma. 
The same group that initially proposed laparoscopic donor hepatectomy on the left liver, has 
more recently described this approach for the right liver in adult-to-adult donation (107). 
Not all research is focused on improving the technical aspects of LLR though. It has long 
been stressed that better levels of evidence or needed to verify the benefits of the 
laparoscopic approach. The highest level of evidence up to date has been provided by meta-
analysis of comparative studies (102). The relatively low number of patients suitable for LLR 
and their heterogeneous pathologies is thought to be a major obstacle for the instigation of a 
RCT (94). The Orange II study, which compared open vs. laparoscopic left lateral 
sectionectomy for example was forced to close prematurely due to slow recruitment accrual 
(108). Its sister trial, the Orange II Plus study which investigates outcome differences 
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between laparoscopic vs. open major hepatectomies (right or left hepatectomy) is still 
recruiting patients. So far only one RCT investigating the differences in postoperative 
morbidity in open vs. laparoscopic liver resections for CRLM (Oslo-CoMet trial) has been 
completed and its results published (109). In this trial, patients undergoing LLR were found 
to have a lower complication rate and better quality of life after surgery.  
Laparoscopic resection was also shown to be more cost effective than open surgery. 
Although the costs of the operation were higher in the LLR group, this was more than 
compensated for by a decreased length of hospital stay. Other parameters of intraoperative 
performance such as operating time, blood loss and oncological resection margins were 
found to be equivalent between both types of surgery (109). The results of this RCT add to 
the steadily accruing evidence that LLR is safe in the right hands, has a positive impact on 
short-term patient outcomes and is non-inferior to open liver resection with regards to long-
term outcomes (98,99,102,109–111). 
1.2.4.1 Robotic liver resection 
Robotic surgery in the abdomen can perhaps best be described as a subcategory of 
laparoscopic surgery where the motion of surgical instruments is finely controlled by robotic 
limbs. The first report on a successful telerobotic operation, a cholecystectomy, was 
published 1997 (112). The aim of robotic surgery is to negate some of the inherent motor 
limitations of laparoscopic surgery such as limited range of movement, tremor magnification 
and the fulcrum effect against the laparoscopic port. An additional advantage is the ability to 
obtain a three dimensional view of the operating site which is thought to improve spatial 
awareness (113). Because the surgical robot is controlled remotely by a surgeon who is 
seated in front of a control module, these procedures were initially described as ‘telerobotic 
surgery’. Over time the terminology has been simplified into ‘robotic surgery’. 
A large variety of abdominal operations has been performed robotically including anti-reflux 
surgery, Heller myotomy, Roux-en-Y gastric bypass, and, more recently, colorectal surgery 
(114,115). The most enthusiastic and enduring uptake of the robotic approach however has 
occurred in prostate and gynaecological surgery (116). A recent meta-analysis comparing 
laparoscopic vs. robotic radical prostatectomy postulated a lower operative blood loss and 
improved outcomes in terms of continence and erectile function for the robotic approach 
(117).  
Robotic liver resection has been compared to LLR in a number comparative studies that 
found a comparable safety profile, similar short term outcomes but also an increased 
operating time (118–120). The disadvantages of robotic surgery in general are a steep 
learning curve, complete lack of tactile feedback and near prohibitive costs (114). Currently it 
remains unclear whether there is any added patient benefit when compared to laparoscopic 
procedures (114,121). Some advocates of robotic surgery argue that it is essentially an aid 
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to expand minimal invasive surgery to procedures that are too challenging to carry out via 
the standard laparoscopic approach (119,120).  
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1.2.5 Challenges in laparoscopic liver surgery 
Compared to other surgical specialties, the uptake of LLR has been relatively slow. This is 
thought to be due to concerns about the ability to control haemorrhage and to achieve 
complete oncological clearance (remove all cancer tissue)during LLR (102,122). Some 
surgeons are also reluctant to embark on laparoscopic resections because the acquisition of 
the necessary skills is associated with a steep learning curve (123–126). 
These concerns may be ultimately related to the inherent technical limitations of 
laparoscopic surgery. Potential patient benefits from a laparoscopic liver resection have to 
be balanced against these limitations that the surgeon must overcome in order to carry out 
the operation successfully. These disadvantages can perhaps be categorised into motor 
limitations (i.e. how to do something) and sensory limitations (i.e. we do not know what a 
structure is). Innovations in laparoscopic instruments and robotic surgery may be a possible 
solution to overcome the motor limitations of laparoscopic surgery but generally they do not 
address the sensory deficits. Of the 5 senses, vision is arguably the most important with the 
sense of touch coming second and the remaining three senses bearing relatively little 
importance. There are several limitations to both vision and touch in LLR or laparoscopy in 
general. The laparoscopic view is displayed in two dimensions (2D) and a limited field of 
view, which impedes spatial- awareness and orientation with subsequent effects on fine 
motor skills and interpretation of anatomy (127–131). The lack of haptic feedback (i.e. 
feeling tissue) has been well documented for laparoscopic surgery (128,132). An additional 
issue in LLR is that bi-manual palpation in conjunction with intraoperative ultrasound is 
important for the detection of liver lesions (33,133,134). It has therefore been postulated that 
recovering or perhaps even extending some of the lost sensory information could help in the 
location of vulnerable structures (e.g. blood vessels) and liver lesion during LLR. Improving 
identification of these structures and lesions would in turn lessen the risk of causing 
inadvertent damage or leaving pathological tissue behind. As an additional benefit, an 
enhanced sensory input may also improve the surgical learning curve associated with LLR 
(123). 
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Figure 1.6 Laparoscopic view during liver resection. 
Note how bleeding and line of sight occlusion from laparoscopic instruments (*) 
further impair the view. The transected liver tissue (transection plane – arrows) can be 
seen centrally whereas the liver surface (#) is visible on either side.  
 
The work in this thesis aims to explore methods of enhancing the sensory information during 
LLR by utilising optical imaging and computer vision. These technologies are based on 
functions of light and as such there are natural advantages of applying them in a 
laparoscopic environment because they can extract additional sensory data, not perceivable 
with the human eye directly through a laparoscopic camera (135,136). If additional 
equipment requires insertion into the abdominal cavity, this can usually be adapted to fit 
through laparoscopic ports without great difficulties (127,137,138). 
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1.3. Thesis hypothesis 
It is hypothesised that optical imaging and computer vision technologies have the ability to 
extract sensory information from the liver that is useful for guiding laparoscopic liver surgery. 
1.4. Objectives of the thesis 
1) To elucidate the ability of confocal laser endomicroscopy to characterise normal and 
pathological liver tissue 
2) To investigate how multispectral imaging may be applied to evaluate the 
composition of liver tissue and its implication on disease states. 
3) To develop and test a quantification method for motion magnified signals in video. 
4) To evaluate the feasibility of using a novel image guidance system for laparoscopic 
liver surgery in a clinical setting and assess its performance. 
In the following chapter the existing literature on in-vivo optical imaging and computer vision 
of the liver will be reviewed. 
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2. Literature review 
To better evaluate the current state of the art in optical imaging and computer vision of the 
liver in a laparoscopic environment, a systematic literature search that combined the terms 
“liver” and “laparoscopy” with optical imaging- or computer vision terms was performed using 
the Medline and Embase databases. Generic and mesh terms used for the search were, 
“optical imaging” and “image guided surgery”. A detailed description of the search strategy is 
outlined in the methods section under “electronic search strategy” below. To complement the 
initial search, each Medline search term indexed under “Diagnostic Techniques and 
Procedures” was screened for relevant optical imaging modalities and included as a 
separate search term if appropriate. 
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2.1. Introduction 
A background on liver surgery and laparoscopic liver surgery has been provided in the 
general introduction of this thesis. The introduction to this chapter focuses on providing 
background information on imaging modalities relevant to this work.  
The use of laparoscopic ultrasound (LUS) prior to parenchymal transection is recommended 
by some surgeons to identify liver lesions and delineate the hepatic vasculature during LLR 
(95,96,123,139,140). Once transection has started however the use of LUS is challenging 
and non-intuitive because it only provides 2D images which are difficult to interpret and do 
not offer much orientation within a 3D space. Additional limitation of LUS is that its 
diagnostic accuracy is decreased in the case of small or vanishing liver lesions or when 
background changes in the liver such as steatosis or cirrhosis are present (141–144). Finally 
it may be difficult to discriminate between benign or malignant liver lesions that are 
incidentally found on LUS and therefore the decision on whether to resect such a lesion 
depends on clinical judgment (134).  
The issues around anatomical orientation have led to research efforts into developing image 
guidance systems (IGS) that enable visualisation of 3D liver anatomy during LLR. Further 
research is directed at creating laparoscopic imaging modalities that enhance the 
visualisation of liver tissues with the intention of enabling surgeons to discriminate between 
different types or normal and pathologic liver tissues. These combined efforts can be 
regarded as an initiative to substitute for a decreased sensory input that is inherent to 
laparoscopic surgery, by enriching and maximising the data that is obtainable in the visual 
domain. Optical imaging and computer vision technology forms the foundation of the 
majority of emerging systems that are being developed to provide enhanced visualisation or 
image guidance (128,135,145). 
Medical optical imaging is an emerging non-invasive modality that is used in conjunction with 
endogenous or exogenous contrast agents. The latter, also known as fluorophores can be 
selected according to disease processes or tissue type of interest. This approach confers a 
high specificity which is unrivalled by conventional radiological imaging modalities. In 
contrast to X-Ray based modalities, optical imaging utilises non-ionising radiation to interpret 
information and transform them into images .i.e. light at visible and invisible wavelengths. 
The former mainly focuses on regular white light illumination whereas the latter includes 
ultraviolet, near-infrared and infrared light. This has the advantage that patients are not 
exposed to harmful radiation and therefore imaging can be repeated multiple times.  
Computer vision is closely related to optical imaging because it utilises image information in 
the visible light spectrum, usually in the form of video. The difference to conventional video 
or other forms of optical imaging is that processing and interpretation of these images is 
carried out by computer algorithms. This approach conveys the advantage of being able to 
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detect subtle details in a large volume of information or performing complex image analysis 
procedures that would be beyond the abilities of a human user.  
Some examples for optical imaging modalities are spectral imaging, laser microscopy, 
optical coherence tomography and fluorescence imaging all of which share common 
characteristics such as excellent spatial resolution, high specificity, real-time image 
processing, lack of ionising radiation and the wide availability of miniaturised equipment 
which facilitates its use in minimal invasive procedures. Most of these traits also apply to 
computer vision which is inherently related to optical imaging because they rely on the optics 
within camera and because they are frequently used in conjunction with other optical 
modalities (e.g. laser range scanner). Viewed within this wider context, computer vision can 
be referred to as an optical imaging modality for the purpose of this article. 
Technical background of common imaging modalities  
Microscopic fluorescence imaging 
Probe based confocal laser endomicroscopy (CLE) is a relatively well established 
microscopic fluorescence imaging technique that utilises a fibre-optic bundle to emit and 
receive light signals which are subsequently processed into µm-scale resolution images. 
Light emission is generated by a laser scanning unit that is situated at the proximal end of 
the fibre (i.e. further away from the tissue). The optical lenses required to focus the light at a 
specific imaging plane and to collect the resulting fluorescence emissions can be located at 
the distal or proximal end of the fibre. The former solution generally results in a more bulky, 
rigid endomicroscope design because the lenses have to be incorporated within the tip of 
the probe but this may be offset by a better image resolution (146). Systems that combine 
the laser scanning unit and optics at the proximal end of the fibre on the other hand enable 
use of miniaturised, flexible probes with a minimal diameter of between 0.3 mm whereas 
their rigid counterparts have a minimum diameter of 6.3 mm (147). Either design can readily 
be introduced through a standard laparoscopic port but flexible probes have also been 
deployed trans-gastric and trans–vaginally during natural orifice transluminal endoscopic 
surgery (148,149). To facilitate image acquisition via laparoscopic or natural orifice route, the 
probe is gently pressed on the area of interest with the resulting image visible on a screen in 
real-time. 
Generally fluorescence signals may originate from endogenous or exogenous fluorophores 
but in CLE imaging of the liver only the latter are of relevance (146). Fluorophores can be 
regarded as “contrast agents” that respond to illumination by emitting light at a specific 
wavelength. Most CLE systems are therefore designed to operate a single specific 
wavelength although more recently “dual wavelength” systems with the ability to 
simultaneously acquire images at two separate spectra of light have been developed (150). 
There is a plethora of fluorophores available but for CLE imaging of the liver fluorescein and 
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indocyanine green (ICG) have been employed most frequently. Both have the advantage of 
being licensed for clinical use and as an additional benefit, ICG is exclusively excreted into 
bile, a property which is desirable because it results in a strong and selective contrast in the 
biliary system and healthy parenchym (151,152). It has to be noted however that patients 
with congenital non-haemolytic hyperbilirubinemia (e.g. Gilbert’s and Rotor syndrome) may 
exhibit altered ICG fluorescence characteristics (153). 
Wide field fluorescence imaging 
Parallel to CLE imaging, fluorescence can also be used for the macroscopic visualisation of 
anatomical structures. To facilitate this, the laparoscope needs the ability to view a specific 
wavelength range that corresponds to the fluorophore(s) of interest. This is achieved by 
either filtering undesired wavelengths, using light sources tuned to a certain wavelength 
range or a combination thereof (144,151,152,154–156).  
Endogenous fluorophores have been used for controlling the effectiveness of photodynamic 
therapy in the peritoneum and liver (157) and they are a viable source of fluorescence in 
some organs (158). For hepatic imaging however exogenous fluorophores including 
methylene blue, fluorescein conjugated bile acids and ICG are preferred for experimental 
use (151,154,159). Out of these only ICG has been evaluated clinically so far, most likely 
due to the same above mentioned reasons that made it a popular fluorophore for CLE 
imaging of the liver. 
Multispectral imaging 
The absorption of light within the visible and invisible spectrum can be altered by 
pathological processes that affect cellular composition or tissue structure (160). This effect 
can also be exploited to obtain anatomical and physiological information that is subsequently 
transformed into images. Although there are variations in the names attributed to this 
methodology such as hyperspectral-, multispectral- or narrow band imaging, the basic 
principle remains the same. Tissues are illuminated at one or more specific wavelengths and 
the amount of absorbed and reflected light can consequently be used to infer its 
composition. In contrast to fluorescence imaging and CLE this modality is frequently used 
with endogenous fluorophores. In this context haemoglobin and tissue oxygenation have 
been widely studied but other substances such as fat, water or bile can also be quantified in 
absolute or relative terms (137,161–163). It is possible to obtain information on particular 
tissue components using a single spectrum but the simultaneous or sequential acquisition of 
multiple spectra has the potential to reflect tissue composition in greater detail. 
Enhanced white light vision 
Traditionally laparoscopic vision relies on a monocular scope that views the surgical site at a 
0˚ or 30˚ angle. Regular vision has been improved by the introduction of digital video, 
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automatic focus, and high definition video (164). Above and beyond imaging modalities that 
utilise magnification or invisible spectra of light, there may be an advantage in enhancing the 
laparoscopic view within the visible spectrum. This may be achieved by increasing the 
laparoscopic angle of view through the use of wedge prism (165). A completely different 
approach is to improve the mobility and versatility of laparoscopic equipment by 
amalgamating laparoscope, instrument port and laparoscopic screen into one single piece of 
equipment (166).  
The most widely used example of enhanced white light vision in minimal invasive surgery is 
stereoscopic- or 3D laparoscopy. It is well established that lack of tactile feedback and depth 
perception are the two major drawbacks of laparoscopic surgery. Since stereoscopic vision 
is the main contributor to depth perception, it is unsurprising that the introduction of 3D 
laparoscopy has been repeatedly attempted in the past. Unfortunately previous attempts of 
introduction have been hindered by concerns about cumbersome equipment that induced 
dizziness, fatigue and headaches in the surgical users (167). Driven by the entertainment 
industry, stereoscopic or 3D technology has greatly matured over the last decade and is now 
employed in a number of commercially available laparoscopy systems that do not suffer 
from the disadvantages of their predecessors (137). The laparoscopic camera itself differs 
from its conventional counterparts in that it has two separate, slightly set apart video 
channels instead of one. The right and left video channel are only shown to the 
corresponding eye of the surgeon which creates an effect that simulates true 3D vision to 
the human visual cortex (168). 
Intraoperative image guidance 
A common limitation of optics and vision based approaches is their short penetration depth 
which rarely exceeds 5mm (144). This restriction may be overcome with the use of image 
guidance systems (IGS) where optical technology can be used to project or display 
anatomical data from preoperative scans integrated into the operative site. Use of IGS in 
LLR is particularly appealing because the display of the highly variable vascular and tumour 
anatomy may aid in identifying tumour dimensions, vascular and biliary structures (169,170).  
An IGS is based on three essential components, a 3D model, positional tracking and 
intraoperative registration. Initially a 3D representation of the individual patient anatomy 
(henceforth called 3D model) is created from CT or MRI images. Positional tracking is a 
method that enables the spatial correlation of patient anatomy, surgical view and/or surgical 
instrument. The most frequently employed tracking methods in image guided surgery are 
based on optical markers or electromagnetic signals. Both technologies are in routine clinical 
use and have been extensively investigated (128). For this reason, articles reporting solely 
on the use of optical marker tracking have not been included in this review. Finally the 
precise alignment of 3D model and patient anatomy is carried out in a process called 
registration. It is unsurprising that various methods of registration have been proposed as it 
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is by far the most error-prone and difficult component of an IGS (128,141). Optics and 
computer vision based registration concepts are popular because they offer advantages in 
terms of excellent spatial resolution, high update frequency, lack of invasiveness, 
comparatively low costs, portability and are relatively easy to integrate into existing operating 
equipment (141,171,172). Other non-optical solutions for registration exist (e.g. LUS or MRI 
based) but will not be discussed as this is beyond the scope of this review. 
Although IGS are currently widely used in neurosurgery, orthopaedic surgery and 
otolaryngology, the development of solutions for abdominal surgery has been slow (173). 
The main obstacles preventing a meaningful implementation of this technology are the 
significant mobility of abdominal organs, lack of fixed bony landmarks for orientation and 
cyclical organ motion secondary to diaphragmatic and cardiac movement (141,173,174). 
Further difficulties that have to be addressed by IGS for hepatic surgery are the paucity of 
liver surface features, the inability of viewing the complete organ with a laparoscope and the 
significant deformation that the liver undergoes due to the increased intraabdominal 
pressure from the pneumoperitoneum and surgical manipulation (174).  
Because of these latter issues, AR solutions for retroperitoneally fixed organs such as the 
pancreas or kidney are thought to be somewhat simpler (173). Despite these difficulties, 
researchers have keenly pursued the advancement of AR for LLR because the innate 
drawbacks of laparoscopy such as lack of touch, depth perception and orientation are 
thought to be main factors in delaying the uptake of the laparoscopic liver surgery in the 
international community (122). 
The aim of this systematic review is to provide a comprehensive overview of the potential 
and limitations of minimal invasive optical imaging technology that has been evaluated on 
the liver. To ensure immediate- to mid-term clinical relevance, this review focuses 
exclusively on modalities that have been tested in in-vivo experiments or clinical studies. 
Finally a number of promising optical imaging concepts that have not advanced to this stage 
yet are discussed and key areas for future research focus are highlighted. 
2.2. Methods 
A systematic literature search that included the free text and corresponding controlled 
vocabulary terms for “liver” and “laparoscopy” combined with those for optical imaging,  
computer vision terms, or  “image guided surgery” was performed using the Medline and 
Embase databases. A detailed description of the search strategy is stated in Appendix 1. To 
complement the initial search, each Medline search term indexed under “Diagnostic 
Techniques and Procedures” was screened for relevant optical imaging modalities and 
included as a separate search term if appropriate. 
Full text articles, conference proceedings and conference abstracts describing in-vivo basic 
science or clinical research on optical imaging modalities in laparoscopic liver surgery or 
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laparoscopic liver ablation were retrieved. The time period for article retrieval was set to 15 
years from June 2001 to June 2016. In total 750 articles were identified and their titles and 
abstracts were subsequently screened for inclusion. The reference flow is outlined in Figure 
2.1. 
Exclusion criteria were image guidance based on non optical methods (e.g. CT), image 
guidance for radiotherapy purposes, ex-vivo research, non-primary research and articles not 
written in English. Articles reporting on imaging in open liver resection or laparoscopic 
cholecystectomy were excluded as well. Screening of the titles and abstracts of retrieved 
references was carried out by the author.  
Full texts for eligible articles were retrieved and read. A qualitative summary of the findings 
is given in the results section. Due to the heterogeneous nature of available research no 
quantitative analysis or meta-analysis could be conducted. 
2.2.1 Electronic search strategy 
Given below is a list of search terms and Boolean operators used for conducting a 
systematic review of optical imaging technology in laparoscopic liver surgery. 
Pubmed 
#1 ("Surgery, Computer-Assisted"[Mesh:NoExp] 
#2 "Optical Imaging"[Mesh] OR Optical imaging* 
#3 fluorescence imaging* OR autofluorescence imaging* 
#4 "Spectroscopy, Near-Infrared"[Mesh] OR NIR Spectroscop* 
#5 NIR spectrometr* OR near-infrared Spectrometr* OR Near Infrared Spectrometr* OR 
near-infrared spectroscop* OR near infrared spectroscop* OR infrared spectroscop* OR 
"Photoelectron Spectroscopy"[Mesh] OR photoelectron spectroscop* OR "Spectrometry, 
Fluorescence"[Mesh] OR spectrophotometr* OR spectrofluo* OR fluorescence spectroscop* 
OR "Spectrophotometry"[Mesh] OR spectrophotometr* OR spectroscopic photometry OR 
"Spectrum Analysis, Raman"[Mesh] OR Raman Spectroscop* OR Raman Scatter* OR laser 
raman spectroscop* OR raman resonance spectroscop* OR Absorption spectroscop* OR 
diffuse reflect* OR spectroscopy reflect* OR ellipsometry OR fluorescence correlation 
spectroscop* OR scanning fluorescence correlation spectroscop* OR infrared spectroscop* 
OR ir spectroscop* OR transmission infrared spectroscop* OR fourier transform infrared 
spectroscop* OR near infrared reflect* OR near-infrared reflect* 
#6 "Microscopy, confocal"[Mesh] OR confocal microscop* OR laser scanning microscop* OR 
laser microscop* 
#7 "Intravital microscopy"[Mesh] OR Intravital Microscop* OR in vivo microscop* 
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#8 "Microscopy, Fluorescence"[Mesh] OR fluorescence microscop* OR 
Immunofluorescence microscop* 
#9 "Microscopy, Interference"[Mesh] OR phase contrast microscop* OR interference 
reflection microscop* OR interferometry* OR interference microscop* OR  
microinterferometry* OR differential Interference Contrast microscop* OR nomarski 
interference contrast microscop* 
#10 "Microscopy, Polarization"[Mesh] OR polarized light microscop* OR polarization 
microscop* 
#11 "Microscopy, Ultraviolet"[Mesh] OR Ultraviolet Microscop* 
#12 "Photoacoustic Techniques "[Mesh] OR Photoacoustic* OR Optoacoustic* 
#13 "Stroboscopy"[Mesh] OR Stroboscop* 
#14 "Holography"[Mesh] OR Holography 
# 15 image guided surger* OR image guidance* OR image guided* OR Image-guided* 
#16 "Artificial Intelligence"[Mesh] OR artificial intelligence* 
#17 computer vision* OR machine vision* 
#18 surface reconstruction* 
#19 3D laparoscop* OR three dimensional laparoscop* OR three-dimensional laparoscop* 
#20 virtual reality* OR augmented reality* 
#21 hyperspectral* OR multispectr* 
#22 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or 
#15 or #16 or #17 or #18 or #19 or #20 or #21 
#23 "Laparoscopy"[Mesh] OR laparoscop* OR peritoneoscop* OR celioscopy OR 
peritoneoscop* OR celioscop* 
#24 "Robotic Surgical Procedures"[Mesh] OR robotic surgery OR robotic surgical procedure* 
OR robotic surgery OR robotic assisted* OR robot surgery OR robot assisted surgery 
#25 #23 or #24 
#26 #22 and #25 
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Embase 
#1 spectrometry/ OR (Raman Spectr* OR Raman Scatter* OR laser raman spectr* OR 
raman resonance spectr*).af. 
#2 exp holography/ OR (hologra*).af. 
#3 exp fluorescence imaging/ OR  (Optical imaging* OR fluorescence imaging* OR 
autofluorescence imaging*).af. 
#4 (hyperspectral* or multispectr*).af. 
#5 (intravital microscop* OR in vivo microscop*).af. 
#6 exp confocal microscopy/ OR (confocal microscop* OR laser scanning microscop* OR 
laser microscop*).af. OR exp fluorescence microscopy/   OR (fluorescence microscop* OR 
Immunofluorescence microscop*).af. 
#7 exp phase contrast microscopy/  OR (phase contrast microscop* OR interference 
reflection microscop* OR interferometry* OR interference microscop* OR  
microinterferometry* OR  differential Interference Contrast microscop* OR nomarski 
interference contrast microscop*).af. 
#8 exp polarization microscopy/ OR (polarized light microscop* OR polari* microscop*).af. 
#9 (ultraviolet microscop*).af. 
#10 exp stroboscopy/ OR (Stroboscop*).af. 
#11 exp photoacoustics/ OR (Photoacoustic* OR Optoacoustic*).af. 
#12 *computer assisted surgery/ OR (image guided surger* OR image guidance* OR image 
guided* OR Image-guided*).af. 
#13 exp virtual reality/ OR (virtual reality* OR augmented reality*).af. 
#14 exp artificial intelligence/ OR (artificial intelligence* OR computer vision* OR machine 
vision* OR surface reconstruction*).af. 
#15 (3D laparoscop* OR three dimensional laparoscop* OR three-dimensional 
laparoscop*).af. 
#16 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or 
#15 
#17 exp laparoscopy/ OR exp robot assisted surgery/ OR (laparoscop* OR peritoneoscop* 
OR celioscop* OR robotic surg* OR robotic surg* procedure* OR robotic assisted*).af. 
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#18 exp liver/ OR exp liver surgery/ OR (liver OR hepat*).af. 
#19 #17 and #18 
#20 #16 and #19 
 
2.3. Results 
  
Figure 2.1 Flowchart showing the selection of relevant articles for the literature review 
 
2.3.1 Optical imaging 
Microscopic fluorescence imaging 
Use of CLE has been shown to enable visualisation of liver anatomy and physiology at a 
microscopic level, with a lateral resolution ranging between 0.7-3.5µm and a maximum 
imaging depth of 0-350µm (147,175). Some systems allow the user to adjust the imaging 
depth which raises the potential for 3D reconstruction of tissue volumes (146). This imaging 
modality has previously been termed” virtual histology” due to its ability to not only visualise 
liver lobules, microscopic vasculature and bile ducts but also individual hepatocytes and 
stroma cells. In addition to static histological details, physiological parameters such as blood 
flow velocity and cell apoptosis have also be observed (176,177). Large animal studies have 
demonstrated the feasibility of laparoscopic use (148,149). One group has employed CLE 
imaging in the near-infrared (NIR) and blue light spectrum during mini-laparoscopy to 
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diagnose and quantify liver steatosis and cirrhosis in patients (Figure 2.2). Taking into 
account variations due to different imaging wavelengths and pathologies, a good diagnostic 
correlation with histopathology of 81-90% was demonstrated (177,178). The use of CLE for 
the clinical evaluation of hepato-biliary malignancy has until recently been restricted to 
endoscopic retrograde cholangio- pancreatography based diagnosis of biliary cancer (179).  
The “Persee Project” aims to transfer this technology to a laparoscopic setting by 
demonstrating the use of CLE to diagnose malignancy on peritoneum, lymph nodes and 
abdominal organs including the liver (180,181).  
To maximise the CLE’s real-time potential, this group uses an audio-visual conference with a 
pathologist which enables them to receive immediate feedback in-vivo images.  
 
Figure 2.2 CLE visualisation of normal and steatotic liver. 
a) normal hepatic architecture in healthy human liver, dark intracellular structures 
represent nuclei b) mixed micro & macrovesicular fat inclusions in liver steatosis 
(177). (reprinted with permission from Elsevier, copyright 2010) 
 
To achieve good quality images, a stable contact needs to be made with the tissue of 
interest, ideally at a 90˚ angle while exerting constant pressure to prevent slippage. 
Conversely excessive pressure may reduce microcirculation and thus impair fluorescence 
signals in some organs. To view larger areas of tissue, a smooth and finely controlled motion 
of the CLE probe tip has to be asserted. Addressing all these requirements during 
laparoscopy can be technically challenging (182). Robotic control of the CLE probe or the 
use of a modified intravascular steerable catheter, have been proposed as a possible 
solution to this issue (150,175). A further drawback of CLE is its small field of view which for 
flexible CLE probes rarely exceeds 600µm2 (146,175). A technique called mosaicing can 
enhance the field of view by incorporating multiple adjacent images together into one larger 
image (175).  
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Of all the imaging modalities discussed in this review, CLE has the highest resolution and 
magnification, thus allowing visualisation of cellular and sub-cellular details. Another 
advantage is that a clinically licensed, commercial solution exists. Although licensing is 
currently restricted to luminal endoscopy, the probes can be sterilised to a surgical standard 
which makes a transfer to a laparoscopic application simple (150,183). The main challenge 
to laparoscopic application consists of providing a technical solution that will allow controlled 
and stable acquisition of images in a meaningful field of view and a reproducible method of 
objectively evaluating CLE images. 
Wide field fluorescence imaging 
One of the first groups to investigate wide field fluorescence imaging of the liver used a 
rabbit model to demonstrate that fluorescein conjugated bile acids elicit selective 
fluorescence in hepatocytes and bile ducts with the latter being easy to distinguish from 
blood vessels (151). A non-bolus injection of methylene blue reduces the risk of adverse 
events and in combination with ICG provides good delineation of bile duct anatomy in a 
porcine model. The drawback of using this combination of fluorophores is that repeat 
imaging is difficult because ICG causes strong and prolonged background fluorescence in 
the liver (184). For single fluorophore use, laparoscopic ICG-mediated fluorescence imaging 
(LIFI) has been investigated extensively in experimental and clinical studies. Its advantages 
are rapid hepatic uptake, exclusive biliary excretion and a good safety profile (151). ICG has 
been routinely used for decades to test the preoperative hepatic function (185). Due to its 
propensity of exhibiting residual fluorescence around hepatocellular cancer and liver 
metastasis for up to two weeks, any patient who underwent hepatic function testing can 
potentially undergo LIFI without requiring additional medication (133,152). The emission 
peak for ICG and methylene blue are in the near-infrared range around 800nm and 700nm 
wavelength respectively. In contrast the emission peak of fluorescein and its derivates is 
within the visible light spectrum at around 520nm. 
To the best of our knowledge, only ICG has been studied clinically in the context of 
laparoscopic fluorescence imaging. So far four indications for its clinical application have 
been proposed, namely: the identification of liver malignancy, visualisation of bile ducts, 
delineation of liver segment borders, and as a test for bile leaks. ICG exhibits a selective 
uptake by hepatocytes which results in enhanced fluorescence throughout perfused liver 
tissue (159,186). Excretion into bile starts almost immediately and can last for up to 20 hours 
(187). It has been well documented however that this behaviour deviates in the presence of 
primary and secondary liver malignancy. Hepatocellular carcinoma can either appear as an 
area with globally increased fluorescence intensity or as a rim enhancing lesion (Figure 2.3). 
This phenomenon is thought to be related to the grade of malignant differentiation because 
high grade HCC cells can take up ICG via membrane transport proteins that are also found 
in normal hepatocytes but at the same time they cannot excrete ICG due to concomitant 
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biliary excretion disorders. In contrast to this finding, low grade HCC cells often seem to lack 
the required transport proteins to take up ICG and are therefore more likely to exhibit a rim 
enhancing fluorescence that is also seen with secondary liver metastasis (188). Rim 
enhancing type fluorescence (Figure 2.3) is purportedly caused by pressure induced biliary 
excretion disorders in normal hepatocytes that are adjacent to a liver lesion (189). Based on 
the knowledge of fluorescence patterns, liver lesions can be localised during LLR. In some 
cases this may reveal additional lesions which were not visualised on preoperative CT or 
LUS with subsequent implications on patient management (144,190). One study of 12 
patients comparing preoperative CT and MRI and intraoperative LUS and LIFI reported that 
LIFI had the best sensitivity (190). Another potential benefit of this technique is the 
identification of malignancy on the background of altered liver tissue (e.g. previous RFA) 
which may be difficult to visualise on conventional white light laparoscopy (133). Sensitivity 
is probably related to distance from the surface and lesion size with smaller and deeper 
lesions being harder to detect. One group reported detection of lesions up to 8mm from the 
surface and down to a size of 3mm (152).  
  
Figure 2.3 ICG fluorescence of HCC on LIFI. 
a) HCC exhibiting fluorescence throughout the lesion b) HCC exhibiting rim 
enhancing fluorescence (189). (reprinted with CC BY-NC 4.0 from Wiley) 
 
Fluorescence based imaging of bile ducts has mainly been studied with the aim of 
delineating common bile duct (CBD) anatomy during laparoscopic cholecystectomies but its 
utility for LLR and laparoscopic liver cyst fenestration has also been investigated (191–194). 
During laparoscopic cyst fenestration bile ducts may be severely displaced secondary to 
cyst growth. Utilisation of fluorescence imaging enables visualisation of common bile duct 
(CBD), hepatic ducts and smaller bile ducts in the vicinity of liver cyst a feature which may 
aid surgeons in avoiding inadvertent injury to these structures. One group investigating ICG 
mediated fluorescence imaging in 24 patients undergoing LLR demonstrated that all 
surgically relevant bile ducts could be visualised. Because anatomical guidance can be 
provided in real-time throughout parenchymal transection, this modality may be more 
valuable for LLR than for laparoscopic cholecystectomy, where it is mainly employed prior to 
dissection (191). 
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Postoperative bile leak is a relatively common complication of liver resection and a cause of 
major morbidity. Detection of bile leaks with standard laparoscopy is difficult because bile is 
frequently mixed with blood, making its distinctive green-yellow colour harder to detect (195). 
To enhance detection of bile leaks one group injected diluted ICG into the cystic duct and 
observed any resulting signs of increased fluorescence at the liver resection surface. If 
leakage was observed an abdominal drain was placed in the proximity of the resection 
surface (196). Other groups advocated suture repair of detected bile leaks (197) or 
employed naso-biliary drains for injecting ICG into the biliary system. In contrast to 
radiographic cholangiography, ICG cholangiography may be more attractive because it 
saves time and does not carry a risk of bile duct injury secondary to insertion of a 
cholangiogram catheter (191). 
Anatomical hepatic resection may offer advantages in terms of preserved hepatic volume 
and improved recurrence rates in HCC but is technically more challenging than carrying out 
atypical resections or major hepatectomies (73). LIFI has been proposed as a method of 
delineating liver segment anatomy intraoperatively. Fundamentally there are two different 
approaches called positive and negative staining which are respectively based on either 
increasing or decreasing fluorescence intensity in the segment of interest. Positive staining 
provides clearer delineation of segmental borders but is technically more challenging 
because it requires injection of ICG into the segmental portal vein branch (198). This may be 
facilitated by LUS probes that have a channel for guiding needle insertion (159,186). 
Alternatively, selective arterial cannulation of segmental branches via a percutaneous 
approach from the femoral artery may be an option for positive staining but this has so far 
only been demonstrated in an animal model (198). For negative staining protocols the 
segmental vessels are clamped and subsequently ICG is injected systemically which leads 
to strong fluorescence intensity in all remaining segments (159). Although methylene blue 
has historically been used for positive staining in open liver resection, it is less practical for 
laparoscopic surgery because simultaneous clamping of the segmental artery is required to 
avoid fluorophore washout (159). 
An important technical consideration when employing LIFI is the time of systemic ICG 
injection because this will strongly impact on how fluorescence is observed. For visualisation 
of bile ducts and bile leaks an injection time of at least 20-30 minutes prior to imaging has 
been proposed (191) because ICG excretion into bile starts within minutes and peaks 
around two hours (133). As outlined above, fluorescence related to malignancy can be 
observed within a two week timeframe (133,152,197) but opinions about the optimal 
injection time vary between authors (133,144). Simultaneous imaging of biliary anatomy and 
liver malignancy is not feasible because ICG injections immediately before surgery can lead 
to high fluorescence intensity in both normal liver and tumours (133). 
The concept of LIFI has become more user friendly over recent years with commercial 
products becoming widely available (144,152,193). One solution allows swift change 
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between standard white light and NIR fluoroscopy (144) whereas another system employs 
an overlay display function that integrates white light and NIR spectra into the same image 
(193,199). An important limitation to consider is that penetration depth is thought to be in the 
range of 5mm (144). Deeper lying lesions may be visualised but sensitivity is probably 
decreased (152). 
Multispectral imaging 
A variety of technical solutions has been developed to facilitate laparoscopic multispectral 
imaging (LMSI) of the liver, with no single system being popularised over another so far. 
One of the more complex approaches is the utilisation of a liquid crystal filter which offers a 
spectral range of 650-1100nm. In their study a principal component analysis was carried out 
to establish the variations in absorption profiles between the different anatomical structures 
in a porcine model. The bile duct for example exhibited absorption peaks that could be 
attributed to water and fat whereas in contrast the hepatic artery had absorption peaks 
attributed to oxygenated haemoglobin and water. With this information it was possible to 
enhance image contrasts based on the underlying chemical mixture thus enabling 
visualisation of hepatic artery, portal vein and common bile duct without prior dissection of 
the hepatoduodenal ligament (155). (Figure 2.4) 
 
Figure 2.4 LMSI of the hepatoduodenal ligament in a porcine model.  
The three different gray levels are based on specific absorption spectra for 
oxygenated haemoglobin in the hepatic artery (B - light); oxygenated and 
deoxygenated haemoglobin in the portal vein (C - gray); lipids and water in the 
common bile duct (D – dark) (200). (reprinted with permission from Elsevier, copyright 
2008) 
 
Spectroscopic autofluorescence was successfully used in a patient to demarcate a recurrent 
HCC from surrounding cirrhotic liver tissue. Illumination in the blue spectrum was shown to 
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reveal decreased autofluorescence and haemoglobin associated absorption within the 
tumour (156). The detection of bile leaks may be facilitated by a commercial narrow band 
LMSI system focused at a single spectrum of 415-540nm. Bile may be difficult to detect 
because it is mixed with blood but at this spectrum red substances are filtered from view, a 
feature which enabled surgeon to clearly identify bile as yellow fluid (195). Away from 
classical areas of surgical therapy there has been interest in utilising laparoscopy for the 
diagnosis of chronic liver disease (177,178). One group has evaluated single fibre NIR 
spectroscopy to evaluate liver fibrosis using diffuse reflectance- and fluorescence 
spectroscopy in a laparoscopic rat model. In contrast to the other LMSI systems described 
above however a direct contact between probe and liver tissue is required. Higher levels of 
fluorescence and diffuse reflection were found to correlate with increasing levels of liver 
fibrosis with the latter parameter proving to be more effective. Fluorescence and diffuse 
reflection changes were hypothesised to be caused by alterations in NADH and elastin 
concentration and structural tissue changes respectively (160).  
Enhanced white light vision 
In an attempt to increase the field of view of a laparoscopic camera, one group reported on a 
custom made design which was characterised by a wide angle view endoscope system with 
two wedge prisms. This setup enabled visualisation of almost the entire liver surface in a 
single field of view during a porcine experiment (165). It was hypothesised that a larger field 
of view may result in improved visualisation within a confined surgical space. 
Advances in optical technology are not limited to improving intraoperative imaging but 
instead can be employed to miniaturise laparoscopy systems which may positively impact on 
versatility, mobility and cost effectiveness. An article describing a system that integrated 
camera port, working port and laparoscopic monitor in one piece of equipment was 
previously published. In their article the authors described the feasibility of employing this 
single port, battery powered system for a liver biopsy in a large animal study.  
In addition to decreased invasiveness, portability and lower costs, the system was claimed 
to have ergonomical advantages over conventional laparoscopic setups because it enabled 
in-line working by aligning monitor, surgical work space and instrument along the same axis 
(Figure 2.5) (166).  
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Figure 2.5 Amalgamation of laparoscopic- camera, port and monitor in a single piece 
of equipment (166). (reprinted with permission from IEEE, copyright 2010) 
 
The reports on 3D laparoscopy in liver surgery have been in the main, limited to case reports 
and case series which have studied its application to liver cyst excision, the Glissonian 
approach and to extended right donor hepatectomy (192,201,202). Anecdotally it was found 
that stereoscopic vision enhanced precision and speed of dissection. One of the authors 
hypothesised that 3D laparoscopy was particularly useful in advanced laparoscopic 
manoeuvres such as suturing and knot tying (202). In a recent case-control study a historic 
patient group of conventional LLR’s was matched with LLR’s that were carried out with the 
aid of a 3D laparoscope. In this article it was demonstrated that utilisation of 3D laparoscopy 
lead to significantly reduced operating times. No adverse effects on the surgeon were found 
and an influence of the learning curve effect was felt to be unlikely since all procedures were 
carried out by a single expert for laparoscopic liver surgery within a four year period (203). A 
summary of selected optical imaging modalities is shown in Table 2.1. 
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Technology Application Maturity Resolution 
(max) 
Imaging 
depth (max) 
probe based 
confocal laser 
endomicroscopy 
Diagnosis: malignancy; 
steatosis; fibrosis 
clinical 
study 
1024x1024 350µm 
Wide field 
fluorescence 
Locate: malignancy; bile leaks 
Visualise anatomy: Bile ducts; 
Liver segments  
clinical 
licence 
HD ≈5mm 
Multispectral 
imaging 
Locate: malignancy; bile leaks 
Visualise anatomy: Bile ducts; 
blood vessels 
Diagnosis: Fibrosis 
preclinical 
study 
clinical 
licence 
(narrow 
band) 
HD ≈5mm 
3D laparoscopy Reduce operating time 
Improve laparoscopic learning 
curve 
clinical 
licence 
HD surface only 
Table 2.1 Summary of selected optical imaging modalities. 
 
2.3.2 Intraoperative image guidance 
Intraoperative image guidance is based on three key components or processes which are: 1) 
3D modelling and planning - to create a virtual representation of individual patient anatomy 
2) registration and tracking - to align “virtual” and real anatomy and 3) Visualisation - to 
make the information interpretable to the surgeon. Optical technology mainly contributes to 
registration and tracking but in order to provide a comprehensive overview of intraoperative 
image guidance, the other two processes are covered here as well. The usefulness of 
intraoperative image guidance does heavily depend on the quality of the registration which 
can be expressed as accuracy. As an understanding of accuracy is essential for comparing 
the performance of different image guidance systems, the methodology for accuracy 
analysis and the accuracy results reported from relevant research groups are also 
highlighted in this section. 
Registration 
To facilitate registration it is necessary to obtain geometrical liver features during surgery 
that can be precisely aligned with corresponding features on the 3D model. These features 
may consist of only a handful of points or they may represent a complete surface 
representation of the liver (141). In optics or vision based IGS, an approach called surface 
reconstruction is used which entails the acquisition of intraoperative liver surface points 
68 
 
which are subsequently used to reconstruct geometrical features that will allow a registration 
to the preoperative 3D model (135). 
Initial attempts at recording the liver surface where made with devices that use laser beams 
and their reflections to obtain the structure of solid objects. The basic structure of these 
devices is a source that emits laser beams which are reflected from the liver surface and a 
camera that records and measures the distances of the reflected beams (204). During 
robotic surgery in a porcine model, an IGS based on a laser range scanner (also called laser 
pointing endoscope) has demonstrated its capability of acquiring up to 50 surface points/cm2 
at a rate of 5-6 frames per second. One group demonstrated that these characteristics could 
be used to obtain live updates on liver deformation which facilitated subsequent overlay of a 
3D model onto live video data (205). This approach has been successfully applied to a 
commercial IGS for open hepatic surgery (141) but because its bulky design seriously 
disadvantages laparoscopic deployment, no further studies on its use in LLR have been 
made for over a decade (206). Although this concept has recently been refined and 
employed in an ex-vivo study (127), it has not been applied to LLR in patients yet.  
The visual assessment of the liver anatomy may be used as a simplistic but highly 
translatable method of surface reconstruction. This may be based on the subjective 
identification of corresponding anatomical liver landmarks which allows surgeons to 
manually align 3D model and in situ anatomy (207). For some IGS the registration can be 
done automatically with an algorithm that computes the optimal 3D model position by 
minimising the distance between in situ and virtual landmarks (143,171). In the latter studies 
an optically tracked stylus is used to assign a few landmarks per patient but this approach 
may also be employed to obtain several hundred landmarks in a dense area. This data can 
subsequently be transformed into a surface representation of the liver which enables a 
registration based on the alignment of surfaces instead of singular points (141). 
The camera optics integrated within a laparoscope form the corner stone of any 
laparoscopic or robotic surgical procedure. It is therefore an attractive prospect to utilise 
computer vision techniques to facilitate surface reconstruction. Different methods have been 
proposed, but the only approach that has been investigate in vivo, makes use of a 3D 
camera also known as a stereoscope. This method also known as stereoscopic surface 
reconstruction (SSR) utilises the individual right and left video channels to triangulate points 
on the liver surface (Figure 2.6). These points are subsequently amalgamated together into 
a point cloud that represents the liver surface. A well established process called iterative 
closest point (ICP) matching is subsequently used to find the optimal alignment position 
between 3D model and intraoperative point clouds. Intensive research and development has 
matured SSR and ICP technology to a stage where it can be applied to laparoscopic video 
feeds in real-time (208). Stereoscopic camera systems are an essential component of SSR 
and have been first introduced to the field of minimally invasive surgery with the arrival of the 
DaVinci™ surgical robot (135). Because SSR can be adapted to work with any type of 
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stereoscope, it is anticipated that the more recent commercialisation of high definition 3D 
laparoscopes (129) will make this form of IGS even more accessible to the surgical 
community. 
 
Figure 2.6 Principle of stereoscopic surface reconstruction.  
Viewing the same point through two different spatially fixed video channels allows 
calculation of the point-to-camera distance (135).  (reprinted with permission from 
Springer, copyright 2012) 
 
The first published report on SSR of the liver investigated a computational model of surgical 
liver deformation. In this first instance stereoscopic video data was retrieved and evaluated 
in a retrospective fashion (209). Real-time application of SSR was first reported in a porcine 
model with the aim of developing an AR environment that integrates LUS and 3D video 
images within the same display. The spatial correlation of LUS and video images was 
facilitated by employing optical tracking markers on a rigid LUS probe and a stereo-
laparoscope (210). 
Tracking 
It has been purported that factors contributing to poor registration are inaccuracies 
secondary to tracking, internal camera configuration, organ motion and soft tissue 
deformation (211). Errors from optical tracking are minimal (210) but this modality requires a 
free line of sight which is not always achievable during surgery and can only be used in 
conjunction with rigid instruments or cameras. Electromagnetic tracking does not suffer from 
this restriction but it is more difficult to implement as a tracking sensor has to be integrated in 
the tip of the camera. A novel approach to tracking uses an ICP matching based technique. 
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With the aid of a stereo-laparoscope, an intraoperative liver surface point cloud is matched 
to the most likely corresponding locations on a point cloud from the preoperative 3D model. 
Because specific video frames and point cloud locations are co-registered, it is possible to 
estimate the laparoscope position in relation to the 3D model. This method currently has 
only been functional for static scenes and furthermore it has been shown that ICP tracking is 
inferior to optical tracking or a combination of ICP and optical tracking which achieved the 
best results (129). A robust calibration process is used to adjust the IGS to negate errors 
caused by the internal camera optics configuration. 
Imaging accuracy 
Although the number of reports on new methods to image guided surgery in LLR has 
significantly increased over the last few years, many groups have only presented minimal 
data on imaging accuracy or completely neglected this aspect (143,171,212). Accuracy also 
called the target registration error (TRE) and stated in millimetre (mm) is a measure of how 
well the 3D model represents in-vivo anatomy. There is no consensus on what the limits for 
an acceptable TRE are but it has been advocated that it should be guided by surgical need. 
Some authors have purported that a TRE of 3-5mm is sufficient but it is crucial to verify this 
assumption in clinical practice (213,214).  
It is however important to consider that if a TRE for a certain IGS is known than this will give 
the surgeon the opportunity to increase his resection margin based on this knowledge. For 
other, less forgiving IGS applications such as intracranial surgery a TRE of several mm 
would be less acceptable (141). The methodology of TRE assessment employed by different 
groups has varied widely. In one approach used for VR based IGS, the geometrical 
constellation of intraoperatively acquired anatomical landmarks (141,171,215) or mesh of 
surface points (141,206) is compared to the constellation on the 3D model. This method 
does not actually analyse discrepancies of spatial coordinates between the in-situ and virtual 
space but rather analyses each space individually. As such it can perhaps be regarded as a 
reflection of intraoperative soft tissue deformation rather than an absolute measure of 
accuracy. In AR based IGS, accuracy assessment appears more intuitive as it can be 
subjectively appreciated subjectively when viewing the discrepancy between laparoscopic 
view and superimposed 3D model. For objective TRE evaluation one group has proposed to 
measure the distance between corresponding landmarks on the laparoscopic view and the 
3D model, using a mesh of points that represent the liver surface in-situ (174,216). In this 
scenario the position of landmarks on the laparoscopic video can be regarded as the gold 
standard because without a measurable TRE both the real organ and 3D model should 
match each other perfectly. A better gold standard maybe provided by direct comparison to 
intraoperative surface points that are obtained via a CT scan or a laser range scanner. The 
validity of this method has been a demonstrated by different groups but due to the 
practicalities and ethical implications of employing either modality in patients this approach 
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has so far been restricted to large animal and ex-vivo experiments (216,217). Laparoscopic 
ultrasound may also be used in a similar fashion (210,218) but this has proven a less 
popular method because LUS is more suited to visualise deep lying structures than to the 
recording of surface points or landmarks. An overview of the accuracy performance that has 
been reported in the literature is given in Table 2.2. It is important to note that different 
methods of TRE evaluation have been used by each group and therefore the stated values 
are not comparable.  
Group 
Mean TRE 
in mm 
Reconstruction 
method 
Maturity 
Hayashibe et al. 
2006 
1.0-1.5 Laser range 
scanner 
Preclinical study 
Kingham et al. 
2013 
5.0 Tracked probe Clinical study 
Kang et al. 2014 3.0 LUS on 3D video Preclinical study 
Pessaux et al. 
2014 
2.0 manual alignment Clinical study 
Reichard et al. 
2016 
13 SSR Preclinical study 
Plantefeve et al. 
2016 
<3 SSR Clinical data 
Table 2.2 Listed are published TRE’s for IGS studied in the context of LLS.  
Due to significant variation in the methodology of TRE calculation the measures 
cannot be compared to each other. If several publications exist from the same group, 
then only the most recent TRE are stated. 
 
Soft tissue deformation 
Compared to tracking and calibration, inaccuracies related to organ- shift and deformation 
are thought to be more problematic and are harder to address. Liver shift is caused mainly 
by diaphragmatic and cardiac motion whereas liver deformation is mainly caused by surgical 
manipulation and increased intraabdominal pressure secondary to pneumoperitoneum 
(172,216). Although computational algorithms with the capability of simulating liver shift and 
deformation have been successfully applied to ex-vivo experiments and retrospectively to 
laparoscopic video, a functional real-time implementation has so far proved elusive 
(174,216,219). For this reason clinical IGS applications have relied on rigid (141,171,220) or 
one-off deformable 3D models (221).  
This figures show that considerable more research efforts are required to offer excellent and 
reproducible accuracy in the area of 3-5mm. Only one group has reported TRE’s in patients 
undergoing LLR with values of app 10mm RMS. While this may be sufficient for improving 
72 
 
better intraoperative orientation it is not comparable to precise surgical navigation that can 
be achieved in rigid compartments such as during intracranial surgery.  
Display 
Different methods of displaying data during surgery have been described in the past but in 
the main they can be categorised as either virtual reality or augmented reality displays which 
either shows a standalone 3D model or a composite image of 3D model and real world, 
respectively (Fig. 2.7). Virtual reality configurations make use of two monitors that provide 
the laparoscopic view and 3D model view side-by-side. A tracked object such as an ablation 
probe or surgical instrument is visualised simultaneously in both screens to facilitate 
intraoperative image guidance (141,171,218,222). Augmented reality displays can be 
achieved through a variety of methods including a robotic binocular camera a 3D screen or a 
standard 2D screen (143,210).  
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2.7 Comparison of different IGS display methods. 
a) VR display showing 3D model and operative site in parallel  b) AR display showing 
an overlay of 3D model onto the operative site c) Projector display using a beamer 
projection of a 3D liver model onto the skin (211).  
c 
b 
a 
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(reprinted with permission from a- Springer, copyright 2013; b - with CC BY-NC 4.0 
from Hindawi) 
An alternative screen-less application for an AR overlay display has been proposed by 
several groups that investigated its utility in guiding laparoscopic port placement. The correct 
placement of ports is crucial to facilitate good hand-eye coordination and economy of 
movement during laparoscopic or robotic surgery. Patient obesity or positional changes 
caused by abdominal gas insufflation can make the estimation of the optimal port position 
difficult. To overcome this issue several groups have used a standard commercial beamer to 
project a 3D model of the intraabdominal compartment onto the patients skin prior to port 
insertion. Visual alignment of landmarks such as the umbilicus, the costal margin and the 
anterior superior iliac spine which are visible on preoperative scans and on physical 
examination or standard video, have been used for registration (211,221,223). It was 
demonstrated that using this method accuracy and variability of port placement could be 
improved by 33% and 63% respectively (211). Use of a beam projected 3D model for 
intraoperative guidance is not feasible because of the interference cause by ports, 
instruments, robotic arms and the uneven outline of the distended abdomen (223). The use 
of virtual reality head-mounted displays or glasses has been suggested as a further display 
option but up to date has not been evaluated in image guided LLS (128).  
2.4. Discussion 
In this review a number of optical technologies that can enhance the sense of vision and 
orientation during laparoscopic liver surgery have been evaluated. The employed selection 
criteria ensured that all modalities are non-invasive, have been evaluated in-vivo and if 
required can be used in conjunction with safe and clinically licensed fluorophores. This 
combination of factors means that clinical translation should not be greatly impeded by 
concerns about safety of intraoperative use.  
Although they all rely on functions of light, their distinct properties make them useful for a 
variety of different applications. Microscopic tissue examination during LLR using confocal 
laser endomicroscopy (CLE) for example has been shown to provide real-time histological 
evaluation. Concerns about the training required to properly interpret microscopic images 
may be addressed by establishing live video links with trained histopathologists (150). Due 
to the small field of view it is challenging to examine larger areas of tissue (175) and 
therefore this modality may be better suited to investigate or confirm the histological nature 
of small and well defined areas of interest that have been previously identified with other 
imaging techniques.  
One potential option for “screening” the liver surface for areas that warrant a closer 
microscopic examination is the use of laparoscopic ICG based fluorescence imaging (LIFI). 
It has been shown that this imaging modality can identify superficial liver lesions that have 
not been detected on preoperative scans or laparoscopic ultrasound (144,199). There 
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appears to be a correlation between the type of LIFI fluorescence and the nature of some 
liver lesion (188,189) but as this link as of yet lacks specificity, it appears to be justified to 
advocate a more detailed microscopic examination of suspicious areas. In addition to the 
detection of malignancy, LIFI has been employed in clinical studies to stain liver segments, 
visualise bile ducts and to detect bile leaks from the liver resection surface (196). Out of 
these three indications the detection of bile leaks seems to be the most widely applicable 
and straight forward to use as it is relevant for any type of resection and does not require 
prior identification of vascular branches as is the case for liver segment staining. 
Furthermore LIFI may allow visualisation of intra-parenchymal bile ducts which are close to 
the dissection plane but in the main this option appears to be most useful as an alternative 
approach to intraoperative cholangiography during cholecystectomy (191). 
In parallel to LIFI, multispectral imaging appears to be an imaging modality that is well suited 
for the examination of macroscopic tissue areas and anatomical structures. Its advantage 
over wide field fluorescence techniques is that a plethora of endogenous tissue components 
can be visualised and therefore LMSI may be tailored to specific clinical areas of interest 
such as the evaluation of metabolic variations and histopathological changes over a wider 
area. This flexibility however comes at the expense of more complex imaging equipment and 
analysis algorithms, which is perhaps the reason why LMSI has not been clinically studied to 
the same extent as LIFI. Although different LMSI systems with fixed wavelength spectra 
have been successfully utilised in the diagnosis of liver fibrosis, HCC or bile leaks 
(156,160,195), it is conceivable that a system with an adjustable wavelength spectrum (200) 
will be more desirable for clinical use as it can be employed in a much broader context. The 
drawback of a LMSI system with an adjustable and broad wavelength spectrum however is, 
that it is technically more complex. For the purpose of imaging it is sufficient to utilise relative 
tissue component concentrations which are subsequently translated into colours, shades 
and contrast. Tissue components exhibit distinct absorption spectra which can be regarded 
as a relationship between light absorption and excitation wavelength. If the absorption 
spectrum for a specific tissue component such as lipids or oxygenated haemoglobin is 
known it is possible to calculate the absolute concentration of the substance (161,224). 
Although this approach has yet to be demonstrated on the liver in a laparoscopic setting, it 
presents, a potential opportunity for future research (162,225). 
An inherent weakness of optical imaging is its lack of depth penetration which is ≈5mm in 
the NIR spectrum but may be less at other wavelengths (144). For this reason it is an 
attractive option to integrate it with other imaging modalities that offer good depth 
penetration such as CT, MRI or occasionally LUS. Within this context IGS for LLS represent 
an amalgamation of imaging techniques with the opportunity to combine the best of both 
worlds with excellent resolution, high specificity, non-invasiveness, portability, good update 
speed and miniaturised equipment being provided by optics whereas depth penetration and 
3D reconstruction are provided by preoperative scans or LUS. The main aims of utilising IGS 
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during LLS are improved oncological safety and a reduced risk of vascular injury. 
Unfortunately the development of an IGS for LLS has been slow and although two 
commercial systems have been built for open liver surgery (67,226) there is no clinically 
licensed laparoscopic alternative yet. A variety of optical registration methods have been 
explored previously but SSR is currently the most widely studied approach. This method 
however requires a 3D laparoscope which at this time is significantly more expensive than 
comparable 2D equipment. As 3D technology becomes disseminated into the mainstream, 
prices for stereo-laparoscopes will likely decrease but nonetheless, if liver surface 
reconstruction based on other methods (e.g. shading and motion) becomes feasible in the 
future, then cheaper monocular scopes could be used instead (129,137). The way that IGS 
integrate image guidance information into the surgical workflow is crucial to harness 
maximal benefits. A number of options including beamer-projection, VR and AR displays 
have been shown to be feasible. More recently however AR based displays have been more 
frequently represented in research efforts and on balance this display method would appear 
to be more intuitive to use (216,220,227). 
Alternative registration methods for LLS that have been studied in-vivo include cone beam 
CT (CBCT), MRI and LUS. One clinical team utilised repeated CBCT registration in 
conjunction with a 3D model from a preoperative MRI scan to carry out an image guided 
HCC resection in segment 7. No accuracy measurements for the in-vivo case were reported 
but the authors felt that CBCT image guidance was useful for complex resections. Despite 
having been established as an essential tool for image guidance in endovascular surgery, 
CBCT suffers from several disadvantages including a low resolution, ionising radiation, high 
costs, lack of portability and an inability to allow spatial correlation between instruments and 
3D model in real time (228,229). With the exception of ionising radiation and low resolution, 
MRI based IGS do share most of the shortcomings of their CBCT based IGS with costs 
being an even more relevant factor. MRI also has a slower image acquisition than CBCT but 
the most significant obstacle to utilising it for image guidance during laparoscopy is its 
incompatibility with metallic equipment. This restriction makes the use of custom built metal 
free surgical equipment mandatory (230,231). In contrast to MRI and CBCT, LUS shares 
many practical characteristics with optical image guidance such as portability, miniaturisation 
potential, relatively low costs and good registration update speed. The main differences are 
that LUS offers better depth penetration whereas optical imaging has a higher specificity 
(232). Another issue with LUS is that positional tracking of flexible LUS probes is difficult and 
has yet to be applied in clinical studies (233). LUS acquired images can be integrated into a 
3D model or projected onto the laparoscopic video stream (234,235) but this data may also 
be employed as a method of registration. One group demonstrated how LUS could be 
utilised to reconstruct the highly individual pattern of hepatic vasculature which was then 
subsequently registered to the corresponding vascular pattern on a 3D liver model (236). It 
remains to be seen whether LUS or optics based registration will prove to more 
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advantageous during LLR and perhaps there may be a benefits to combining aspects of 
both methods.  
There are various reports on the utilisation of modern 3D laparoscopy systems for 
laparoscopic surgery but experience in LLS is limited (237–239). Results from a cohort study 
hint towards shorter operating times and it was hypothesised that 3D laparoscopy may 
flatten out the learning curve for “open surgeons” who embark on laparoscopic procedures. 
The authors of a case series suggested that stereoscopic vision is of particular benefit for 
complex laparoscopic manoeuvres such as suturing (202). These finding are supported by 
studies from other surgical specialties (237–239). In the cohort study however, all operations 
were carried out by a single laparoscopic expert and therefore further studies are warranted 
to evaluate how applicable these findings are to other surgical centres. 
Due to the selection criteria applied in this review some promising imaging techniques that 
may become relevant for LLS in the near future were not mentioned. One such an example 
is photoacoustic imaging, a modality that uses ultrasound waves which are created by laser 
light induced excitation of tissue expansion and relaxation. This so called photoacoustic 
effect combines the best of both worlds, optical and acoustic imaging and thus can provide 
images with better specificity and penetration depth than ultrasound or optical imaging, 
respectively (232). The capability of photoacoustic imaging to identify liver fibrosis and 
steatosis has been demonstrated previously (240). When used in conjunction with ICG, PAI 
can been utilised to detect superficial CRLM and HCC tumours (241). The main hurdle for a 
laparoscopic application is the need for a miniaturised laparoscopic probe design that is 
capable of simultaneously delivering light and acquiring ultrasound waves (242). Another 
more recently developed technique is based on the processing of standard RGB video data, 
an approach that makes it innately attractive for laparoscopic imaging. Video magnification 
for example utilises computer algorithms to analyse imperceptible changes in video colour. 
These colour variations are subsequently enhanced to make them visible to the naked eye. 
The potential of this work was demonstrated on real life examples e.g. by visualising the 
percutaneous pulsation of the ulnar artery and the pulse dependent change of facial colour 
(136). In clinical research, video magnification has been proposed as a method to monitor 
the effectiveness of regional anaesthesia (243) and to localise blood vessels during minimal 
invasive kidney and prostate surgery (244,245). Analysis of colour variation can be 
expanded onto stereoscopic video which has the advantage of enabling estimation of tissue 
haemoglobin concentration and oxygen saturation in near real-time (246).  
In conclusion there are a number of optical imaging techniques available that can enhance 
surgical sensing by enabling different degrees of tissue examination or intraoperative image 
guidance during LLS. The individual strengths, limitations and outstanding development 
needs for each imaging modality were highlighted in this review. Despite the specific nature 
of development needs there are perhaps three key areas that warrant focus for future 
research which are: standardisation, integration and clinical translation. To allow effective 
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comparison and evaluation of potential clinical benefit a standardised image acquisition and 
interpretation approach in tissue examination and a consensus on the evaluation of 
accuracy in IGS studies would appear to be beneficial. The diversity of available optical 
technologies and their respective indications seems extensive but it is perhaps useful to take 
a more holistic approach and analyse how individual modalities could supplement each 
other to improve laparoscopic “sensing”. One existing example is how stereoscopic vision is 
used to facilitate surface reconstruction in SSR. The feasibility of integrating co-registered 
LUS images into AR based IGS has already been demonstrated (210,236) and it is 
conceivable that this approach can be replicated for optical modalities such as CLE or MIS. 
Ultimately any advances in optics based tissue examination and laparoscopic image 
guidance should focus on improving patient outcomes and safety by enhancing the 
surgeon’s perception and awareness of the intraoperative field. 
  
79 
 
3. General methods 
3.1. Confocal laser endomicroscopy 
The ability of confocal laser microscopy to discriminate between normal (i.e. healthy) and 
pathological liver tissue was explored in two separate animal models. Initially a murine 
model was used to look at discrimination between normal and cancerous tissue. 
Subsequently a porcine mode was employed to evaluate discrimination between normal and 
ablated liver tissue. In addition this model was also thought to reflect realistic conditions of 
laparoscopic surgery that would be encountered in a clinical scenario. Because the same 
system was utilised for murine and porcine experiments, a general description of the 
technology and equipment is given first before the specifics of each model are outlined. 
3.1.1 General description of confocal laser endomicroscopy 
Confocal laser endomicroscopy (CLE) is a novel optical imaging technology that enables 
accurate microscopic assessment of in-vivo histopathology. Its utilisation in a variety of 
experimental and clinical scenarios has been increasingly reported. CLE utilises a fibre optic 
element as its objective lens, allowing confocal microscopy with a micron-scale resolution 
that enables visualisation of sub-cellular details using endogenous or exogenous 
fluorescence. Exogenous fluorescence is provided by fluorescent dyes which can be applied 
in a systemic (e.g. intravenous) or topical fashion and are commonly referred to as 
fluorophores. They enhance CLE image contrast by absorbing and emitting light at 
wavelengths that are specific for each individual agent and circumstance (146,247).  
CLE during laparoscopy or NOTES (Natural Orifice Transluminal Endoscopic Surgery) has 
been performed either with a rigid endomicroscope which contains the scanning optics in its 
tip (146) or with a slim, flexible optical fibre bundle which transmits light signals to laser 
scanning equipment situated at the far (e.g. extra-corporeal) end of the intrusive fibre 
(177,248). An example for a fibre based CLE system is Cellvizio™ (Mauna Kea 
Technologies, Paris, France) which is CE-marked for clinical use in luminal endoscopy and 
can be operated with probes that have a diameter range of 0.3-4.5mm. During endoscopy, 
Cellvizio™ can reveal histopathological cellular changes and has been shown to enhance 
accuracy in the diagnosis of malignancy and dysplasia (146,249). 
3.1.2 CLE Equipment 
Experiments were performed sequentially in a “dual wave length approach” using both 
488nm (blue) and 660nm (red) laser lines which were connected to separate CLE imaging 
systems (Cellvizio™ 488nm & Cellvizio™ 660nm, Mauna Kea Technologies, Paris). For CLE 
image acquisition 0.5-1.5mm, flexible confocal probes (MiniZ, Ultra MiniO and S1500, 
Mauna Kea Technologies, Paris, France) were used, all compatible with conventional 
endoscopic instrument channels. The CLE imaging systems control laser illumination and 
fibre scanning, delivering12 frames per second which enables near real-time image 
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acquisition. Images at different wavelengths were recorded “in turn”, meaning without 
parallel co-registration of the red- and blue-light laser systems. Imaging parameters were 
probe dependent with 1.4-3.5µm lateral resolution, 10-30µm axial resolution, 0-70µm 
imaging depth and a 240-600µm² fields of view. 
3.1.3 Murine experiments 
A murine model of colorectal cancer liver metastasis was evaluated to study the ability of 
CLE to distinguish between normal and cancerous tissue.  
3.1.3.1 Orthotopic murine model of colorectal cancer liver metastasis 
The human colorectal carcinoma cell line SW1222 was cultured under aseptic technique in 
Dulbecco’s Modified Eagles Medium containing 5mM L-glutamine and 10% v/v Foetal 
bovine serum. All animal studies were conducted in accordance with UK home office 
regulations and the guidelines for the welfare and use of animals in cancer research. The 
liver metastasis model used has been previously described (250). Briefly, eight (n=8) MF1 
nu/nu mice (female, 6-8 weeks old, 25-30g) underwent a laparotomy in order to directly 
inject 1x106 cells in to the spleen. Splenectomy was performed after 5 minutes to stop 
formation of a primary tumour at the site of injection, with cells that had been carried by the 
blood flow through to the liver forming the solid tumours of the metastatic model. At 
conclusion of the procedure the laparotomy incision was closed and animals were 
recovered. In the described animal model, female mice are exclusively used due to their 
better compliance. Liver tumour maturation took between 5-6 weeks. The progression of 
metastatic disease was monitored once per week with non-invasive magnetic resonance 
imaging under general anaesthesia. The evolving disease pattern showed a heterogeneous 
distribution of distinct solid tumour nodules of varying sizes (app. 2-12mm) throughout the 
lobes of the liver. Typically disease burden comprised of 10-20 tumour nodules that could be 
visualised on magnetic resonance imaging. 
3.1.3.2 CLE Image acquisition murine model 
A transverse laparotomy was carried out under general anaesthesia to allow unrestricted 
access to the liver. CLE imaging at 488nm and 660nm was performed with two different CLE 
imaging stacks with separate laser scanning units, probes and image processing computers. 
Both systems were initialised and calibrated at the start of each experiment. Switching 
between wavelengths simply required imaging probes to be swapped over. Due to the 
inability of CLE to visualise tissues beyond 100µm depth, images were exclusively acquired 
from superficial tissue, while the probes were manually maintained in contact with the liver 
surface. Images were acquired with the Z-probe at 488nm and the miniZ probe at 660nm 
wavelength. Probe characteristics were the following: probe diameter 18 or 9.4mm; lateral 
resolution 3.9µm, axial resolution 44 or 13µm, working distance 80 or 65µm, maximal field of 
view 426x302µm or 323x323µm.for the Z probe or mini-Z probe, respectively. 
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The liver was macroscopically categorised into normal and cancerous tissue areas based on 
its respective brown or white appearance. This approach was made possible by the radically 
different appearance of normal liver vs. CRLM. No attempt was made to identify microscopic 
disease because the aim was to establish reproducible CLE criteria of CRLM which could 
then be translated to the detection of microscopic disease in future studies. Baseline CLE 
images were recorded over a representative area prior to fluorophore administration. To 
provide exogenous fluorescence for CLE imaging at 488nm and 660nm excitation, 
fluorescein sodium (molecular weight 376.27g/mol – henceforth called “fluorescein”) and 
ICG (molecular weight 774.96g/mol) were mixed with 0.9% sodium chloride or 5% dextrose 
respectively. Subsequently, fluorescein (4-7mg/kg) and indocyanine green (0.3-0.5mg/kg) 
were sequentially injected into the tail vein with a delay of 20-40 minutes between injections 
to allow adequate time for imaging. In preliminary experiments it was confirmed that neither 
fluorescein nor ICG elicited unintentional “cross”-fluorescence signals. 
An initial image sequence of 1-3 minutes was recorded to monitor and confirm distribution of 
the fluorophores in the liver. Several short sequences ranging from 10-20s were taken from 
normal and malignant tissue in different locations. It was not possible to co-register tissue 
areas between 488nm and 660nm CLE imaging. But due to the relatively small size of 
mouse livers it was hypothesised that approximately the same areas were imaged at both 
wavelength. For statistical analysis which is described below, all values for individual 
animals were pooled into one group and hence co-registration is less relevant than for the 
visual comparison of image features. The mean fluorescence values for each image frame 
from these sequences were subsequently analysed. 
3.1.3.3 Preparation and examination of murine liver tissue samples 
Following termination of the animals, the livers were resected, fixed in 10% formalin and 
embedded in paraffin blocks. Tissue samples were sliced at 4µm thickness with a microtome 
and sections mounted on glass slides. The presence of colorectal cancer metastases was 
confirmed by using a standard structural Haematoxylin and Eosin stain. Because areas of 
normal liver and CRLM in this disease model looked radically different, histological 
examination enabled us to confirm infiltration of adenocarcinoma cells in representative liver 
areas which previously underwent CLE in-vivo examination. 
3.1.3.4 Statistical analysis of murine CLE data  
Cellvizio™ is packaged with image analysis software (Imagecell™) that records and displays 
basic values termed relative fluorescence units (RFU), from which the maximum, minimum, 
median and mean were calculated and exported for each image frame. Relative 
fluorescence units are based on a reconstruction of single fibre fluorescence intensity at a 
given point in time. A number of factors such as fibre injection rate, fibre collection rate, fibre 
auto-fluorescence, biological sample fluorescence and laser source intensity influence 
fluorescence intensity. These variables are factors in an equation that allows the real time 
reconstruction of fluorescence intensity in individual fibres each of which corresponds to an 
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image pixel of the CLE image. A detailed description of the equation and other relevant 
methodology has been published previously (251). At the start of each imaging session a 
calibration is carried out using solution that provides a uniform value of background 
fluorescence. The calibration procedure results in homogenisation of the individual probe 
fibres to give them uniform detection sensitivity (which corresponds to a measured light 
intensity) (252). This process enables comparison of fluorescence values between individual 
fibres (i.e. pixels) of the probe, for a given calibration. However, whilst the absolute 
background fluorescence value in the calibration solution is uniform it may change between 
repeated calibrations and different solution containers, meaning that fluorescence units have 
to be regarded as relative, as opposed to absolute values. Thus, imaging data were only 
compared within the same animal.  
Negative RFU values either correspond to image noise or can be caused by a reduction in 
fibre autofluorescence due to prolonged illumination. To avoid misinterpretation, negative 
RFU values were thresholded at zero. All RFU values underwent a square root 
transformation to reduce data skew and kurtosis. 
Routine statistical comparison e.g. by paired Wilcoxon rank sum test (individual animal 
paired with RFU) was not possible due to specific constraints of the acquired data which 
were: 1) unequal number of frame counts for normal and CRLM tissue and 2) potential 
introduction of a repeat sampling error. These circumstances lead us to choose a 
generalised linear mixed model (GLIMMIX) analysis which can accommodate for the 
described data constraints by estimating the interaction of fixed and random effects. 
Fixed effects in GLIMMIX work in analogy to a regular linear or logistic regression analysis in 
that a covariate (e.g. age) is assigned a fixed coefficient that determines its impact on the 
dependent or response variable( e.g. morbidity) in the statistical model. A random effect in 
contrast to this can have different coefficients that are depending on a subgroup (e.g. ward 
on hospital) within a dataset. Combination of fixed and random effects may allow elucidation 
of a better statistical model fit in some circumstances. The difference between linear mixed 
models and generalised linear mixed models is that the relationship between the dependent 
variable and the effect terms is non-linear. This non-linearity is expressed via a link function 
which utilises a transformation (e.g. logit, probit, gaussian) between the effect terms and 
dependents in the equation. For the data in this study for example a binominal distribution 
with a logit link function was used to conduct the GLIMMIX analysis.   
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 The GLIMMIX analysis enabled modelling of the probability of the acquired images 
corresponding to normal liver parenchyma. The measured RFU value and animal ID were 
set up as fixed effect and random effect for this model, respectively.  
Different estimation methods such as Pseudo Likelihood, Laplace and Gauss-Hermite 
quadrature can be used for GLIMMIX analysis. For the purpose of this study, the Laplace 
method was chosen because it exhibited satisfactory convergence and the best fit 
characteristics as assessed by Akaike information criterion (AIC). GLIMMIX analysis results 
are given as the change in odds ratio for an increase in RFU at a standardised value. For 
example, an odds ratio of 2 at a standardised RFU increase of 100 to 101 means that the 
odds ratio of liver parenchyma being normal increases by 2 if the RFU value increased by 
one from 100 to 101.  
To test the validity of the GLIMMIX model resulting from the study data, a ROC analysis was 
performed. The covariates and intercepts provided by the GLIMMIX analysis were used to 
calculate the log odds, odds and finally the probability of identifying normal liver tissue. Each 
single probability value corresponded to a single observation (mean RFU per frame), a 
specific animal ID and a tissue type which enabled us to perform a ROC analysis based on 
this data. Because animal ID was a random effect due to the difference in probe calibrations 
between experiments, the same RFU value would result in different probability values for 
individual animals.  
To determine if a probability based threshold value could be used to distinguish between 
normal and malignant tissue random sample cross validation was carried out. To this end, all 
observations were randomised into a training and a validation dataset. The training set was 
used to build a GLIMMIX prediction model whose output subsequently underwent ROC 
analysis. A threshold value with an optimal sensitivity and specificity for identifying normal 
liver tissue was then chosen from the ROC curve coordinates. This threshold probability 
value was subsequently applied to the validation set, to evaluate its performance in 
distinguishing between normal and malignant liver tissue and calculate the resulting 
sensitivity, specificity and accuracy for this test. 
An estimation of erythrocyte flow velocity calculated from the available image data was also 
carried out. To calculate flow velocity (in mm/s), the distance travelled by a single 
erythrocytes in the time period between two image frames (=41.7ms at 24 frames per 
second) was measured. Depending on the amount of available data, 5-10 individual 
erythrocytes were assessed per tissue type and animal ID. 
Statistically significant differences were assumed if p<0.05. Statistical analysis was 
performed using SPSS™ Version 21 (IBM, Armonk, NY, USA) with exception of the 
GLIMMIX analysis which was carried out with SAS™ Version 9.4 (SAS Institute, Cary, NC, 
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USA). Quantitative data (RFU and erythrocyte flow velocity) is given as median and 
interquartile range. Odds ratios are stated together with their 95% confidence intervals (CI). 
The author of this thesis was not involved in: establishing the animal model, pre-operative 
imaging (to confirm cancer seeding) or in the operative procedure required for image 
acquisition or preparation of histology. The author did help with CLE image acquisition itself 
and performed subsequent image analysis and data evaluation. 
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3.1.4 Porcine experiments 
A porcine model of laparoscopic liver resection and liver ablation was used to study the CLE 
imaging characteristics of normal and ablated liver tissue and assess the feasibility of using 
this imaging modality during laparoscopy. These experiments were conducted as part of a 
series of experiments that in addition to CLE also evaluated an image guidance system and 
video magnification studies (see below). Establishing the model and image data acquisition 
was done on separate days to accommodate requirements for the image guidance 
experiments. To illustrate this, a detailed description of the experimental steps involved is 
given below.  
3.1.4.1 Porcine model of laparoscopic liver surgery 
3.1.4.1.1. Sequence of events 
The experimental flow of the model is listed below, sequentially: 
Laparoscopic microwave ablation – OP1. 
Recovery period of 7 to 10 days. 
Laparoscopic CLE image acquisition (following laparoscopic liver resection in 2 cases) and 
intraoperative image guidance experiments OP2. 
Post mortem liver biopsies. 
3.1.4.1.2. Study animals 
Following approval by the local animal ethics committee, experiments were performed at 
Northwick Park Institute for Medical Research (London). A total of 4 female landrace mini-
pigs with a bodyweight ranging between 50-80kg were studied. Following best practice 
husbandry, the animals were acclimatised to their surroundings with free access to food and 
water at least one week prior to experiments. To avoid intestinal distension animals were 
fasted 24 hours prior to surgery but continued to have access to water. Each animal 
underwent two procedures under general anaesthesia on separate days with a 7-10 day 
recovery period in between. On the first procedure, laparoscopic liver ablation zones were 
produced (Medical microwave systems research group, Bangor University, UK). During the 
second procedure CLE images, intraoperative image guidance data and liver biopsies were 
obtained. In two animals a laparoscopic left hemi-hepatectomy was carried out to simulate 
intraoperative conditions and to allow CLE examination of the surgical resection margin.  
3.1.4.1.3. Preparation and Anaesthesia 
Following best practice animal husbandry, the mini-pigs were acclimatised to their 
surroundings with free access to food and water at least one week prior to experiments. To 
avoid intestinal distension animals were fasted 24 hours prior to surgery but had continual 
access to water. Oral endotracheal intubation facilitated general anaesthesia with 2% 
Isoflurane in oxygen in a recovery (ablation) or non-recovery (CLE imaging and 
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intraoperative image guidance) algorithm with 200mg Pentobarbitone euthanasia at 
termination of surgery. Orogastric intubation decompressed the stomach during 
laparoscopy. All procedures were carried out with the animals in a supine position.  
3.1.4.1.4. Liver ablation 
Thermal ablation of the liver was carried out to create an experimental model that supported 
two different experimental designs. Firstly microscopic imaging using CLE was carried out 
with the aim of studying ablation induced changes on a cellular level. Secondly 
intraoperative image guidance experiments using an image guidance system were 
performed where ablation zones were treated as substitutes for liver tumours. The 
simulation of liver tumours was necessary because there is no suitable porcine model of 
liver malignancy and research towards such a model has so far not produced any convincing 
results (253). The ablated liver lesions could be visualised by a CT scan and therefore they 
could be subsequently incorporated into a 3D liver model.  
Laparoscopic liver ablation was performed under general anaesthetic on OP1. Sterile 
conditions were created by cleaning the abdominal wall with Chlorhexidine solution and 
placement of sterile operating drapes. To facilitate laparoscopy, a pneumoperitoneum was 
established using port insertion under direct vision. A periumbilical 10mm port was used for 
the laparoscopic Viking 3DHD Visions System™ (Viking Systems, Inc., Westborough, MA, 
USA) with one additional 5mm port inserted in the right subcostal region to facilitate 
microwave liver ablation. Liver ablation was performed using a custom made microwave 
ablation system (Medical microwave systems research group, Bangor University, UK). The 
ablation probe was inserted through the anterior surface of the liver with the utmost caution 
to avoid injury to organs lying behind the liver. Due to the relative thinness of the porcine 
liver this step can be technically challenging. Ablation zones of approximately 1cm were 
created at different locations in the liver. Number of ablations ranged between 3-6, with care 
being taken to ensure a sufficient distance between ablations. This was necessary so that 
they could be individually distinguished on CT. If lesions were too close together they would 
erroneously be displayed as one lesion on CT. Because a number of lesions were induced 
superficially, they had the benefit of functioning as additional anatomical landmarks which 
was an important feature in the determination of IGS accuracy as described below. After 
completion of ablation the abdominal cavity was examined for any signs of inadvertent organ 
injury. Laparoscopic ports were left in-situ while the pig was moved to the CT scanner still 
under general anaesthesia. On return from the CT scanner ports were removed and the 
fascia closed with 1-0 Vicryl at the periumbilical port-site. Skin incisions were closed with 3-0 
Vicryl and subsequently all port sites were dressed. The animals were woken up, extubated 
and returned to postoperative intensive monitoring. 
3.1.4.1.5. Operative technique 
Pneumoperitoneum was established using either the Veress technique or port insertion 
under direct vision. A periumbilical 10mm port was used for the laparoscopic camera with 
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additional 5mm and 12mm ports inserted in the right and left upper quadrants. For ablation, 
one additional 5mm port was inserted in the right subcostal region. Liver resection was 
performed using four ports in addition to the camera port; three in the right upper and one in 
the left upper abdomen. Pneumoperitoneum was constantly monitored and maintained at 8-
12mmHg. The porcine equivalent of a left hemi-hepatectomy was carried out without 
vascular inflow occlusion. A portable ultrasonic scalpel (Sonicision™, Covidien, Dublin, 
Ireland) was used for transection of the liver parenchyma. Small vessels were controlled with 
ultrasonic scalpel or metal clips, whereas major vessels were divided with a laparoscopic 
stapling device (Echelon Endopath™, Ethicon Endo-Surgery, Blue Ash, USA). 
3.1.4.2 In-vivo image acquisition in the porcine model 
Following establishment of the pneumoperitoneum, abdominal contents were visually 
inspected for potential ablation induced collateral injuries. All imaging experiments were 
recorded with the laparoscopic camera and stored as digital files. Position of the Cellvizio™ 
probe tip in relation to the ablation zones examined could be identified on video and 
correlated with the recorded CLE images for future analysis. Immediately before liver 
imaging, a standardised Cellvizio™ system calibration procedure (251) was carried out in 
theatre. Baseline CLE images were recorded over normal and ablated liver, respectively. 
Fluorescein sodium (molecular weight 376.27g/mol – henceforth called “fluorescein”) and 
ICG (molecular weight 774.96g/mol) were mixed with 50 ml 0.9% sodium chloride or 5% 
dextrose respectively just prior to intravenous injection. Intravenous injection of fluorescein 
(at 4-7mg/kg) and indocyanine green (at 0.3-0.5mg/kg) was carried out sequentially with an 
interval of 30-60 minutes between injections. Fluorescein and ICG acted as fluorophores for 
CLE imaging at 488nm and 660nm wavelength, respectively. CLE image acquisition was 
carried out with separate systems for each individual wavelength (Cellvizio™ 488nm & 
Cellvizio™ 660nm, Mauna Kea Technologies, Paris). In addition to this protocol, two animals 
underwent fluorophore injection 15 minutes prior to ablation therapy to determine if the time 
point of injection impacted on CLE imaging characteristics. In preliminary bench 
experiments, it was confirmed that the illumination – emission spectra were so widely 
separated, that there was no cross-talk between the 488-fluorescein and the 660-ICG 
systems. An initial image sequence was recorded to monitor and confirm distribution of the 
fluorophores in the liver. This was followed by several short sequence acquisitions taken in 
equal numbers from normal parenchyma and ablated regions. Short sequences ranged from 
10-20s and were later analysed to determine variations of relative fluorescence between 
healthy and ablated liver tissue.  
When visualisation became impeded by blood or other detritus that had attached itself to the 
tip of the probe, it was cleaned with normal saline. This reflects the value of an imaging 
scheme rather than a single fibre spectrometer. In the latter case a low signal could 
represent either a lack of fluorophore or a fouled fibre tip – enhancing the risk of a false 
reading from a given sampling site. 
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Before experiments commenced, a training session was conducted to familiarise surgeons 
with CLE probe handling during laparoscopy. Particular attention was paid to probe tip 
pressure because too little pressure resulted in insufficient tissue contact, whereas too much 
pressure severely diminished fluorescence intensity. Both extremes resulted in the loss of 
any measurable fluorescence intensity and hence a black image which again demonstrates 
the value of an imaging system rather than a spectrometer fibre. The training session 
allowed surgeons to find a narrow range of tip pressure that enabled image acquisition at a 
visibly stable fluorescence level. From a surgical technique point of view, deliberate 
adjustment of pressure within this narrow window was very challenging, without haptic 
feedback so no formal quantification of probe tip pressure was undertaken. None of the 
image data acquired during the training session was used for analysis. 
The confocal probes were inserted into the peritoneal cavity through the lumen of a 
steerable catheter (Agilis™ St. Jude Medical, Saint Paul, MN, USA) which was itself 
introduced through a 5mm laparoscopic port. The steerable catheter, designed for intra-
vascular use, allowed subtle manipulation of the probe tip during laparoscopy (Figure 3.1). A 
technical note on this approach to probe manipulation has been reported elsewhere (254).  
 
Figure 3.1 Laparoscopic CLE imaging of porcine liver with fluorescein/488 nm.  
The ablated regions are highlighted with dashed circles. (1) Steerable catheter 
inserted through a laparoscopic port; (2) CLE probe with blue light reflex at the tip. 
 
3.1.4.3 Preparation and examination of porcine liver tissue samples 
Following termination of the animals, the ablation zones and the surrounding healthy liver 
were resected for histological analysis. During surgery, if more than one ablation zone was 
examined, they were assigned numbers and their anatomical position was recorded during 
laparoscopy with the intention to facilitate postoperative CLE image analysis for each 
individual lesion. No attempt was made to perform a more detailed spatial correlation 
between CLE- and histopathological images because the CLE probe’s field of view 
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(<300µm2) was too small to accurately localise with markings that would have been visible 
on laparoscopy. 
Samples were fixed in formalin and then embedded in paraffin. Tissue samples were sliced 
with a histiotome in a direction parallel to the liver surface. These slices were placed on 
glass slips and stained according to a standard Haematoxylin & Eosin protocol. 
3.1.4.4 Statistical analysis of porcine CLE data 
The statistical analysis of the porcine model liver ablation model was conducted along 
similar principles as the analysis of normal and CRLM liver tissue which has already been 
described (3.1.3.4). Further details are outlined here to describe where this process differed 
from the above. 
Image acquisition was more difficult during laparoscopy and hence some of the CLE images 
had to be discarded. To adjust the data for erratic probe movement all laparoscopic videos 
were reviewed. If there was a clear disconnection between the probe tip and the liver 
surface the relevant data sequence was excluded from analysis. Due to the difficulty in 
keeping constant contact between CLE probe and liver surface, it was not feasible to 
measure erythrocyte velocity as was done in the murine CRLM model. In contrast to the 
murine CRLM model, the GLIMMIX analysis was set up to model the probability of the probe 
being on normal (i.e. non-ablated) liver parenchyma. Fixed and random effects were 
handled in a similar fashion as described already. 
To test the validity of the GLIMMIX model a receiver operating characteristic (ROC) analysis 
was performed. The covariates and intercepts provided by the GLIMMIX analysis were used 
to calculate the log odds, odds and finally the probability of identifying non-ablated tissue. 
Each single probability value corresponded to a single observation (mean RFU per frame), a 
specific animal ID and a tissue type, which enabled us to perform a ROC analysis based on 
this data. Because animal ID was a random effect, the same RFU value would result in 
different probability values for the individual animals. This relationship explains why based 
on our data, no single RFU cut-off value can be estimated as an optimal threshold to 
distinguish ablated from non-ablated tissue. No cross validation was carried out on the 
ablation model because there was insufficient data to facilitate randomisation into a training 
and validation dataset. The workflow for the statistical analysis is shown in Figure 3.2.  
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Figure 3.2 Workflow of statistical analysis of porcine CLE data.  
The workflow depicted here was also used for the murine model. 
 
The author of this thesis was not involved in the preparation of histology. The author helped 
during establishment of the animal model and during laparoscopic surgery, carried out CLE 
image acquisition and performed subsequent image analysis and data evaluation. 
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3.2. Digital image processing techniques used in this work 
The analysis methodologies used in the chapters on multispectral imaging and video 
magnification make extensive use of image and video processing techniques. All colour 
images and video material was processed in the 8bit RGB colour space. Images from 
multispectral experiments were processed in an arbitrary grayscale format based on the 
camera recording characteristics as described below (3.3.4). A detailed description of digital 
image processing basics is beyond the scope of this chapter. For detailed background 
information please see here (255). 
3.3. Multispectral imaging 
Multispectral imaging experiments were conducted with the aim to develop an imaging 
platform that enabled examination of tissue spectra. This platform was consequently utilised 
to evaluate spectra from normal and pathological liver tissues.  
3.3.1 General principle 
The principle behind this imaging modality is that the chemical and physical composition of 
tissue alters the way that light is absorbed. This property is a function of light spectrum i.e. 
tissues absorption changes depending on light wavelength. This behaviour is reflected in the 
absorption coefficient which is specific for individual substance compounds such as lipids or 
haemoglobin. Tissue characteristics can therefore be inferred by exposing it to light of 
different wavelengths.  
Absorption coefficients for specific substances can be plotted against wavelength in a 
spectral response curve which exhibits a typical pattern that depends on the underlying 
substance. The shape of the curve can be used to infer not only the presence of a 
substance but also in some cases its concentration. In biomedical science the substances 
that are most relevant are oxyhaemoglobin, deoxyhaemoglobin, lipids and water. Other 
substances such as collagen and bilirubin have been studied as well but to a lesser extent 
as they are not as ubiquitous. Typical spectral response curves for these substances are 
shown in (Figure 3.3). 
3.3.2 Ex-vivo tissues for multispectral evaluation 
To develop the imaging platform, animal tissue intended for consumption was purchased 
and tested. Animal tissue was more readily available than human tissue and hence was 
more attractive for preliminary testing. When the development phase was concluded, 
experiments continued with liver tissue excised from patients undergoing liver resection and 
from discarded donor livers. The aim was to get at least 2-3 samples (161,163) for any 
pathological condition (i.e. CRLM, steatosis), but ideally > 6 samples (256,257). Ultimately 
the number of specimen was limited by clinical availability. The former tissues were chosen 
to examine liver malignancy and the latter tissues to examine liver steatosis because 
explanted livers are frequently discarded because they are too fatty. Imaging was conducted 
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on ex-vivo liver tissue as previously described by other authors (162,256). These samples 
had the advantage of being more representative of clinical disease then tissue from cell 
cultures or animal models. Additionally it was technically not feasible to move the imaging 
platform to animal labs or to hospital facilities at this early development stage because of 
concerns about laser safety and the fragility of the system.  
3.3.2.1 Animal tissue  
For preliminary experiments on some of the imaging modalities, commercially available 
animal tissues marketed for consumption were purchased from food stores. The type of 
animal product depended on the tissue of interest. To study multispectral imaging (MSI) on 
lipids for example goose fat was found to be useful whereas beef liver was frequently used 
to obtain preliminary confocal laser endomicroscopy data. The interchange between muscle- 
(red part of the bacon) and fat tissue in bacon proved useful to study the spatial resolution of 
MSI imaging. The composition of these tissues was not quantified because preliminary 
experiments served towards testing of equipment and refining of image acquisition system. 
Experiments were not used to correlate image data with tissue constitution. For transport to 
the laboratory, no additional cold storage precautions were made. In the lab, specimen were 
cut into dimensions appropriate to the imaging modalities field of view. Subsequently they 
were placed on a stationary platform for examination. For MIS studies a translation stage 
was used whereas tissue for CLE examination was simply placed on a plastic tray. 
3.3.2.2 Patient tissue 
Ethical approval for the research use of patient tissues from the Royal Free Hospital, London 
was granted by the UCL Biobank Ethical Review Committee (Reference number 
NC2015.012). Tissue from patients undergoing liver resection for malignancy was collected 
during surgery. Following resection of the cancer and surrounding normal liver the specimen 
was placed in a bowl. Specimen were then taken for further analysis. During excision of liver 
samples for experiments, it was crucial that the oncological resection margins i.e. the area 
where the diseased liver was transected from the healthy liver during surgery was not 
compromised as this would have affected the histopathological evaluation. The maximal size 
of the specimen was tailored to fit under microscope glass slides (75 x 25mm). Frequently 
however the maximal size was limited by the available liver tissue especially in minor liver 
resections which are of a smaller resection volume. The number of excised specimen again 
was mainly dependent on the size of the resected specimen (i.e. less in smaller specimen).  
The main goal of tissue acquisition was to obtain at least one sample of healthy and 
cancerous tissue for each patient. If there was a large resection specimen or multiple tumour 
nodules, the aim was to take multiple biopsies representative of different tumour nodules 
and areas of normal liver tissue. In some patients it was not feasible to excise tissue without 
compromising the resection margin and in these cases only normal liver tissue was excised. 
For transport, biopsies were placed in a container filled with cooled (app. 4 ˚C) organ 
storage solution (KPS-1). After transport the liver samples were removed and placed on a 
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dry gauze swabs to remove excess fluid and prevent smearing between tissue and glass 
cover slip. For image acquisition samples were then placed on a translation stage that was 
covered with an incontinence sheet (dry gauze on top with water proof sheet at the bottom) 
commonly used in hospitals. Smaller samples were placed in a row and covered with one 
glass slip whereas larger samples were covered with individual glass slips (Figure 3.4)  
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Figure 3.3 Absorption spectra of endogenous chromophores. 
Plots of absorption coefficients on the y-axis against excitation wavelengths on the x-
axis for common endogenous chromophores. 
 
 
Figure 3.4 Placement of ex-vivo specimen for MSI studies. 
On the right 4 liver specimen which are covered with glass slides can be seen. On the 
left is a white reflectance standard which is used as reference point for image 
processing. 
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There are two technical challenges to accurate multispectral image acquisition (MSI). Firstly 
the wavelength used for recording, needs to be precisely controlled. Secondly a camera 
sensor which is sensitive to the wavelengths used, which are often within the invisible 
spectrum, needs to be used. For wavelength control unwanted spectra can be filtered out by 
interposing a filter between camera lens and light sensor. Alternatively an excitation source 
that emits light at a specific wavelength can be used. The type of camera sensor depends 
on the desired imaging spectrum. 
3.3.3 Specific setup of the multispectral imaging platform 
Light excitation was conferred via an optical parametric oscillator (OPO) laser that is 
tuneable within a wavelength range of 700nm-2000nm. The light signal itself was conducted 
through an optical fiber with silica-core/silica-cladding and a core diameter of 910 μm. For 
acquisition of multispectral images the wavelength was changed at 5-10 nanometre (nm) 
intervals while images were taken. An Indium-Gallium-Arsenide (InGaAs) sensor camera 
(C10633-23, Hamamatsu, Welwyn Garden City, UK) with the capability of viewing images in 
the near-infrared (NIR) spectrum with a sensitivity ranging from 950-1700nm (henceforth 
called NIR camera) was used to record images. Images were saved on the hard drive of a 
Windows 8™ laptop for subsequent processing and analysis. 
3.3.3.1 Laser excitation and tuning 
As a light excitation source the optical parametric oscillator (OPO) (VersaScan L-532, GWU-
Lasertechnik) was used. This type of laser uses a fixed laser as input source which is being 
fed into an oscillating crystal. As the oscillating speed is adjustable, the output wavelengths 
of the laser can be tuned to a desired wavelength. This OPO was pumped by a frequency-
doubled Q-switched Nd-YAG laser frequency with a wavelength of 532 nm, a repetition rate 
of 10 Hz, and a pulse width duration of 6-10 ns (Quanta-Ray INDI-40-10, Spectra-Physics). 
The idler beam of the OPO was coupled to a silica-silica optical fibre with a core diameter of 
910 µm (FG910LEC, Thorlabs). The idler wavelengths were varied by motorised rotation of 
the nonlinear crystal in the OPO. 
At maximum light intensity the laser produced an over illumination in the camera sensor (i.e. 
a completely white image). Therefore additional optical filters of 6 optical densities were 
positioned between laser source and optical output fibre to reduce light intensity. Before 
experimental use the OPO was calibrated to ensure an accurate wavelength output with an 
error margin of approximately 5nm. The robustness and validity of the calibration was 
checked at regular intervals with a spectrometer that was connected to the optical fibre. The 
calibration was renewed if there was evidence of misalignment. 
3.3.3.2 NIR camera and specimen placement 
The camera was fixed to a 150 mm x 150 mm x 12.7 mm breadboard (metal plate with 
holes) with a 25mm x 100mm optical post (Thorlabs, Newton, NJ, USA). The same 
breadboard also carried the post which held the optical fibre through which the excitation 
96 
 
laser was emitted. The breadboard itself was installed onto a 1.5” x 300mm optical post 
which enabled adjustment of the distance between camera and the specimen. The NIR 
camera connected to a Windows 8 laptop via an USB 2 port. NIR camera control and image 
recording was controlled with custom build code written in Labview™ Professional, a high 
level programming language which is widely used for the purpose of controlling physics 
instruments in a experimental environment. 
The camera was fitted with a low magnification lens (machine vision lens - Navitar, 
Rochester, NY, USA) whose focus was adjusted to achieve optimal image sharpness. The 
lens aperture was varied to identify a threshold where maximal light intensity was achieved 
while simultaneously avoiding over illumination (i.e. too much brightness). To study 
absorption behaviour of tissues it is important to reduce the amount of light that is directly 
reflected back from the tissue surface at the same angle at which the excitation light hit the 
surface. To reduce these so called specular reflections (Figure 3.5) a microscope glass slide 
was placed over specimen as described above.  
 
Figure 3.5 Example of specular reflections during MSI experiments. 
The liver specimen can be seen centrally. Specular reflections cause over saturation 
of the camera sensor which results in data loss. To standardise absorption 
coefficients a white reflection normalise was placed in proximity to the liver 
specimen. 
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3.3.3.3 Laser and camera synchronisation 
The NIR camera operated with a maximal and variable rate of 50 frames per second. The 
OPO had a fixed pulse rate (i.e. the frequency that the laser was admitted with) of 10 Hz. 
The exposure time of the camera could be varied between 0.1-15ms whereas the duration of 
the OPO light emission was fixed at 10ns. This means that synchronisation of NIR camera 
exposure and light emission was necessary to ensure that the timing of light emission 
coincided with the exposure time of the NIR camera in a reliable fashion. The OPO 
generated an output signal in the form of an electrical voltage signal which can be used to 
trigger other devices e.g. initiate image acquisition. Unfortunately the NIR camera could not 
be triggered through such a voltage signal but instead could be triggered through a software 
generated signal which had the disadvantage of being slower than a hardware signal.  
To enable a synchronisation of image acquisition and laser pulse it was therefore important 
to transform the voltage signal from the OPO into a software signal that could be recognised 
by the camera. Transformation of the voltage signal i.e. hardware trigger to a software 
trigger was facilitated by a digital input/output box (henceforth called I/O box; National 
Instruments™, Austin, TX, USA) that received the hardware signal in the form of a voltage 
threshold through BNC connectors and send the software signal in the form of a binary 
signal (on or off) to the controlling computer. Because the incoming hardware trigger voltage 
was below the 2.2 Volt (V) limit required by the I/O box, the signal was amplified via an 
oscilloscope (DPO3032, Tektronix, Beaverton, OR, USA) to raise it above the 2.2V 
threshold. The connections, signals and equipment activity was controlled and monitored 
through custom written Labview code. The Oscilloscopes 2nd channel was used to visualise 
the timing of the camera software trigger to aid in evaluating delays between hardware to 
software signal transformation (Figure 3.6). 
 
Figure 3.6 Oscilloscope for OPO light source and NIR camera synchronisation. 
Oscilloscope screen showing the OPO trigger in yellow and the NIR camera trigger in 
blue. Good synchronisation between both signals was crucial for successful image 
acquisition. 
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The transformation of hardware to software signal in addition to the execution of one cycle of 
the image acquisition algorithm took in the range of 0.4s. To accommodate for this delay, the 
maximum rate of camera triggering was forcibly reduced to 1s. This ensured that the 
preceding image was recorded and that the NIR camera was ready for the next image 
acquisition. As opposed to the Labview code, the delay caused by the signal transformation 
was inconsistent at times which lead to an approximate 15-25% loss of synchronisation and 
hence image data. Desynchronised images were under illuminated i.e. virtually black. To 
avoid recording and processing of desynchronised images, an algorithm was implemented 
into the Labview code to automatically delete images where the maximal light intensity per 
pixel fell below a certain light intensity threshold that indicated lack of illumination. The 
threshold was set at 4.000-7.000 depending on the running time of the NIR camera and 
operating wavelength of the OPO because both factors positively correlated with the 
intensity of black pixels (i.e. at higher wavelength and after longer running time black pixels 
had a higher intensity). A photo of the experimental setup is shown below to illustrate the 
workflow and components of the system (Figure 3.7). 
 
Figure 3.7 Experimental setup for MSI studies. 
Signal control and storage is controlled via the laptop. To the left the fibre holder and 
NIR camera can be seen placed above the black translation table that normally holds 
the specimens, 
 
3.3.4 Image processing 
Images were recorded as grayscale pictures in the uint16 format. This commonly used 16-bit 
deep format enables depiction of 65.536 different gray levels in an image. The image size 
was 320x256 pixels but the NIR camera originally saved image data in bytes (i.e. pixels) in 
single 81.920 long sequence of Little-endian order. The order (Big-endian vs. Little-endian) 
describes in which order the sequence must be read correctly when transforming it to other 
formats i.e. a 2D image, as was the case in these experiments. Image data was transferred 
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to MATLAB™ (MathWorks™, Natick, MA, USA) for transformation, processing and 
subsequent analysis. The sequence of pixels was initially transformed to a corresponding 
320x256 pixel image with 65.536 gray levels (uint16). Essentially the gray levels of zero and 
65.536 represented the lowest (i.e. black) and highest (i.e. white) possible pixel intensity. In 
the experimental design described here, high pixel intensity correlates with a low absorption 
in the corresponding tissue and vice versa. Because each image acquisition was repeated at 
different wavelength, the change in pixel intensity can be plotted against wavelength to 
evaluate changes in tissue absorption. This form of representing absorption coefficients, can 
also be called spectral response curve (Figure 3.8). Generally this approach could be 
applied to a region of interest that may consist of a small tissue area or the whole image. 
Alternatively a spectral response curve may be studied for a single pixel that represents a 
minute tissue area of <1mm2 (Figure 3.9). 
 
Figure 3.8 Example of a spectral response curve (SRC). 
Tissue light absorption on the y-axis is plotted against excitation wavelength on the 
x-axis to reveal the spectral response curve of a tissue specimen. 
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Figure 3.9 Spectral response curve from ROI vs. single pixel. 
Spectral response curves can be plotted from larger tissue areas consisting of 
multiple pixels or the whole image (left). Alternatively a spectral response may be 
plotted for single pixels (right). 
 
3.3.5 Image recording 
Specimen were placed on an incontinence sheet. As described above specimen were 
covered with microscope glass slides to reduce specular reflections. A white reflection 
standard was placed close to the specimen to ensure that it was exposed to the excitation 
laser to the same extent that the liver specimen were.  
Initially single images were recorded to ensure that specimen were placed centrally in the 
field of view. Following this the lens aperture was adjusted so that the maximum intensity in 
the images stayed below 16.383 intensity units (maximum of arbitrary units used by NIR 
camera). Beyond this value over-illumination (i.e. white out) occurs which results in loss of 
data. Finally background images were recorded without any illumination to determine the 
background values that were needed for the normalisation process. Once background 
values were recorded, MSI acquisition commenced. For each wavelength step at least 20 
frames were recorded to reduce the impact of outliers. Once the desired complement of 
frames was recorded, the acquisition was paused to allow a manual change of the excitation 
wavelength. This process was repeated until the pre-determined wavelength range required 
to create a spectral response curve was covered. 
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3.3.6 Colour representation of multiple spectra 
It is possible to visualise the single spectrum images in a variety of ways in an attempt to 
improve comprehensibility and mental integration of the observer. The simplest form of 
visualisation is to translate the recorded intensities and therefore the absorption 
characteristics into a gray scale image. This is straightforward and also the default option of 
the NIR camera’s standard issue software package. For improved visualisation the gray 
levels can be converted to a variety of colours and their corresponding hues. For this 
purpose, colourmaps can be employed which assign colours to numerical values, which in 
this specific case correlate with intensity levels. When using the MATLAB™ colourmap jet 
for example low and high intensities are assigned to blue and red respectively (Figure 3.10).  
 
Figure 3.10 Example of different colour maps used for MSI. 
Grayscale 16 bit image representation (left) and the equivalent image shown in colour 
(jet colourmap). 
 
Transformation into colour can perhaps be regarded as a 1:1 conversion where no additional 
data is available to the observer. It is however possible to integrate data from multiple 
spectra (Figure 3.11) into the same two dimensional image to increase the amount of data 
visualised. The only factor changing over time during MSI experiments with individual 
specimen is the wavelength (i.e. single spectra) whereas the tissues are completely 
stationary.  
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Figure 3.11 Variations in pixel intensity according to wavelength. 
Each thumbnail image shows a colour representation of the changing light absorption 
of three liver specimen at wavelengths from 1100-1690nm. 
 
It is therefore possible to combine information pertaining to multiple absorption spectra of the 
same pixel (i.e. tissue area) into a single two-dimensional (2D) image. In a perhaps 
simplified way this could be described as “squeezing” the data contained in a spectral 
response curve into a single pixel colour. There are almost limitless possibilities of 
combining the various spectra, starting with the number of wavelengths to include which 
could range from only two wavelengths up to the maximum number of 61 wavelengths used 
in these experiments. Perhaps even more important is the method of combining intensities 
from different wavelengths. Values can be combined with simple arithmetic operations such 
as addition or division (Figure 3.12). The area under the spectral response curve can be 
determined and used for false colour representation. In a perhaps more complex approach, 
intensity values at particular wavelengths could be employed as variables in an equation or 
regression analysis. 
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Figure 3.12 Example of ‘false colour’ visualisation. 
The same specimen as in figure 3.10 & 3.11 are shown here. Pixel intensities (jet 
colourmap) have been derived by dividing absorption at 1290nm/1450nm hence the 
pixel intensities can be regarded as a function of the two respective wavelengths. 
 
An approach optimised according to a statistical analysis is of utilising different false colour 
options are described in the results section. To systematically assess which wavelengths are 
the most relevant for discriminating normal liver tissue from malignant liver tissue, multiple 
wavelengths absorption coefficients have been evaluated statistically using Bland-Altman 
plotting to determine the wavelengths with the greatest discriminatory power and 
subsequently using these as covariates for inclusion into a generalised linear mixed model 
analysis The statistical methodology is further described in the Statistics part of the relevant 
results chapter. 
3.3.7 Statistical analysis 
Tissue spectra are compared by plotting pixel intensity which is inversely related to 
absorption, against changes in wavelength. As indicated either mean values or scatter plots 
are used. To facilitate statistical comparability between different experiments the intensity 
values were normalised as described in the relevant chapter (6.3.4). Normalised intensity 
values were visualised on a Bland-Altman plot to evaluate if any intensities lying outside the 
limits of agreement were associated with any particular wavelengths. Consequently, the 
normalised pixel intensities are then analysed in a generalised linear mixed model analysis 
to elucidate if intensity variations at particular wavelengths are indicative of pathological 
tissue states. The model used normalised intensity and wavelength as fixed terms whereas 
patient ID and cancer type were used as random terms. Further details about the statistical 
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model can be found below (6.3.4). Statistical analysis was performed using SPSS™ Version 
21 (IBM, Armonk, NY, USA). Statistical significance was assumed for p<0.05. 
With the exception of histological preparation of liver biopsies, all aspects of this research 
were carried out by the author. 
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3.4. Video magnification 
The experiments in this section were conducted to evaluate a video processing technique 
called Eulerian video magnification. Initially a method is developed to analyse and compare 
the signals that result from applying this technology to video. This method is then applied to 
a mechanical flow phantom and subsequently to a porcine model of laparoscopy that has 
already been described above (3.1.4.1).  
3.4.1 General concept 
The experiments outlined in this chapter are based on a work of Wu et.al (136) who have 
created a video processing algorithm called Eularian Video Magnification (VM) that was 
designed to reveal subtle changes in colour or motion that are invisible to the naked eye. In 
brief, the algorithm partitions the field of view into different sections (spatial decomposition) 
to make location of changes possible. The video then undergoes temporal filtering which 
essentially means that only signals that repeatedly occur at a given range of frequencies 
(e.g. physiologic heart rate) are selected for amplification.  
Although algorithms with similar capabilities have been developed in the past, the VM 
algorithm has the advantage of being less computationally expensive (i.e. runs faster) and it 
therefore can process videos in real time on a personal computer. This is made possible by 
measuring and amplifying changes in pixel values such as colour and brightness whereas 
previous algorithms relied on accurate motion estimation (e.g. Lagrangian method), a 
process that requires more computing power and is more prone to errors. A detailed 
description of the work underlying VM can be found here (136). 
The VM algorithm has been written in MATLAB™ (MathWorks, Natick, MA, USA) and is 
freely available from the authors (CSAIL, Massachusetts Institute of Technology). A regular 
video in MP4 or AVI format is used as input and following processing a MP4 video that 
visualises the VM induced changes is stored in MP4 format. A number of parameters can be 
adjusted within the supplied MATLAB code to control the VM processing in detail. Two 
frequency values in Hertz (Hz) determine the frequency bandwidth for video signals which 
will undergo amplification. This means that only signals that occur at a given repetitive rate 
will be amplified by the algorithm.  
A spatial frequency variable determines the level of detail that the VM (henceforth called 
video magnification - VM) algorithm will analyse. Spatial frequency can be described as the 
level of detail from a stimulus (e.g. light or contrast) that is present per degree of visual 
angle. In other words a high spatial frequency translates into a greater level of details in an 
image and vice versa. In regards to the VM algorithm a higher spatial frequency value (e.g. 
100) means that signals that fall below this level of detail are excluded from the 
magnification process. The use of filters suppresses video signals outside the selected 
spatial frequency bandwidth which has the benefit of reducing the video noise in the final 
product. The magnification factor α determines the factor with which signals within the 
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bandwidth are multiplied. In practice, higher amplification factors are able to highlight subtler 
signals but this also results in an overall noisier (i.e. more grainy) output video.  
The choice of temporal band pass filters affects the way that signals outside the selected 
frequency bandwidth are handled. These should be selected based on the desired 
application of VM. A broad band pass filter like the Butterworth filter for example exhibits a 
mildly attenuated amplification for frequencies that are adjacent to the selected frequency 
bandwidth. Amplification is increasingly attenuated the farther away the frequency lies from 
the selected bandwidth. Narrow temporal bandwidth filters like the ideal filter on the other 
hand almost completely suppress magnification of signals outside the selected bandwidth. In 
terms of application, broad temporal band pass filters are well suited for magnification of 
motion signals whereas their narrow counterparts are superior when applied to colour 
change signals. All temporal band pass filters were tested initially to select the most suitable 
filters for motion and colour magnification respectively. Filters were chosen depending on 
optimal visual results and on the fastest processing time as further described in the results 
chapter.  
Colour clipping artefacts result when colour intensity is outside the level that can be 
displayed within a frame which may be caused by excessive magnification. Some artefacts 
may be reduced by increasing the chrominance attenuation in the VM algorithm. For 
standardisation purposes the same chrominance attenuation was used for an individual set 
of image data (e.g. all videos from on patient).  
3.4.2 Flow phantom 
Flow phantoms are normally constructed from a pump that circulates fluid, a channel or 
several channels through which fluid flows, and a tissue-mimicking phantom that surrounds 
the channels (258). Below is a description of how the was constructed. The construction of 
the flow phantom for the purpose of experimenting with video magnification signals in a 
controlled environment is described in the following sections. 
3.4.2.1 Tissue component and flow channels 
Tissue mimicking models with internal structures as a substitute for blood vessels have been 
extensively used for experimental and training purposes. These models can be further 
subdivided into flow phantoms that have vessels with or without walls (wall-less vessels). A 
variety of construction methods have been described (259).  
Limitations of wall-less phantoms is their fragility e.g. they are less able to withstand higher 
pressures from flow (258,260). Because it was intended to conduct some experiments with 
high pressures, a vessel mimicking phantom that could withstand higher pressures was 
chosen for this study. Limitations for vessel mimicking phantom mostly pertain to their use in 
conjunction with ultrasound. The border between flow channel and tissue mimicking 
substance may have an unrealistic appearance on ultrasound and may impede image 
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analysis. If the model is used as a training phantom for percutaneous needle interventions 
then repeat penetrations with a needle may damage the integrity of the flow channels (260). 
Flow channels for the phantom used in this study were created by Foley catheters (hollow 
silicone tubes). The tissue mimicking substance was built from polyvinyl chloride plastisol 
(PVCP) a deformable plastic substance. PVCP has the advantage that its consistency and 
colour can be altered during the production phase. 
Urinary Foley catheters (medical use for draining the urinary bladder) were purchased from 
commercial suppliers (Tiga-Med, Ronneburg, Germany). A catheter size of 12Fr was chosen 
to construct the flow channels because preliminary tests showed that at this size catheters 
were able to withstand pressures of >400mmHg, and because their diameter (3-4mm) is 
similar to medium sized liver vessels. Smaller sizes such as 10Fr were considered as well 
but they turned out to be too fragile for manipulation during the building of the model. Clear 
catheters were used so that they could blend into the PVCP which was also of a clear 
colour. 
The PVCP used for these experiments can be treated with additives that can make it harder, 
softer or change its colour. To establish a consistency and stiffness reflects that of human 
liver tissue, 3 surgeons were asked to rank 4 mixtures of PVCP that differed in stiffness. The 
mixture that all three surgeons opted for unanimously was chosen for all experiments. 
The PVCP (Lure factors, Doncaster, UK) was purchased in its liquid form. For solidification 
the PVCP was heated at 200˚-250˚ C for 20-30 minutes. During this process its colour 
changes from a milky opaque to a colourless translucent appearance. Heating was carried 
out on a laboratory heater-stirrer under a fume hood. On completion the liquid was poured 
into a rectangular plastic container for cooling. Once cooled sufficiently, holes were drilled at 
corresponding heights at either end of the plastic container to prepare it for insertion of the 
silicone catheters. A tract for the catheter was created by pushing a knitting needle through 
opposing holes. A guidewire was then inserted into the catheters to provide some stiffness 
and steerability during insertion. Subsequently catheters were inserted along the previously 
created needle tract crossing over from one end of the container to the other. In some cases 
the surface of the tissue model was inadvertently damaged while advancing the catheters. 
Smaller defects were repaired by adding an additional layer of PVCP onto the disrupted area 
(Figure 3.13). 
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Figure 3.13 Clear flow phantom. 
The completed flow phantom containing two Foley catheters (arrow) that are 
surrounded by clear PVCP. 
 
Several tissue models with different catheter positions which were altered depending on the 
experimental setup were created. For preliminary experiments a model with one catheter 
tract was used initially. Two catheters inserted side by side were used to study the presence 
of a perfusion signal versus a control standard. To study the effect of tissue depth on 
perfusion signal strength, three catheters were inserted, one just below the surface and then 
at app. 2 cm depth and 4 cm depth.  
All initial experiments were conducted with a clear PVCP mixture to measure non-concealed 
VM signal strength. To create a tissue model that closer resembles the colour of human 
livers, a brown mixture was created from black, brown, red and yellow colour additives. This 
colour was added to a tissue model which had two catheters side by side (Figure 3.14) 
(same as shown in Figure 3.13). 
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Figure 3.14 Brown flow phantom. 
A brown coloured flow phantom was created to study how colour and opacity affects 
motion related VM signals. Because the flow channels are not visible, two yellow 
markers were placed at the left side of the screen to facilitate selection of the correct 
region of interest for statistical evaluation. 
 
3.4.2.2 Perfusion circuit 
Circulation of fluid was facilitated by a metering pump powered circuit that was constructed 
with the option to adjust flow rates and pressures. The basic principle was that fluid was 
taken from a container and propelled through this circuit by a pumping mechanism. The 
circuit was connected to the catheters which were embedded into the tissue model. 
Following perfusion through the catheters the fluid drained back into the container to be 
available for further re-circulation . 
An electronic metering pump (LPJ7E2, E-Series, Pulsafeeder, Punta Gorda, FL, USA) was 
used to create flow within the circuit. The pump comes with adjustable stroke rate of 5-125 
beats per minute (bpm) and output pressure of 1.1-5.5bar. Solenoid operated metering 
pumps create pulsatile flow with an inflow phase during which fluid is suctioned into the 
pump from a reservoir and an outflow phase during which the pressurised fluid is discharged 
through the efferent tubing. This characteristic makes metering pumps suitable to simulate 
flow conditions similar to that of the cardiac cycle with the inflow phase and outflow phase 
corresponding with the diastolic and systolic phase respectively. The advantage over roller 
pumps is that the stroke frequency and pressure can be adjusted to closely resemble 
physiological conditions (258). Connectors on the pump enable attachment to standard 3/8” 
tubing via plastic National Standard Pipe Thread (NPT- screw tightening) adapters.  
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The minimum pump output pressure of 1.1bar translates into approximately 825mmHg and 
therefore pressures needed to be reduced further to bring them into the physiological range 
between 50-250mmHg. This was facilitated by inter-positioning a pressure dampening fluid 
reservoir between metering pump and flow phantom. The reservoir was constructed from a 
25ml serum pipette that was inserted into a T-piece connector that enabled connection to 
the rest of the flow circuit. A stopcock was fitted to the upper end of the pipette which made 
it possible to adjust the amount of fluid and air within the pipette. The ratio between air and 
fluid in the reservoir has an influence on circuit pressures. If the reservoir is devoid of fluid 
(i.e. filled with air), the amount of outflow pressure reduction is at its greatest. Pressure 
reduction moves inversely to the amount of fluid in the pipette. An additional effect is that the 
circuit pressure during the inflow phase drops off less quickly. So in essence the “systolic” or 
outflow pressure can be adjusted with the aid of the reservoir. The “diastolic” or inflow 
pressure can be adjusted with a pinch valve installed distally to the flow phantom (i.e. in the 
outflow limb). Increased pinch pressure reduces the outflow diameter and hence increases 
flow resistance according to the Hagen- Poiseuille law. Increased resistance affects the 
circuit by increasing pressure and flow velocity during the inflow phase. There is also an 
effect on circuit pressure during the outflow phase. 
Pressures were measured continuously by connecting a pressure meter (Comark, Milford, 
MA, USA) to the circuit via a T-piece connector. Flow was measured when required with a 
Flowmeter (Transonic, Ithaca, NY, USA) that utilised ring-shaped Doppler probes that 
encircled the flow tubing. To establish how flow and pressure within the circuit were affected 
by pump and reservoir settings, calibration experiments were carried out initially. During 
these experiments a combination of different settings for pump pressure, pump stroke 
frequency, reservoir filling and outflow resistance were studied and the resulting flow rates 
and circuit pressures were recorded (Figure 3.15).  
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Figure 3.15 Complete flow phantom setup during experimentation.  
1 – Fluid reservoir; 2 – Solenoid pump; 3 – Perfusion tubing; 4 – Camera on 
adjustable arm; 5 – Flow meter; 6 – Adjustable reservoir (pipette with stopcock); 7 – 
Pressure meter; 8 – Tissue phantom with flow channels 
 
3.4.2.3 Camera setup 
It was hypothesised that a maximum of image details in terms of resolution, contrast, motion 
and colours would result in richer video magnification signals. To enhance data extraction a 
research grade multi-pixel camera (Grasshopper GS3-U3-32S4C-C, FLIR Integrated 
Imaging Solutions Inc. – formerly Point Grey, Richmond, BC, Canada) with a high frame rate 
and image resolution was therefore chosen for flow phantom experiments. At maximum 
settings, a resolution of 2048x1536 pixels can be recorded at a rate of 121 frames per 
second (fps). The camera was connected to a standard windows computer via a USB3 port. 
Company issued software (Flycap2™) was used to record video sequences at maximum 
resolution and 30 fps. All sequences were recorded in the AVI file format at a running length 
of 7 seconds (s). This duration was chosen because the file size was limited to 2 gigabyte by 
the recording software which corresponded to a video duration of 7s at a desirable resolution 
and fps combination. In preliminary experiments no detrimental effect in VM signal quality 
was found in relation to video duration at lower video resolutions that enabled recording of 
longer periods. 
3.4.3 Porcine study 
3.4.3.1 Concept 
The underlying hypothesis is that VM signal strength or quality would be influenced by the 
presence of circulation and associated blood vessel motion during pulsatile flow. An animal 
model was chosen to compare VM signals from a number of organs including the liver 
during presence of blood flow intraoperatively and the absence of flow following euthanasia.  
1 
2 
3 
4 
5 
6 
7 8 
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3.4.3.2 Camera and recording 
An experimental model of porcine laparoscopic liver resection was used to sequentially 
record data for CLE and VM experiments. For a description of the model please see above 
section on CLE imaging. VM data was recorded prior to CLE data. A stereo-laparoscope 
(Conmed – formerly Viking, Utica, NY, USA) was used for recording of sequences. Data 
from only one of the two laparoscope channels was processed for experiments. The channel 
with the best image quality (i.e. no smears or smoke causing visual occlusion) was chosen 
for processing. During recording the laparoscope was held in a stable position with both 
hands to reduce the amount of involuntary tremor that is common with laparoscopic videos. 
No mechanical laparoscope clamp was used. Sequences were recorded in H264 format at a 
resolution of 1920x1080 pixels and subsequently converted to MP4 format for further VM 
processing. File conversion was carried out using a non-commercial software programme 
(RipBot264, Freeware written by Atak Snajpera). 
3.4.3.3 Impact of motion on VM signals 
All sequences were recorded before and after euthanasia to evaluate if the cessation of 
circulation had a measurable impact on VM signal strength. It was anticipated that 
extraneous motion i.e. image tremor from holding the laparoscope and respiratory motion of 
the diaphragm would also influence VM signals. Therefore several sequences were 
recorded during brief apnoeic episodes of no more than 5s and then repeated during regular 
ventilation. The VM signals extracted from these sequences were then subsequently 
compared to each other. 
Laparoscopic ultrasound doppler signals were recorded during some of the experiments to 
verify the presence of flow in the organ areas that were recorded for VM signal processing. 
Further doppler signals were recorded following euthanasia to verify the absence of blood 
flow.  
3.4.3.4 Experimental design 
To develop and test a quantification method for VM signals, a number of experiments were 
conducted that compared motion signals using the following experimental designs.  
In flow phantom experiments, different areas in the same field of view (ROI’s) were 
compared t each other. This was useful because perfusion and pulsation could be 
deliberately controlled. In the porcine experiment, two separate videos were recorded from a 
standardised scenario (e.g. laparoscopic view of the liver) during the presence or absence of 
perfusion (Figure 3.16). 
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Figure 3.16 Experimental design structure for video magnification studies.  
 
3.4.4 Use of the Gray level co-occurrence matrix for motion signal 
quantification 
Quantification of motion signals could not be measured by simply plotting variations in pixel 
intensity as described previously (136) because the intensity of a pixel representing a 
moving object may or may not change with the extent of movement. Popular methods of 
estimating motion in video such as the use of a Kalman filter or Lucas-Kanade optical flow, 
work by tracking the change of object position over several video frames. Magnified motion 
signals however reveal themselves as a repetitive change in texture or outline of edges. 
Therefore applying the aforementioned methods to motion estimation in VM is problematic 
because there are no clearly identifiable objects that can be tracked. A more recently 
proposed method of motion estimation is based on the analysis of image texture through 
utilisation of the gray level co-occurrence matrix (GLCM). The GLCM can be regarded as a 
representation of the spatial relationship between pixels of an image that have been ordered 
into groups according to their grayscale intensity. The number of gray levels and spatial 
relationship to neighbouring pixels (e.g. horizontal direct neighbour or vertical 3 pixels distant 
neighbour) can be specified individually (Figure 3.17). It has been demonstrated previously 
(261) that temporal changes in the GLCM (i.e. image texture) can be used to estimate 
motion in video sequences. Statistics derived from a GLCM such as Energy, Homogeneity, 
Contrast and Correlation allow quantification of these temporal changes and these statistics 
will be employed in this work to measure and compare VM motion signals. 
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Figure 3.17 Example for variation in pixel offset for GLCM processing.  
The pixel of interest may be compared to its direct neighbour or pixels that are further 
distant. The spatial relationship is further defined by neighbourship direction on a 
horizontal, vertical or diagonal plane (262). (reprinted with permission from Elsevier, 
copyright 2014) 
 
3.4.4.1 Selecting regions of interest 
With a few exceptions, VM signals in a video sequence are not represented throughout the 
whole field of view. Therefore it is necessary to focus evaluation and quantification of signals 
on a defined region of interest (ROI) such as the liver surface on a laparoscopic video for 
example. To facilitate VM signal assessment in ROI’s, a MATLAB function was created to 
define and retrieve image data (henceforth referred to as “grabbing”) from a fixed region of a 
video sequence. In essence the retrieved data can be regarded as a cut-out “mini-video” that 
is part of the original video sequence (Figure 3.18). The colour and motion VM signals in the 
grabbed data were subsequently analysed using the methods outlined above. For 
standardisation purposes, fixed ROI dimensions were used for statistical comparison of 
signals from the same video or from the VM and control video as appropriate. 
 
Figure 3.18 ROI marking in laparoscopic video 
A ROI is marking a superficial liver tumour at the bottom edge of the liver. For 
subsequent image signal processing only signals from the ROI are processed. 
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3.4.4.2 Quantification of motion signals 
The GLCM statistics were processed in the following manner. Initially two ROI’s of identical 
dimensions were marked in regions were motion quantification was intended. Usually this 
involved one region with pulsatile motion and one region without, in flow phantom studies. In 
the porcine experiment identical ROI’s from different videos were evaluated as described 
above. The video data from each ROI was stored separately and subsequently underwent 
transformation into 8bit grayscale format to enable GLCM processing. Consequently, the 
GLCM parameters: Energy, Correlation, Homogeneity and Contrast were extracted for each 
ROI. To facilitate comparison, GLCM statistical values were plotted against time in a 2D-
coordinate system (Figure 3.19). In addition mean, median and standard deviation were 
calculated for the entire ROI window and visually compared using bar charts (Figure 3.20). 
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Figure 3.19 Plot of GLCM statistics. 
GLCM statistics, measured on a perfused flow phantom, plotted over time. The top 
row shows the ROI's marked on the screen. In this experiment a third ROI was marked 
as control. 
 
Figure 3.20 Mean GLCM statistics. 
Mean GLCM statistics from the same experiment as figure 3.19 presented as bar 
charts of the mean values over the whole period. 
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3.4.4.3 Statistical analysis 
Group values are stated as median ± IQR. The distribution for GLCM statistical values was 
evaluated with the Shapiro-Wilks test and found to be non-parametric. Therefore the 
Wilcoxon-sign or Kruskal Wallis tests were employed to compare groups as appropriate. 
Binominal regression analysis was used to elucidate if GLCM statistical values were 
independent predictors for the presence of motion. The variable selection method ‘Enter’ 
was used for the regressions analysis. Finally ROC analysis was carried out to determine 
the diagnostic accuracy of GLCM statistics for indicating presence of flow. As indicated 
below the GLCM statistics or their respective gain values are correlated with the presence of 
flow (perfused catheter vs. control catheter). Optimal sensitivity and specificity values were 
chosen arbitrarily, based on the highest combined values for sensitivity and specificity from 
an output table that summarises the relationship of these parameters as seen in the ROC 
curve. Depending on the scientific question a different cut-off point can be selected. For all 
tests, statistical significance was assumed at p<0.05. Statistical analysis was performed 
using SPSS™ Version 21 (IBM, Armonk, NY, USA). 
The author helped with carrying out the surgery in the porcine laparoscopic model. All other 
experimental procedures were performed by the author himself. 
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3.5. Image guided surgery 
Experiments related to the development of an image guidance system for laparoscopic liver 
surgery were carried out on the porcine model already described above (3.1.4.1). Once the 
system had matured sufficiently, it was evaluated in a clinical feasibility study, where its 
performance in terms of imaging accuracy in a real surgical setting could also be assessed.  
3.5.1 General principle 
Intraoperative image guidance facilitated by the use of an image guidance system (IGS) is a 
technology that is widely used in neuro- and spinal surgery and more recently has created 
considerable interest for laparoscopic applications (128,129,141,210). In essence an IGS 
allows the surgeon to view structures that can be seen on preoperative scans but that are 
not visible with a laparoscopic camera (128). This is highly desirable in LLR because it 
enables the surgeon to localise crucial subsurface structures such as tumours or blood 
vessels in real-time. This approach of combining virtual data in the form of a computer 
graphic with real life images from a video feed is also called augmented reality (AR).  
The IGS consist of 3 key components or processes, namely: 1) 3D modelling and planning - 
to create a virtual representation of individual patient anatomy 2) registration and tracking - 
to align “virtual” and real anatomy and 3) Visualisation - to make the information 
interpretable to the surgeon. The individual processes are outlined in greater detail below. 
3.5.2 IGS development and evaluation in a porcine model 
The IGS (prototype named SmartLiver) used in these experiments was developed by a 
collaboration of clinicians and computer scientists at University College London. All IGS 
software component s with the exception of the 3D model creation process were developed 
de-novo by this team. In contrast to this the hardware components (e.g. laparoscopic 
camera, infrared tracked objects etc.) are all commercially available. The author of the thesis 
contributed significantly to this work at certain development stages, namely the preclinical 
(porcine experiments) and clinical stages, and will therefore present results from this 
collaboration within the relevant chapters. There was no author involvement in the technical 
development stage which included the creation and testing of an IGS hardware and software 
platform, but since the underlying concept is important to understand the experiments below, 
a brief summary of the technical phase will be provided here.  
The SmartLiver software system has been assembled from a number of independently 
developed software components that each control individual tasks such as e.g. visualisation, 
tracking control or registration. To transform and integrate the single components into a 
working system the NifTK software platform was used (263). The advantage of the platform 
is that it excels in streaming stereoscopic video and tracking data simultaneously which 
means it is well placed to form the basis of a laparoscopic IGS. New software components 
were evaluated on a silicon liver imaging phantom (data not included in thesis as author did 
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not partake in these experiments) to ensure a robust and fluent performance before being 
transferred to in-vivo experiments (Figure 3.21).  
 
Figure 3.21 Silicone liver phantom. 
A liver phantom was created from silicone to emulate the subtle surface features of 
the human liver. The phantom was used to evaluate the SmartLiver in an ex-vivo 
setting. 
 
One of the novel aspects of the IGS presented here is the use of stereoscopic surface 
reconstruction to automatically register 3D model and patient liver. Because processing 
speed for real time stereoscopic surface r is crucial, the first step was to create a computer 
algorithm that made use of fast parallel computing which is based on graphics processing 
units (GPU) that are commonly found in computer graphics card. The main advantage is that 
complex problems can be computed simultaneously as opposed to computer processor unit 
(CPU) based applications that use a sequential mode. To achieve this, the computer vision 
method of matching propagation was adapted to process multiple high resolution frames, an 
approach which overcomes essential restrictions on parallel data processing and therefore 
enabled a GPU implementation of the algorithm. The underlying work does not form part of 
this thesis and has been described in detail previously (264). 
As an alternative to surface based reconstruction, a manual registration algorithm was also 
implemented into SmartLiver. Manual registration is based on moving a hand-held tracked 
object in which acts as a representative of the 3D liver model. Movement in the real world is 
translated into movement on the screen until a satisfactory position is achieved, which can 
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be locked and remain in place until the liver is manipulated which may require a further 
registration cycle. Although this approach proved useful in the preclinical phase it was 
complicated to use in the clinical study due to operating sterility issues. Therefore an 
additional option to carry out manual alignment with a graphic user interface (GUI) was 
implemented. At the later stages of the clinical study a GUI for SmartLiver was written which 
substituted system control via the NiftyK programme and made it amenable for use by non-
technicians. The testing and integration of infrared tracking system, the stereo-laparoscope 
and the CT acquisition for the creation of 3D models is described in detail below.  
3.5.2.1 Experimental workflow 
A detailed description of the porcine model has been provided above (3.1.4.1). On the first 
day (OP1), ablation zones were created to simulate liver tumours. A CT scan was obtained 
while the pig remained under general anaesthetic and the data from this scan was 
transformed into a 3D model of the liver. Following the 7-10 day recovery period, the animal 
underwent a second laparoscopic operation that either was purely exploratory (i.e. no 
procedure was carried out) or that included a laparoscopic left hemi-hepatectomy as 
described above (OP2). During this 2nd operation the 3D model was registered to the porcine 
liver as seen on the laparoscopic screen which enabled the creation of an augmented reality 
environment. Data recorded during the 2nd procedure was subsequently analysed to study 
organ motion, deformation, overlay accuracy and to compare different methods of 
registration (manual vs. surface based registration). Following termination the 
pneumoperitoneum was maintained while a cone beam CT (GE healthcare, Chicago, IL, 
USA) of the porcine liver was obtained post-mortem to quantify postoperative liver 
deformation. 
3.5.2.2 Intraoperative CT scans and 3D model creation 
Prior to any abdominal surgery being carried out, central venous access was established to 
facilitate injection of intravenous contrast. This was achieved through a cut-down to the 
internal jugular vein and insertion of a 16G central venous line into the proximal portion of 
the internal jugular. The distal end of the vein was ligated immediately after insertion of the 
line. Contralateral internal jugular veins were used for access on OP1 and OP2. After 
removal of the line on OP1 the proximal end of the vessels was ligated as well.  
A total of five CT scans were acquired for each animal. Two triple-phase CT’s with 
intravenous contrast were taken on OP1 and OP2; one with a fully inflated 
pneumoperitoneum (10-12mmHg) and one with the pneumoperitoneum deflated (<5mmHg). 
These scans provided the basis for 3D liver models representing the organs shape with and 
without soft tissue deformation caused by increased intraabdominal pressure. Timing of 
scans was immediately after liver ablation on OP1 and after establishing the 
pneumoperitoneum on OP2. To facilitate imaging, laparoscopic ports were disconnected 
from the insufflators but kept close to maintain positive intraabdominal pressure. Animals 
remained under general anaesthetic and were then transported to a mobile CT scanner unit 
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(Name of company). Following CT scanning under insufflation, the laparoscopic ports were 
opened and a second CT scan was carried out in a deflated state. Triple phase CT’s 
rendered arterial, venous and non-contrast liver image volumes at 2.5mm slice thickness. 
Following termination on OP2, a cone beam CT (company and parameters) without contrast 
was acquired post mortem to assess the amount of deformation caused by liver resection. 
CT data was then submitted to the visible patient service provided by IRCAD™ (Strasbourg, 
France) (265) which created a 3D computer model depicting the livers vascular and biliary 
anatomy in relation to the ablation zones. The resulting computer model was loaded onto a 
custom made software platform (263) that was used as an experimental user interface for 
processing the image overlay and recording of resulting imaging and accuracy parameters. 
3.5.2.3 Theatre layout 
The surgeon was positioned on the right side of the operating table for most of the 
procedure.  In addition to the laparoscopic monitor, two screens displaying to composite 
image overlay were positioned on either side of the operating table. The optical tracker was 
mounted onto a mobile, telescopic tripod system that could be adjusted in height to obtain a 
free line of sight of the tracking markers. In most instances an optimal position was achieved 
on the left top-end of the table. A wheeled stack containing a computer and video capture 
equipment was positioned on the left periphery of the operating theatre and connected to 
laparoscopy stack, additional screens and optical tracker via cables. The position of this 
stack was altered as required so as not to interfere with the surgical procedure. 
3.5.3 Clinical evaluation 
3.5.3.1 Description of the clinical image guidance system 
3.5.3.1.1. Virtual 3D liver model 
The 3D models used in this study (Figure 3.22) were reconstructed by Visible Patient™ 
(Strasbourg, France). In brief, the 3D models were produced from a contrast enhanced CT 
with a slice thickness of 0.5-3mm, which was carried out as part of routine clinical practice 
for staging of patients with suspected hepato-pancreato-biliary cancers. Patients were 
consented in outpatient clinic and their scans were retrieved from the hospitals imaging 
database. Subsequently images were transferred securely and anonymously to Visible 
Patient™. Maximal processing time for the 3D models was within a time frame of 5 working 
days. 
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Figure 3.22 Example of a 3D liver model as used in the clinical study. 
A 3D model showing the anatomical relationship of hepatic vasculature (hepatic 
veins, light blue - thick arrows, portal veins, dark blue – thin arrows; arteries, red - #) 
and liver tumours (green - *) is created in the first stage of the image guidance The 
semi-opaque brown volume delineates the outer margin of the liver parenchyma. 
 
3.5.3.1.2. Tracking 
Tracking was achieved by attaching passive infrared reflecting markers to the laparoscope 
prior to surgery (Figure 3.23). Intraoperatively, the position of these markers was then 
continuously recorded with a Polaris Spectra™ optical tracking camera (NDI Medical, 
Waterloo, Canada) which was positioned in the proximity of the operating table. Because 
SmartLiver provides AR visualisation (i.e. integration of real world video and virtual world 3D 
modelling), there is no need to track or calibrate surgical instruments as their positional 
relationship with the 3D model can be appreciated throughout the procedure. 
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Figure 3.23 Position of tracking markers on the stereo-laparoscope. 
Intraoperative configuration of passive reflective optical tracking markers installed 
onto a stereo-laparoscope. 
 
3.5.3.1.3. Registration 
SmartLiver was designed to enable either a manual or an automatic registration between the 
liver model produced from the pre-operative CT scan and the laparoscopic visualisation of 
the liver at surgery. Manual registration is facilitated by using the graphical user interface 
buttons on a touch screen monitor (Figure 3.24) to manipulate the 3D model into an 
anatomically appropriate position. The automatic registration mode utilises a computer vision 
technique called stereoscopic surface reconstruction (SSR) which recovers 3D geometry 
optically (208,264). In essence, the right and left channel of a 3D laparoscope (IMAGE 1S - 
TIPCAM, KARL STORZ, Tuttlingen, Germany) are used to triangulate the geometry of the 
visible liver surface. This geometric data is transformed into a cloud consisting of several 
hundred thousand points which represent the in-vivo liver surface shape Figure 3.25). Point 
clouds constructed from multiple views of the liver are composited using the tracking 
information from the Polaris tracking system. The point clouds are then resampled (i.e. 
points are combined to reduce their number) to several thousand points to make them 
computationally manageable. A corresponding point cloud is generated from the surface of 
the 3D liver model and subsequently both point clouds are computationally aligned with each 
other (i.e. registration process) using the iterative closest point (ICP) algorithm. Optimal 
alignment is calculated by minimising the residual error between 3D model and in-vivo liver 
surface. Our group has previously refined this registration method and demonstrated its 
feasibility in a porcine model of laparoscopic liver resection (172,264). 
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Figure 3.24 Touch screen control of the registration process. 
The 3D model can be registered to the laparoscopic video stream via touch screen 
buttons. 
 
 
Figure 3.25 Point cloud used for ICP based registration. 
The point cloud can be seen as yellow dots that outline a surface that is a close 
match to the 3D liver model outline. 
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3.5.3.1.4. Integration of the IGS into the operative workflow 
The SmartLiver system consists of a mobile stack that contained all the required hardware 
and software components, a separate high definition (HD) screen and an additional flexible 
arm attachment for the positioning of the optical tracking camera (Figure 3.26). The 3D 
laparoscope system which has its own HD screen was kept on a separate factory-issue 
stack.  
 
Figure 3.26 IGS setup in theatre. 
The optical tracking camera attached to an adjustable arm can be seen on the right of 
the image. The laparoscopic screen showing a video feed without the 3D model 
overlay is further to the left. 
 
In general, the setup process can be divided into a pre- and intraoperative phase. Prior to 
surgery both stacks were moved into the operating room and connected to each other using 
a DVI to SDI image splitter (ROI™ Mini-Converter, AJA, Grass Valley, USA). Subsequently, 
the SmartLiver system was initialised and the patient specific 3D model was loaded onto the 
platform. At completion of the anaesthetic induction the tracking camera was positioned at 
the head end of the operating table at approximately 160-190cm height to obtain an 
unobstructed line of sight of the laparoscopic camera with mounted trackers. Intraoperative 
setup commenced with the installation of the custom made collar bearing the tracking 
markers, onto the case of the laparoscopic camera. Tracking attachments were not sterilised 
and hence were covered with a sterile sheath to allow intraoperative handling. Subsequently 
a calibration procedure according to the Zhang (266) chequerboard method or in later cases 
according to our own “cross-hair” method (267) was carried out to adapt the system to the 
position of the tracking markers.. In practice the calibration involved filming of a standardised 
graphic figure from different angles. Once successful calibration was confirmed the 
recording of study data commenced. 
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3.5.3.2 Clinical study 
The study was approved by the local research ethics committee (Reference: 14/LO/1264 & 
10/HO720/87 and registered with ISRCTN (ID: 77923416). Patients who were 18 years or 
older undergoing staging laparoscopy or laparoscopic liver resection were eligible for 
inclusion in the study. Initially it was planned to only include patients undergoing LLR but 
because patients undergoing a staging laparoscopy offered the same potential for assessing 
SmartLiver, it was decided to include patients undergoing staging laparoscopy. 
Demographic patient information and perioperative data including operative time were 
recorded for all patients. In addition to these the conversion to open surgery rate, serious 
perioperative incidents, significant intraoperative blood loss, postoperative complications 
(Clavien-Dindo grade), resection margin status and length of hospital stay were also 
recorded for LLR patients. Significant intraoperative blood loss was defined as a requirement 
for intra- or postoperative blood transfusion or a reduction in postoperative haemoglobin 
level of ≥3g/dl compared to preoperative levels. Ethical approval allowed evaluation of the 
IGS, but surgeons were not permitted to use the displayed information to adjust 
intraoperative strategy. 
3.5.3.3 Task description and endpoints of the clinical evaluation 
The aim of the study was to assess the feasibility of using the SmartLiver system for 
intraoperative image guidance, to evaluate how accurately the 3D model represented in-vivo 
anatomy and to assess usability. The primary endpoint was defined as a successful 
registration resulting in an augmented reality display of 3D model and laparoscopic video 
feed. Secondary endpoints were the anatomical accuracy of the AR display, usability 
evaluation and the occurrence of critical incidences. Additionally, postoperative outcome 
data for patient that underwent LLR was also recorded.  
The protocol for intraoperative data collection included the following steps. After the 
calibration was completed the laparoscope was inserted into the abdomen to record liver 
surface points individually from the anterior left and right hemi-liver. To prevent loss of 
surface data the laparoscope was moved at a slow and steady pace in an attempt to cover 
the entirety of each lobes anterior surface. To facilitate manual registration, the laparoscope 
was kept stationary focusing at anatomical landmarks of the right or left lobe such as the 
liver edge or the porta hepatis. While the surgeon handled the laparoscope one of the 
technical developers carried out the manual registration. 
For the first patient registration was carried out intraoperatively to confirm the functionality of 
the system. The complete duration of the intraoperative data collection protocol was found to 
be in the range of 20-30 minutes. It was felt that this was too much time to add to a staging 
laparoscopy. To save time it was decided to focus solely on intraoperative data acquisition 
for the subsequent patients and to carry out the registration process after surgery. For 
standardisation purposes this approach was also maintained for LLR patients recruited to 
the study. 
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3.5.3.4 Clinical usability evaluation 
A usability survey was drawn up by the research group with the aim of obtaining surgeon 
feedback on the systems usability. The questions were drawn up to guide the ongoing 
development of SmartLiver and to allow workflow adjustments if necessitated by clinical 
requirements. Following completion of each procedure, surgeons were asked to fill out the 
usability survey which was focused on system ergonomics and user friendliness. Seven 
standardised questions were scored on a Likert scale from 1-5. In addition there was space 
on the survey to provide suggestions for improvements.  
3.5.3.5 Analysis of imaging accuracy 
Due to the lack of any standardised methods for assessing the imaging accuracy of AR 
based IGS, our group has previously proposed a novel evaluation method which was also 
employed in this study (172). In summary the method utilises the 2D distances between 
corresponding anatomical landmarks on the laparoscopic video and the 3D model (Figure 
3.27). Therefore the landmark position on the video can be regarded as the gold standard 
because it reflects the true position of liver anatomy as perceived by the surgeon. The 
accuracy for each relevant landmark is typically evaluated over multiple video frames to 
account for intra-patient variation. Finally the root mean square (RMS) value of all individual 
distance errors in millimetres is calculated to provide a meaningful estimate of the target 
registration error (TRE) for each patient.  
 
Figure 3.27 Anatomical landmark based accuracy estimation. 
Distance between patient anatomy (blue landmarks) and 3D model anatomy (green 
landmarks) is measured to determine the registration error. 
 
It is important to consider that due to current technological limitations, IGS depend on the 
static and rigid 3D models which do not change position or shape to reflect the physical 
forces exerted on the liver by respiratory motion, cardiac motion, increased intra-abdominal 
pressure or surgical manipulation. Therefore the TRE consists of three surgically relevant 
key components, namely the errors introduced by registration, motion and deformation. To 
provide an estimate of how much each of these components influences the final TRE, an 
assessment of motion error and deformation error is stated in addition to the overall TRE. 
The median and interquartile range of the motion error is stated in mm and was calculated 
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by plotting the maximum positional change of each video frame based landmark over time. 
Essentially it can be regarded as a measure of how much the liver moves in relation to the 
theatre environment. The deformation error in contrast to this measures how much the liver 
changes shape during surgery. It is calculated by observing to what extent the distances 
between different anatomical landmarks change over time. The landmark distances on the 
3D model serve as a gold standard. In parallel with the TRE, overall deformation is 
expressed as root mean square in millimetres.  
The author of this thesis was not involved in ex-vivo experiments on the silicon liver 
phantom. For the data acquisition during porcine experiments and clinical study he worked 
jointly as part of a research team. Analysis of the clinical data was carried out by the author 
with some assistance (provision of customised software modules) from the computer 
science members of the research team. 
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4. Identification of Liver Metastases with Probe-Based 
Confocal Laser Endomicroscopy at Two Excitation 
Wavelengths  
4.1. Introduction 
Colorectal cancer is one of the most common cancers globally, being the third most 
commonly diagnosed cancer in men and second most common in women 
(16)￼(268)￼(269)￼(270).  
Surgical resection of solid tumour metastases is the preferred treatment for curative intent 
(271,272), resulting in 5-year survival rates approaching 60% (270). Incomplete tumour 
resection occur in up to 17% of cases and detrimentally affect patient survival (273,274). 
Macroscopically, colorectal cancer liver metastases (CRLM) usually exhibit a white 
appearance that makes larger nodules easy to distinguish from normal liver tissue, which 
appears brown.  
Unfortunately, visual assessment is insufficient to confirm complete tumour excision. 
Although intraoperative ultrasonography (IOUS) and bi-manual palpation are frequently used 
to determine tumour location within the liver, this approach is not suitable to identify residual 
cancer following resection because it is mainly of a microscopic nature (275,276). 
Identification of residual disease using histopathology is not feasible during liver resection. 
An imaging modality that can confirm or refute the presence of malignancy within liver tissue 
at a microscopic level would therefore be helpful in ensuring complete resection, reducing 
the amount of liver tissue resected, or to avoid an unnecessary excision if cancer can be 
excluded (277).  
Other imaging modalities such as cone beam CT, magnetic resonance imaging and near 
infrared fluoroscopy may be able to enhance imaging during liver surgery, but none of these 
modalities provides an image resolution that would enable identification of residual disease 
at a microscopic level (229,278,279).  
Optical imaging modalities offer micrometer scale image resolution but at this stage only 
optical coherence tomography (OCT) and confocal laser endomicroscopy (CLE) are 
available in compact designs that make an intraoperative application feasible. Either imaging 
modality can visualise liver tissue ex-vivo, but only CLE has been extensively studied in an 
in-vivo setting (176,280–282). When employed in a compact design, CLE has a better lateral 
resolution than OCT at 1.4µm vs. 7µm (283). This is an important advantage of CLE which 
may allow imaging at subcellular level in greater detail. CLE can be performed with a bulkier 
rigid endomicroscope which contains the required optics in its tip (146) or with a thin, flexible 
fibre based endomicroscope that conducts the excitation laser and transmits signals to an 
external laser scanning unit (248,282). For the latter, a commercially available solution is the 
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Cellvizio™ system (Mauna Kea Technology, Paris) which can be used in conjunction with 
fibre-optic probes ranging from 0.3-4.5mm diameter. 
Studies comparing confocal laser endomicroscopy (CLE) with standard histology in animal 
models, have proven its ability to visualise the cellular architecture of tissues, thereby 
providing a method of obtaining virtual, in vivo histology in real-time (281,284). In clinical 
practice, probe based confocal laser endomicroscopy (CLE) is licensed for the endoscopic 
diagnosis of gastrointestinal, bronchial and urinary malignancy and dysplasia. Depending on 
the tissue type, diagnostic accuracy is in the range of 86-91% (249,285–287). Recent 
reports suggest that CLE may also be a useful tool for the detection of breast and head and 
neck cancers (288,289)  
4.1.1 Aims 
The specific aims in this chapter are: 
1) describe virtual histology of normal murine liver on CLE examination using 
fluorescein at 488nm and indocyanine green at 660nm illumination. 
2) describe virtual histology of liver metastasis in this murine model and examine blood 
circulation characteristics in its tissue, using the same CLE imaging technique as in  
3) assess the ability of CLE to predict the presence of normal vs. cancerous liver tissue 
based on fluorescence intensity variations. 
4.2. Methods 
General and specific methodology has already been described above (3.1.3). It was felt to 
be advantageous for ease of reading to avoid separating the methodology across chapters. 
4.3. Results 
4.3.1 Test sample size  
The orthotopic CRLM model was established in 8 mice. One animal died before any CLE 
measurements could be carried out. The remaining 7 mice underwent CLE examination. In 
two animals the tumour burden relative to normal liver was too great to allow meaningful 
statistical comparison. Two animals died during image acquisition; one (ID6) before 
sufficient data at either wavelength could be collected and a further animal following 
completion of CLE imaging with fluorescein at 488nm (ID7). In summary 6 animals 
underwent consequential CLE imaging and of these, 4 (fluorescein / 488nm) and 3 (ICG / 
660nm) experiments provided sufficient data for statistical analysis.  
4.3.2 Evaluating normal liver at 488nm wavelength with fluorescein 
Examples of CLE images and H&E histology for normal and CRLM tissue are shown below. 
Each example is from the same animal but due to the frequently small size of lesions, no 
attempt was made to spatially correlate CLE images with histological slides. Macroscopic 
lesion size was larger than the CLE field of view but otherwise variable between animals. 
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The smallest lesions were 1-2mm whereas in some animals the majority of the liver surface 
was covered by metastatic deposits.  
Prior to administration of fluorescein no endogenous fluorescence was observed in normal 
or metastatic tissue. The initial period following fluorescein injection was termed the inflow 
phase. During this phase the fluorescein strongly accumulated within the vascular 
compartment and could be observed in hepatic sinusoids and interlobular vessels Figure 
4.1). Occasionally, individual erythrocytes could be visualised moving through blood vessels 
or sinusoids. Because erythrocytes did not take up fluorescein they could be seen as small, 
dark, round or discoid shapes outlined against the bright contrast signal of the intravascular 
fluorophore (Figure 4.1). Generally, inflow phase images were dominated by a meshwork 
pattern of bright interlobular vessels criss-crossing dark areas which represented the 
parenchyma of liver lobules (Figure 4.1).  
 
 
Figure 4.1 CLE of normal murine liver parenchym during the inflow phase at 488nm. 
(a) A CLE image (488nm) showing fluorescein entering the intravascular space (bright 
areas) shortly after injection. (b) At completion of the inflow phase (>12 minutes after 
fluorophore injection), hepatocyte cords appear dark, whereas the intravascular 
space which includes sinusoids and larger lobular vessels is bright. (c) Erythrocytes 
can be seen as dark shapes within the bright intravascular space (arrow). The 
remainder of the image shows the typical pattern of normal liver parenchym 
consisting of a mixture of hepatocyte cords and sinusoids. (d) Histology of normal 
liver tissue with two blood vessels (arrows) containing erythrocytes.  
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Inflow phase duration varied between animals but was approximately 7-11 minutes. At the 
end of the inflow phase, the fluorophore shifted from the intravascular compartment to the 
liver parenchyma and connective tissue, which resulted in high signal intensity within liver 
lobules. This stage of the CLE examination, lasting throughout the remainder of 
observations, was termed the parenchymal phase. Throughout its duration, cords of 
hepatocytes and the sinusoid structure could frequently be observed (Figure 4.2). Sinusoids 
and other liver vessels appeared largely dark and devoid of fluorescence, and this 
phenomenon became more marked at the later stages of image acquisition.  
Differentiation between types of vasculature (e.g. portal vs. central venous vessels) was 
challenging at either imaging phase but could sometimes be accomplished by interpreting 
the vessel’s location and morphology. For example, a central vein (which drains towards 
hepatic vein) could be identified by its location and orientation within the middle of a liver 
lobule (Figure 4.2). 
 
Figure 4.2 CLE of normal liver tissue in the parenchymal phase at 488nm. 
(a) In the parenchymal phase of fluorescein administration, hepatocytes appear bright 
in CLE images (488 nm) whereas the intravascular space (*) is dark due to 
extravasation of the fluorophore into the interstitium. (b and c) The central vein (*) can 
be visualised as a round area in the middle of the hepatic lobule with feeding sinusoid 
vessels (arrows) converging towards it. (c) Histology with a similar configuration to 
the CLE image in b. 
 
4.3.3 Evaluating liver metastases at 488nm wavelength with fluorescein 
Areas of CRLM could be analysed in detail at 488nm wavelength using fluorescein. The 
majority of malignant tissue showed a pattern of dark patches criss-crossed by bright linear 
structures. The areas devoid of fluorescence represented malignant tissue which was 
interspersed by torturous, neoangiogenic vessels that traversed throughout the metastasis. 
Fluorescein appeared to be retained within tumour vessels for longer than in the healthy 
hepatic vasculature.  This resulted in neoplastic vessels displaying high intensity 
fluorescence throughout most of the image acquisition. Infrequently, glandular structures 
typical of moderate to well differentiated colonic malignancy could be visualised (Figure 4.3).  
Visible erythrocytes exhibited a mostly slow and erratic movement when compared to 
normal hepatic vessels (Fig. 3b & c). In two animals there was sufficient image data to 
estimate erythrocyte flow velocity in both tissue types. Median flow velocity in normal tissue 
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was 0.47±0.13mm/s and 0.52±0.31mm/s compared to 0.18±0.15mm/s and 0.15±0.1mm/s in 
CRLM tissue for animal ID1 and ID8 respectively. Subjective discrimination between normal 
and malignant tissue was feasible and a demarcation line could be visualised in all animals 
(Figure 4.3). 
 
 
Figure 4.3 CLE of CRLM in the parenchymal phase at 488nm. 
(a) In the mouse model, fluorescein enhancement in CRLM tissue during the 
parenchymal phase was characterised in CLE images by dark, irregular, round 
structures that retain some of the original glandular architectural features that can 
also be seen on histology. The concentric arrangement of adenocarcinoma cells 
(arrows) results in the “bullseye” appearance of a dark ring around a bright centre on 
CLE and H&E histology. (b) Irregularly arranged vessels containing erythrocytes (*) 
can be seen throughout the tumour tissue. In contrast to normal liver tissue, the 
intravascular space within CRLM retained the circulating fluorophore throughout the 
entirety of the observation period. (c) The corresponding histology features showing 
concentrically arranged adenocarcinoma cells (arrows) and irregular vessels (*). (d) 
The border (arrows) between normal (bright) and cancerous tissue (dark) can be 
readily appreciated on CLE imaging. (e) Border between normal and cancerous tissue 
on H&E histology. 
 
4.3.4 Evaluating normal liver at 660nm wavelength with ICG 
CLE examination at 660nm did not reveal any endogenous fluorescence in areas of normal 
liver or CRLM tissue prior to ICG injection. In contrast to CLE imaging at 488nm with 
fluorescein, no signal was detectable from blood vessels during the inflow phase following 
ICG administration, and erythrocyte movement could not be visualised. In the parenchymal 
phase however, structures with the configuration of central lobular veins could be identified 
(Figure 4.4). These had the typical appearance of round, irregularly outlined structures, 
situated in the centre of the lobule. During the parenchymal phase, ICG’s high specificity for 
the cytoplasm of hepatocytes, resulted in good visualisation of sinusoidal structures and 
allowed distinction between hepatocytes and the surrounding vasculature (Figure 4.4).  
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In general, blood vessels were identified as linear or round structures that had a lower 
fluorescence signal, relative to the surrounding hepatocytes. Because of the prominent 
cytoplasmatic fluorescence, the nuclei of individual hepatocytes were identifiable as dark 
intracellular areas (Figure 4.4). Approximately 15 minutes after injection of ICG, bright 
regions of around 5-20µm diameter could be observed throughout the parenchyma. This 
phenomenon possibly represents areas of ICG accumulation (e.g. bile juice) (Figure 4.4). 
 
 
Figure 4.4 CLE of normal liver tissue at 660nm. 
(a) A central vein (*), acquired in vivo with CLE (660 nm), surrounded by normal 
parenchyma, acquired following ICG administration, which can also be seen in a 
corresponding H&E image. (b) The distribution pattern of ICG mediated fluorescence 
enables discrimination between sinusoids (thin arrows), larger blood vessels (wide 
arrow), and the hepatocytes, the latter of which make up most of the image. Vessels 
and their bifurcations are represented by dark linear structures (arrows). (c) 
Hepatocyte nuclei can be seen as small contrast sparing areas (thin arrows), 
surrounded by bright cytoplasm. (d) At the end of the parenchymal phase, 
hepatocytes have lost most of their fluorescence. Bright regions (arrows) spaced 
throughout the normal tissue likely presents areas where bile juice is concentrated 
(e.g. bile ducts). (e) Section of normal liver histology depicting a central vein (*), 
nuclei (thin arrows), and larger interlobular vessels (wide arrows). 
 
4.3.5 Evaluating liver metastases at 660nm wavelength with ICG 
In contrast to CLE imaging of fluorescein at 488nm, areas of CRLM, as identified by visual 
inspection, did not emit any measurable fluorescence and therefore appeared as dark areas 
covering several fields of view (Figure 4.5). Although no specific tumour characteristics could 
be appreciated, it was possible to visualise the delineation between CRLM and normal 
hepatic tissue by observing a demarcation between high- and low intensity fluorescence 
areas (Figure 4.5). 
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Figure 4.5 CLE of CRLM tissue at 660nm. 
(a) A CLE image of a region of CRLM, which is devoid of any fluorescence following 
ICG administration. (b) An irregular transition (arrows) from low to high fluorescence 
represents the demarcation line between CRLM and normal tissue in a CLE image 
acquired at 660 nm. (c) The border between metastasis and normal liver tissue viewed 
on H&E histology. 
 
4.3.6 Statistical analysis of fluorescence values  
RFU values measured during the parenchymal phase in metastatic tissue were 53-94% 
lower for fluorescein/488nm and 65-100% lower for ICG/660nm when compared to normal 
liver tissue (Table 4.1 & Figure 4.6). GLIMMIX analysis showed that higher RFU values 
measured during the parenchymal phase were statistically significant predictors for the 
presence of normal liver tissue at either fluorophore and wavelength combination.  
 488nm with fluorescein 660nm with ICG 
ID normal 
(n=2195) 
CRLM 
(n=1922) 
RFU 
chang
e (%) 
normal 
(n=2681) 
CRLM 
(n=2050) 
RFU 
change 
(%) 
1 3720 
(2857) 
226 (216) 94% 126 (53) 0 (0) 100% 
2 2259 
(760) 
678 (308) 70% 462 (150) 0 (0) 100% 
7 523 (164) 51 (128) 90% * * * 
8 2164 
(1948) 
1153 
(1763) 
53% 310 (43) 110 (113) 65% 
Table 4.1 Relative fluorescence value changes at 488nm & 660nm. 
Comparison of relative fluorescence units in normal liver and colorectal cancer liver 
metastasis. Median RFU values in normal and CRLM tissue during the parenchymal 
phase are shown for each animal with the interquartile range stated in brackets. 
Decrease of RFU from normal to CRLM tissue is shown in percent. Negative RFU 
values were thresholded to zero. * - no data collection as animal expired during 
experiment.  
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For the fluorescein / 488nm combination, a RFU value change from 37.8 to 38.8 increased 
the odds ratio of liver tissue being normal (e.g. non-metastatic) by 1.2 (p<0.0001, CI 1.21-
1.24). This was also true for the ICG / 660nm combination where a RFU value change from 
10.5 to 11.5 resulted in an odds ratio increase of 4.6 (p<0.0001, CI 3.8-5.7). The impact of 
treating individual animals as a random effect did significantly contribute to the fit of either 
model with a covariance parameter of 3.9±2.8 (SE, p<0.001) for fluorescein / 488nm and 
43.0±35.8 (SE, p<0.05) for ICG / 660nm. The covariance parameter estimation indicates to 
what degree the random variable affects the fit of the mathematical model (e.g. aids in 
predicting outcome) and its associated standard error gives a measure of repeat sampling 
variability.  
Subsequently, observations were randomised into a training- and validation set for each 
fluorophore and wavelength combination. GLIMMIX analysis of the training samples retained 
statistical significance with a RFU increase from 37.7 to 38.7 and 10.6 to 11.6 resulting in an 
odds ratio increase of 1.22 (p<0.0001, CI 1.20-1.24) and 5.08 (p<0.0001, CI 3.62-7.12) for 
the fluorescein / 488nm and ICG / 660nm combinations, respectively. Again the random 
effect from performing measurements in different animals did contribute to the fit of the 
model with a covariance parameter of 3.8±2.7 (SE, p<0.001) for fluorescein / 488nm and 
49.2±42.0 (SE, p>005) for ICG / 660nm.  
ROC analysis of the training set resulted in an area under the curve of 0.934±0.003 (CI 
0.928-0.941) for fluorescein / 488nm and 0.994±0.001 (CI 0.992-0.997) for ICG / 660nm. A 
probability threshold value of 0.67 for fluorescein / 488nm and 0.69 for ICG / 660nm 
(representing a fixed RFU value and random animal effect) with a high corresponding 
sensitivity and specificity was chosen from the ROC curve coordinates. Based on these 
threshold values, the validation set observations were categorised into either normal or 
metastatic tissue which consequently enabled calculation of sensitivity and specificity for the 
proposed quantification method. For the fluorescein / 488nm combination, sensitivity and 
specificity was 82.9% (CI 81.1% - 84.6%) and 85.2% (CI 83.2% - 87.0%) respectively. For 
CLE imaging of ICG at 660nm wavelength the sensitivity and specificity was 97.9% (CI 
97.0% - 98.6%) and 97.5% (CI 96.4% - 98.4%), respectively.  
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Figure 4.6 Relative fluorescence values normal tissue vs. CRLM. 
(a) Median RFU values and 95%CI comparison between normal and CRLM tissue for 
each animal liver imaged at 488nm with fluorescein. (b) Median RFU values and 95%CI 
comparison between normal and CRLM tissue for each animal liver imaged at 660nm 
with ICG. Note that the median and 95%CI for CRLM tissue in animal ID 1 and ID2 is 
zero and is, therefore, not displaying on the bar chart. 
 
4.4. Discussion 
This article represents the first in vivo comparison of dual-wavelength CLE imaging in 
combination with two exogenous fluorescent probes as a method of differentiating liver 
metastases from normal liver parenchyma. The CLE system used in this study allows high-
resolution (3.9 μm), imaging of fluorescence with a field of view of 424x302μm (488nm) or 
323x323μm (660nm), thereby allowing in-vivo tissue structure and function evaluation in real 
time. 
Two distinct phases of CLE liver imaging, based on fluorophore behaviour, have been 
described. The inflow phase lasted up to 11 minutes and was characterised by accumulation 
of fluorophore (and hence signal intensity) in the intravascular space. Following on 
seamlessly, and lasting for the remainder of the CLE examination, the parenchymal phase 
showed a signal intensity shift to the liver lobules. Images obtained in healthy liver tissue at 
488nm wavelength with fluorescein provided good detail of the sinusoidal structure and 
hepatic vascular architecture. In contrast CRLM tissue showed a pattern of tumour cell 
agglomerations which were traversed by haphazardly-arranged blood vessels.  
Quantitative estimation revealed that erythrocyte flow velocity in CRLM tissue was slower 
than in normal liver tissue. In contrast to healthy vessels that relatively quickly lost 
fluorescence during the inflow phase, the signal intensity in tumour vasculature remained 
high throughout the inflow and parenchymal phases of imaging. This was intriguing because, 
commonly, tumour vessels are reported as having increased permeability (290) which can 
lead to a rapid extravasation from the intra- to the extravascular compartment. This might 
have resulted in rapid transfer of fluorescence from the vasculature to the surrounding 
cancer tissue, whereas, In fact, the visualised cancer tissue was largely devoid of signal 
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which remains unexplained by our experiments. This finding could potentially be explained 
by a number of tumour specific or general factors such as local tissue necrosis, systemic 
hypoperfusion, arterio-venous shunts or the unique nature of the tumour cell line. 
Alternatively, tumour vasculature associated factors such as reduced permeability due to 
accelerated vessel maturation or volume expansion of the extravascular space causing 
dilution of fluorophore concentration could also be responsible for the observed lack of 
fluorescence intensity. Without further studies, it is difficult to put these findings into context 
because to the best of our knowledge, CLE imaging of a comparable small animal model 
has not been reported in the past. 
Imaging at 660nm wavelength with ICG was dominated by the rapid uptake of ICG into the 
cytoplasm of normal hepatocytes. Visualising the whole field of view enabled sinusoid 
architecture to be identified, whereas on an intracellular level, hepatocyte nuclei could be 
observed as dark areas contrasted by the strong cytoplasmatic fluorescence signal. 
Localised regions of high intensity fluorescence that were seen at the later stage of imaging 
could not reliably be attributed to a specific feature of liver histology. Because ICG is known 
to be exclusively excreted by bile (291) it is possible that these regions were small bile 
ductules where the fluorophore accumulated before being transported to the larger bile 
ducts. During image acquisition, no vascular contrast could be observed but occasionally 
vessels could be identified as dark linear or circular structures outlined against the bright 
surrounding liver parenchyma.  
Areas of CRLM were characterised by lack of ICG mediated fluorescence purportedly due to 
the lack of ICG uptake in the cancerous tissue. The absence of any relevant imaging signal 
prevented the characterisation of CRLM tissue with this wavelength and fluorophore 
combination. The general finding was that fluorescein in combination with CLE at 488nm 
was more suited to the imaging of the vasculature and for examining CRLM morphology, 
which was characterised by a mosaic of dark areas, irregular vasculature and, occasionally, 
glandular structures. In contrast, CLE imaging of ICG at 660nm appeared to be better suited 
to assess the structure of sinusoids and the surrounding hepatocytes  
Although some reports on in vivo CLE examination of human liver disease have been 
published to date (178,282), no data exists describing the application of CLE in liver surgery 
for cancer. Several of the imaging features described in this animal model, indicate that they 
could be usefully translated to patients. For example the combination of glandular 
architecture and proliferation of irregular vasculature with abnormal flow characteristics, as 
observed on CLE examination of fluorescein at 488nm, is a common histological feature of 
human CRLM (292–295). A lack of ICG related fluorescence that was apparent at 660nm 
has previously been reported using camera based near-infrared imaging during liver 
resection for colorectal metastases (279). 
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The feasibility of using CLE intraoperatively to confirm complete removal of cancer in the 
resection of intracranial malignancy has been demonstrated previously (296). This approach 
could also be of benefit during resection of CRLM, where confirmation of malignancy at the 
borders of a resection may allow a more radical procedure to be performed with the intention 
of increasing cure rates. If presence of microscopic malignancy can be excluded on the 
other hand, it would allow surgeons to minimise the resected total liver volume which in turn 
can reduce the incidence of postoperative complications (297).  
The same rationale can also be applied to ablation therapy of CRLM which is emerging as a 
feasible alternative or auxiliary treatment modality beside surgical resection. In liver ablation, 
cancerous tissue is destroyed by inducing coagulation necrosis through a variety of methods 
(e.g. radiofrequency, microwave ablation) (298). Because Cellvizio™ and other non-
commercial CLE systems are not yet licensed for clinical use during surgery, it was crucial to 
investigate its potential benefit in an animal model before considering its clinical evaluation. 
In the current study it was demonstrated that utilising a dual wavelength approach may be 
more advantageous than using single wavelength CLE (178,282), because two fluorophores 
and their respective imaging properties in tissue can be evaluated in short succession. 
Fluorescein and ICG CLE visualisation in hepatic tissue differs because the former has 
properties suited to the visualisation of vasculature (178) whereas the latter is exclusively 
cleared by the liver and therefore has a stronger affinity to hepatocytes and bile ducts (291). 
Other groups have explored the potential of CLE imaging for identifying cancers and 
evaluated these in animal models (281,299,300). These, however, have been based on non-
clinically approved CLE systems which would need further development before they can be 
used in a clinical context (284,299). The experiments outlined here were all performed with a 
CE marked device that has found widespread interest for the clinical diagnosis of 
malignancy (287,301–303) and it is hoped that the relatively widespread dissemination of 
this CLE imaging platform can help in facilitating the further clinical evaluation of the findings 
presented here.  
Previous articles on CLE imaging of malignancy have been based on subjective, observer 
dependent image interpretation but have not identified quantifiable and reproducible 
parameters of malignancy (284,304). To establish such a quantifiable parameter that would 
allow discrimination between normal and malignant liver, a tissue evaluation centred on 
numerical fluorescence values was proposed. A GLIMMIX analysis revealed that normal 
liver tissue was more likely if high RFU values were recorded with either wavelength and 
fluorophore combination. Based on a random set of observations, a threshold probability 
value for distinguishing normal liver from CRLM tissue has been established for the 
measured CLE data. Subsequent validation on the remaining observations revealed a very 
good and excellent diagnostic accuracy of 83.9% and 97.8% for the fluorescein / 488nm and 
ICG / 660nm, combination, respectively. Based on the diagnostic results in the validation 
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datasets, CLE imaging of ICG at 660nm may be better suited for the use of fluorescence 
intensity to discriminate between normal and CRLM tissue. The superior performance when 
using CLE imaging of ICG at 660nm for this purpose probably reflects the more 
homogenous nature of CRLM tissue visualised with this CLE setting. As described above, 
an abundance of high intensity vascular structures seen with CLE imaging of fluorescein at 
488nm causes a heterogeneous imaging pattern in areas of CRLM. Whether a combination 
of both fluorophore and wavelength combinations can enhance diagnostic accuracy, could 
not be shown in this study due to the inability of applying simultaneous dual waveband CLE 
imaging to exactly the same field of view. A new version of Cellvizio™ capable of 
simultaneous dual waveband imaging is now available but we did not have access to this 
system for application in this study. 
Because probability values used for ROC analysis are based on a combination of a fixed 
(RFU) and a random effect (animal ID) it cannot be extrapolated into a specific RFU value 
for future studies. Before this can be considered, it is crucial to standardise RFU value 
calibration which could potentially result in reproducible and absolute fluorescence units that 
could be globally applied across different research groups. 
Further limitations that have to be taken into account regarding the presented findings 
pertain to the animal model and the technical characteristics of confocal laser microscopy. 
The animal model of CRLM that was studied uses a human cancer cell line and a portal 
venous route of establishing liver metastasis which is the most common route of GI 
malignancy disseminating to the liver in humans (305). Despite these similarities, research 
on murine models of malignancy have well-described limitations when it comes to applying 
results to a clinical setting (306). A further issue is that experiments have focused on a 
single cell line of colorectal neoplasia. This cell line was chosen specifically because it 
exhibits a moderate- to well differentiated tumour histology that can display colonic glandular 
architecture (307) and therefore was felt to be more visually distinct on CLE imaging. It is 
however only representing a small spectrum of the histological characteristics that CRLM 
may exhibit on virtual histology and therefore further validation on different colorectal cancer 
cell lines may be necessary. No formal liver resection was carried out and therefore it is 
difficult to predict if cutting into CRLM tissue would lead to alteration of its fluorescence 
properties. 
A clear trend for lower fluorescence intensity in CRLM compared to healthy liver tissue was 
especially prominent on CLE imaging of ICG fluorescence, probably because it has a strong 
affinity for hepatic tissue. Colorectal cancer liver metastasis is a common indication for 
surgical resection of liver malignancy in the western hemisphere and is generally regarded 
as the only curative treatment option for this disease (213,308). Some of these results may 
become relevant for this patient population in the future, but it is unlikely that these findings 
can be directly transferred to primary liver malignancy (e.g. hepatocellular carcinoma), 
because fluorophore behaviour probably depends on the organ of origin of the cancer. For 
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example, groups examining patients undergoing liver resection for either CRLM or 
hepatocellular carcinoma, found decreased or increased ICG related fluorescence within 
cancerous tissue, respectively (279,309). 
Further restrictions that have to be accounted for are related to the technology behind CLE 
imaging. Optical imaging modalities including CLE can visualise details down to a sub-
cellular level but at the cost of a limited imaging depth. The maximal imaging depth of the 
Cellvizio™ probes used by our group was 0-70µm depending on probe type, which means 
that only liver cell architecture that is either superficial or adjacent to the resection margin 
could be assessed. It has been shown that removal of tumour within an area of <1mm 
conveys a patient survival benefit in the resection of CRLM (310). Therefore a potential use 
of CLE would be to confirm that a resection margin is clear of cancer by probing the cut 
surface. Because of CLE’s limited depth penetration it should not be considered as a 
potential substitute for intraoperative ultrasound imaging but more as a complementary 
modality that expands the borders of intraoperative imaging into the microscopic domain. 
The Cellvizio™ probes used in this study had a maximal field of view of 600µm2 which may 
limit its applicability in the clinical examination of liver resection margins which are usually in 
the cm2- range. It has previously been shown however that clinically relevant CLE imaging 
with a field of view of approximately 2mm2 (282) is possible. Robotic control of CLE during 
laparoscopic liver surgery has been utilised to create even larger fields of view (150). If 
clinical translation for intraoperative use of CLE is considered, it would be crucial to 
encourage the development of probes that offer a field of view of ≥1mm2, because this would 
greatly improve the integration of CLE imaging into the surgical workflow. 
Currently, Cellvizio™ probes are only marketed for endoscopic applications and are not 
certified for intraoperative use. Some of the probes, however, can be fully sterilised and may 
potentially be used for imaging during laparoscopic liver resection. If a clinical benefit for the 
intraoperative usage of this system can be defined, sterility issues and clinical re-certification 
should not present a major obstacle. 
4.5. Conclusion 
In conclusion, a clinically licensed CLE system was used to provide a detailed description of 
discriminatory tissue characteristics in an orthotopic murine model of CRLM. A dual 
wavelength approach in conjunction with two fluorophores was found to be of benefit 
because CLE imaging of fluorescein at 488nm enabled better visualisation of metastatic 
tissue whereas quantification of ICG mediated fluorescence intensity demonstrated a better 
potential to objectively discriminate between normal liver and CRLM tissue at a cellular level. 
In the following chapter the findings relating to fluorescence intensity based tissue 
discrimination from the current chapter are applied to CLE imaging in a laparoscopic large 
animal model. Evaluation of simultaneous (i.e. non-sequential) dual waveband imaging and 
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standardisation of fluorescence values is the next crucial step to advance CLE imaging of 
liver malignancy. 
In the next chapter CLE examination will be studied in a large animal model of laparoscopic 
liver surgery to assess the feasibility of using this imaging modality during laparoscopy to 
evaluate the adequacy of liver ablation. 
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5. Use of dual wavelength probe based confocal laser 
endomicroscopy to determine the adequacy of 
laparoscopic liver ablation 
5.1. Introduction 
Thermal ablation is a minimal invasive therapy which can be used for the treatment of 
primary or secondary liver malignancy (298,311). During the procedure an ablation probe is 
inserted into the liver lesion where it causes thermal-mediated denaturisation of proteins 
which results in the destruction of cancer cells. Most commonly, heat is created by 
radiofrequency or microwave energy, but laser or high intensity focused ultrasound induced 
heat can also be employed (311). The ablation probe can be applied by percutaneous, 
laparoscopic or open approaches. The laparoscopic approach allows easy access to 
tumours which are difficult to treat percutaneously such as those superficially in the liver or 
high under the diaphragm. It also permits use of laparoscopic ultrasound to localise the 
lesion and assess its relationship to local vital structures, hence reducing the incidence of 
collateral injuries (312).With small solitary liver cancers thermal ablation may produce 
comparable results to liver resection with a reduced morbidity and mortality (50).The main 
concern regarding thermal ablation is the high incidence of local recurrent disease and the 
main aim of ablation therapy is therefore to destroy not only the cancer harbouring tissue but 
also a 5-10mm safety margin to include any local satellite lesions. Ablated liver tissue 
changes in colour from brown to white (total coagulation effect) but the spatial dimension of 
cellular destruction and functional damage extends well beyond this phenomenon, therefore 
making ablation monitoring crucial and mandating development of a visual inspection or 
detection device to locate the real damage margins. Using ultrasound for monitoring is 
unreliable because ablation therapy generates gas bubbles within the hepatic tissue which 
subsequently creates an acoustic shadow effect, negating any diagnostic value to the 
images (313,314). Conventional computer tomography (CT) and magnetic resonance 
imaging (MRI) are commonly used for the postoperative assessment of ablation efficacy 
(315,316) only, whereas intraoperative cone beam CT and open MRI scanners may be used 
but technical restrictions such as incompatibility with metal instruments (MRI) (317) and 
limited imaging quality (cone beam CT), make them impractical for the intraoperative 
evaluation of ablation therapy. 
During thermal ablation there is a significant change in tissue temperature which in itself can 
be regarded as a surrogate marker for cellular destruction (314). This relationship has been 
exploited for the purpose of non-invasive ablation monitoring, with MR- or CT thermography 
(317). In a more direct approach, tissue temperature can also be measured invasively by 
placing optical fibres under image guidance within liver tissue (313). This approach however 
confers the risk of needle tract seeding (318), i.e. the risk of displacing tumour cells with the 
needle, into normal tissue and therefore disseminating the malignancy unnecessarily. 
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Measuring changes in tissue elasticity by shear wave elastography has also been 
investigated for its utility in ablation monitoring (317,319). The modalities listed above 
measure surrogate markers for tissue necrosis but a method of directly imaging the changes 
in the ablation zone has yet to be identified. 
Confocal laser endomicroscopy (CLE) is a novel optical imaging technology that enables 
accurate microscopic assessment of in-vivo histopathology. Its utilisation in a variety of 
experimental and clinical scenarios has been increasingly reported. CLE utilises a fibre optic 
element as its objective lens, allowing confocal microscopy with a micron-scale resolution 
that enables visualisation of sub-cellular details using endogenous or exogenous 
fluorescence. Exogenous fluorescence is provided by fluorescent dyes which can be applied 
in a systemic (e.g. intravenous) or topical fashion and are commonly referred to as 
fluorophores. They enhance CLE image contrast by absorbing and emitting light at 
wavelengths that are specific for each individual agent and circumstance (146,247).  
CLE during laparoscopy or NOTES (Natural Orifice Transluminal Endoscopic Surgery) has 
been performed either with a rigid endomicroscope which contains the scanning optics in its 
tip (146) or with a slim, flexible optical fibre bundle which transmits light signals to laser 
scanning equipment situated at the far (e.g. extra-corporeal) end of the intrusive fibre 
(177,248). An example for a fibre based CLE system is Cellvizio™ (Mauna Kea 
Technologies, Paris, France) which is CE-marked for clinical use in luminal endoscopy and 
can be operated with probes that have a diameter range of 0.3-4.5mm. During endoscopy, 
Cellvizio™ can reveal histopathological cellular changes and has been shown to enhance 
accuracy in the diagnosis of malignancy and dysplasia (146,249).  
Liver ablation has been visualised using a bench-top confocal laser microscope in a small 
animal model (320), but the diagnostic ability of a clinically approved CLE system to 
distinguish between healthy and necrotic liver tissue in a laparoscopic setting have yet to be 
tested. In these experiments, the aim was to evaluate if CLE imaging employing the 
Cellvizio™ system’s can differentiate ablation induced tissue necrosis from normal liver 
tissue in an in-vivo porcine model of laparoscopic microwave liver ablation.  
For establishment of the model, percutaneous microwave ablation was conducted under 
direct laparoscopic visualisation. As the CLE system used in this study has a limited imaging 
depth of <100µm, only superficial ablation zones were created and assessed. Optical 
scattering in hepatic tissue is very high and imaging depths are likely to be no better in any 
other optical technique. Imaging of subsurface ablation zones was not attempted. However, 
imaging of deeper ablated areas is of clinical relevance, and CLE via a placed optical fibre 
within the periphery of an ablation volume may be a potential approach to achieving this. 
Due to the small size of the probes, placement without significant damage to blood vessels 
or bile ducts should be feasible. 
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Previous groups evaluating laparoscopic CLE have used single fluorophores that are usually 
visible on CLE imaging within the blue-light or near-infrared spectrum (178,248,282). For the 
experiments presented here dual wavelength CLE imaging at 488nm (blue) and 660nm (red) 
wavelength was facilitated by the fluorophores fluorescein and indocyanine green (ICG). By 
evaluating liver tissue at two discreet wavelengths and dissimilarly partitioned fluorophores, 
we aimed to maximise imaging information and highlight any potential advantages or 
disadvantages between the wavelengths and their corresponding fluorophores. The image 
acquisition software (ImageCell™) supplied with Cellvizio™ can compute basic image 
values (mean, median, maximum, minimum intensities). As well as comparing images, basic 
image summary statistics have been analysed to establish if they can aid in defining the 
zone of tissue necrosis associated with microwave ablation.  
5.1.1 Imaging of pathological tissue in a porcine model 
In this chapter the focus is on the CLE examination of ablated liver tissue. For continuity and 
comparability, imaging of liver malignancy in a porcine model would have been preferable 
but this would have introduced a number of issues related to studying liver malignancy in 
large animal models. Although chemical induction of hepatocellular carcinoma in pigs has 
been reportedly successful, this approach is lengthy, costly and time consuming (253). The 
main obstacle to application of CLE in humans is technical handling and analysis of visual 
data. Both aspects can be studied without the presence of malignancy and hence it was felt 
that using the discrimination of ablated vs. non-ablated tissue would be a suitable substitute 
outcome to study the tissue visualisation characteristics of CLE.  
5.1.2 Aims 
In this chapter the aims are to: 
1) describe virtual histology of normal porcine liver on CLE examination using 
fluorescein at 488nm and indocyanine green at 660nm illumination. 
2) evaluate the technical feasibility and limitations of visualising virtual histology with 
CLE in a laparoscopic setting.  
3) assess the ability of CLE to predict liver tissue necrosis induced by ablation therapy. 
5.2. Methods 
General and specific methodology has already been described above (3.1.4). It was felt to 
be advantageous for ease of reading to avoid separating the methodology across chapters 
in this case. 
5.3. Results 
5.3.1 General histology 
The histological samples obtained within 7-10 days of microwave ablation showed different 
degrees of cellular injury in the ablated areas. Centrally, within the ablation zone, tissue 
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appeared macroscopically white and on histology, showed complete coagulation necrosis. 
Surrounding these areas was a rim of tissue that showed signs of sinusoidal obstruction, cell 
shrinkage and disruption of lobular architecture. On macroscopic inspection these areas 
were difficult to distinguish from the normal liver tissue in the periphery, validating the use of 
a sensitive imaging instrument for this purpose.  
5.3.2 CLE evaluation of fluorescein at 488nm - normal liver  
CLE images are shown adjacent to histology sections, obtained from normal porcine liver 
after conclusion of the experiments. To facilitate comparison, CLE images are shown in 
parallel to histology slides with comparable architectural features from the same animal. 
When using 488nm CLE, no auto-fluorescence signals were recordable from the tissue 
before fluorescein administration. Intravenous fluorophore injection was followed by an 
“inflow phase” where the fluorophore is distributed and taken up by the liver parenchyma. 
This phase lasts for approximately 7-10 minutes after injection and is characterised by bright 
signals in blood vessels contrasting with dark lobule areas (Figure 5.1). Using CLE imaging 
of fluorescein at 488nm, individual erythrocytes flowing through blood vessels could be 
observed with greater regularity than was possible with CLE imaging of ICG at 660nm. 
Unfortunately the limited image resolution made a more detailed analysis of blood vessel 
flow difficult at either wavelength.  
The inflow phase was followed by the “parenchymal phase” when the fluorescence pattern is 
reversed as the fluorophore has been redistributed from the vasculature into the liver 
parenchyma. During this phase, the vasculature is devoid of fluorescence signal and can be 
visualised as dark lines of increased contrast (i.e. absence of fluorescence) that surrounds 
the liver lobules which had by then become rich in fluorescein (Figure 5.1). CLE imaging of 
fluorescein at 488nm allowed sinusoid structure and individual hepatocyte cords 
visualisation (Figure 5.1). Usually a distinction between different types of vessels (arterial / 
venous) is not feasible, but in some instances the location and morphology of blood vessels 
can reveal its specific characteristics (Figure 5.1).  
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Figure 5.1 CLE of normal liver tissue at 488nm. 
Comparison of CLE imaging with fluorescein/488nm and H&E liver histology. (a and 
b) Strong fluorescence signal in the intravascular compartment during the inflow 
phase. _Liver lobules; arrows, interlobular vessels. (c and d) Shift of fluorescence 
signal from the intravascular- to the intracellular compartment in the parenchymal 
phase. #Liver lobules; _vessel bifurcation; arrows, vessel branches. (e and f) Pattern 
of sinusoidal architecture. _Horizontal sinusoid; arrows, perpendicular sinusoid. (g 
and h) Vessel bifurcation of a centrilobular vein. _Vessel lumen; arrows, vessel 
branches. 
 
5.3.3 CLE of ICG at 660nm - normal liver  
Similar to the fluorescein system, 660nm CLE illumination of ICG, demonstrated no tissue 
auto-fluorescence and thus no imaging of liver architecture was possible prior to fluorophore 
administration. 
In contrast to CLE of fluorescein under 488nm excitation, it was not possible to visualise any 
significant fluorescence within the intravascular compartment during the “inflow phase”. The 
combination of ICG and 660nm CLE however appeared to be better suited to imaging the 
sinusoid structure within liver lobules (Figure 5.2). Because ICG is rapidly taken up and 
cleared by the hepatocyte cytoplasm, the hepatocyte nuclei were seen outlined as dark 
spots within the liver cells (Figure 5.2). Central lobular veins that drain the blood towards the 
hepatic venous system could be seen as round dark structures within the centre of a lobule 
(Figure 5.2). Because the vasculature and connective tissues were both devoid of 
fluorescence signal in the parenchymal phase, blood vessels could not be distinguished 
from interlobular septations when using ICG as sole fluorophore (Figure 5.2). Within this 
limitation, the visualisation of fibrous tissue septations between lobules was readily 
reproducible with ICG CLE at this wavelength. Between 30-40 minutes after ICG infusion, 
bright spots were seen appearing throughout the liver parenchyma (Figure 5.3). This 
phenomenon possibly represents areas of ICG accumulation (e.g. bile juice).  
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Figure 5.2 CLE of normal liver tissue at 660nm. 
Comparison of CLE imaging with ICG/660nm and H&E liver histology. (a and b) 
Typical sinusoidal architecture of normal porcine liver. _Sinusoids. (c and d) 
Hepatocyte nuclei appear as intracellular contrast sparing. arrows, nuclei. (e and f) 
The dark central area represents a centrilobular vein. Note how the vessel lumen 
appears ragged because ICG does not accumulate in the vascular endothelial cells. (g 
and h) Interlobular septations appear as linear contrast sparing areas between liver 
lobules. #Septation; *liver lobule. 
 
 
Figure 5.3 CLE of normal liver and resection surface at 488nm & 660nm. 
(a) Bright foci of fluorescence (arrows) at the later stages of CLE imaging with 
ICG/660nm may correlate with areas where bile juice accumulates. The surface of the 
resected liver is mostly devoid of fluorescence but occasionally band-like 
fluorescence signals can be seen at 488nm (b) and 660nm (c) wavelength. 
 
5.3.4 Probe manipulation, placement and image quality 
As the CLE probe has no inherent navigability, the use of an intravascular catheter (Agilis™ 
St. Jude Medical, Saint Paul, MN, USA) afforded free rotation, flexion and retroflexion to 180 
degrees. Familiarity with the steering system allowed instant successful use of the CLE 
instrument without additional prior expertise or training. 
This degree of manoeuvrability allowed access to virtually any area on the liver surface 
(Figure 3.1). The main detractor to image quality was the respiratory movement of the liver. 
This made methodical and complete examination of liver tissue difficult because tissue 
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contact loss would frequently occur with each respiratory cycle. The problem of respiratory 
interference to CLE signal was greater on the anterior and superior surfaces of the liver and 
was compounded by pooling of fluids or blood on the liver surface which increased probe tip 
slipping. The size of the steerable access catheter allowed parallel insertion of two CLE 
probes, this method however made overall handling difficult and impaired image quality.  
5.3.5 Evaluating ablation zones and liver resection surface 
In ablated liver tissue, the characteristics of CLE images recorded with fluorescein and ICG 
were similar in all the animals studied. Whether the fluorophore was injected before or after 
ablation was carried out, did not affect visualisation of tissue characteristics. In the majority 
of the ablation zone no fluorescence was detectable which corresponded to zones of 
ablation induced injury on histology (Figure 5.4). When examining the border region between 
normal and ablated liver, the change from high to low fluorescence zone could often be 
observed in the same field of view (Figure 5.5). Because it was technically difficult to 
stabilise the probe over a very small area (<1mm), no differentiation between zones of 
cellular apoptosis and necrosis could be made. Similar to zones of ablated liver, the liver 
resection surface (divided using the ultrasonic scalpel) did not show any significant 
fluorescence signals. If signals were recorded on the resection surface they usually 
originated from linear structures of high signal intensity that potentially represent vessels 
(Figure 5.3) or zones of fluorophore extravasation following the destruction of fluorophore 
containing vessels.  
 
Figure 5.4 CLE images of liver necrosis at 488nm & 660nm. 
Areas of complete necrosis with fluorescein/488nm (a) and ICG/660nm (b) show loss 
of fluorescence intensity which correlates with complete destruction of hepatic 
architecture on H&E histological analysis (c). 
 
 
Figure 5.5 CLE images of liver necrosis and viable tissue at 488nm & 660nm. 
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The border between complete necrosis (#) and partial cellular injury (_) can be 
visualized with fluorescein/488nm (a) and ICG/660nm (b). The corresponding H&E 
histological appearance can be seen in (c). 
 
5.3.6 Analysis of fluorescence values  
Overall RFU values measured in non-ablated vs. ablated tissue decreased by 75-94% and 
77-100% for CLE imaging with the fluorescein / 488nm system and the ICG / 660nm system 
respectively (Figure 5.6). In Table 5.1, median RFU values for each animal and tissue type 
are shown with ablated tissue further subdivided into individual lesions.  
 
Figure 5.6 Relative fluorescence in normal vs. ablated liver tissue. 
(a) Median RFU values_95%CI for each animal liver studied with fluorescein/488 nm. 
(b) Median RFU values_95%CI for each animal liver studied with ICG/660 nm. The bar 
for ablated tissue in animal ID 1 is not visible because the median and 95%CI is zero. 
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Animal ID. Type of tissue Fluorescein & 488nm ICG & 660nm 
1 Non-ablated * 514(624) 
 Ablated * 0(20) 
 RFU change in %  100% 
 Lesion 1 * 20(18) 
 Lesion 2 * 0(0) 
2 Non-ablated 3030(1868) 893(240) 
 Ablated (Lesion 1) 169(862) 210(123) 
 RFU change in % 94% 77% 
3 Non-ablated 5978(3782) 570(254) 
 Ablated 1177(949) 37(29) 
 RFU change in % 80% 94% 
 Lesion 1 1177(949) 17(8) 
 Lesion 2 * 63(106) 
 Lesion 3 * 36(2) 
4 Non-ablated 1778(846) 1221(532) 
 Ablated 443(627) 27(3) 
 RFU change in % 75% 98% 
 Lesion 1 838(871) 24(3) 
 Lesion 2 381(192) 20(16) 
 Lesion 3 953(707) 27(1) 
Table 5.1 Relative fluorescence value changes per ablated lesion for 488nm & 660nm. 
The interquartile range is given in brackets. RFU change states the decrease of 
median RFU values in non-ablated (set as 100%) vs. ablated tissue. *No image 
acquisition for these lesion due to technical issues. 
 
With CLE of fluorescein using 488nm excitation, a standardised RFU value change from 41 
to 42 increased the odds ratio of liver parenchyma being normal (i.e. non-ablated) by 1.16 
(p<0.0001; CI 1.15–1.17). At this fluorophore and wavelength combination the variation 
introduced by imaging individual animals and re-calibrating the Cellvizio™ system did not 
contribute to the fit of the model as a random effect with a covariance parameter of 
1.66±1.66 (SEM, p>0.05). The covariance parameter estimation indicates to what degree 
the random variable affects the fit of the model (i.e. it aids in predicting outcome) of the 
model and its associated standard error gives a measure of repeat sampling variability. This 
means that the same RFU values could be applied across different animals in the study to 
predict the presence of healthy liver tissue. ROC analysis resulted in an area under the 
curve of 0.955±0.003 (p<0.0001, CI 0.95-0.96). 
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A standardised RFU value change from 17 to 18 with CLE imaging of ICG at 660nm 
increased the odds ratio of liver parenchyma being normal by 1.58 (p<0.0001, CI 1.54-1.63). 
Variation introduced by individual animals and re-calibration did significantly contribute to the 
fit of the model as a random effect with a covariance parameter estimation of 4.6±3.8 (SEM, 
p<0.05). This means that the predictive RFU values were not interchangeable for different 
animals in the study as each individual’s fluorophore distribution pattern within the areas of 
interest, were unique to that animal. ROC analysis resulted in an area under the curve of 
0.999±0 (p<0.0001, CI 0.998-1.0). 
5.4. Discussion 
This study has demonstrated that confocal laser endomicroscopy can be used in-vivo to 
distinguish thermally ablated liver, from healthy liver, during laparoscopic surgery. The main 
discriminating factor between healthy and ablated tissue was loss of fluorescence intensity 
as expressed by RFU. This phenomenon was independent from the time point of 
fluorophore injection which means that it is unlikely to be caused by the destruction of 
fluorophore carrying vasculature. It is proposed that the destruction of fluorophore containing 
cellular and intercellular structures that occurs during liver ablation is the most likely 
explanation for this finding. 
Evaluation of ablated liver tissue is of relevance because similar to surgical excision of 
malignancy, a complete ablation margin around a treated lesion is necessary to optimise 
patient survival (321). An important limitation of thermal ablation is that it is relatively 
contraindicated when the tumour is close to vulnerable structures such as major bile duct 
and blood vessel structures (322). Proximity to large blood vessels also renders ablation 
less effective and predictable because of the “heat sink effect” (322). Although not 
demonstrated here, CLE probes could be deployed close to vulnerable structures to detect 
thermal injury and allow the progress of ablation to be monitored. Because the approach 
evaluated in this article enables direct visual tissue assessment in small and distinct areas of 
liver parenchyma, it may be advantageous compared to measuring surrogate markers of 
tissue necrosis such as temperature. 
An analysis based on generalised linear mixed modelling has indicated that loss of 
fluorescence intensity can be used in vivo to identify ablated or non-vital liver tissue. This 
type of analysis was chosen over and above a more simplistic group-wise comparison 
because of the specific constraints that the collected data presented. Firstly we had to 
account for comparing two different types of tissues in the same animal (normal and 
ablated); secondly the tissue types were repeatedly measured to account for the 
inconsistency introduced by CLE probe movement and a small field of view; thirdly an 
incongruent number of mean RFU values in each group resulted from having a different 
number of frames available for analysis. Lastly the absolute values of the measured RFU 
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were not comparable between different experimental days because each new calibration of 
the Cellvizio™ altered the RFU value.  
The general linear mixed model analysis allows for all these considerations and takes into 
account the correlation in measurements between different tissues in the same animal. It is 
also able to handle non-parametrically distributed data. A separate ROC analysis has been 
used to confirm the validity of the model. Before fluorescence values can be used to inform 
clinical decision making however, it is imperative that standardised, absolute fluorescence 
values are established. If an ablation dependent variability in absolute fluorescence can be 
validated in more extensive datasets, it has the potential to be transformed into a 
computational image recognition algorithm. This algorithm could then be integrated into a 
clinical imaging system with the ability to monitor and map liver ablation. 
Each frame value was treated separately because unavoidable probe movement meant that 
some sections of tissue may just be represented by a single frame. Although a single image 
frame may not provide enough data for clinicians to evaluate tissue, it could provide 
sufficient data for an automatic tissue evaluation algorithm based on fluorescence intensity. 
A description has been provided comparing key characteristics of liver tissue architecture as 
imaged on fluorescein and ICG facilitated CLE examination at 488nm and 660nm 
wavelength. To account for temporal variations in imaging characteristics following 
fluorophore injection, a categorisation into hepatic “inflow” and “parenchymal” phases has 
been proposed here. The inflow phase lasts approximately 7-10 minutes and takes place 
while the fluorophore is mainly concentrated in the hepatic vasculature. This blends over into 
the parenchymal phase when the bulk of fluorophore concentration has been re-distributed 
into the intracellular compartment. Although a number of articles have evaluated CLE of the 
liver for different indications in animals and humans, (148,177,178,248) no report to date has 
made a comparative description by employing a dual wavelength approach. Because 
fluorescein and indocyanine green have different distribution properties in tissues 
(282,291,323) they could be employed sequentially and within a time frame to allow 
examination of a particular area of interest. Overview images obtained during the inflow 
phase had different characteristics for both fluorophore and wavelength combinations. When 
focusing on blood flow evaluation in this phase, CLE examination of fluorescein with the 
blue-light system was advantageous because it enabled regular visualisation of erythrocyte 
movement within sinusoids and larger parenchymal vessels. Although ICG is similarly 
distributed through the vasculature, it was not possible to detect intravascular ICG mediated 
fluorescence in this study. A group investigating near-infrared CLE imaging of ICG in 
patients with liver disease were able to visualise blood flow in 8 out of 21 patients (282) 
possibly reflecting low / slow function of the hepatocytes in these particular 8 cases. No ICG 
related fluorescence was visualised within sinusoidal vessels which was also the case in our 
experiments. It is not possible to draw any conclusions from this because the employed CLE 
systems have different specifications and with only 4 subjects in our study, the inability to 
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visualise hepatic blood flow may have been accidental but it is tempting to ascribe it to good 
hepatocyte affinity for ICG in health, allowing a one-pass clearance effect. 
In the parenchymal phase, CLE of the fluorescein /488nm system was better suited to 
imaging blood vessel morphology because low contrast areas correlated better with blood 
vessels, whereas these areas in the ICG/660nm system were consistent with both fibrous 
tissue septations and vasculature. A more homogenous and intense distribution of 
fluorescence throughout the liver tissue indicated that fluorescein accumulated in 
hepatocytes and other cells (e.g. fibrocytes and vascular endothelial cells). In comparison, 
ICG CLE at 660nm revealed a high affinity of ICG to hepatocytes with nuclear sparing, 
providing a strong contrast. Visualisation of interlobular septation architecture appeared to 
be better suited to the 660nm CLE system with ICG, which was able to clearly delineate liver 
lobules from surrounding fibrous tissue. At 30-40 minutes after ICG injection areas of 5-
20µm2 could be observed that accumulated high fluorescence intensity. Given that ICG is 
known to be rapidly excreted via bile (291) it is proposed that these signals may represent 
bile canaliculi, the smallest division of bile ducts . The fluorophore choice of fluorescein and 
ICG was guided by potential clinical applicability. There are many other potential 
fluorophores for 488 – 660nm CLE, but none are currently approved for clinical use or have 
the same low risk profile as fluorescein and ICG (291,323). The latter two fluorophores have 
been used in CLE studies of the human liver in the past (178,282) which could aid in the 
transferability of our findings to a clinical evaluation of CLE imaging in liver ablation. 
Overall the detection sensitivity of ICG fluorescence intensity at 660nm was lower when 
compared to fluorescein at 488nm wavelength. This was likely due to the fact that the optical 
absorption maximum of ICG is 800nm (near-infrared spectrum) so our excitation efficiency 
was poorer at 660nm, and while not optimal, was adequately within the excitation range to 
excite fluorescence emissions for this fluorophore. This illumination wavelength is a 
manufacturer pre-set and cannot be altered. Near-infrared CLE imaging however is not 
available yet in a CE marked system and we felt that adequate signal was achieved in the 
system described, as the fluorophore has attractive properties relevant for clinical liver and 
bile duct imaging (291). 
Although porcine models are frequently used to evaluate novel surgical technologies 
(324,325) the resulting findings have to be interpreted with caution. Firstly, porcine liver 
histology differs from humans with more pronounced interlobular septations. Despite these 
differences authors with extensive experience in CLE imaging of the liver state that data 
acquired from animal studies can be regarded as equivalent to human data (247). Secondly, 
we found during laparoscopy that the pig’s distinctive multi-lobulated liver configuration 
altered the handling and manipulation of the liver considerably in comparison with the 
expected characteristics in humans. Although the number of animals tested was small, the 
extensive data acquisition was  comparable to similar studies published by other groups 
(248,326). The acquired number of images was sufficient to describe dual wavelength CLE 
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imaging features and to evidence the feasibility of using fluorescence values to distinguish 
between vital and ablated liver parenchyma in an individual. Establishing large animal 
models of liver malignancy is expensive, time consuming and not routinely employed for 
research purposes (253). Therefore the pig model employed in this article solely focused on 
assessment of ablated tissue and did not account for the presence of malignant tissue with 
its commonly associated vascular disturbances, as would be encountered during clinical 
liver ablation procedures. The advantage of CLE imaging compared to a simpler 
fluorescence detection device is that it has the ability to demonstrate tissue architecture and 
thus discriminate between malignant and benign tissue (146), but due to the limitations of 
the porcine model this aspect could not be evaluated in this study. In addition the image 
quality alludes to fouling of the tip – a danger in single fibre spectrophotometry systems 
reporting no signal due to absence of fluorophore or a fouled tip?  
The relation and distribution of fluorescence characteristics in healthy and ablated liver 
tissue demonstrated in this article indicate that CLE may well have utility in ablation 
monitoring but further research is required. Before absolute RFU values can be compared 
between different experiments or between research groups the Cellvizio™ platform or 
alternative CLE imaging systems would need to be adjusted and standardised to allow 
reproducible calibration of fluorescence intensity.  
At this stage CLE imaging can offer micron level resolution in discriminating ablated from 
non-ablated liver tissue and may therefore be of interest as a novel imaging tool in liver 
ablation research. If clinical translation is considered in the future, technical limitations 
imposed by CLE imaging depth and probe vulnerability will have to be addressed.  
The feasibility of utilising needle based, diffuse optical spectroscopy to evaluate liver 
malignancy (225,256) and steatosis (327) has been demonstrated in the past. A similar 
needle based approach could also be applied to increase the imaging depth of CLE which is 
currently restricted to <200µm. The smallest commercially available CLE probe has a 
diameter of 300µm which would enable insertion through the bore of a 24G needle which is 
smaller than liver core biopsy needles currently in routine use and therefore less likely to 
cause inadvertent injuries. Once placed within the bore of the needle, the CLE probe could 
be inserted into the liver parenchym under US guidance. Correlation of US and CLE images 
could then respectively provide anatomical and functional information about the adequacy of 
ablation therapy. 
 In the diagnosis and treatment of abdominal malignancy, there are a number of scenarios 
(e.g. transgastric fine needle aspiration of the pancreas, irreversible electroporation of the 
pancreas, liver biopsy) where a needle is intentionally inserted into malignant tissue. This is 
feasible because the risk of needle tract seeding is either small or outweighed by the clinical 
benefits of the procedure (328–330). To minimise the risk of needle tract seeding from 
needle based CLE, an ablation of the needle tract should be carried out which is advocated 
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by some authors as routine practice in any laparoscopic liver ablation (312). In addition, if 
the procedure is being conducted anyway, the obtaining of CLE data through the same 
needle track simply adds to the benefits side of the risk evaluation and offers the possibility 
of increased data yield from the same clinical exercise. Further testing and validation in an 
experimental setting will be required to elucidate if this solution is feasible. Until feasibility 
has been confirmed, experimental CLE ablation monitoring should be restricted to superficial 
liver tumours that do not require a needle based approach.  
Another technical issue is the CLE probe’s vulnerability to high temperatures. The 
Cellvizio™ probes are only licensed to work within the range of normal body temperature 
whereas liver ablation may generate temperatures in excess of 100˚C. This may prevent real 
time CLE monitoring within the centre of an ablation zone but the temperature in the 
periphery of an ablated region is generally lower than in the centre and rapidly deteriorates 
(331). Temperatures that are within the working range of a CLE probe can be expected 
within minutes of completing liver ablation therefore potentially allowing assessment during 
the same treatment session as near-real time monitoring. 
5.5. Conclusion 
In summary, this chapter has assessed dual-wavelength CLE for evaluating ablation therapy 
of focal liver lesions under laparoscopic guidance. Intraoperative CLE image acquisition 
during liver resection has been shown to be technically possible. In analogy to CLE studies 
conducted on murine CRLM in chapter 4, it was demonstrated that numerical analysis of 
fluorescence intensity can be employed to confirm the extent of liver ablation. Based on 
these findings, CLE may be of interest as a novel imaging modality in liver ablation research. 
Further investigation seems warranted to examine if technical limitations, that currently 
prevent a clinical translation of this approach, can be overcome. 
In the following chapter normal and pathological liver tissue will be studied on a macroscopic 
scale with multispectral imaging. 
  
157 
 
6. Multispectral imaging 
6.1. Introduction 
The way that tissues interact with light is too a large extend determined by their chemical 
composition. As a generalisation it can be said that within the visible spectrum, tissues that 
appear bright reflect light (i.e. “throw” it back at the observer) whereas dark tissues mostly 
absorb light. Light absorption and reflection are inversely related to each other. This 
phenomenon also takes place outside the visible range e.g. in the infrared and ultraviolet 
spectrum. It has previously been established that as tissues undergo a pathological process 
they will often alter their absorption behaviour (and vice versa for reflection) within the visible 
and invisible spectra of light. The absorption characteristics of tissues and potential changes 
can be elucidated by obtaining a spectral response curve (SRC). These curves are created 
by plotting tissue absorption or reflection against light wavelengths. Many substances (e.g. 
lipids or water) have one or more absorption maxima (a wavelength where more light is 
absorbed than in the adjacent wavelengths) that is specific to them and that can be used to 
infer their respective presence and estimate their tissue concentration (224). The 
characteristics of SRC has been shown to reflect the tissue composition through further 
detailed analysis conclusions may be drawn as to the concentrations of a number of 
substances such as lipids, water or haemoglobin to name a few (163,224). This principle has 
found wide spread use in pulse oxymetry where the fractions of oxygenated vs. 
deoxygenated haemoglobin are measured with the aid of red and infrared light to allow the 
assessment of oxygen saturation. 
Previously it was demonstrated that this technique can be transferred to laparoscopic 
surgery by fitting the laparoscope with a light filter that narrows the reflected (i.e. received by 
the laparoscope) light down to a certain spectral range (e.g. range of 20nm) by filtering out 
light received from tissue that is outside the desired range. This approach was facilitated by 
employing either an adjustable filtering process controlled by a liquid crystal tuneable filter 
(LCTF) (163)or by the use of a multiple bandpass filter that was used in conjunction with the 
RGB colour channels of the camera sensors (332). For example a multiple bandpass filter 
may allow transmission of light at 425-455nm, 500-535nm and 590-620nm. If an image is 
exclusively processed using the blue RGB channel then only light reflected at the range of 
425-455 is recorded. The authors demonstrated that this method enabled laparoscopic 
evaluation of relative haemoglobin concentration (163) and an improved visibility of 
superficial vasculature (332). A different group that also utilised a LCTF showed that by 
focusing on determination of fat, water and haemoglobin contents, it was possible to clearly 
visualise the hepatic artery, portal vein and the common bile duct in a porcine model (155). 
A more detailed analysis of tissue spectra can allow quantification of substance 
concentrations within tissue. One group has described the development of a needle-based 
probe device that can be used to perform diffuse optical spectroscopy by putting it into direct 
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contact with organic material. In one of their first publications they verified the devices 
capability to estimate concentrations of lipid and water in tissue phantoms and ex-vivo 
porcine liver samples (161,224). This approach has been further expanded to include the 
estimation of haemoglobin and bile content. By analysing various physiological and 
morphological parameters of spectral response characteristics of oxygenated haemoglobin, 
deoxygenated haemoglobin, water, bile and lipid, it was possible to fit a model representing 
the SRC of normal (i.e. non-pathological) liver tissue. This model was then subsequently 
utilised to distinguish between normal and malignant tissue in ex-vivo liver specimen that 
were resected from patients with CRLM. This technique has also been recently applied to an 
in-vivo model of primary liver cancer. Using probe-based diffuse optical spectroscopy, 
reduced fractions of lipids, blood and reduced tissue oxygenation were detected in areas of 
HCC in 5 woodchucks (257). Although these results are promising there are several 
disadvantages to employing a probe based design intraoperatively. Firstly, the tissue 
evaluation is limited to a small volume of tissue due to the small separation between the 
optical fibres delivering and receiving light (1.84 mm). This means it may take a long time to 
assess a clinically meaningful area. Secondly the tissue analysis depends on changes in the 
spectroscopic response curve which is not an intuitive or time efficient way to mentally 
integrate information during surgery.  
Spectroscopic discrimination of tissue characteristics the nature of tissue has potential 
advantages for its application in laparoscopic surgery because it may replace in part the 
sense of touch that is lost in minimal invasive surgery, by displaying normally invisible tissue 
qualities to the surgeon. Tissues types of surgical relevance that have been successfully 
identified using either multispectral imaging (MSI) or diffuse optical spectroscopy include 
veins, arteries, bile ducts, steatotic liver and cancerous liver. To avoid the aforementioned 
disadvantages of diffuse optical spectroscopy however, it would be important to develop a 
no-touch method of spectroscopic assessment that does not require direct contact or the 
insertion of needles into tissue. It is hypothesised that a multispectral imaging system that 
can reproduce the tissue discrimination approach demonstrated for diffuse optical 
spectroscopy would be a potential solution to this problem. 
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The aim of this chapter is to formulate a technique and analysis method that enables 
intuitive, image based spectroscopic interpretation of liver tissue characteristics. The 
spectroscopic studies will be carried out on ex-vivo human liver tissue. 
6.1.1 Aims 
The specific in this chapter aims are to: 
1) develop and test an imaging platform that enables spectroscopic tissue evaluation in 
a continuous wavelength range. 
2) examine spectra of normal and pathological liver specimen and compare findings to 
data published in the literature. 
3) perform statistical analysis of the predominant predictive components of the spectral 
response curve in liver tissue.  
6.2. Methods 
6.2.1 General setup 
In this chapter spectroscopic response curves are recorded from liver tissue samples. This is 
achieved by illuminating tissue with an Optical Parameteric Oscillator, a wavelength-
tuneable light source that can be finely tuned to wavelengths between 700-2000nm. The 
amount of light absorbed by tissues corresponds is inversely related to the amount of 
reflected light. Reduction of background illumination is achieved by conducting the 
recordings in a darkened room without additional light sources. A NIR camera with an 
InGaAs sensor is employed to record the reflected light which is measured as pixel intensity 
on a scale of 0-16.383. Generally it can be stated that higher pixel intensities correspond to 
higher tissue scattering and lower tissue absorption. The excitation wavelength is changed 
over time while images are recorded from the stationary liver specimen. As an analogy it can 
perhaps be compared to recording a video sequence where instead of moving objects, a 
change in light spectra is recorded. Tissues from the same source (e.g. patient) but different 
characteristics (e.g. healthy vs. pathological tissues) are always examined at the same time 
and within the same field of view. To reduce variability in illumination that is introduced by 
the synchronisation between OPO light pulse and camera recording, several frames (usually 
20, if different number it is stated) are recorded at each wavelength. Approximately <1% of 
frames were grossly under-illuminated despite synchronisation. These were excluded from 
analysis using on an automatic outlier recognition algorithm that was based on the median 
absolute deviation method (333) that has been shown to be efficient in datasets with non-
parametric distributions such as the spectroscopic data recorded for the experiments in this 
chapter. Simultaneous examination reduces experimental variables and ensures that most 
of the variability in the tissue spectra originates from differences in tissue composition. At the 
conclusion of the spectroscopic examination, specimen biopsies are taken for histological 
examination. Finally histological findings are correlated with spectroscopic response curves. 
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6.2.2 Comparison of spectral response curves 
Initially results are analysed by observing the spectral response curves from whole tissue 
samples. For example in an experiment with three tissue sample, each sample is marked 
with a region of interest (ROI) and the mean pixel intensity (y-axis) from each ROI is 
subsequently plotted against the excitation wavelength (x-axis). This results in three 
separate spectral curves plotted on the same graph. Background noise is accounted for by 
subtracting the average value of non-illuminated frames that were recorded prior to each 
experiment. The characteristics of the spectral curves are compared against each other and 
in addition to spectroscopic tissue data from the literature. 
 
6.2.3 Normalisation process 
A limitation to statistical comparison across different experiments was that a number of 
factors such as illumination area, lens to specimen distance, specimen size and number 
varied between different experiments. To make the spectroscopic curves comparable, 
recorded data was normalised.  
Normalisation was carried out by calculating the background noise subtracted mean 
intensity from all recorded tissue samples (including normal and pathological tissue) at 
individual wavelengths. The resulting mean intensity value for each wavelength was then set 
to a value of 1. The pixel intensities recorded at an experiment is subsequently expressed as 
a multiplicative term at each wavelength. If for example the intensity at 1200nm is 50% of 
the mean value across experiments, it is translated into a normalised value of 0.5. The 
equation for the normalisation process is shown in Equation 6.1. 
𝐼 =
𝐼𝑜 − 𝐼𝑏
𝐼M
 
Equation 6.1 Equation used to normalise pixel intensities of MIS images. Pixel 
intensities inversely correlate with light absorption. I - normalised intensity; o - 
original intensity; b - background intensity; M – background subtracted mean 
intensity across all samples 
This approach was chosen as initial attempts of utilising a white reflection standard (which 
can be seen in most images) were unsuccessful because there was too much of a 
discrepancy between the light absorption exhibited by liver samples and the reflection 
standard, respectively. As light absorption of the liver tissue was much higher, the 
illumination levels needed to produce a spectral response curve from tissue was at a level 
were at the majority of wavelengths, the reflectance standard was over-illuminated (i.e. at 
maximal intensity). A spectral response at maximal intensity, which was a limit set by the 
physical characteristics of the cameras sensor, translates into a flat line which cannot be 
used for data analyses purposes (Figure 6.1).  
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Figure 6.1 SRC of the white reflectance standard. 
The spectroscopic response curve of the white reflection standard “flatlines” at most 
wavelengths at the illumination levels needed for producing spectroscopic response 
curves from liver tissue, due to detector saturation.  
 
6.2.4 Statistical analysis 
For statistical analysis single pixel values were compared rather than whole tissue samples. 
This method was chosen because images of cancer samples at certain wavelengths often 
appeared to be more heterogeneous than images from normal tissue. When taken the mean 
of a larger ROI however these variances would potentially cancel each other out. 
Normalised single pixel intensities were grouped according to tissue origin (normal tissue vs. 
cancer) and wavelengths (Cancer type distribution in results). Patient ID and cancer type 
(CRLM or HCC) were also recorded as covariates. At first it was investigated if any specific 
wavelengths would be particularly suitable to distinguish normal tissue from cancer. Bland-
Altman plotting (334) was carried out initially to look at distribution differences between 
patients and subsequently to look at differences between wavelengths. In Bland-Altman 
plots the mean value of two tests, in this case pixel intensity for normal and cancer tissue, on 
the x-axis is plotted against the absolute difference between both tests on the y-axis. If both 
tests have congruent results the resulting plot follows a horizontal which is set at zero 
difference. Different test results diverge from this line. To carry out the analysis the 
BlandAltman function (©Ryan Kerner) that is available from MATLAB file exchange was 
used. Subsequently generalised linear mixed model analysis was carried out with two aims 
1) to determine if normalised pixel intensities could independently predict the presence of 
cancer vs. normal tissue and 2) which particular wavelengths are most useful in 
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discriminating tissue. The analysis was conducted using SPSS™ Version 21 (IBM, Armonk, 
NY, USA). Intensity and wavelengths are used as fixed term whereas cancer type and 
patient ID (representing confounding factors between different experiments) are used as 
random terms for the analysis. For the analysis a multinominal distribution type was chosen 
combined with a logit link function. 
6.3. Results 
6.3.1 Assessment of feasibility and spatial resolution of the SCR 
The first experiment was carried out to find the optimal setup configuration for and to 
evaluate image quality, to establish the spatial resolution of the spectroscopic data and to 
obtain preliminary data from spectral ranges that have been previously related to fat and 
water content. The setup configuration included lens to camera distance, upper illumination 
limit (i.e. maximum illumination without crossing the saturation limit of the camera sensor) as 
determined by use of optical filters and lens aperture. The preliminary experiments were 
conducted without synchronisation between camera and OPO laser source. 
A low power output of the OPO at 900-1000nm meant that images recorded at this spectrum 
were hugely under-illuminated. It was possible to adjust for this by widening the lens 
aperture but this unfortunately meant that subsequent images at higher wavelengths were 
grossly over-illuminated and could therefore not be analysed. A decision was made at this 
point to limit MSI image acquisition to wavelengths > 1100nm (The OPO could not be tuned 
to wavelengths between 1000-1100nm).  
For these experiments no synchronisation or automatic selection process was used, which 
means all frames regardless of illumination levels were recorded. A large number of frames 
were under-illuminated and hence a scatter plot representation was used to assess tissue 
SCR. A mean representation in the plot would have been heavily influenced by the under-
illuminated frames. 
Tissue used for this experiment were commercially purchased bovine liver and streaky 
bacon. The bacon was thought to be useful because of its contrast between lipid rich (fatty 
stripe) and water rich (red stripe) tissue. Bovine liver was used as a substitute to human liver 
samples. In addition a white reflectance standard was used to evaluate the consistency of 
the illumination. The reflection level is expected to be almost unchanged across 
wavelengths. Experiments were repeated three times, but at each repetition there was at 
least one wavelength for which no measurable illumination was recorded. These frames 
were depicted on the plots as circles lying directly on the x-axis which means that the 
corresponding mean ROI pixel intensity equalled zero or near zero. These values have been 
removed from the scatter plots to improve readability (Figure 6.2). The spectra with the 
lowest data loss are presented in the plots below, which compare SRC’s at 1150-1250nm 
and 1400-1500nm from the same tissue area. These wavelength ranges were chosen 
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because the former contains the lipid absorption peak around 1200nm and the latter 
contains a water absorption peak which is broader at around 1450nm (224). 
The ROI marked over the fatty region of the bacon slice exhibited the highest intensity (i.e. 
lowest absorption) of all the tested regions. Due to the lost data it is hard to interpret but it 
was felt that there is a suggestion of stronger absorption at 1200 & 1210nm (arrow). At 
1400-1500nm the absorption was higher compared to 1150-1250nm (Figure 6.2). The ROI 
marked muscle tissue (red bacon stripe) was <1cm distant from the fatty area but did show a 
different spectral response. The absorption was stronger at both wavelength ranges 
compared to the lipid rich area (Figure 6.3). The absorption at 1400-1500nm was strongest 
for the liver tissue sample perhaps indication a greater water content (Figure 6.4). The 
spectral response of the white reflection standard, although exhibiting a slightly higher 
absorption at 1150-1250nm was generally constant (Figure 6.5). 
Optimal camera lens to specimen distance was found to be 20-25cm which provided a good 
balance between a sharp image focus and a good illumination level. To prevent over-
illumination, the lens aperture was kept very narrow and optical filters of 6 optical densities 
strength were used. Spatial resolution of the MSI imaging system was found to be in the 
range of app. 1mm meaning that tissues 1mm apart can display different absorption 
behaviour. Generally the absorption at 1400-1500nm was found to be higher for all tissues 
but the absorption for the liver sample was most pronounced. An absorption peak over the 
fatty tissue was recorded in two out of three experiments. In the 3rd experiment no usable 
image data was recorded at 1200nm and the adjacent wavelengths. It became apparent that 
a solution to prevent data loss in future experiments was required. 
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Figure 6.2 Scatter plot - SRC from lipid rich tissue. 
Spectral response of fat tissue from a piece of bacon. Plotted is background noise 
subtracted pixel intensity on the y-axis and wavelength on the x-axis. Each circle 
represents one frame that was recorded at the respective wavelength. Top - ROI. 
Middle – spectrum of 1150-1250nm, The lipid absorption peak at 1210nm is annotated 
with an arrow. Bottom – spectrum of 1400-1500nm.  
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Figure 6.3 Scatter plot - SRC from muscle tissue. 
Spectral response of muscle tissue from a piece of bacon. Plotted is background 
noise subtracted pixel intensity on the y-axis and wavelength on the x-axis. Top - ROI. 
Middle – spectrum of 1150-1250nm. Bottom – spectrum of 1400-1500nm. 
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Figure 6.4 Scatter plot - SRC from liver tissue. 
Spectral response of bovine liver tissue. Plotted is background noise subtracted pixel 
intensity on the y-axis and wavelength on the x-axis. Top - ROI. Middle – spectrum of 
1150-1250nm. Bottom – spectrum of 1400-1500nm.  
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Figure 6.5 Scatter plot - SRC from a white reflectance standard. 
Spectral response of the white reflection standard. Plotted is background noise 
subtracted pixel intensity on the y-axis and wavelength on the x-axis. Top - ROI. 
Middle – spectrum of 1150-1250nm. Bottom – spectrum of 1400-1500nm. A smaller 
area of the standard was marked because illumination did not reach the whole area of 
the standard 
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To improve data acquisition the Labview code was reprogrammed to ensure that at a 
minimum number of frames (usually 20) was obtained for each wavelength. Frames whose 
maximum intensity did not pass a certain threshold were automatically discarded. This new 
approach ensured that there were no further issues with “empty” wavelengths (Figure 6.6). 
An ongoing issue was however that some under-illuminated frames were still recorded 
because specular reflections did occasionally cross the required maximum intensity 
threshold. 
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Figure 6.6 Scatter plot – SRC from liver tissue recorded with an improved image 
acquisition algorithm. 
Automatic frame selection enabled continuous recording of SRC without "empty" 
wavelengths. Shown is a SRC from bovine liver tissue as a scatter plot. 
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6.3.2 Assessment of normal vs. steatotic liver  
Before studies on steatotic liver tissue were conducted, an improved image acquisition 
algorithm was programmed. This minimised loss of data to <1% (Figure 6.7). A detailed 
description of the algorithm has been given in the General Methods section (3.3.3.3).  
Steatotic liver samples were retrieved from discarded donor livers. Non-steatotic liver 
samples were retrieved from liver resections carried out for cancer. The samples were taken 
from areas of the liver that did not show any cancer involvement. The tissue spectra were 
plotted and assessed for differences between steatotic and non-steatotic samples. A 
prominent absorption peak at 1210nm indicating a greater lipid content in the steatotic 
samples was observed Figure 6.8). The plotted intensity represents noise subtracted raw 
pixel intensity. No normalisation process was carried out due to the low number of tissue 
samples which made statistical analysis unfeasible. Therefore, absolute intensity differences 
could potentially be due to changes in illumination intensity, the shape of the spectra would 
however not be influenced by this. Presence of liver steatosis as indicated by vacuole 
formation was confirmed on H&E stain histology examination (Figure 6.9 & Figure 6.10). 
Vacuoles form at the location of adipocytes (fat cells) during the preparation process of 
histology slides (335). 
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Figure 6.7 Scatter plot – SRC recorded using the final version of the MSI acquisition 
algorithm. 
The improved MIS image acquisition improved data loss significantly. Each 
wavelength step has been measured with 15 repetitions. Out of a total of 56x15 
frames, only 3 have been under-illuminated. These frames are excluded from further 
analysis by automatic outlier exclusion based on the median absolute deviation. 
 
 
Figure 6.8 SRC from steatotic and non-steatotic liver specimen (n=2 each) 
Tissue spectra from steatotic (S01 & S02 – solid lines) and non-steatotic (N01 & N02 – 
dashed lines) liver samples. The dotted vertical line (arrow) marks 1210nm where an 
increased absorption could be observed in steatotic liver tissue. Background noise 
has been subtracted from the plotted intensity. 
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Figure 6.9 H&E histology from non-steatotic liver biopsies. 
Histology H&E stains from non-steatotic livers. Vacuole formation indicating fat 
content (arrows) was only infrequently observed in one of the samples (N01). The 
other sample (N02) was virtually free of vacuole formation. 
 
 
 
Figure 6.10 H&E histology from steatotic liver biopsies. 
In steatotic liver tissue vacuole formation indicating fat content was frequently 
observed (arrows). 
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6.3.3 Qualitative assessment of cancer vs. normal liver  
6.3.3.1 CRLM 
Multi-spectral imaging was carried out on tissue samples from patients with CRLM (n=3). 
Images were analysed to create SRC from regions of interest that covered the whole tissue 
area. These were subsequently compared between normal and cancerous tissue (Figure 
6.11). For patient ID’s C02 and C03 one sample each was evaluated whereas for patient ID 
C03 one cancerous and 3 normal samples were evaluated. The number of samples was 
determined by the size and nature of the liver resection specimen. Samples for MSI 
experiments could only be obtained if the pathological resection margin would not be 
compromised. At the conclusion of experiments, tissue biopsies were taken for histological 
evaluation (Figure 6.12), which was used to confirm the nature of the tissue sample (i.e. 
normal vs. cancer). Analysis of the SRC did not reveal any obvious differences between 
cancerous and normal tissue. Samples taken from different patients did however exhibit 
different MSI characteristics, but this could not be clearly attributed to the absorption 
characteristics of a specific substance. 
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Figure 6.11 SRC of CRLM tissue vs. normal liver tissue. 
Tissue absorption spectra of normal vs. CRLM tissue obtained from three different 
patients. Background noise has been subtracted from the plotted intensity. 
 
 
Figure 6.12 H&E histology from liver samples with CRLM. 
H&E stained histology from a liver specimen containing CRLM. a) The arrows mark 
the border between normal tissue on the left and CRLM tissue on the right. b) Normal 
hepatocyte architecture with a few vacuoles on the left of the screen. 
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6.3.3.2 HCC 
In analogy to MSI experiments on CRM tissue, data was obtained from HCC specimen using 
the same protocol. Tissue was obtained from two patients. For patient ID C01, two normal 
and one cancerous sample were available for examination, whereas for patient ID C04 two 
normal and three cancerous samples were available. Subjective analysis of the absorption 
spectra did not reveal any overt difference between normal and cancerous tissue. There 
were differences in the SRC characteristics between the two patients (Figure 6.13). It was 
also noted that C01 who had mild liver steatosis as marked on histological evaluation, 
exhibited a marked absorption peak at around 1210nm.Presence or absence of cancer was 
verified based on tissue histology (Figure 6.14). 
  
176 
 
 
Figure 6.13 SCR of HCC vs. normal liver tissue. 
Tissue absorption spectra of normal vs. HCC tissue obtained from two different 
patients. Background noise has been subtracted from the plotted intensity. 
 
 
Figure 6.14 H&E histology from liver sample with HCC. 
a) A accumulation of HCC cells (arrow) within fibrotic liver tissue. b) Tissue obtained 
from a normal section of tissue shows regular hepatocyte architecture with a slightly 
higher than normal amount of vacuoles. 
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6.3.4 Statistical analysis of cancer vs. normal liver 
Because subjective evaluation of the tissue absorption spectra from cancer and normal 
tissue could not discern any defining characteristics it was decided to perform a statistical 
analysis on the available MSI data. It was noted that on visual inspection, liver tissue 
containing cancer often had a heterogeneous appearance. Therefore the main focus of the 
statistical analysis was on evaluating potential differences on a pixel by pixel basis. At first 
data from all samples was normalised as described above (6.2.3). The resulting normalised 
absorption spectra are shown below (Figure 6.15 & Figure 6.16). 
 
Figure 6.15 Normalised SRC of tissue from patients with CRLM.  
 
 
Figure 6.16 Normalised SRC of tissue from patients with HCC. 
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The next step was to analyse the data for differences between patients and between 
individual wavelengths using Bland-Altman plotting (BAP). For each patient ID, normalised 
intensity values were averaged for cancer and normal tissue to facilitate BAP. This was 
necessary because only two groups (i.e. normal & cancer) per patient ID can be analysed 
with BAP. 
The resulting BAP initially grouped by patient ID (Figure 6.17) and then by wavelength 
(Figure 6.18) are depicted below. The aim was to identify any particular wavelengths that 
would be outside the expected distribution which is highlighted by the dashed horizontal 
lines which represent limits of agreement between cancer and normal tissue intensities. It 
was intended to include any wavelength that was repeatedly (i.e. across patient ID’s) outside 
the agreement limit in a subsequent generalised linear mixed model analysis. Although 
several wavelengths were found to be outside this area this was not consistent across 
patients and was therefore more likely due to inter-individual differences. 
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Figure 6.17 Bland-Altman Plot ordered according to patient ID’s. 
The left graph depicts cross-correlation between cancer and normal tissue values. 
The graph on the right is the actual Bland-Altman plot. It can be observed that 
normalised intensities for patient ID C05 and to a lesser extent C02 (both CRLM) are 
outside the limits of agreement. 
 
Figure 6.18 Bland-Altman plot ordered according to wavelengths.  
The wavelengths outside the agreement limit were largely in the range of 1400-
1600nm. 
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Because no particular wavelengths could be identified in the BAP, a generalised linear 
mixed model analysis was carried out including all wavelengths from 1100-1700nm. 
Essentially the pixels from all previously marked ROI’s were combined and divided into two 
groups, cancer vs. normal, according to the tissue sample the ROI was taken from. The 
analysis included normalised intensity and wavelength as fixed terms whereas patient ID 
and cancer type were used as random terms. The tissue type cancer vs. normal tissue was 
used as dependent. A multinominal model with a logit link function was used. According to 
the analysis, the normalised pixel intensities measured at 14 out of 61 wavelengths (Table 6) 
were statistically significant as an independent predictor for the presence of normal vs. 
cancer tissue. The classification accuracy of the model was 69.1%. 
 
Wavelength Coefficient 95% 
lower 
95% CI 
upper 
p-value 
1100 0.238 0.2 0.276 0 
1110 0.125 0.087 0.162 0 
1130 0.041 0.004 0.079 0 
1180 -0.04 -0.078 -0.003 0.034 
1190 -0.067 -0.105 -0.03 0 
1220 -0.044 -0.082 -0.007 0.02 
1320 -0.043 -0.08 -0.005 0.025 
1430 0.038 0.001 0.075 0.047 
1470 0.039 0.001 0.076 0.042 
1480 0.061 0.023 0.098 0.001 
1570 0.05 0.012 0.087 0.009 
1600 0.047 0.01 0.084 0.014 
1610 0.048 0.011 0.086 0.012 
1660 0.042 0.005 0.079 0.028 
Table 6.1 Results of the generalised linear mixed model analysis. 
Wavelengths that were shown to be independent predictors for the presence of 
malignancy are shown in the table. 
 
6.3.5 False colour visualisation 
A ‘false colour’ image was created by combining data from several wavelengths in one 
image frame as described above (3.3.6). Image data obtained at wavelengths that were 
statistically significant with a positive coefficient on generalised linear mixed model analysis 
was averaged for each pixel. The resulting image is shown below (Figure 6.19). 
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Figure 6.19 ‘False colour’ representation of multiple wavelength spectra.  
a) Image obtained at 1130nm. The sample containing CRLM is marked (arrow).  b) 
False colour image combining the average for all wavelengths that were shown to be 
independent predictors for the presence of normal vs. CRLM tissue (arrow). 
 
6.4. Discussion 
In this chapter a system has been developed and tested to enable multispectral imaging of 
ex-vivo tissue samples. It was shown that depending on field of view MSI images enabled 
reconstruction of tissue absorption spectra at fine spatial resolution that could be interpreted 
based on individual pixels. Because a tuneable OPO was employed as excitation source, 
the spectral resolution was (i.e. distance between individual wavelengths) was in the range 
of 3-5nm. An additional advantage of this approach was that no direct contact with the tissue 
was required and the area of multispectral evaluation could be altered by changing the field 
of view. 
Liver tissue specimen from normal and diseased tissue were qualitatively examined and the 
resulting SRC were compared to data from the existing literature. A prominent absorption 
peak at 1210nm was observed in steatotic liver samples which is congruent with previous 
reports (224,336). The steatosis in the specimen was not formally quantified because with 
tissue only being available from two patients an in depth quantitative analysis between fat 
content correlation and strength of the absorption peak would not have been feasible. Based 
on estimation however the steatosis involved <30% of the histological samples which means 
the steatosis was likely to be in the mild category (335). In preliminary experiments using 
bacon and bovine liver as ex-vivo tissue phantoms, the spectral range between 1400-
1500nm which includes an absorption peak for water exhibited lower absorption in lipid rich 
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tissue. In the red meat part which was treated as a substitute for muscle tissue, the 
absorption at this range was stronger and in liver tissue it was the most prominent 
absorption out of all three examined tissues. It is hypothesised that this was due to greater 
water content in liver over muscle tissue but because a detailed tissue analysis was not 
performed this claim could not be verified. 
The examination of liver specimen containing primary and secondary liver cancer did not 
show any obvious differences in the SRC characteristics of normal and cancerous liver 
tissue. There was however a difference when looking at tissue from different patients and 
between CRLM and HCC tissue. The generalised linear mixed model analysis indicated that 
a combination of absorption values taken at 14 different wavelengths could predict the 
presence of normal vs. cancerous liver tissue. 
Having identified the most relevant wavelengths for the prediction of tissue quality, these 
were consequently incorporated into a false colour image processing algorithm. The aim of 
this approach was to enhance the visual perception of tissue quality in an intuitive and time 
efficient manner.  
There were some limitations to the data presented in this chapter. The reported variations in 
the intensity values, normalised or otherwise could in part be explained by changes in 
experimental factors such as camera lens to specimen distance, which had to be altered to 
adjust the field, ensuring that specimen of different sizes were visible. Another factor with an 
impact on pixel intensity is the varying power output of the OPO laser source.  
It is hypothesised however that impact of these two factors was attenuated because under-
illuminated frames were automatically excluded during the image acquisition process. Using 
patient ID (tissue from different patients was examined on separate days) a random factor in 
the generalised mixed model accounts for variations in unknown parameters that could have 
changed between individual experiments. As is true for other optical imaging technologies, 
the imaging depth for MSI is limited. Penetration of light will vary slightly depending on 
wavelength but generally it has to be assumed that only tissue quality up to a maximal depth 
of ≈ 5mm can be assessed at present (144). There is some indication that stronger light 
sources may allow a deeper penetration within the region of >1cm depth (337) but if this is 
translatable to MSI remains to be seen. A further limitation is the small number of samples 
and the heterogeneous nature of the samples. The number of available cancer samples was 
limited due to practical issues. Tissue could only be obtained from one surgeons practice 
due to ethical considerations. The time frame in which tissue could be obtained was < 6 
months because it took a substantial amount of time to build the MSI system and its 
accompanying software algorithm. In this context the process of synchronisation was 
especially time consuming. The samples themselves could only be obtained if a resection 
specimen was large enough to allow tissue harvest without compromising histopathological 
evaluation (i.e. to confirm that surgical excision of cancer was complete). The number of 
183 
 
liver specimen with steatosis underlay even greater restrictions because access depended 
on availability of discarded donor organs and sufficient staffing at the local tissue bank. A 
further limitation was that the effect of tissue perfusion could not be examined because all 
experiments were conducted on ex-vivo samples. Finally the breadth of the measured 
absorption spectra was limited by technical considerations. The InGaAs NIR camera used 
for recording the SRC had a wavelength range of 900-1700nm. The OPO laser source could 
be tuned to wavelengths between 700-1000 and 1100-2000nm.The power output and hence 
illumination intensity at 900-100nm was very low and hence it was decided to omit the range 
of 900-1000nm completely, because it would not have been possible to record a continuous 
spectrum. Evidence from the literature suggests that within the measured range of 1100-
1700nm it is feasible to assess the absorption peaks of water and lipids because they have 
absorption peaks at around 1450nm and 1200nm respectively (224). Absorption peaks of 
other biologically relevant substances such as haemoglobin and bile lie within the range of 
600-800nm. 
The results from this chapter have highlighted the potential of MSI to remotely sense 
aspects of tissue composition that may reveal pathological changes. Further work is required 
before transferring this imaging modality into a clinical evaluation phase. Initially it would be 
useful to expand the width of the measured spectra to include biologically important 
substances such as bile and haemoglobin. This for example could be achieved by 
combining the existing system with an additional laser excitation source and sensing camera 
or a LCTF based system that can cover the range between 600-1100nm (155). It is also of 
crucial importance to expand the tissue data that was employed for building the predictive 
model. Because the nature, origin, biological behaviour and pathological composition of liver 
cancer types differs (20,23,338) it is proposed to evaluate tissue absorption spectra divided 
by cancer type. Once the spectral behaviour of different liver cancer types has been further 
evaluated the focus could be switched to developing a laparoscopic MSI system that can 
translate this methodology into clinical use. Although laparoscopic systems with MSI 
capabilities exist they are currently targeted at relatively narrow spectral range of a few 
hundred nanometres (155,195). It remains to be seen whether laser excitation, multi-
bandwidth filtering or an alternative technique is the most useful method for MSI in 
laparoscopy. Based on the findings in this chapter a multi-bandwidth filter system appears to 
be the technically more feasible option because tuneable laser excitation sources are time 
consuming to use and comparably fragile. In terms of required timing for example, the 
InGaAs camera employed for the experiments in this chapter had a frame rate of 30fps, 
which translates to 30 individual wavelength spectra recorded per second. This frame rate 
was however limited by the OPO light emission frequency of 10Hz (i.e. 10fps). In contrast to 
this a bandwidth filter system would not have the same restriction.  
  
184 
 
6.4.1 Conclusion 
In summary, the development of a broad spectrum remote multispectral imaging platform 
has been described. Its ability to record and visualise absorption spectra in liver tissue has 
been demonstrated and it was shown that variations in these spectra may allow prediction of 
pathological processes such as steatosis or malignancy. Statistical analysis of tissue spectra 
has led to the formulation of a predictive model that was consequently employed to develop 
an enhanced MSI based visualisation method for liver malignancy. 
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7. Video magnification 
7.1. Introduction 
In a previous chapter it was shown that CLE can visualise blood flow in small vessels and 
capillaries. Aside from tumour associated changes in microcirculation, the assessment of 
blood flow is of great importance during surgical procedures to evaluate the vitality of tissue 
and to guide surgical dissection. Failure to excise non-vital tissue, can result in ischaemic 
damage and this can activate inflammatory pathways and stress response (339). 
Guidance is needed to make surgeons aware of blood vessel location which is important to 
avoid inadvertent injury that can lead to significant blood loss and associated morbidity. To 
achieve this form of guidance a technology that enables early detection of blood vessels and 
allows estimation of organ perfusion would be of benefit (67,141,265). Another scenario 
where visualisation of blood flow may be useful is during hepatectomy with hilar dissection 
(control of inflow vessels). When performing a traditional hepatectomy, the blood inflow to 
the liver is divided before liver tissue is transected. It can be difficult to appreciate which part 
of the liver is de-vascularised and hence decide on the optimal plane of transection. 
Visualisation of blood flow or segmental borders can be of benefit in this circumstance (159). 
Because visual inspection to assess tissue perfusion is subjective and unreliable attempts 
have been made to develop an objective technique that can aid surgeons in this context. 
The approaches that have been proposed so far require the use of additional equipment 
and/or intravenous contrast agents which may increase procedure time or may have a 
negative impact on patient safety (184,340). 
High resolution video that is routinely recorded during laparoscopic surgery contains 
potential physiological and anatomical information. However, surgeons cannot take 
advantage of this information because they are restricted by the limitations of the human 
visual system. A recent work on “Eularian Video Magnification” (136) has shown that 
physiological and anatomical information available due to variations in motion, colour and 
light can be brought to the attention of the observer by analysing space-time related 
variations of specific image regions in the video. Skin colour for example has been shown to 
fluctuate at the same rate as the heart frequency, which in turn can be translated into signals 
to record the pulse rate. Recording and analysis of vessel pulsation- and respiratory rate has 
also shown to be possible (136,341). 
Despite these promising preliminary findings, major challenges have to be solved before real 
time VM can be used to assess tissue perfusion and detect hidden vasculature. One 
challenge for example is a standardised quantification or measurement method that enables 
researchers to directly compare different VM methods. Many improvements to the original 
work of Wu have been proposed (244,245,342). It is however difficult to decide without 
standardised metrics which of these methods is best suited to laparoscopic surgery. As part 
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of establishing quantifiable metrics, it would also be prudent to assess if the strength of the 
VM signal bears any correlation to the underlying physiological process e.g. when assessing 
blood vessels in the arm, would a higher blood pressure result in a stronger VM signal? 
Another challenge is to look at how VM processing is affected by different environments. 
Although pulsation of subsurface blood vessels (e.g. ulnar artery) have been made visible, it 
is not clear if this finding is transferable to the liver which has a much darker surface which 
absorbs more light. In this chapter video magnification is applied to experiments on imaging 
phantoms and a porcine laparoscopy model. Because it is a “wide field” method that 
encompasses the entire field of view it is more appealing for assessment of blood flow than 
a microscopic point based method such as CLE, where a vessel is only visualised when it is 
directly targeted. As a technology, VM could potentially be useful during laparoscopy by 
delineating perfused from non-perfused tissues and by localising non-visible blood vessels. 
The texture of digital images can be analysed to extract features from a scene that enables 
an estimation of its content. This method has been popularised by some authors for the 
estimation of crowd density and crowd motion. The rationale behind this is that the texture 
becomes finer with an increasing crowd size because more persons on an image equate to 
a more detailed texture. These crowd and motion estimation algorithms are based on the 
Gray-level co-occurrence matrix (GLCM), a statistical texture representation method first 
described by Haralick (343). The GLCM methodology has been further described above 
(3.4.4.2). In this chapter the feasibility of employing GLCM analysis to estimate video 
magnification signals will be analysed. The proposed method will then be applied to the 
estimation of video magnification signals. 
7.1.1 Aims 
The aims in this chapter are to: 
1) evaluate the feasibility of using texture based analysis to identify video magnification 
signals that originate from pulsatile motion. 
2) elucidate if the analysis method from 1) enables quantification of pulsatile motion. 
3) assess in how far the analysis method from 1) can be applied to pulsatile motion 
from structures that are concealed. 
These objectives will be evaluated in a controlled laboratory setting first before being 
translated to an in-vivo model of laparoscopic liver resection. 
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7.2. Methods 
7.2.1 Flow phantom experiments 
In this section VM signals are evaluated on a pulsatile flow phantom. Tests in a controlled 
environment were a prerequisite to exploring this technology before evaluating VM signals in 
an in-vivo model. The first series of experiments was focused on determining the best 
combination of settings for 1) camera recording 2) VM processing 3) GLCM settings. The 
second series of experiments tested the ability of VM to enhance pulsatile motion 
(henceforth called ‘VM signals’) in a phantom with visible flow channels (henceforth called 
‘clear phantom’). The third series of phantom experiments repeated the same tests in a 
phantom with concealed flow channels (henceforth called ‘brown phantom’) which was 
created to better reflect the visual appearance of liver tissue. 
All video sequences were processed and analysed using the same workflow. At first a video 
sequence is recorded. This is then processed with a VM algorithm to enhance motion. A 
region of interest (e.g. perfused catheter) is marked on the video to allow region specific 
processing of GLCM statistics.  Finally the GLCM data is analysed for the presence of 
repetitive signals (e.g. pulsation) (Figure 7.1). 
 
Figure 7.1 Steps involved in texture based VM signal analysis. 
Flowchart showing the individual steps that are involved in analysing motion signals 
from VM enhanced videos. 
 
7.2.1.1 Establishing the optimal evaluation setup  
Before the evaluation of VM processing on the flow phantom could be carried out it was 
important to standardise three types of settings, namely 1) Camera recording settings 2) VM 
algorithm processing settings and 3) GLCM processing settings. Because all these settings 
have an impact on the characteristic of the resulting VM signal, it is crucial that the impact of 
different settings is well understood. Until now, the impact of video resolution, colour codec 
and recording speed on VM signals has not been evaluated. 
7.2.1.2 Camera and video codec settings 
In their first publication on VM processing Wu et al. (136) suggested that the field of view is 
centred on the object of interest and any additional objects should be avoided from this view. 
The field of view during experiments was therefore positioned to be completely occupied by 
the flow phantom. The camera was kept in a stationary position with the help of an 
adjustable camera arm which was fixed to a perpendicular pole (Figure 3.15). Lens- aperture 
and focus were set to provide a clear image avoiding formation of reflections and shadows 
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where possible. Video sequences were then recorded at different image resolutions; colour 
codecs (methods of compressing video data) and recording speeds (frame rates). 
7.2.1.3 GLCM settings 
The GLCM is processed based on the positional relationship of grayscale pixels in an image. 
Change in the statistical parameters of the GLCM reflect a change in image texture and as 
such can be utilised to estimate motion (261,344). The following set of parameters for the 
graycoprops MATLAB function determine the precise method of GLCM processing.  
Offset: determines the position of the neighbouring pixel which can be found in any of 8 
horizontal, vertical or diagonal directions (Figure 3.17). 
Numlevels: Determines how many graylevels are used for processing. Default is 8, which 
means that all graylevel intensity values (e.g. 255 in an 8 bit image) are binned into 8 ordinal 
categories from low to high. If more levels are used then the bin categories shrink. 
Graylimits: Sets the cut off points for the lowest and highest grayscale intensity. Any values 
below or above the threshold are binned into the next closest category. 
7.2.1.4 Video magnification settings 
As described above (3.4.1) video magnification settings determine how the original video 
data is processed.  
 
In brief, a frequency range that includes the frequency of interest is selected (e.g. 60-
100bpm for normal heart rhythm). The magnification factor ‘alpha’ determines the extent to 
which the signals are magnified. The spatial frequency ‘lambda’ is used to select the level of 
detail that is magnified with a high frequency chosen for finer details. Motions that fall below 
this level are filtered out. In general the amount of potential motion magnification is inversely 
related to image quality i.e. a strongly magnified video including many spatial and time 
frequencies results in a noisier image than videos that are weakly amplified. All sequences 
were processed using a temporal Butterworth filter, which is a filter setting targeted at 
enhancing motion (136). 
7.2.1.5 Objective evaluation of motion signals 
To enable objective decision making on optimal camera, VM and GLCM settings a 
quantifiable and reproducible evaluation method needed to be construed. The motion 
signals were analysed over time to evaluate if VM can elucidate frequency and flow pressure 
within the phantom at different depths. As described above (3.4.4.1) GLCM statistical values 
from a region of interest in the video are plotted over time. Subsequently they are processed 
using the MATLAB function ‘correlation’ that allows quantification of signal repeatability and 
an approximation of its frequency (i.e. number of pulsations over time). As a sensitivity 
analysis the signal frequency was additionally evaluated using Periodogram power spectral 
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density estimation employing the MATLAB function ‘periodogram’. Results from these 
calculations for all four GLCM statistical parameters energy, homogeneity, correlation and 
contrast were saved in a table format.  
Signal processing methodology: At first two regions of interest are defined, one marking an 
area of pulsation and the other an area of exactly the same size and shape without 
pulsation. The mean value of the four GLCM stats is saved over time in a data matrix. 
Because of image noise the signal is often distorted by interference but can be improved by 
smoothing functions (described below at 7.3.1.2.1). At the beginning of each VM processed 
video there is a short time span of 1-2 seconds that is extremely noisy and therefore this is 
manually excluded from analysis. For normalisation purposes the smoothed signal is 
subtracted from its mean value before further processing (Figure 7.2). 
 
 
Figure 7.2 Processing steps of raw GLCM signal. 
The raw signal (a) is smoothed using a loess filter (b). To avoid noise which 
frequently occurs at the start of the sequence, a starting point (dashed line in c) for 
data analysis is selected manually. Finally signals from both ROI’s are normalised by 
subtracting the mean over the whole sequence (d). 
 
The signals from both ROI’s then undergo autocorrelation i.e. in simple terms the signal is 
phase shifted backwards and forwards over time to evaluate if there is some degree of 
matching between the signals curves (i.e. if the same pattern repeats itself in the signal). 
This phase shift is also called lag. For example every signal has maximal autocorrelation at 
zero lag. A completely homogeneously repetitive signal (e.g. sine curve) with a frequency of 
1Hz would show a maximal correlation when phase shifted for a one second interval. The 
‘coefficient’ option is chosen to normalise the signal meaning that at zero lag the 
autocorrelation is 1.0 (Figure 7.3). The resulting autocorrelation for each GLCM stat is then 
plotted and analysed using the ‘findpeak’ MATLAB function. This function essentially finds 
the position of a peak within a plot, peak being defined as a point on the x-axis where both 
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neighbouring points have lower values. The mean value of the distance between the peaks 
is then calculated. This reveals the average time passed between signals and hence the 
signal frequency. 
Autocorrelation can be regarded as a measure for sameness and repeatability. For example 
a continuous sine wave signal at 1Hz does exhibit maximal autocorrelation values at 1s 
intervals corresponding with the signal interval.  
 
 
Figure 7.3 Example of autocorrelation analysis. 
A sine wave of 1Hz (a) exhibits peaks of high autocorrelation values (b) at 1s 
intervals. A random waveform without regular components does not display any peak 
values other than at 0 lag when the signal is directly overlayed with a copy of itself. 
 
Processing of autocorrelation gives us a measure of signal frequency and sameness. 
Another way of evaluating the signal characteristics is to compare it to a standardised signal 
with a known frequency. To achieve this, a sine-form signal was created with a frequency 
that corresponded to the pulse rate used in the perfusion phantom. This sine wave was used 
as the gold standard to which the signal from the VM sequence ROI was cross-correlated. 
The main difference between cross- and auto- correlation is that in the latter case the signal 
is compared to itself. The value of cross-correlation is again normalised with the coefficient 
option meaning that two identical signals would result in a value of 1.0 at a point other than 
zero lag.  
As a sensitivity analysis, the signal was finally evaluated using the power spectral density 
estimation. This method uses a discrete fourier transform to represent the input signal as a 
frequency domain graph. The discrete fourier transform is useful because it reveals the 
periodicity of data as well as relative strengths of periodic components. The graphs x-axis 
represents the frequency spectrum (limited to 0-5Hz for relevance) and the y-axis indicating 
the power of the frequency. For example a sine wave signal of 1Hz would have a peak at 
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1Hz (Figure 7.4). Signals with multiple components do have several peaks, with the highest 
peak indicating the most dominant signal component (345).  
 
 
Figure 7.4 Example of periodogram analysis. 
a) Two sine waves with distinct frequencies. b) Using periodogram analysis the two 
underlying frequencies can be identified at a point of maximal spectral density power. 
c) Two random waveforms. d) Periodogram analysis does not reveal a clear maximum 
of spectral density power because many frequencies are represented in the original 
waveforms. 
 
As a measure of image quality the signal-to-noise ratio (SNR) for each VM sequence was 
processed (Equation 7.1). The SNR which frequently used in medical imaging is a value that 
describes the clarity of an image. A higher value results in more prominent and clear main 
signal (e.g. TV show). For example a standard definition video does have a lower SNR than 
a full high definition video. 
𝑆𝑁𝑅 =  
𝑃𝑆
𝑃𝑁
 
Equation 7.1 SNR - signal to noise ratio; Ps – power signal; Pn – power noise 
 
7.3. Results 
7.3.1 Graylevel co-occurrence matrix statistics are representative of motion 
within a video area of interest 
7.3.1.1 Workflow to determine the optimal parameters for VM signal 
evaluation 
For every video there are a number of parameters for camera recording, VM- and GLCM 
processing. Taken together, all possible combination of parameters or settings result in an 
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unmanageable plethora of variations. Therefore it was initially important to elucidate the 
combination of parameters that would result in the optimal enhancement of pulsatile motion. 
To start with the optimal smoothing filter was tested. This was essential because without 
smoothing, signals were too noisy to be analysed with the methodology described above 
(7.2.1.5). Once the optimal filter was determined further tests focused on GLCM settings, 
VM processing parameters and camera recording settings in this order (Figure 7.5). It should 
be noted that the evaluation process was not conducted in a strictly linear fashion because 
occasionally new results led to a re-evaluation of earlier experiments. The video sequence 
used to test these settings was chosen because it subjectively showed a strong motion 
enhancement without suffering from excessive image noise (VM settings: magnification 
amplitude 100, spatial frequency 30, frequency bandwidth = 0.33 – 3.33Hz, chrominance = 
0; GLCM settings: offset = [-1 1], symmetry = false, graylevel = 16, graylimit [] = no limit). 
 
Figure 7.5 Stepwise approach to determining optimal VM processing parameters. 
This flow diagram depicts the stepwise approach used to elucidate settings to enable 
the optimal enhancement of pulsatile motion in VM processed videos. 
 
7.3.1.2 Testing settings for the processing of GLCM data 
7.3.1.2.1. Data smoothing 
First the issue of plot smoothing was addressed by testing different smoothing filter 
functions. Due to an abundance of image noise, non-smoothed GLCM data did not enable 
the extraction of any significant signals related to pulsation in the flow phantom (Figure 7.2). 
Smoothing filters create an approximating function from a given data set to enable the 
recognition of important patterns. During smoothing very high or low data points are 
approximated to neighbouring values to create a smoother curve that allows interpretation of 
slow change phenomena. The filters tested were the average-, loess-, robust- loess-, loew-, 
robust loew- and the Savitzky-Golay filter each at 4 different spans. A more detailed 
description of filtering can be found here (346). The filter span determines how many 
adjoining data points are used for filtering. Visual evaluation of the resulting plots was 
carried out to establish which filter function resulted in the best signal. While many filters 
resulted in a good representation of the expected pulse signal (e.g. 75 peaks per minute for 
a pump frequency of 75bpm), many did also show an extent of over-smoothing (flattening 
signal amplitude). Based on these tests and following visual assessment of the resulting 
plots, the loess filter with a span of 21 data points was selected (Figure 7.6).  
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Figure 7.6 Comparison of smoothing filter functions. 
a) Each smoothing filter was tested at different data point spans. This figure shows 
the best spans for each individual filter. b) From the selection in (a) the Loess filter at 
a span of 21 was selected because it displayed the best compromise between noise 
reduction and signal yield.  
 
The next step involved a decision on the optimal GLCM settings. To this end a VM file was 
chosen as reference standard (Offset - [-1 0]; Numlevel - 32; Symmetry - off; Graylimit – no 
limitation) to which other processed files were compared. Each GLCM parameter was 
subsequently varied and tested against this reference file to compare resulting changes to 
signal strength. The settings with the strongest signal in all 4 GLCM statistical parameters 
were: Offset [0 1]; NumLevel 16 and Symmetry off. The offset [-1 1] was chosen over [0 1] 
because it resulted in an almost equally strong signal but had the theoretical advantage of 
assessing movement in two dimensions (up and down, left and right). 
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7.3.1.2.2. Selection of optimal GLCM stats processing 
For the tested data set, the Loess filter method with a span of 21 data points showed a good 
balance between signal amplitude and noise suppression. For GLCM processing the 
settings chosen for all future experiments were: Numlevel =16; Offset = [-1 1] without any 
restrictions on Graylimit.  
7.3.1.3 Video magnification settings 
7.3.1.3.1. Amplitude and spatial frequency 
A video file was recorded at a resolution of 800x600 in an analogy to the original work of Wu 
et al (136). This file was VM processed with a combination of different amplitude factors - 
alpha signified by “A” (25A, 50A, 100A and 200A) and spatial frequencies –lambda signified 
by “L” (20L, 30L, 40L, 60L, 80L and 100L). The resulting signal strengths were analysed and 
compared to elucidate the combination that resulted in the best signal. Additionally it was 
assessed how well the known pulse frequency of 75 could be identified with the ‘findpeak’ 
and ‘periodogram’ methods (henceforth called frequency discrimination). The combinations 
40L & 50A; 30L & 100A; 60L & 100A and 80L& 100A produced the best signal. On visual 
assessment a pulsation in the perfused section of the phantom was clearly visible for all 
tested combinations. With the exception of videos processed at 20L who had a very poor 
SNR (i.e. high image noise), no obvious difference was found with regards to image noise 
between the other combinations as is evidenced by comparable SNR values (SNR 9.4 – 
10.1). 
7.3.1.3.2. Frequency range 
The signal strength in terms of autocorrelation and gold standard signal cross-correlation 
was best for a range of 1Hz (1.83Hz- 0.83Hz) and 3Hz ( 3.3Hz – 0.3Hz). During this stage it 
was not clear which frequency range would result in optimal VM signals and hence it was 
decided to carry out flow phantom experiments using a 1Hz and 3Hz range. 
7.3.1.3.3. Chrominance 
Chrominance was evaluated at a setting of 0.25, 0.5, 0.75 and 1.0. The impact of 
chrominance on signal strength and SNR was minimal hence a setting of zero was chosen 
for future experiments.  
7.3.1.3.4. Selection of optimal VM processing settings  
Based on the experiments above, camera settings were evaluated with the following spatial 
frequency and amplification settings: 30L/100A, 40L/50A, 60L/100A and 80L/100A. Each of 
these settings was evaluated at 1Hz and 3Hz frequency range. Chrominance was kept at 
zero. 
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7.3.1.4 Camera settings  
7.3.1.4.1. Resolution  
The three magnification and spatial frequency combinations with the best signal strength 
(40L & 50A; 60L & 100A, 80L& 100A and 30L & 100A) were further evaluated at different 
video resolutions. The aim was to establish if there was a relationship between video 
resolution and VM signal characteristic. In their original work Wu et al. recommended use of 
non-HD video (around 800x600) for VM processing. Hypothetically however a higher 
resolution could result in a less noisy video and a better pick up rate for subtle signals. The 
resolutions tested in addition to the reference file were 640x480, 1024x786 and the maximal 
camera resolution of 2048x1536. Processing the video sequence at the highest resolution of 
2048x1536 resulted in the best VM signal and frequency discrimination. 
7.3.1.4.2. Colour codec 
Video sequences recorded at maximal resolution and processed at 30L/100A were 
processed at two different colour codecs to evaluate any differences in the resulting VM 
signals. From the 5 available codecs three (Directional, Rigorous and Integrated 
Performance Primitives codec) were excluded because they required extensive processing 
speed that was beyond the processing power of the laptop used for these experiments. The 
two remaining codecs namely ‘Edge Sensing’ and ‘Multithread’ were evaluated. No 
difference was found in the signal strength, frequency discrimination or image noise between 
the two colour codecs. The ‘Multithread’ codec was chosen for future experiments because it 
performed more stable (i.e. less software crashes). 
7.3.1.4.3. Frame rate 
Video sequences were recorded at 90fps at a resolution of 800x600. Although a higher 
frequency is supported by the camera, the processing speed of the laptop used did not allow 
recording at speeds beyond 90fps. No improvement in the VM signal or frequency 
discrimination was found at the highest feasible frame rate of 90fps. The SNR (9.6) was the 
same at 30fps and 90fps.  
7.3.1.4.4. Selection of optimal camera recording settings 
With the exception of 640x480 it was possible to extract good VM signals and to discriminate 
pulsation frequencies from all tested resolutions. The best mixture of signal strength, 
frequency discrimination and image noise however was elucidated at the maximal resolution 
of 2048x1536. The impact of frame rate and colour codec choice on signal strength was 
minimal and hence the standard settings used at the outset were maintained in future 
experiments. 
7.3.1.5 Preliminary pressure and frequency evaluation 
Using the previously determined settings for camera recording, GLCM stats and VM 
processing two further sequences were recorded at a 100bpm and pressures of 
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250/30mmHg and 140/20mmHg respectively. Each sequence was processed at two 
different frequency ranges of 1.17Hz – 2.17Hz (1Hz range) and 0.67Hz – 3.67Hz (3Hz 
range). At 140/20mmHg only the 3Hz range produced a signal that was stronger over the 
perfused channel. Frequency recognition was not functional as the same frequency was 
attributed to the perfused and non-perfused catheters. The periodogram sensitivity analysis 
did however yield valid frequency results. At pressures of 250/30mmHg use of either 
frequency range did result in a strong signal and good frequency discrimination. At 1Hz 
range signal strength was better compared to the 3Hz range Table 7.1. 
Pressure 
(mm/Hg) 
Range  
(Hz) 
Auto-
correlation 
Cross-
correlation 
Findpeak 
(Hz) 
Periodo-
gram 
(Hz) 
mean 
SNR 
130/70 1 0.39 vs. 
0.06 
0.35 vs. 
0.15 
1.33 1.29 9.1 
3 0.39 vs. 
0.12 
0.36 vs. 
0.16 
1.30 1.29 8.7 
140/20 1 0.16 vs. 
0.17 
0.14 vs. 
0.07 
1.68 0.97 10.0 
3 0.2 vs. 
0.1 
0.19 vs. 
0.03 
1.64 1.64* 8.5 
250/30 1 0.55 vs. 
0.11 
0.33 vs. 
0.03 
1.64 1.64 9.8 
3 0.44 vs. 
0.09 
0.28 vs. 
0.06 
1.63 1.64 8.4 
Table 7.1 VM signal strength based on GLCM Energy stats.  
The strongest signal based on autocorrelation is recorded at 250/30mmHg whereas 
the strongest cross-correlation signal is found at 130/70mmHg. Frequency 
discrimination is most accurate at 130/70mmHg. * - frequency discrimination same 
over perfused and non-perfused catheter. 
 
7.3.2 Correlation of perfusion pressure and location with the VM signal 
7.3.2.1 Experimental design and perfusion settings 
A flow phantom containing three flow channels, respectively embedded just below the 
surface and at app. 2 cm and 4 cm depth was created using clear PVCP as described above 
(3.4.2). The construction required a plastic container of greater depth and width than the 
container used for the flow phantom that contained two catheters at equal depth. There were 
no other substantial differences between the perfusion phantoms.  
Each catheter was perfused at three different pressures, namely 90/40mmHg, 120/80mmHg 
and 200/100mmHg at a stroke frequency of 75bpm (1.25Hz) and 100bpm (1.67Hz) while 
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video sequences were recorded. Solenoid pump power was adjusted to achieve the required 
perfusion pressures which were constantly measured throughout the experiment. Because 
the catheters were at different depths and hence were exposed to different external pressure 
from the PVCP material, the pump power varied according to the catheter position. This was 
also reflected by the variation in perfusion flow which was constantly measured using a 
flowmeter. Video recording for each pressure and frequency combination was recorded at 
least twice using the settings established in (7.3.1). Each video sequences was processed at 
two frequency ranges of 1Hz and 3 Hz respectively (i.e. at 100bpm:1.17Hz - 2.17Hx and 
0.67Hz-3.67Hz; at 75bpm 0.83-1.83 and 0.33Hz – 3.33Hz). Subsequently signals were 
analysed as described above (3.4.4.3). Experiments were conducted on three separate 
days. As a control two sequences were recorded without any flow being present on each 
day. 
7.3.2.2 VM signals do not reflect perfusion depth in the clear perfusion 
phantom 
On subjective evaluation, catheter motion was not clearly visible in any of the tested 
perfusion pressure and frequency settings. In some sequences it appeared that the whole 
phantom as opposed to individual catheters was in pulsatile motion. All comparison and 
statistical tests were carried out separately for sequences processed at 1Hz and 3Hz 
frequency range. In the main data was of a non-parametric distribution type. Median values 
at different pressures and depths are shown in Table 7.2 and Table 7.3.  
Paired Wilcoxon signed rank test was performed for all 4 GLCM values. No statistical 
significant difference (p>0.05) between values obtained during pulsatile perfusion (PP 
group) and without perfusion (NP group). 
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Pressure Position Energy Correlation Contrast Homog. 
90/40 
(n=6) 
bottom 
PP 
0.129 
(0.051) 
0.145 
(0.167) 
0.109 
(0.070) 
0.108 
(0.076) 
bottom 
NP 
0.106 
(0.052) 
0.083 
(0.114) 
0.100 
(0.084) 
0.100 
(0.062) 
middle 
PP 
0.141 
(0.113) 
0.122 
(0.092) 
0.207 
(0.108) 
0.206 
(0.105) 
middle 
NP 
0.146 
(0.071) 
0.179 
(0.129) 
0.145 
(0.159) 
0.195 
(0.185) 
top PP 0.127 
(0.104) 
0.167 
(0.090) 
0.116 
(0.053) 
0.116 
(0.058) 
top NP 0.141 
(0.146) 
0.189 
(0.064) 
0.190 
(0.132) 
0.219 
(0.138) 
120/80 
(n=4) 
bottom 
PP 
0.162 
(0.174) 
0.105 
(0.076) 
0.120 
(0.101) 
0.122 
(0.083) 
bottom 
NP 
0.160 
(0.168) 
0.090 
(0.062) 
0.108 
(0.097) 
0.108 
(0.097) 
middle 
PP 
0.086 
(0.143) 
0.121 
(0.194) 
0.068 
(0.201) 
0.073 
(0.178) 
middle 
NP 
0.152 
(0.072) 
0.123 
(0.187) 
0.199 
(0.206) 
0.197 
(0.211) 
top PP 0.197 
(0.048) 
0.154 
(0.090) 
0.137 
(0.142) 
0.136 
(0.142) 
top NP 0.095 
(0.086) 
0.101 
(0.080) 
0.188 
(0.710) 
0.185 
(0.259) 
200/100 
(n=6) 
bottom 
PP 
0.129 
(0.062) 
0.130 
(0.097) 
0.122 
(0.071) 
0.129 
(0.047) 
bottom 
NP 
0.138 
(0.050) 
0.155 
(0.097) 
0.131 
(0.124) 
0.146 
(0.124) 
middle 
PP 
0.109 
(0.080) 
0.176 
(0.114) 
0.135 
(0.139) 
0.141 
(0.150) 
middle 
NP 
0.141 
(0.086) 
0.149 
(0.133) 
0.168 
(0.068) 
0.163 
(0.066) 
top PP 0.138 
(0.088) 
0.166 
(0.017) 
0.097 
(0.038) 
0.094 
(0.040) 
top NP 0.110 
(0.012) 
0.112 
(0.091) 
0.136 
(0.062) 
0.136 
(0.076) 
Table 7.2 Median values and (IQR) of GLCM autocorrelation stats at 1Hz 
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Pressure Position Energy  Correlation  Contrast Homog. 
90/40 
(n=6) 
bottom 
PP 
0.095 
(0.067) 
0.083 
(0.085) 
0.1 
(0.157) 
0.107 
(0.181) 
bottom 
NP 
0.134 
(0.165) 
0.124 
(0.181) 
0.139 
(0.103) 
0.143 
(0.135) 
middle 
PP 
0.122 
(0.154) 
0.148 
(0.222) 
0.185 
(0.142) 
0.169 
(0.123) 
middle 
NP 
0.155 
(0.146) 
0.164 
(0.395) 
0.159 
(0.226) 
0.207 
(0.3) 
top PP 0.149 
(0.093) 
0.188 
(0.105) 
0.132 
(0.089) 
0.119 
(0.079) 
top NP 0.121 
(0.078) 
0.168  
(0.2) 
0.106 
(0.015) 
0.111 
(0.025) 
120/80 
(n=4) 
bottom 
PP 
0.126 
(0.1) 
0.152 
(0.118) 
0.092 
(0.078) 
0.095 
(0.08) 
bottom 
NP 
0.119 
(0.033) 
0.107 
(0.054) 
0.07 
(0.032) 
0.071 
(0.05) 
middle 
PP 
0.13 
(0.12) 
0.216 
(0.278) 
0.165 
(0.104) 
0.149 
(0.1) 
middle 
NP 
0.132 
(0.085) 
0.186 
(0.678) 
0.131 
(0.226) 
0.13 
(0.21) 
top PP 0.204 
(0.17) 
0.183 
(0.666) 
0.207 
(0.246) 
0.206 
(0.247) 
top NP 0.094 
(0.069) 
0.319 
(0.794) 
0.246 
(0.736) 
0.24 
(0.746) 
200/100 
(n=6) 
bottom 
PP 
0.113 
(0.066) 
0.093 
(0.11) 
0.117 
(0.044) 
0.113 
(0.052) 
bottom 
NP 
0.102 
(0.053) 
0.207 
(0.178) 
0.097 
(0.077) 
0.121 
(0.084) 
middle 
PP 
0.116 
(0.21) 
0.162 
(0.014) 
0.123 
(0.066) 
0.125 
(0.083) 
middle 
NP 
0.117 
(0.143) 
0.191 
(0.111) 
0.12 
(0.092) 
0.131 
(0.071) 
top PP 0.164 
(0.124) 
0.146 
(0.159) 
0.161 
(0.135) 
0.172 
(0.125) 
top NP 0.083 
(0.064) 
0.175 
(0.198) 
0.104 
(0.072) 
0.113 
(0.07) 
Table 7.3 Median values and (IQR) of GLCM autocorrelation stats at 3Hz 
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Looking exclusively at absolute GLCM values obtained during perfusion (PP group), there 
was no obvious relation to perfusion -pressure or -depth. To get a better understanding of 
relative changes in GLCM values they were standardised with the aid of the control signal 
from the NP group. Mean values obtained from the ROI’s overlying the perfused and non-
perfused catheter were expressed as percentage change using the formula below (Equation 
7.2Error! Reference source not found.). Simplified this means that the ROI (either PP or 
NP) with the stronger signal has a value of >100%. 
𝐺 = 100 × (
(𝑥𝑃 − 𝑥𝑁)
|𝑥𝑁|
) 
Equation 7.2 Calculation of fractional change in GLCM values expressed as 
percentage.  
For the calculation of the non-perfused Gain, xP and xN are reversed. G – Gain; xP – 
perfused GLCM value; xN – non-perfused GLCM value. 
 
The gain values (Figure 7.7) were subsequently compared across individual depths and 
perfusion pressures (e.g. 90/40mmHg vs. 120/80mmHg vs. 200/100mmHg at middle depth 
or bottom vs. middle vs. top catheter at 90/40mmHg) using the Kruskal-Wallis test. At 1Hz 
range there were two statistical significant differences found. First there was a difference in 
median Energy gain when comparing individual depths (-15.7% -bottom vs. -45.1% - middle 
vs. 127.4% - top; p <0.05). For the catheter closest to the surface (top) differences in Energy 
gain (0.1% – 90/40mm/Hg vs. 127.4% - 120/80mmHg vs. 16.5% - 200/100mm/Hg; p<0.05) 
and Correlation gain (-27.7% - 90/40mmHg vs. 75.9% - 120/80mmHg vs. 41.7% - 
200/100mm/Hg; p<0.02) were found. No statistically significant differences were elucidated 
at 3Hz range. 
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Figure 7.7 Median GLCM stat gains at 1Hz (left) and 3Hz (right).  
Error bars indicate 95% CI. Y-axis dimension has been limited to improve visibility of 
bar the graphs.  
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To assess if Gain is an independent predictor of flow in an examined ROI, a binominal 
regression analysis was carried with presence of flow as the dependent and Gain, perfusion 
pressure, depth and perfusion rate as covariates. To improve the fit o the model any variable 
except Gain could be removed. None of the covariates was found to be an independent 
predictor for this model (p>0.05). To assess if despite these negative findings GLCM gain 
could be used as a test for predicting VM enhanced motion a ROC analysis was carried out 
for the original GLCM values and the processed gain values. None of the GLCM stats or 
their respective gains had an AUROC of>0.65 and statistical significance was not reached 
for any of them (p>0.05). 
7.3.2.2.1. Utilisation of cross-correlation and sinus wave controls to 
assess presence of flow 
In the paragraph above, GLCM auto-correlation values and their respective gain values were 
analysed. The same analysis approach was then applied to cross-correlation values which 
were obtained by comparing GLCM signal changes to a sinus wave which functioned as a 
gold-standard signal (i.e. perfect pulsatile signal). The median cross-correlation values are 
shown in Table 7.4 and Table 7.5. 
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Pressure Position Energy Correlation Contrast Homog. 
90/40 
(n=6) 
bottom 
PP 
0.104 
(0.049) 
0.107 
(0.055) 
0.101 
(0.053) 
0.096 
(0.05) 
bottom 
NP 
0.081 
(0.053) 
0.094 
(0.074) 
0.097 
(0.062) 
0.097 
(0.059) 
middle 
PP 
0.135 
(0.15) 
0.103 
(0.067) 
0.101 
(0.06) 
0.098 
(0.058) 
middle 
NP 
0.085 
(0.05) 
0.105 
(0.042) 
0.104 
(0.055) 
0.095 
(0.043) 
top PP 0.083 
(0.131) 
0.107 
(0.088) 
0.084 
(0.087) 
0.086 
(0.083) 
top NP 0.097 
(0.128) 
0.077 
(0.089) 
0.096 
(0.104) 
0.095 
(0.09) 
120/80 
(n=4) 
bottom 
PP 
0.146 
(0.082) 
0.102 
(0.056) 
0.111 
(0.039) 
0.109 
(0.04) 
bottom 
NP 
0.123 
(0.088) 
0.081 
(0.092) 
0.118 
(0.065) 
0.108 
(0.059) 
middle 
PP 
0.086 
(0.059) 
0.065 
(0.04) 
0.089 
(0.039) 
0.081 
(0.046) 
middle 
NP 
0.121 
(0.072) 
0.07 
(0.041) 
0.061 
(0.091) 
0.062 
(0.07) 
top PP 0.111 
(0.063) 
0.104 
(0.062) 
0.125 
(0.072) 
0.12 
(0.062) 
top NP 0.115 
(0.04) 
0.083 
(0.071) 
0.096 
(0.042) 
0.094 
(0.041) 
200/100 
(n=6) 
bottom 
PP 
0.101 
(0.077) 
0.081 
(0.043) 
0.108 
(0.061) 
0.115 
(0.054) 
bottom 
NP 
0.124 
(0.09) 
0.079 
(0.021) 
0.104 
(0.052) 
0.108 
(0.053) 
middle 
PP 
0.08 
(0.134) 
0.079 
(0.041) 
0.097 
(0.045) 
0.09 
(0.053) 
middle 
NP 
0.102 
(0.078) 
0.067 
(0.075) 
0.082 
(0.076) 
0.074 
(0.073) 
top PP 0.105 
(0.175) 
0.087 
(0.077) 
0.135 
(0.063) 
0.118 
(0.066) 
top NP 0.111 
(0.042) 
0.072 
(0.037) 
0.087 
(0.052) 
0.08 
(0.045) 
Table 7.4 Median values and (IQR) of GLCM cross-correlation stats at 1Hz 
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Pressure Position Energy Correlation Contrast Homog. 
90/40 
(n=6) 
bottom 
PP 
0.094 
(0.039) 
0.062 
(0.058) 
0.076 
(0.044) 
0.071 
(0.034) 
bottom 
NP 
0.071 
(0.021) 
0.098 
(0.066) 
0.081 
(0.039) 
0.077 
(0.034) 
middle 
PP 
0.086 
(0.051) 
0.077 
(0.053) 
0.081 
(0.081) 
0.076 
(0.068) 
middle 
NP 
0.084 
(0.085) 
0.09  
(0.04) 
0.088 
(0.034) 
0.083 
(0.029) 
top PP 0.088 
(0.06) 
0.105 
(0.087) 
0.09 
(0.087) 
0.091 
(0.082) 
top NP 0.163 
(0.07) 
0.072 
(0.085) 
0.111 
(0.113) 
0.114 
(0.113) 
120/80 
(n=4) 
bottom 
PP 
0.119 
(0.069) 
0.091 
(0.033) 
0.107 
(0.058) 
0.108 
(0.056) 
bottom 
NP 
0.113 
(0.09) 
0.099 
(0.062) 
0.088 
(0.079) 
0.093 
(0.079) 
middle 
PP 
0.107 
(0.105) 
0.065 
(0.042) 
0.085 
(0.043) 
0.081 
(0.035) 
middle 
NP 
0.079 
(0.092) 
0.048 
(0.068) 
0.047 
(0.086) 
0.047 
(0.074) 
top PP 0.105 
(0.112) 
0.086 
(0.033) 
0.079 
(0.1) 
0.076 
(0.1) 
top NP 0.099 
(0.077) 
0.077 
(0.053) 
0.095 
(0.044) 
0.09 
(0.049) 
200/100 
(n=6) 
bottom 
PP 
0.114 
(0.06) 
0.077 
(0.051) 
0.09 
(0.044) 
0.084 
(0.049) 
bottom 
NP 
0.09 
(0.047) 
0.075 
(0.046) 
0.096 
(0.056) 
0.093 
(0.045) 
middle 
PP 
0.073 
(0.038) 
0.066 
(0.033) 
0.067 
(0.025) 
0.072 
(0.028) 
middle 
NP 
0.095 
(0.091) 
0.064 
(0.034) 
0.09 
(0.04) 
0.084 
(0.055) 
top PP 0.1 
(0.064) 
0.085 
(0.084) 
0.089 
(0.047) 
0.073 
(0.04) 
top NP 0.089 
(0.045) 
0.062 
(0.03) 
0.061 
(0.03) 
0.063 
(0.025) 
Table 7.5 Median values and (IQR) of GLCM cross-correlation stats at 3Hz 
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Paired testing of the PP vs. NP group (Figure 7.8) values did not show any statistically 
significant difference. Testing across different catheter depths revealed a statistically 
significant difference for Correlation gain at 90/40mmHg perfusion pressure (6.95% - bottom 
vs. -4.30% - middle vs. 5.03% - top; p<0.03). No such difference was found when comparing 
different perfusion pressures. Regression analysis results indicated that at 1Hz Correlation 
gain (p<0.07; CI 1.01-1.03), Contrast gain (p<0.04; CI 1.00-1.02) and Homogeneity gain 
(p<0.05; CI 1.00-1.02) were all independent predictors for the presence of flow. At 3Hz 
range only Correlation gain (p<0.07; CI 1.00-1.02) was found to be an independent 
predictor. ROC analysis yielded statistically significant results for Correlation gain with an 
Area under the Curve (AUC) of 61% (p<0.05) at 1Hz and an AUC of 64% (p<0.02) at 3Hz. 
Sensitivity and specificity were 57% and 55% at 1Hz and 68% and 52% at 3Hz.  
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Figure 7.8 Median GLCM cross-correlation stat gains at 1Hz (left) and 3Hz (right).  
Error bars indicate 95% CI. Y-axis dimension has been limited to improve visibility of 
bar the graphs. 
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The recorded GLCM signals were examined using the findpeak function (Table 7.6) and 
periodogram function (Table 7.7) as described above (7.3.1.3.1). Frequency discrimination 
was deemed to be successful if the estimated frequency was within a ±20% range of the 
actual perfusion rate. At 75bpm (=1.25Hz) the frequency range where a result was counted 
as positive was at 1-1.5Hz whereas at 100bpm (=1.67Hz) the range was 1.3-2Hz. Positive 
frequency discrimination also occurred in the NP group in some cases even if this was not 
the case in the PP group. Frequency discrimination with the findpeak method was best for 
Energy at 1Hz but even here only 50% of cases had the correct frequency. The majority of 
these cases did also exhibit positive frequency discrimination at the corresponding NP 
signal. Frequency discrimination using the periodogram method was overall poor with only a 
few positive measurements. Anecdotally a peak was often observed at the correct frequency 
but this was only rarely the maximal peak and hence could not be counted. During initial 
experiments (7.3.1.3) one or two dominant peaks was found in most cases whereas the 
periodograms for the experiments in this section exhibited several peaks which indicates 
that many different frequencies were present at once.  
Frequency 
range 
Group Energy Correlation Contrast Homogeneity 
1Hz 
n=56 
PP 28 12 23 21 
NP 28 14 20 20 
3Hz 
n=56 
PP 24 11 13 14 
NP 23 5 16 17 
Table 7.6 Frequency discrimination using the findpeak method. 
Frequency 
range 
Group Energy Correlation Contrast Homogeneity 
1Hz 
n=56 
PP 5 0 1 1 
NP 7 0 3 3 
3Hz 
n=56 
PP 0 0 0 0 
NP 0 0 0 0 
Table 7.7 Frequency discrimination using the periodogram method. 
 
7.3.3 Enhancing motion of concealed structures  
7.3.3.1 Experimental design and perfusion settings 
Using brown dye a fully opaque perfusion phantom containing two catheters both at 
approximately 0.5cm depth was created. With the exception of PVCP colour the phantom 
construction was the same as the 2-catheter phantom used in 7.3.1.3. The same perfusion 
pressures and pulsatile frequencies were used as for the 3-catheter phantom. For each 
setting at least two recordings were acquired. As control two sequences were recorded 
without any flow being present (Table 7.8 & Table 7.9).  
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Pressure Perfusion Energy Correlation Contrast Homog. 
90/40 
(n=11) 
PP 0.156 
(0.103) 
0.189 
(0.383) 
0.127 
(0.072) 
0.129 
(0.076) 
NP 0.142 
(0.076) 
0.181 
(0.102) 
0.133 
(0.078) 
0.125 
(0.058) 
120/80 
(n=10) 
PP 0.163 
(0.142) 
0.133 
(0.077) 
0.178 
(0.105) 
0.172 
(0.108) 
NP 0.114 
(0.113) 
0.183 
(0.143) 
0.151 
(0.066) 
0.144 
(0.069) 
200/100 
(n=13) 
PP 0.123 
(0.076) 
0.138 
(0.154) 
0.149 
(0.209) 
0.151 
(0.211) 
NP 0.118 
(0.058) 
0.137 
(0.099) 
0.11 
(0.107) 
0.14 
(0.13) 
Max. pres 
(n=9) 
PP 0.159 
(0.156) 
0.22  
(0.22) 
0.173 
(0.18) 
0.166 
(0.165) 
NP 0.114 
(0.075) 
0.15 
(0.131) 
0.144 
(0.157) 
0.145 
(0.16) 
Table 7.8 Median values and (IQR) of GLCM stats at 1Hz 
 
Pressure Perfusion Energy Correlation Contrast Homog. 
90/40 
(n=11) 
PP 0.191 
(0.134) 
0.196 
(0.196) 
0.083 
(0.058) 
0.143 
(0.166) 
NP 0.097 
(0.074) 
0.183 
(0.248) 
0.068 
(0.146) 
0.12 
(0.141) 
120/80 
(n=10) 
PP 0.094 
(0.123) 
0.138 
(0.118) 
0.07 
(0.123) 
0.107 
(0.043) 
NP 0.109 
(0.062) 
0.159 
(0.133) 
0.072 
(0.082) 
0.113 
(0.105) 
200/100 
(n=13) 
PP 0.116 
(0.114) 
0.126 
(0.256) 
0.081 
(0.204) 
0.182 
(0.208) 
NP 0.092 
(0.09) 
0.098 
(0.084) 
0.081 
(0.116) 
0.106 
(0.196) 
Max. 
pres 
(n=9) 
PP 0.072 
(0.074) 
0.18 
(0.266) 
0.071 
(0.067) 
0.09 
(0.128) 
NP 0.067 
(0.032) 
0.153 
(0.125) 
0.07 
(0.052) 
0.104 
(0.094) 
Table 7.9 Median values and (IQR) of GLCM stats at 3Hz 
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7.3.3.2 Pulsatile motion of concealed structures in a perfusion phantom is 
enhanced by VM processing  
Original GLCM values were compared between the PP and NP group using the paired 
Wilcoxon sign test. At 1Hz range a statistical significant difference was found for Contrast (p 
< 0.02) and Homogeneity (p<0.01), whereas differences between groups at3Hz range were 
found to be non significant. Gain values for different perfusion pressures are shown in Figure 
7.9. On statistical analysis of GLCM gain differences between perfusion pressures, a 
statistical significant difference was found for Correlation at 3Hz range (p=0.05).  
  
 
Figure 7.9 Median GLCM stat gains at 1Hz (left) and 3Hz (right).  
Error bars indicate 95% CI. Y-axis dimension has been limited to improve visibility of 
the bar graphs. 
 
Binominal regression analysis was carried out for each raw and gain GLCM value to assess 
if they were independent predictors for the presence of flow in the phantom. Contrast 
(p=0.055,OR CI 0.91-14461.49), Contrast gain (p=0.077, OR CI 1.00-1.01) and 
Homogeneity gain (p=0.074, OR CI 0.79 - 14388.69) came close to reaching statistical 
significance. Reviewing the graphical representation of this data revealed a very wide 95% 
confidence interval for values recorded at 90/40mmHg pressure. Exclusion of these values 
did have a substantial impact on the results of the binominal regression analysis with 
Contrast (p<0.05, CI 1.32- 83470.08), Contrast gain (p<0.02, OR CI 1.00-1.02) and 
Homogeneity gain (p<0.04, CI 1.00-1.01) becoming statistically significant independent 
predictors for the presence of flow.  
To evaluate if GLCM stats could be useful in determining the presence of flow in VM 
processed videos, a ROC analysis was carried out for raw GLCM and gain GLCM values, 
individually at 1Hz and 3Hz range respectively A number of these showed statistically 
significant results with an AUC of <0.65. The best ROC performance however was identified 
for Contrast gain (AUC = 0.70, p<0.005, CI 0.58-0.81) and Energy gain (AUC = 0.71, 
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p<0.005, CI 0.59-0.82) at 1Hz. Sensitivity and specificity were 74% and 65% for Contrast 
gain and 81% and 60% for energy gain, respectively (Figure 7.10). 
 
Figure 7.10 ROC curve for Energy gain (left) and Contrast gain (right) both at a range 
of 1Hz. 
 
7.3.3.2.1. Utilisation of cross-correlation and sinus wave controls to 
assess presence of flow in concealed structures 
Auto-correlation values for VM sequences recorded on the brown flow phantom are shown 
in Table 7.10 and Table 7.11. Paired Wilcoxon-matched pair-signed rank testing did not 
reveal any statistical significant differences between GLCM cross-correlation values in the 
PP and NP group. GLCM gain values (Figure 7.11) were tested across different perfusion 
pressures using the Kruskal-Wallis test which showed a statistical significant difference 
between pressures Figure 7.11) at 1Hz for Correlation gain (p<0.03) and at 3Hz for Contrast 
gain (p<0.05) and Homogeneity gain (p<0.003).  
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Pressure Perfusion Energy Correlation Contrast Homog. 
90/40 
(n=11) 
PP 0.118 
(0.062) 
0.067 
(0.124) 
0.117 
(0.08) 
0.113 
(0.081) 
NP 0.063 
(0.097) 
0.064 
(0.07) 
0.107 
(0.041) 
0.1 
(0.031) 
120/80 
(n=10) 
PP 0.109 
(0.073) 
0.087 
(0.034) 
0.125 
(0.072) 
0.119 
(0.083) 
NP 0.07 
(0.083) 
0.075 
(0.05) 
0.108 
(0.066) 
0.109 
(0.066) 
200/100 
(n=13) 
PP 0.085 
(0.06) 
0.075 
(0.069) 
0.091 
(0.104) 
0.078 
(0.106) 
NP 0.088 
(0.052) 
0.077 
(0.094) 
0.08 
(0.084) 
0.061 
(0.087) 
Max. pres 
(n=9) 
PP 0.147 
(0.168) 
0.108 
(0.283) 
0.244 
(0.283) 
0.242 
(0.239) 
NP 0.137 
(0.073) 
0.114 
(0.07) 
0.133 
(0.128) 
0.126 
(0.135) 
Table 7.10 Median cross-correlation values and (IQR) of GLCM stats at 1Hz 
 
Pressure Perfusion Energy Correlation Contrast Homog. 
90/40 
(n=11) 
PP 0.065 
(0.07) 
0.06 
(0.096) 
0.079 
(0.015) 
0.068 
(0.044) 
NP 0.076 
(0.065) 
0.063 
(0.038) 
0.074 
(0.021) 
0.07 
(0.042) 
120/80 
(n=10) 
PP 0.086 
(0.062) 
0.088 
(0.062) 
0.091 
(0.036) 
0.082 
(0.038) 
NP 0.084 
(0.063) 
0.087 
(0.069) 
0.099 
(0.028) 
0.087 
(0.042) 
200/100 
(n=13) 
PP 0.071 
(0.058) 
0.069 
(0.07) 
0.075 
(0.021) 
0.052 
(0.036) 
NP 0.078 
(0.064) 
0.074 
(0.068) 
0.076 
(0.025) 
0.071 
(0.047) 
Max. pres 
(n=9) 
PP 0.102 
(0.101) 
0.124 
(0.312) 
0.087 
(0.105) 
0.096 
(0.212) 
NP 0.093 
(0.025) 
0.111 
(0.074) 
0.085 
(0.048) 
0.08 
(0.04) 
Table 7.11 Median cross-correlation values and (IQR) of GLCM stats at 3Hz 
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Figure 7.11 Median GLCM stat cross-correlation gains at 1Hz (left) and 3Hz (right).  
Error bars indicate 95% CI. 
 
Binominal regression analysis found that Contrast (p<0.02, CI 6.3- 88157175.9) and 
Homogeneity (p<0.03, CI 4.5 - 52670673.02) as well as Energy gain (p<0.02, CI 1.00-1.02), 
Contrast gain (p<0.02, 1.00-1.02) and Homogeneity gain (p<0.02, CI 1.00-1.02) were all 
statistically significant independent predictors for the presence of flow at 1Hz range, in the 
brown flow phantom. At 3Hz only Correlation gain (p<0.05, CI 1.00-1.02) was found to be a 
statistically significant independent predictor. ROC analysis found that Energy gain 
(AUC=66%, p<0.02), Contrast gain (AUC=65%, p<0.02) and Homogeneity gain (AUC=65%, 
p<0.02) –values crossed the threshold of statistical significance for the prediction of flow 
presence. 
Frequency discrimination utilising the findpeak method was best for Homogeneity at 1Hz 
with 21/43 positive results (Table 7.12). Again virtually the same numbers of positive results 
were obtained for the PP and NP group (21 vs. 19). When using periodogram based 
frequency discrimination, optimal results were obtained for Energy at 1Hz (22/43). In 
contrast to previous results there were virtually no positive results found for the NP group at 
this setting Table 7.13). 
Taken together with the results from the clear phantom it is suggestive that Energy at 1Hz 
range may be the GLCM statistic best suited to determine the frequency of a signal in a VM 
processed video. 
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Frequency 
range 
Group Energy Correlation Contrast Homogeneity 
1Hz 
n=43 
PP 18 13 21 21 
NP 14 8 18 19 
3Hz 
n=43 
PP 13 13 10 10 
NP 10 10 12 10 
Table 7.12 Frequency discrimination using the findpeak method. 
 
Frequency 
range 
Group Energy Correlation Contrast Homogeneity 
1Hz 
n=43 
PP 22 5 6 6 
NP 2 2 6 4 
3Hz 
n=43 
PP 10 5 1 3 
NP 0 2 1 2 
Table 7.13 Frequency discrimination using the periodogram method. 
 
7.3.4 Assessment of VM motion signals in an in-vivo setting 
7.3.4.1 Setup for signal recording 
The premise of the following experiments was to transfer the GLCM stats based motion 
signal methodology to an in-vivo model of laparoscopic surgery. To this end the porcine 
model of laparoscopic surgery that has already been described in the General methods 
section (3.4.3) was used. Image sequences of abdominal organs with and without the 
presence of pulsatile blood flow were recorded with a laparoscopic camera. While the animal 
was alive (PP group) videos were recorded with the hand held laparoscope in a stationary 
position. To reduce respiratory motion, ventilation was stopped during sequence recording. 
Each organ/area was recorded with the laparoscope very close to its surface and then again 
with the laparoscopic tip further away so that adjacent areas or organs could be viewed as 
well.  
Following euthanasia, another video which served as the control (NP group) was recorded 
from the same organ area, again from up close and at a greater distance. The absence of 
blood flow was confirmed by monitoring the ECG trace and performing ultrasound duplex 
imaging of the organ area in question. 
Original videos were stereoscopic (i.e. 3D video) and required transformation into monocular 
sequences before VM processing could be carried out. Results from the flow phantom 
indicated a frequency range of 1Hz appeared to be superior to a 3Hz range in terms of 
retrieval of GLCM motion signals. Also it was felt that a wider range may lead to inclusion of 
non-pulsatile repetitive signals such as respiratory motion. Therefore VM processing was 
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only carried out with a 1Hz range. Because the pulse rate of the animal fluctuated wildly 
between 70-120bpm, an average pulse rate of 100bpm (1.32 Hz) was utilised as the gold 
standard and control. All other VM processing settings including magnification factor, 
chrominance and spatial frequency were used at identical settings to the flow phantom 
experiments above (7.3.1.3). 
To compare GLCM signals between the PP and NP group, ROI’s of equal dimensions and 
shape were marked on the pre- and post mortem recorded video sequences. IN contrast to 
the flow phantom experiments however the ROI position had to be altered because it was 
not possible to record each organ area from exactly the same camera position and distance. 
The GLCM signals retrieved from these ROI’s were subsequently processed and analysed 
in exactly the same manner as described above. 
7.3.4.2 Respiratory motion impairs the interpretation of VM signals during 
laparoscopy 
Video sequences were recorded from the liver, small bowel, colon and stomach. 
Subjectively there was strong respiratory motion visible in the VM processed videos that 
were obtained pre euthanasia. Although mechanical ventilation was held during recording, 
the animals started to breathe spontaneously hence causing a motion signal. Comparison of 
GLCM signals in the PP and NP group only rarely showed stronger autocorrelation or cross-
correlation in the PP group. When a positive gain (i.e. stronger signal pre-mortem) was 
present, this was usually at a frequency that correlated with respiratory motion (around 
0.3Hz). As evidenced by duplex scanning, flow was absent in the NP group. Despite the lack 
of perfusion, low amplitude GLCM signals were present (Figure 7.12, Figure 7.13). 
Frequency discrimination was not successful for any of the examined organs. Due to the 
lack of viable VM signals and the comparably small number of VM processed videos, no 
attempt at statistical analysis was made. 
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Figure 7.12 Periodogram of VM signals recorded over porcine liver (blue pre-mortem; 
red post-mortem).  
The dominant frequency is around 0.2Hz which falls within the respiratory rate 
observed during surgery of app. 10-18 breaths per minute. 
 
 
Figure 7.13 Autocorrelation of the same VM signal as in Fig. 7.12.  
The VM signal recorded pre-mortem exhibits a maximal autocorrelation at app. 4.5s 
lag which corresponds well with the periodogram analysis in Fig. 7.12. 
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7.4. Discussion 
In this chapter it was shown that the utilisation of texture analysis, specifically the time based 
plotting of the Gray-level co-occurrence matrix (GLCM) allows an objective assessment of 
VM signals and can provide metrics for subsequent statistical analysis. The repeatability of 
these methods has been verified as it has produced constant results in 12 different video 
sequences, using a variety of image resolutions and colour codecs and having been 
recorded over the space of a day. Based on these metrics a number of VM processing 
settings and camera recording options were established based on their utility for recording 
sequences in the environment used for subsequent flow phantom experiments. It was also 
established that higher image resolution enhances the quality of the VM signal to a certain 
extent. GLCM analysis has previously been used to assess the flow of crowds on CCTV 
cameras (261,344) but this approach has not been used previously to assess VM signals. It 
is purported that it is advantageous to use texture based motion analysis over more 
conventional approached such as the Lucas-Kanade method for the estimation of optical 
flow (347) because it does not rely on specific markers or objects to motion. It is very difficult 
to use foreign objects in a surgical site for the sole purpose of research. Although this has 
been successfully employed in open surgery by some groups for the purpose of 
intraoperative image guidance (348), it is exponentially more complicated to replicate this 
method in laparoscopic surgery as objects would have to be placed and retrieved via narrow 
laparoscopic ports. To circumvent this limitation one group has utilised tattooing of the liver 
to facilitate landmark recognition during surgery organs to create a tractable objects (349). 
This latter approach, has the disadvantage of requiring the use of additional procedures and 
substances and hence there are some additional ethical and workflow considerations that 
have to be taken into account. 
A number of flow phantoms were produced to facilitate testing of VM signals in a controlled 
environment. These phantoms were integrated into a solenoid pump powered person circuit. 
The circuit‘s settings were adjustable via a number of adapters and connectors which made 
it possible to fine tune a variety of pressure and perfusion rate combinations. The perfusion 
circuit’s pressure and flow rate was closely monitored and hence the creation of a consistent 
experimental environment was made possible. These circuit design was previously proven 
to provide a close approximation of the systolic and diastolic phase found in human blood 
circulation (258).  
The hypothesis that the strength of the VM signal can allow conclusions about the strength 
or location of the underlying motion process could not be verified. The flow phantom has 
been recorded under a multitude of perfusion settings including different perfusion –
pressures, rates and –depths. Although a statistical significant difference of GLCM stats was 
found between different pressures and perfusion depths in some experiments, these 
differences were not expressed in any coherent pattern. For example, frequently the highest 
perfusion pressure exhibited lower GLCM stat values than lower pressures and perfusion at 
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the shallowest depth did not usually produce stronger VM signals as would have been 
expected. 
Although no direct correlation between VM signal and signal source strength was found, 
statistical test indicated that the difference between perfused and non-perfused regions as 
expressed as percentage gain could be useful in determining the presence or absence of 
motion. Using cross-correlation and comparison to a gold-standard sine wave signal, 
binominal logistic regression analysis revealed that increased gain for Correlation, Contrast 
and Homogeneity was an independent predictor for the presence of flow. The ROC analysis 
using gain values resulted in AUC levels that indicated a poor accuracy (<0.7) for the 
prediction of flow. The same analysis using auto-correlation based analysis did not yield any 
significant results. 
In parallel to the clear phantom experiments, no correlation between perfusion pressure and 
VM signal strength was found in the brown flow phantom where flow tubes were concealed. 
Binominal regression analysis however indicated that gain for Contrast and Homogeneity 
was an independent predictor of flow presence using the auto-correlation. In contrast to 
results from the clear phantom the raw Contrast values also reached statistical significance. 
ROC analysis showed that Energy gain and Contrast gain exhibited a fair accuracy (both > 
0.7) for the prediction of flow presence.  
Cross-correlation based evaluation indicated that Contrast, Homogeneity, Energy gain, 
Contrast gain and Homogeneity gain were all independent predictors for the presence of 
flow. Perhaps somewhat surprisingly, ROC analysis using these GLCM stats did not result in 
an accuracy > 0.65. Because no correlation between perfusion depth and VM signal 
strength was found in the clear phantom, no attempt was made to replicate this experiment 
with concealed perfusion catheters in the brown phantom. 
Frequency discrimination using either the findpeak- or the periodogram method was poor for 
either phantom type. This is a striking difference to initial experiments conducted to evaluate 
optimal settings. Based on the experiments on both phantoms, it is purported that a 
frequency range of approximately 1Hz centred around the expected frequency of a 
physiological signal is better suited for VM analysis than a frequency range of 3Hz. 
It was not possible to demonstrate an implementation of statistical VM signal analysis in the 
in-vivo model. The overpowering motion signal during all sequences was at around 0.2-
0.4Hz and hence most likely originated from diaphragmatic motion. It is also possible that a 
tremor originating from the surgeon’s hand holding the laparoscope added further motion 
noise (350) to some extent. Attempts were made to minimise respiratory motion by 
executing a “breath hold” (i.e. stopping mechanical ventilation. This was however futile 
because the animal would start to breath spontaneously almost immediately. In a surgical 
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setting this would probably not be a problem because patients receive muscle relaxants. The 
use of muscle relaxants was not included in the ethical approval for these experiments. 
It is clear that respiratory motion from the diaphragm and perhaps to some extent cardiac 
motion will pose one of the biggest limitations to implementing VM processing in 
laparoscopic surgery. Interestingly this was not an issue that was highlighted by other 
groups who published their experience on VM in laparoscopic surgery. One group 
developed and utilised a new algorithm in robotic nephrectomy to detect vessels that were 
obscured by retroperitoneal fat (351). Although the kidney is also in close proximity to the 
diaphragm, it is less affected by respiratory motion because it lies in the retroperitoneal 
space and as such is in a more fixed position than the liver (352). The same can be said for 
the prostate. A different group used a similar approach in robotic prostatectomy (245) and 
again no issues with respiratory motion were reported. 
Further limitations in the experiments described here is that it was not possible to control the 
presence of shadows in the recorded video sequences because the configuration of the 
laboratory and the use of regular ceiling lighting made this difficult. Attempts were made to 
minimise these effects by positioning light blocking screens at certain positions in the lab. 
Regarding the construction of the flow phantom it may be that the consistency of the flow 
catheter wall which was stiffer than that of a human blood vessel had some impact on the 
flow characteristics. The use of wall-less flow phantoms which avoid this limitation has been 
reported previously (353). It could however be argued that human blood vessels do have a 
wall that regularly is of a different consistency to surrounding tissues. Subjectively it was 
striking that the VM motion signals were very strong during the initial experiments that were 
conducted to establish optimal settings. Out of 12 sequences only one sequence which was 
recorded at a low resolution (640x480) did not show a clear and unequivocally perceptible 
motion signal. This was however not true for videos recorded for experiments on the clear 
(three catheters) and the brown phantom during subsequent experiments. Although the 
same setup was used, motion signals were only visible in a minority of video sequences. In 
some sequences the entire background was moving which perhaps indicates that the kinetic 
energy from the perfusion circuit was transferred onto the plastic case that envelops the flow 
phantom. This may also explain why rate discrimination was often equally positive for the 
ROI in the PP and the NP group. The difficulties encountered in the visual interpretation of 
VM signals does highlight the importance of having a reproducible quantification method. 
Instead of relying on observer interpretation for example it would potentially be feasible to 
extract statistical values from ROI’s in VM processed video sequences and then base the 
discrimination of motion signals on this data. If shown to be feasible in future experiments, 
this approach may improve the interpretation of VM videos that have been recorded under 
less than ideal conditions. If taken further this approach may allow to leave the analysis of 
VM signals entirely to a computer algorithm based on GLCM stats. It would then be possible 
to extract the location of VM signals on the screen and overlay it on the regular video feed. 
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The advantage would be that the surgeon would still benefit from the motion enhancing 
abilities of VM but would no longer be distracted by the often rather noisy original VM video. 
In summary it was shown that quantification of VM signals using a texture based approach is 
feasible. Pulsatile flow in concealed structures was shown to be independently predicted by 
analysing GLCM based stats. It could not be established if VM signal strength correlates 
with the strength of the underlying signal. It is hypothesised that this may have been due to 
poor recording quality of the video sequences examined. Analysis of perfusion based VM 
signals in an in-vivo setting was prevented by strong respiratory motion. Future efforts in VM 
for laparoscopic use should focus on enabling perfusion signal extraction in the presence of 
added motion noise (e.g. respiratory, cardiac, hand tremor). Another important factor is 
processing speed which will need to be improved significantly to allow analysis of high 
definition video feeds (136). 
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8. Image guided surgery 
8.1. Introduction 
Laparoscopic liver resection (LLR) has been shown to benefit patients by improving short 
term outcomes such as pain control, length of hospital stay and rate of complications while 
offering comparable oncological long term outcomes to open liver resection (74,98,102,122). 
Most HPB units are carrying out some liver resections laparoscopically. However major 
procedures are being carried out routinely in only a small number of centres because of the 
technical challenges of major laparoscopic liver resection. A very small number of centres 
have championed increasingly complex and technically challenging laparoscopic techniques 
such as the Glissonian-, trans-diaphragmatic- and single port approaches to LLR (354–356).  
Concomitant with these novel surgical techniques, the potential indications for LLR have 
been expanded from minor segmental-, sectional and non-anatomical liver resections to 
major hepatectomies, superior-posterior segmentectomies and donor hepatectomies 
(73,74,357). Although uptake has been generally slow (122,123), the laparoscopic approach 
for liver resection is becoming increasingly popular with a recent world wide review reporting 
on over 9000 cases that have been published in the literature so far (102). A 2014 
consensus conference found that minor LLR (≤2 liver segments) have now progressed to 
stage 3 of the Balliol IDEAL framework and can therefore be regarded as standard practice 
(74). In contrast to this, the technically more challenging complex and major LLR are mainly 
carried out in highly specialised centres with doubts remaining about external reproducibility 
(123). A major contributor to the technical complexity of LLR is the intraoperative loss of 
anatomical orientation which is caused by the lack of depth perception, tactile feedback and 
a reduced field of view, factors which are further exacerbated by the liver’s intricate vascular 
anatomy (127,141). These issues have led to concerns about the technical difficulty, 
haemorrhage control and oncological radicality of LLR. Many authors perceive these 
concerns as one of the major obstacles to the wide spread dissemination of LLR 
(94,102,122–124,358). 
Although routine use of laparoscopic ultrasound during laparoscopic liver surgery is 
recommended (74), its utility is limited by its two-dimensionality and because some lesions 
may be difficult to identify as they have a tissue density similar to liver. The latter is 
especially true for, lesions in steatotic livers, livers with chemotherapy associated changes, 
cirrhotic livers and with small or vanishing (shrinking tumour size following neoadjuvant 
chemotherapy) lesions (141,142,218). Further issues are related to the practicalities of using 
laparoscopic ultrasound during surgery because it is difficult to use once parenchymal 
transection has started (141,143,144) and visualisation of ultrasound images on a separate 
screen is not intuitive (210). 
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The development and implementation of novel technologies in laparoscopic liver surgery has 
been driven by an effort to lessen its complexity, to make it simpler and quicker to perform, 
and to increase safety through identification of key structures during resection. It may also 
improve the learning curve for surgeons training in advanced laparoscopic liver surgery. 
Some examples for technologies that have been proposed as surgical aids in LLR are: near-
infrared laparoscopy, parenchymal transection with energy devices or the use of 
preoperative surgical simulation (74,133).  
Intraoperative image guidance facilitated by the use of an image guidance system (IGS) is a 
technology that is widely used in neuro- and spinal surgery and more recently has created 
considerable interest for laparoscopic applications (128,129,141,210). In essence an IGS 
allows the surgeon to view structures that can be seen on preoperative scans but that are 
not visible with a laparoscopic camera (128). This is highly desirable for LLR as it enables to 
surgeon to localise crucial sub-surface structures such as tumours or blood vessels in real-
time. Two IGS licensed for open hepatic resection have been shown to facilitate anatomical 
orientation and the detection of vulnerable structures (66,359). Their integration into the 
surgical workflow involves several steps. Liver structures are visualised with the aid of a 3D 
liver model which is constructed from a preoperative CT or MRI scan. During surgery the 
position of the in-vivo liver is recorded with a probe and these location coordinates are 
subsequently used to align the 3D model with the intraoperative site. This process, called 
“registration” is the technically most complex step in an image guidance procedure. The 
positional relationship of the probe, liver, patient and surgical instruments is continuously 
determined with the aid of optical tracking markers which are attached to the instruments 
and probe. 
These licensed devices have also been adapted and applied to laparoscopic and robotic 
liver resection (141,143) with one study demonstrating comparable image guidance 
accuracy in laparoscopic and open surgery (141). Both IGS do however have significant 
limitations that have prevented their widespread uptake by the surgical community. Firstly, 
the visual interpretation of image guidance data is rendered somewhat counter-intuitive due 
to the utilisation of a parallel screen configuration where the 3D model is shown on a screen 
next to a regular laparoscopic screen. This approach is cumbersome because it requires 
additional mental integration by the surgeon to analyse the provided image guidance 
information analogous to the simultaneous viewing of laparoscopic video and laparoscopic 
ultrasound images. Another design issue of these systems that has a negative impact on 
workflow and registration error is the probe based registration method which due to its user 
dependency, is a potential source of errors and time delay. 
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8.1.1 Aims 
The specific aims in this chapter were: 
1) To assess the feasibility of using the proposed IGS during laparoscopy 
2) To determine the systems performance with regards to accuracy and usability 
3) To evaluate manual and automatic registration methods for aligning 3D liver model 
and patient in-situ anatomy 
The initial IGS development carried out on a porcine model is described before the clinical 
study to better illustrate the concept of the systems concept. 
8.2. Results 
8.2.1 Preclinical evaluation 
Automatic registration and real time AR visualisation during surgery was attempted in 5 
animals.  Due to issues with excessive organ deformation following the ablation procedure, 
registration was possible in 3/5 of cases. The ablation caused adhesions between thin 
porcine liver lobes and the diaphragm which resulted in overt kinking of the liver lobe and a 
grossly deformed surface area of the whole liver. The extent of the deformation was so great 
that the similarity between intraoperative liver and 3D liver model shape was insufficient to 
perform a successful registration. In the remaining animals an automatic registration was 
carried out and its accuracy calculated as described above (3.5.3.5). The resulting accuracy 
is compared to 2 best case scenarios. The first called best single deformation uses a one-off 
deformation (i.e. as opposed to continuous) to adjust the preoperative 3D liver models shape 
so that it closer matches that of the intraoperative liver. This registration mode relies on data 
from the intraoperative CT scans that were taken during the first surgical procedure. The 
best rigid registration registers the liver based on the postoperative accuracy analysis. 
Corresponding landmarks on 3D model and intraoperative liver are registered to each other 
to achieve an alignment with minimal residual distances between corresponding landmarks. 
Both registration modes are based on data that is not usually available during routinely 
performed laparoscopic procedures. The final registration method which is intended to form 
the principle registration mode for SmartLiver is based on stereoscopic surface 
reconstruction (SSR) and an ICP matching process as described above (3.5.3.1.3). As 
opposed to single deformation and best rigid registration it is functional without requiring 
additional pre- or post-operative data. Due to these restrictions, the single deformation and 
best static registrations were carried out postoperatively only. Real-time registration during 
attempted laparoscopic liver resection was only carried out using the SSR based registration 
method. All three methods yielded TRE’s <10mm RMS. The resulting accuracies from 
carrying out the three different registration methods (172) are shown in the table below 
(Table 8.1).  
  
223 
 
Animal ID 
Single 
deformation 
Best rigid SSR 
No. of 
frames 
No. of 
landmarks 
1 5.1 (20.7) 7.3 (20.2) 8.6 (18.2) 476 4 
2 6.1 (26.0) 8.2 (33.4) 10.7 (25.6) 234 6 
3 6.5 (46.7) 6.9 (48.7) 9.0 (43.3) 483 6 
Table 8.1 The TRE in mm RMS (max) for three different registration methods and each 
study animal.  
The number of frames and landmarks used for accuracy calculation is also given. 
 
8.2.1.1 Patient characteristics and registration outcome 
In total 12 patients were recruited for the study, of which 5 were scheduled for LLR and 7 for 
staging laparoscopy (SL). The gender ratio was 7 women to 5 men and the mean age was 
59 years at time of surgery (range 38-77). Three of the 12 patients had to be excluded prior 
to data processing, two due to a fault with the laparoscopic camera and one patient due to a 
technical failure to establish a pneumoperitoneum secondary to extensive previous surgery. 
In the remaining 9 patients data acquisition was successful however in one patient a 
registration was not possible due to a calibration error. Hence, a successful registration 
could be carried out in 8 cases. No critical intraoperative incidents occurred in the study 
population. All patients undergoing staging laparoscopy were discharged on the same day 
with the exception of one patient who stayed overnight due to urinary retention. Patient 
characteristics for LLR patients are summarised in Table 8.2.Total operative time for LLR 
patients was 210-360 minutes. All patients had clear resection margins (R0) on 
histopathological evaluation. Two patients had to be converted to open surgery, one for 
failure to establish pneumoperitoneum secondary to extensive adhesions (LR03) and the 
other patient required a more extensive hepatic resection than pre-operatively anticipated 
(LR04) and therefore was converted for safety reasons. There was only one postoperative 
complication (Clavien-Dindo grade 4) in a patient who required re-intubation on 
postoperative day 2 for type 1 respiratory failure and hospital acquired pneumonia. Median 
length of hospital stay was 7 days (range 3-14). 
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Patient 
ID 
Indication 
Op 
time 
Blood 
loss 
Conversion 
Liver 
segment 
affected 
Lesion 
size 
(in mm) 
LOS 
LR01 Adenoma 210 y n 5&6 60mm 6 
LR02 CRLM 240 n n 5&6 25mm 3 
LR03 CCA 275 y y 2&3 35mm 7 
LR04 CRLM 360 y y 3&4 84mm 8 
LR05 HCC 240 y n 4 a&b 60mm 14 
Table 8.2 Characteristics of laparoscopic liver resections.  
CCA – cholangio carcinoma; CRLM – colorectal cancer liver metastasis; HCC – 
hepatocellular carcinoma; LOS – length of hospital stay 
8.2.1.2 Assessment of intraoperative workflow and usability feedback 
Preoperative setup took 20-35 minutes and because it was carried out before or during 
anaesthetic induction it did not impact on the operating time. In contrast to this the 
intraoperative setup added approximately 10-20 minutes to the operating time. Setup time 
did not include the time needed for manual or automatic registration, which was carried out 
postoperatively in all but one case. Following the introduction of the “crosshair calibration” 
method (267) it was found that intraoperative setup time decreased by approximately 5 
minutes.  
Feedback forms were completed fully for 8 cases. The surgeon survey was largely positive 
about handling of the altered laparoscope, visual profile and the positioning of the 
SmartLiver equipment stack. Negative feedback largely centred on the difficulty of the 
intraoperative setup (collar installation, calibration) and the associated delay it caused in the 
surgical workflow (Table 8.3). Comments for improvement suggested a more convenient 
way of fixing the tracking collar and a desire for a smaller footprint of the SmartLiver stack.  
Question Mean Median 
Did the system impair handling of the laparoscopic 
camera? 
1 (no impairment) – 5 (substantial impairment) 
2.4 2 
Did the system impair handling of the laparoscopic 
instruments? 
1 (no impairment) – 5 (substantial impairment) 
1.6 1 
How easy was the system to setup? 
1 (very easy) – 5 (very difficult) 
3.2 3 
Did you feel that the equipment setup caused delay in 
completing the surgical procedure? 
1 (no delay) – 5 (substantial delay) 
3 3 
Did the system setup impair your line of view of the 1.2 1 
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patient? 
1 (no impairment) – 5 (substantial impairment) 
Did the system setup impair your line of view of the 
laparoscopic monitor? 
1 (no impairment) - 5 (substantial impairment) 
1.2 1 
Were you overall satisfied with the positioning of the 
system within the theatre environment? 
1 (very satisfied) – 5 (very unsatisfied) 
1.7 2 
Table 8.3 Summary of surgeon feedback (n=8) on a Likert scale of 1-5. 
 
8.2.1.3 Manual vs. automatic registration 
Manual registration was successfully performed in two patients intraoperatively (Figure 8.1) 
and in 7 patients postoperatively. Initially it proved to be impossible to carry out an automatic 
registration for any of the cases. This was surprising as pre-clinical studies from our group 
on a porcine liver resection model had indicated that automatic registration should be 
possible in at least a third to a half of the cases. An error analysis revealed that the 
acquisition of surface points worked well but the computer algorithm was unable to 
discriminate between surface points from the liver and other surrounding structures (e.g. 
stomach, diaphragm). This issue rendered it impossible to match the corresponding point 
clouds to each other, resulting in a failure of the automatic registration. To confirm our 
hypothesis, the video data of one patient was visually analysed and the liver surface was 
manually marked out in several hundred video frames. In essence, this pre-processing of 
video data enabled the computer algorithm to now discriminate between liver and non-liver 
surfaces. Subsequently automatic registration was successfully carried out on this data set. 
 
Figure 8.1 Real time AR display of a patient with hepatic adenoma in segment 5/6.  
The liver surface is not displayed to allow a clear view of the vasculature. AR 
visualised structures: green – adenoma; blue – portal veins; cyan – hepatic veins; red 
– hepatic artery; arrows liver edge. 
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8.2.1.4 Anatomical accuracy 
The target registration error (TRE) as a measure of anatomical accuracy was calculated as 
described above (Table 8.4). Usually several video sequences were recorded for each 
patient. Separate registrations for anatomical left lobe (i.e. segment 2&3), anatomical right 
lobe and the area between lobes were carried out and analysed individually. The number of 
video frames and landmarks used for TRE evaluation are also given in the table. The best 
possible TRE’s were <10 mm RMS in one patient, ≈10mm RMS in two patients, ≈ 15mm 
RMS in three patients and 20-25mm RMS in two patients. A TRE >30mm occurred in 3 
patients and 5 separately recorded sequences and was considered as a failure of 
registration because on visual inspection the resulting AR images looked anatomically 
grossly inaccurate. There was no statistically significant correlation found between organ 
deformation and TRE (Pearson correlation coefficient = 0.3; p>0.05). In fact soft tissue 
deformation of the liver was in the main consistent around ≈10mm RMS in patients with low 
and high TRE’s which may indicate that this factor has a constant impact on accuracy. In 
contrast to this, liver motion was greatly variable between patients and a statistically 
significant correlation with the TRE was found in this study population (Pearson correlation 
coefficient = 0.53; p<0.05). (Table 8.5).  
 
Patient ID 
Liver 
lobe 
No of 
frames 
No. 
landmarks 
Best TRE  
(RMS mm -range) 
LR01 RL 75 13 17.7 (0.3-47.8) 
 LL 22 4 15.4 
LR02 RL n.a. n.a. n.a. 
 LL 146 7 22.7 (0.4-44.6) 
LR05 
manual 
RL n.a. n.a. n.a. 
 LL 34 6 9.4 (0.6-44.7) 
LR05 - 
automatic 
RL n.a. n.a. n.a. 
 LL 39 6 8.5 (0.3-17) 
LS03 RL 64 6 24.6 (0.3-87.5) 
 LL n.a. n.a. n.a. 
LS04 RL* 42 7 5.9 (0.2-12.2) 
 LL 102 8 5.9 (0.1-26.6) 
LR04 RL 35 4 14.5 (0.2-28.6) 
 LL 68 4 83.7 (3.6 142.7) -fail 
LS06 RL* 23 11 18.9 (0.1-27.5) 
 LL* 162 12 16.1 (0.2-59.1) 
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LS07 RL 28 4 10.0 (0.6-19.2) 
 LL 4 8 10.7 (1.1-24.9) 
Table 8.4 Listed is the best possible TRE for each liver lobe and all sequences 
combined.  
*RL and LL combined in sequence. In LR02, LR05 and LR04 only one liver lobe was 
available for analysis. 
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Patient ID Liver lobe Deformation in 
mm RMS 
Motion in mm ± SD 
(IQR)  
LR01 RL 7.5 22.9±18.6 (0.9-34.7) 
 LL 5.1 8.5±3.8 (5.8-11.8) 
LR02 RL 8.7 15.3±4.9 (1.3-46.5) 
 LL 8.8 23.5±19.3 (9.1-80.7) 
LR05 
manual 
RL na na 
 LL 11.3 18.5±27.6 (3.6-43.3) 
LR05 auto RL na na 
 LL 9.3 18.6±19.8 (5.7-55.7) 
LS03 RL 9.8 14.2±22.3 (2.4-34.4) 
 LL 21 25.8±27 (18-55.2) 
LS04 RL 10.7 15.6±18.5 (3.8 66.6) 
 LL 36.2 17.8±38.7 (12-63.6) 
LR04 RL 7.9 28.7 18.9 (12.5 39.0) 
 LL 19.8 32.6 50.7 (1.1 95.2) 
LS06 RL 13.6 13.7 18.7 (1.5 - 46.7) 
 LL 15.1 12.5 21.7 (3.2 - 58.7) 
LS07 RL 12.1 18.9 41.4 (0.7 48.8) 
 LL 5.7 16.2 23.3 (1.2 41.6) 
Table 8.5 Shown are measures of soft tissue deformation and liver motion. 
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8.3. Discussion 
This study has demonstrated that SmartLiver is capable of providing augmented reality 
based intraoperative image guidance for use in laparoscopic liver surgery. Applied for the 
first time in patients, a computer vision technique called stereoscopic surface reconstruction 
was used to automatically register a 3D model which had been created pre-operatively to an 
individual patient’s anatomy. All components required to perform image guidance were used 
intraoperatively without any incidents or safety concerns and the perioperative patient 
outcomes for patients undergoing LLR were similar to previous reports on minor LLR 
(102,360,361).  
Image guidance systems (IGS) have been used in neurological surgery for decades before 
this concept was transferred to intraabdominal surgery (226). In open liver resection and 
ablation, IGS have demonstrated their ability to improve intraoperative orientation and 
precisely indicate the location of blood vessels and tumours (66,218,359). There is ongoing 
interest in exploiting the benefits of IGS for laparoscopic procedures other than liver 
resection. In a recent example a group has presented its experience with using a side-by-
side display IGS with manual alignment in 23 patients undergoing laparoscopic gastrectomy 
(131). With a mean TRE of 14mm the system was found to be a useful tool for identifying the 
correct blood vessels prior to division. 
As with open liver resections, the precise knowledge of tumour location and its relationship 
to major vascular structures is crucial to prevent incomplete resection and uncontrolled 
haemorrhage in LLR. Because it is technically more challenging than open surgery, the 
benefit gained from use of IGS in LLR is hypothetically greater than for open liver resections. 
Previously a group reported on the advantage of producing an individualised “stand alone” 
3D liver model without image guidance components, for improving anatomical orientation 
during LLR. The authors stated that a non-registered 3D model displayed alongside the 
laparoscopic screen was found to improve the safety and accuracy of hepatic resection in 
the cases studied (362). 
An accurate spatial correlation between the 3D model and patient anatomy is likely to yield 
greater benefits, but to maximise the potential of IGS in LLR it is important to make it easy to 
use and to enable a smooth integration into the operative workflow. The main benefit of an 
AR display is to facilitate the intuitive use of image guidance information by obviating the 
need for mental image integration that is required when using two separate screens and 
therefore reducing the potential for associated errors (210). Employing user independent 
automatic registration to align the 3D model will likely confer further benefits in terms of 
eliminating operator bias while at the same time being more user friendly. 
An alternative approach to image guided surgery is the use of intraoperative cone beam CT 
to identify anatomical landmarks on the liver and subsequently register them with a 
preoperative 3D model. Compared to manual alignment of 3D models, this method has the 
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advantage of smaller registration errors but this comes at the cost of exposing the patient to 
ionising radiation, workflow interruptions to facilitate repeat CT acquisition and the lack of 
real time spatial correlation between surgical instrument and anatomical site (229). Another 
limitation of this approach is that it can only be performed in specially designed operating 
theatres with an integrated cone beam CT system, a requirement which confers significant 
cost implications.  
Instead of recovering camera movement from optical tracking the “Simultaneous 
Localisation and Mapping” method (SLAM) utilises vision to estimate the trajectory and 
speed of camera motion (363). In a recent publication the feasibility of using SLAM to 
determine the laparoscope position during experimental liver surgery was demonstrated 
(129). The advantage of this method is that there is no requirement for a direct line of sight 
between optical tracking camera and laparoscope. Indeed no additional tracking equipment 
is needed. At the current development stage however SLAM based tracking in liver surgery 
is associated with higher tracking inaccuracies when compared with optical tracking (129).  
Laparoscopic ultrasound (LUS) is currently the gold standard for anatomical orientation 
during LLR. Its limitations derive from the fact that it is a two dimensional imaging modality 
and as such it contributes little to the understanding of complex 3D liver anatomy (142). In 
addition, laparoscopic ultrasound is impractical to use while simultaneously carrying out 
transection of hepatic parenchyma. In large animal studies, our group has previously 
demonstrated the feasibility of visually combining laparoscopic US images with a 3D liver 
model (236). This approach enables surgeons to record US images at the start of surgery 
and subsequently recall and display them within seconds in the anatomically correct position 
on the 3D model, without having to redeploy the laparoscopic US probe(236). 
Utilising SSR registration in porcine laparoscopy, the TRE’s where in the range of 9-10mm 
RMS. Analysis of the TRE’s resulting from single deformation- and best rigid- registration 
methods, revealed some important information about factors that contribute towards the 
accuracy of AR guided surgery. In single deformation registration the 3D model is deformed 
to create an optimal match with the intraoperative liver shape, hence the majority of the TRE 
will be caused by dynamic organ motion (e.g. ventilation and heart beat). In best rigid 
registration additional error is introduced by subjective picking of anatomical landmarks and 
the rigidity of the 3D model. For both cases a triangulation error caused by use of a stereo-
laparoscope is also present. The triangulation error may lead to imprecision when picking 
anatomical landmarks on the video-laparoscopic stream Based on an analysis of these 
factors it is estimated that the optimal TRE for a rigid 3D model is ≈ 8mm RMS, for single 
deformation ≈ 5mm RMS and for dynamic real time deformation ≈ 3mm RMS. An 
improvement of accuracy beyond this limit would require better tracking technology and can 
therefore not be addressed by optimising registration (172). 
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With the exception of one outlier that was considered as a failed registration, the TRE in the 
patients studied varied in the range of 5.9-24.6 mm RMS. To the best of our knowledge, this 
is the first report on registration errors in an IGS that offers real-time AR visualisation. 
Anatomical accuracy in parallel screen based systems has been evaluated before in open 
hepatic surgery but these TRE values are not directly comparable to an AR environment 
because there is no real gold standard that can be used as reference. The accuracy 
evaluation method used in this study is based on anatomical landmarks located on the 
visible surface of the liver that are directly compared to their counterparts on the 3D model. 
On a parallel screen display the 3D model and intraoperative site are not integrated on the 
same screen and therefore the error calculation is based on landmark features that are 
located with a tracked stylus. Because the liver anatomy outside these landmark features is 
not perceivable, the resulting registration errors are perhaps more representative of local 
liver deformation as opposed to a global evaluation of anatomical accuracy.  
Our group has previously studied a number of factors that affect alignment errors in 
SmartLiver. The 3D tracking system has an innate albeit small error in determining the 
position of tracking markers. This error is magnified by the long distance between the collar, 
which is the reference point for tracking, and the laparoscope tip, which is the point of 
interest. For better understanding this phenomenon could perhaps be described as an 
“optical tracking lever effect”. If a manual alignment is performed, this may become 
erroneous by the user failing to sufficiently match visible landmarks on the in-situ liver and 
3D model. Automatic registration on the other hand can occasionally confuse different 
regions on the liver surface with each other because they consist of structurally similar point 
cloud configurations. This is a particular weakness of using stereoscopic surface 
reconstruction on smooth and relatively featureless surfaces such as the liver. As was 
demonstrated in this study, SSR of the human liver may be feasible if areas of an image 
which represent the liver surface are pre-selected. Although promising, this process is very 
time intensive and it is therefore not suited for real time intraoperative image guidance. With 
recent advances in machine learning however it may be possible to teach SmartLiver to 
independently discriminate between the liver surface and adjacent structures. Using Caffe, a 
deep learning framework (364), our group has recently reported promising results with this 
approach (365) and it is intended to integrate and evaluate this method within an upgraded 
version of SmartLiver. 
In our previous work it was estimated that even if all the above mentioned sources for 
registration errors could be rectified, a residual TRE of app. 7.5mm RMS would remain due 
to the liver motion and deformation (172) which are caused by a number of intraoperative 
factors including cardiac motion, ventilation, pneumoperitoneum and surgical manipulation 
(174,216). Because currently used 3D models are non-deformable and fixed in space this 
baseline TRE must be regarded as the optimal reference standard that IGS should currently 
be measured against. Therefore it is important to address technical components of the IGS 
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to improve anatomical accuracy but a residual error will remain until a feasible solution for 
modelling intraoperative soft tissue deformation has been found. 
The research community has attempted to predict liver deformation by developing computer 
algorithms that can alter the shape and position of 3D models to reflect intraoperative 
conditions. Despite recent advances, (219,366) this technology has not yet matured enough 
to be employed in a clinical environment because the modelling of soft tissue deformation is 
exceedingly complex and computationally expensive. A positive correlation between organ 
motion and TRE was found in our study population and therefore we hypothesise that 
compared to deformation, organ motion has a more pronounced impact on the registration 
error in IGS that use a rigid 3D organ model. The significance of this assumption is that in 
contrast to liver deformation, it is technically less challenging to model repetitive liver motion 
from ventilation and cardiac movement. If this can be confirmed in future studies it may re-
direct research efforts towards liver motion which potentially has a greater translatable 
value. 
Although the results from this study have demonstrated the feasibility of using SmartLiver as 
a image guidance tool in LLR, there are some limitations that have to be taken into account. 
In two patients SmartLiver setup, registration and AR visualisation has been performed in 
real time. For the remainder of the study however, data was collected at surgery but the 
registration and overlay was performed later to reduce the time during surgery, particularly 
for patients who underwent staging laparoscopies which are relatively short procedures. By 
choosing a retrospective approach for this study it was possible to maximise data acquisition 
in a relatively limited time frame and therefore accelerate the development of SmartLiver. 
Once the overlay procedure can be done more quickly overlays will be carried out during 
surgery. 
The average intraoperative setup time of up to 20 minutes was longer than reported for 
parallel screen display IGS used in open hepatic resections (359). This is likely due to the 
fact that the latter do not require a laparoscopic camera calibration. The calibration time 
however was improved by approximately 5 minutes in the later stages of the study by 
implementing the cross-hair calibration method (30). Another time intensive step in the 
intraoperative setup was the installation of the tracking collar which had to be manually 
tightened with small screws. Alternative methods for the fixation of tracked objects onto the 
laparoscope have been explored for future studies and it is expected that this will further 
reduce setup times.  
Based on the surgeon survey, the procedural delay caused by the intraoperative setup time 
was felt to be the most negative aspect of SmartLiver. However this represents only a small 
fraction of the time taken to perform a laparoscopic liver resection. In addition to making 
improvements to laparoscope calibration and tracking collar fixation, our group is also 
working on a graphic user interface which will allow non-technical users to setup SmartLiver 
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independently, a feature which hypothetically could further decrease the required setup time. 
A further concern raised in the survey was that the 30 degree laparoscope angle movement 
of the IMAGE 1S – TIPCAM is restricted. This is a limitation of 3D laparoscopy caused by 
fixed spatial relationship of the two video channels and is not a specific for SmartLiver. 
Furthermore 3D laparoscopes have been demonstrated to be a safe tool in complex LLR 
(202,203). 
Intraoperative use of SmartLiver does not require tracking of surgical instruments. Although 
instrument tracking has advantages such as allowing point based registration and interaction 
with the 3D model during surgery (67,367), it does also has disadvantages because 1) each 
additional instruments has to be calibrated which increases setup time and 2) overall 
accuracy may deteriorate because further tracking errors are introduced for each additional 
instrument used.  
In summary, this paper has described a novel augmented reality image guidance system for 
LLR and in addition reported crucial anatomical accuracy metrics that can be utilised as 
benchmarks for future development work in this field. It was demonstrated that the system is 
able to operate in real time during surgery. Stereoscopic surface reconstruction was shown 
to be a feasible approach to user independent registration with a comparable target 
registration error to manual alignment. Future research efforts in our group are dedicated to 
improving SmartLiver’s setup speed, user friendliness and the target registration error. The 
latter may potentially be achieved by refining the stereoscopic surface reconstruction 
algorithm with the aim of enabling it to independently discriminate between the liver and 
adjacent organs. 
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9. General discussion and conclusions 
9.1. Summary of results 
In this doctoral research project, the aim was to investigate the hypothesis that optical 
imaging and computer vision technologies have the ability to extract sensory information 
from the liver that is useful for guiding laparoscopic liver surgery. 
The results shown here provide evidence that optical imaging technology can be employed 
to characterise liver tissue to an extent that is not possible with the naked eye. Computer 
vision was shown to enable creation of an augmented reality environment to facilitate 
intraoperative guidance for laparoscopic liver surgery. During laparoscopic surgery the 
sense of touch is lost which deprives surgeons of an important sense that in the main is 
used to assess the firmness of tissue which is increased in disease processes such as liver 
cirrhosis or malignancy. While the imaging modalities tested within the framework of this 
thesis cannot completely replace the sense of touch, they may provide a lot of information 
usually provided by touch, for example, whether the tissue is normal liver tissue or cancer, or 
the position of blood vessels in the operating site. Therefore, they can enhance and extend 
surgical vision and therefore, can substitute and in some cases, may even provide additional 
information that is not available from touch. 
The first two results chapters (chapter 4 & 5) of this thesis focused on utilising confocal laser 
endomicroscopy to image minute details of liver tissue at the microscopic level. In chapter 4 
one objective was to describe normal and cancerous liver histology using a dual wavelength 
method in a mouse model of colorectal cancer liver metastasis. It was demonstrated that 
using CLE imaging, typical features of normal and cancerous virtual liver histology could be 
described which correlated with tissue H&E histology examination from liver biopsies. It was 
found that evaluation at two different wavelengths, within the visible spectrum, was 
complementary and improved the quality of tissue characterisation. This was likely made 
possible by exploiting differences in the behaviour of the exogenous fluorophores fluorescein 
and indocyanine green. In addition, erythrocyte flow velocities could be estimated using this 
technology. Another objective in this chapter was to evaluate if fluorescence intensity could 
indicate the nature (i.e. normal vs. cancer) of examined tissues. Statistical analysis found 
that the relative fluorescence in tissue could be employed as an independent predictor for 
the presence of normal vs. cancerous tissue. An increase in relative fluorescence unit raised 
the odds ratio for the presence of normal liver tissue by 1.2 and 4.6, for CLE imaging at 
488nm and 660nm, respectively. These findings indicate that virtual histology images can be 
obtained with probe-based CLE. Whether fluorescence intensity can indicate the presence 
of liver malignancy in patients cannot be commented on until this imaging modality is 
evaluated in a clinical setting. 
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Once it had been established that CLE imaging enables discrimination between normal and 
pathological liver tissue, the next question was if this could be applied during laparoscopic 
surgery. The objective in the subsequent chapter (chapter 5) was to test the feasibility of 
employing CLE during laparoscopic surgery in a porcine model and to evaluate if a 
visualisation of virtual liver histology can be achieved in analogy to the preceding chapter. It 
was shown that virtual liver histology can be visualised but that it is more problematic due to 
the technical difficulties of controlling the imaging probe. In parallel to chapter 4, 
fluorescence intensity was shown to be an independent predictor for the presence of normal 
vs. ablated liver tissue. Statistical analysis indicated that an increase in one relative 
fluorescence unit raised the odds ratio for the presence of normal liver tissue by 1.2 and 1.6 
for CLE imaging at 488nm and 660nm, respectively. The results in this chapter indicate that 
laparoscopic CLE is feasible but would require an additional laparoscopic port and a 
steerable catheter. To determine if discrimination between normal and ablated liver tissue is 
feasible in humans, would require a clinical study for further evaluation.  
In the chapters 4 and 5 it was shown that optical imaging can be utilised to sense 
pathological (malignant) or therapeutically induced (tissue necrosis secondary to thermal 
ablation) changes in liver tissue. As a microscopic imaging modality, CLE has limited use in 
sensing tissue on a larger macroscopic level (i.e. > 1-2cm2). In other words, it is impractical 
to apply CLE to sensing a wider field of view. The aim of the subsequent chapter (chapter 6) 
was therefore to evaluate an optical imaging modality, called multispectral imaging, that 
could provide optical sensing on a wider field of view. The first objective in chapter 6 was to 
develop and test an imaging platform that enables spectroscopic tissue evaluation in a 
continuous wavelength range. Development and testing of a multispectral imaging platform 
consisting of an OPO light source and a NIR camera was outlined and the platforms ability 
to reliably obtain multispectral images was confirmed. The next objective was to acquire 
images from pathological ex-vivo liver tissue and compare it to tissue spectra that were 
previously published in the literature. This was only partially successful as no clear 
delineation between normal and malignant liver tissue spectra could be observed. It was 
however possible to record increased light absorption at 1210nm which corresponded with a 
well documented spectral feature which is associated with an increase in tissue lipid 
concentration. The presence of steatosis and malignancy was confirmed on H&E histology 
examination. The last objective in chapter 6 was to identify any particular wavelengths in the 
tissue spectra that are predictive for the presence of liver malignancy (HCC or CRLM). A 
generalised linear mixed model analysis carried out on the recorded multispectral data 
revealed a number of wavelengths that were statistically significant independent predictors 
for the presence of normal vs. cancerous tissue. The classification accuracy of the resulting 
model was relatively poor at 69.1%. 
The concept of the multispectral imaging platform used in chapter 6 was based on 
equipment that allows a detailed spectroscopic examination but that due to limitations with 
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regards to laser safety and robustness (i.e. ability to withstand positioning in theatre) may 
not be ideally suited for laparoscopic use. Suggestions for the future development of a MSI 
system more suitable for laparoscopy were made (6.4.). The appeal of such a system is that 
it could potentially be incorporated into a laparoscope without requiring additional 
instruments or probes. Computer vision technology is similar in this aspect because it 
utilises video data as its main sensory input and therefore it can be applied to laparoscopy 
without requiring additional probes. To further investigate this avenue, the next chapters 
(chapter 7) aimed to investigate to what extent Eulerian video magnification could provide 
visual sensing during laparoscopic liver surgery.  
The first objective in the chapter was to develop and test a texture based analysis method to 
quantify VM signals that were derived from motion. The proposed analysis method correctly 
and repeatedly identified the presence of VM signals in 12 different video sequences 
obtained from observations of a flow phantom. In some sequences the VM enhanced 
pulsatile motion was not clearly visible but a variation in GLCM statistics enabled 
identification despite this. It is therefore postulated that this approach to VM signal analysis 
may be useful in scenarios were enhanced motion is not clearly visible to the observer. The 
second objective in this chapter was to establish if the texture analysis method could be 
employed to quantify the extent of pulsatile motion. The series of experiments did not verify 
this hypothesis. The third objective in chapter 7 was to apply texture based VM signal 
identification to concealed flow channels in an opaque flow phantom. It was demonstrated 
that VM signals could be correctly identified in a majority of occasions. On ROC analysis, the 
diagnostic test accuracy was found to be fair (>0.7) for two out of four GLCM statistical 
values (Energy and Correlation). It was therefore concluded that identification of VM signals 
in concealed structures is feasible using the proposed method. Finally an attempt was made 
to utilise the texture based analysis method in an in-vivo setting. Video recorded during 
laparoscopy in a porcine model was processed and subsequently analysed. No VM signals 
related to pulsatile motion were discernible and it is purported that this was due to 
extraneous respiratory motion. This result suggests that VM processing algorithms require 
further refinement in order to allow filtering of undesired motion signals. 
A shared limitation of the imaging modalities tested in chapters 4-7 is that they have a 
limited penetration depth and are therefore not capable of sensing deep lying structures 
within the liver. In chapter 8 an image guidance system (IGS) was evaluated as an example 
of a computer vision technology that can overcome this restriction. By using stereoscopic 
surface reconstruction to register detailed 3D liver model to the liver surface, the system 
exemplifies how the precision of computer vision technology can be amalgamated with the 
detailed volumetric data from a preoperative CT scan. The data in this chapter has been 
obtained as part of a clinical feasibility study. Before any of the objectives are addressed, a 
description is given of how the system was developed and how it performed in the pre-
clinical phase. The first objective in this chapter was to assess the feasibility of using the IGS 
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during laparoscopy. In 9 out of 12 recruited patients, the IGS was functional and no incidents 
were recorded. As two out of the three failures to function were secondary to a technical 
fault of the laparoscope with no malfunction recorded in any of the IGS components, it was 
concluded intraoperative use is feasible. In the next step, accuracy and usability were 
assessed. The target registration error was in the region of 14mm RMS. Based on the user 
survey the main issue regarding usability was the additional time required for the setup of 
the IGS. The last objective was to compare manual and automatic registration. Manual 
registration was always possible but occasionally yielded high registration errors. Although it 
was fully functional during preclinical evaluation, automatic registration was hampered by the 
systems inability to distinguish liver tissue from other surrounding tissues in humans. With 
the aid of manual delineation of the liver surface (manual segmentation), automatic 
registration at a TRE of <6mm RMS, was successfully demonstrated in one patient. This 
approach however is very time intensive and hence would not be an option during surgery. It 
was therefore concluded that manual registration is fully functional, whereas automatic 
registration required further refinement before meaningful clinical evaluation of its 
performance could be continued. Suggestions of how to implement a machine learning 
algorithm that can aid in liver segmentation, has been made (8.3) and its feasibility of use 
has been demonstrated elsewhere (365). 
Development and clinical evaluation of an augmented reality based image guidance system 
in chapter 8, investigated the ability of computer vision techniques to enhance imaging on a 
centimetre (i.e. macroscopic) level. The current accuracy of the system was shown to be in 
the region of 10-20mm which was sufficient to improve anatomical orientation during 
laparoscopic surgery. A positive correlation between organ motion and imaging accuracy 
was elucidated and it is hypothesised that accuracy may be improved by implementing 
adjusting factors for organ motion into the registration process.  
9.2. Potential clinical application 
Intraoperative ultrasound is an essential tool for the visualisation of functional liver anatomy 
and has therefore to be regarded as the gold standard for imaging in laparoscopic liver 
resection (73–77,368). Its advantages are a good spatial- and temporal resolution which is 
combined with an excellent depth penetration (232,352). Its use in LLR does however have 
some limitations such as operator dependence and decreased diagnostic accuracy for small 
lesions especially if found on the background of liver cirrhosis or steatosis. Furthermore it is 
a 2D imaging modality and hence does not offer much orientation in space (141–144,233). 
In this section potential clinical applications for the imaging modalities explored in this thesis 
are described. An attempt is also made to highlight how alternative experimental imaging 
technologies could be used in this context. Because LUS has already found widespread use 
in LLR and is clinically established (74), it will not be elaborated on any further in this 
section. The potential clinical applications of novel imaging technologies are focused on 
areas where LUS has limitations (e.g. 3D imaging, small lesions). 
238 
 
None of the tested imaging modalities in this thesis are at a technical maturity level where 
they could be applied in clinical studies to inform a change in surgical strategy. Confocal 
laser endomicroscopy and SmartLiver have been demonstrated to be safe in a laparoscopic 
environment (150). It is however crucial to determine the optimal way of utilising the 
provided image data to guide surgical therapy before potential benefits for patient care can 
be evaluated. Multispectral imaging and video magnification are perhaps even further away 
from being evaluated clinically but the underlying technology behind these systems can be 
integrated into existing laparoscopic equipment without having to overcome great technical 
hurdles. In the case of video magnification the main requirement on hardware would be the 
use of a high definition laparoscope. From a software point of view it would be crucial to 
increase the processing speed of existing algorithms to enable the real time implementation 
for high definition video (136). Multispectral imaging has already been used in laparoscopic 
surgery and threre are even commercially available systems (103,108). To truly evaluate 
and unlock the potential of this modality it would however be pertinent to develop a device 
that can examine a wide range of spectra including the wavelengths from 600-1500nm and 
perhaps even beyond. Outlined below are some ideas and visions of how to apply optics 
and computer vision in a clinical context. To relate directly to clinical translation, potential 
forms of applying enhanced visualisation are divided according to clinical need.  
9.2.1 Intraoperative histology 
With the exception of the primary tumour in case of liver metastasis, the majority of liver 
resections are only beneficial if there is no extrahepatic spread. If tissue is suspicious for 
malignancy it is often excised and sent for histological evaluation. This however is time 
consuming and has a comparatively low accuracy. An imaging method such as CLE may 
enable the examination of suspicious tissue at a microscopic level and in future studies this 
may be shown to be beneficial. One group is currently exploring the feasibility of sending the 
image information obtained via CLE through a video conference to a histopathologist for 
real-time evaluation (150). The increasing role for parenchyma sparing liver resection for 
HCC and CRLM has already been discussed above (1.1.5). An intraoperative microscopic 
imaging modality could be a useful adjunct if unexpected disease (e.g. HCC nodules and 
regenerative nodules) is found outside the planned resection area (369). 
The safety and feasibility of using CLE during laparoscopic surgery has been demonstrated 
almost a decade ago (178). Based on the results of this thesis, the main hurdle to the use of 
CLE in LLR is that the fine control of the CLE probe tip is not sufficiently accurate yet. 
Suggestions of how address this issue in the future have been outlined below (9.4.1). 
9.2.2 Verifying clear oncological margins 
The complete removal of malignancy is an important factor in improving long term survival 
rates. Indeed if based on preoperative imaging a complete removal is not feasible then 
alternative techniques of cancer treatment need to be considered (55,370). Enhanced 
intraoperative orientation such as can be provided by image guided surgery (chapter 8) may 
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improve chances of locating cancer lesions. Before utilisation of IGS for precise 
intraoperative guidance can be advocated though, it is crucial to improve accuracy to a 
degree where surgeons can be confident that the position of lesions displayed within an AR 
environment are correct. In addition it needs to be ensured that an IGS can provide excellent 
accuracy on a consistent level. Suggestions on how this could be achieved with future 
research efforts are stated below (9.4.4).  
A different approach to ensuring that cancer has been cleared completely in the immediate 
vicinity of the operating site (i.e. avoiding R1 resections) is to develop a method of checking 
the resection margin of the liver for any residual disease. Within this context MSI could be 
utilised to directly examine the margins of the liver remnant. If future studies confirm that 
detection of malignancy by MSI is reliable, than a routine examination of resection margins 
could reveal if any disease is left behind. Narrow band spectral imaging is already clinically 
licensed, therefore the main obstacle to clinical implementation of ‘broad band’ spectral 
imaging or in other words MSI, is to find a technical solution to expanding the wavelength 
range of existing systems (195). A complementary approach to this would be the ICG 
mediated visualisation of NIR fluorescence. Based on previous reports an increased 
fluorescence in contrast to surrounding liver parenchyma may be present in the rim of CRLM 
lesions or throughout the whole of a HCC lesion (189). Fluorescence ICG imaging can be 
described as MSI in conjunction with an exogenous fluorophore, because existing MSI 
systems would be able to visualise ICG mediated fluorescence in addition to the previously 
described tissue spectra (6.3.3). Therefore it is proposed that both imaging approaches 
could be utilised in a complementary fashion. Theories on how to take MSI based imaging 
forward and mature it to a stage where it can be studied clinically are given below (9.4.2). 
9.2.3 Assessing the vitality of tissue 
Assessment of liver vitality and perfusion is useful to guide parenchymal transection of the 
liver. A popular technique for carrying out major liver resections involves the ligation and 
division of blood vessels that carry blood into the liver. Once blood flow is cut off, the 
affected portion of the liver changes its colour. The border between changed and unchanged 
liver is used as orientation for the parenchymal transection line. It may however be difficult to 
appreciate this line in some circumstances and here is where an evaluation of tissue vitality 
and perfusion may be helpful. A number of the evaluated imaging modalities could be used 
in this context. The use of CLE may highlight absence of fluorophore inflow in the non-
perfused part of the liver. Imaging via MSI may reveal a reduction in oxygenated 
haemoglobin (aspect not tested in this thesis) whereas video magnification could be used to 
enhance an imperceptible change in colour. Restrictions to the clinical translation of CLE 
and MSI have already been discussed above (9.2.1, 9.2.2). An important limitation of VM to 
its application in LLR is liver motion secondary to respiration, a finding of this work which has 
been described above (7.3.4.2). Potential solutions to overcome this issue are stated below 
(9.4.3). 
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9.2.4 Haemorrhage preventive techniques 
Major haemorrhage from the liver can lead to a blood loss of several litres within minutes. It 
is difficult to control laparoscopically and is one of the leading causes for converting to open 
surgery (358). For this reason, prevention of haemorrhage is paramount in laparoscopic liver 
resection and for this to be effective, it is important to appreciate the vascular anatomy and 
location of individual blood vessels. Providing a registered and accurate 3D liver model 
during surgery as has been outlined in chapter 8 is likely to be of value in enhancing the 
surgeons understanding of the livers vascular anatomy and its use may prevent inadvertent 
injury to vascular structures. Multispectral imaging has been shown to enable visualisation of 
extrahepatic blood vessels that were obscured by fat (155). If it is possible to extend this 
application to intrahepatic vessels, even if only at 1-2mm imaging depth then it may be 
another tool useful for the prevention of haemorrhage. The limitations that prevent a clinical 
translation of IGS and MIS for laparoscopic liver surgery have been outlined above (9.2.2) 
and potential solutions are proposed below (9.4).  
9.2.5 Identification of hilar structures 
A standard approach to major hepatic resection is to identify and control the blood vessels 
that carry blood into the liver (hepatic artery and portal vein). If a blood vessel is identified 
wrongly and consequently divided, it can have fatal consequences for the patient. In this 
scenario a number of imaging modalities may be helpful. Successful discrimination between 
hepatic artery, portal vein and common bile duct in a porcine model has been reported by a 
group that used a LCTF based MSI laparoscope (155). Video magnification could be used to 
highlight pulsation in the hepatic artery and interpretation of hilar anatomy may be facilitated 
by comparing it with a registered 3D liver model as can be provided by an image guidance 
system. Obstacles to the clinical translation of MSI, VM and IGS have already been 
described in this section and potential solutions are outlined below (9.4). 
9.2.6 Assessing the future liver remnant 
A crucial paradigm in liver surgery is that the volume and function of the liver remaining after 
resection must be sufficient to prevent postoperative liver failure (371). Generally liver 
function is difficult to assess, it is well documented though that patients with cirrhotic or fatty 
livers are more prone to develop postoperative liver failure. Hence the use of MSI to quantify 
liver steatosis in such patients may theoretically be of benefit. One group reported on the 
successful use of spectroscopic fibre based analysis in the evaluation of liver cirrhosis. 
Although this has not been translated into a remote image based approach yet, this is 
certainly an enticing prospect. In this context the assessment of liver fibrosis and cirrhosis 
utilising CLE via a mini-laparoscopic approach has previously been demonstrated in 47 
patients (147,178). This method of assessing tissue quality could potentially be combined 
with a 3D liver model based estimation of residual liver volume. Segmental vascular 
anatomy and precise volumetric assessment of the liver is an inherent part of the 3D liver 
model. It is relatively straight forward to visualise this data and it could also be employed to 
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simulate a liver resection and assess the functional residual volume (371,372). The 
limitations of CLE, MSI and image guided surgery have already been discussed in this 
section and potential solutions to facilitate a future clinical translation are outlined below. 
(9.4) 
9.2.7 Alternative imaging modalities 
There are several alternative experimental imaging technologies that could be applied to the 
clinical situations that have been described above.  
Optical coherence tomography is an alternative microscopic optical imaging modality and as 
such it could potentially be used to assess virtual in-vivo histology (9.2.1) and be used to 
evaluate the quality of liver tissue in the future liver remnant (9.2.6). It has a similar limitation 
in terms of depth penetration to CLE but a further disadvantage is that it has an inferior 
lateral resolution at (7µm vs. 1.4µm) compared to CLE. This means optical coherence 
tomography is less suited to visualising subcellular details in liver architecture (283,373). 
Also its ability to image liver tissue in-vivo has not been evaluated yet (374).  
Photoacoustic imaging is a hybrid imaging technology that combines optical and ultrasound 
technology (232). The majority of photoacoustic research is focused on macroscopic 
imaging but a number of systems have been developed that enable imaging on a 
microscopic scale which potentially could be applied to obtaining virtual in-vivo histology 
(9.2.1). The design of microscopic photoacoustic systems is however very complex and at 
this stage a miniaturisation for laparoscopic use has not been reported yet to the best of my 
knowledge (375). More commonly photoacoustic imaging is evaluated for macroscopic 
imaging (i.e. millimetre scale). It has been shown to have the potential to enable highly 
specific imaging of oxyhaemoglobin, deoxyhaemoglobin and bilirubin in a mouse model 
(240). If this can be replicated in a clinical setting, this modality could become a useful aid 
for the identification of structures in the liver hilum (9.2.5). Visualisation of oxygenated and 
deoxygenated haemoglobin could also enable photoacoustic imaging based evaluation of 
liver tissue vitality (9.2.3). Hypothetically, decreased vitality would be associated with a 
decrease in oxygen content. The design of a laparoscopic probe that is capable of 
visualising haemoglobin has previously been described (242). In this report though the probe 
was only studied ex-vivo and to the best of my knowledge, a laparoscopic application has 
not been reported.  
The majority of preoperative liver diagnostic for surgical planning and surveillance is 
conducted with CT and MRI. They can also be utilised intraoperatively in the form of cone 
beam CT (CBCT) and open plane MRI. Excellent accuracy for of CBCT used in LLR has 
been demonstrated by one group (229) and in addition depth penetration is not an issue with 
this modality or with open plane MRI. Intraoperative imaging to facilitate: verification of clear 
oncological resection margins (9.2.2), prevention of haemorrhage (9.2.4), identification of 
hilar structures (9.2.5) and for the volumetric assessment of the future liver remnant (9.2.6) 
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should all be potentially possible. There are however many disadvantages to utilising CBCT 
for image guidance in LLR including a low resolution, ionising radiation, high costs, lack of 
portability and an inability to allow spatial correlation between instruments and 3D model in 
real time (228,229). With the exception of ionising radiation and low resolution, open MRI 
based image guidance has the same limitations. MRI also has a slower image acquisition 
time than CBCT but the most significant obstacle to utilising it for image guidance during 
laparoscopy is its incompatibility with metallic equipment. This restriction makes the use of 
custom built metal free surgical equipment mandatory (230,231).  
Finally 3D ultrasound could enable the volumetric assessment of the future liver remnant 
(9.2.6). One group reported on the reconstruction of liver volumes in ex-vivo porcine tissue 
(376). If this can be replicated in-vivo, then it could provide a useful tool for assessing the 
volume of the future liver remnant. Disadvantages of 3D ultrasound are comparable to its 2D 
variant perhaps with the exception of providing a better spatial orientation within the imaged 
volume (9.2). 
9.3. Limitations of the current work 
The experimental results presented as part of this thesis have several limitations. The 
mouse model used for CLE assessment has been widely reported on and has been shown 
to be a reliable and reproducible model in the study of metastatic liver disease (250). 
It is however only representative for colorectal cancer liver metastasis and hence findings 
cannot be transferred to other types of liver cancer. Furthermore this animal model is 
created with one specific colorectal cancer cell line. This line was chosen because it is 
known to stem from a well differentiated cancer that was more likely to have typical imaging 
characteristics that would set it apart from hepatic cells. It is however important to verify the 
applicability of CLE imaging for identification of metastatic disease on a variety of cancer cell 
population because this is more reflective of the clinical setting.  
The ability to sequentially record CLE images and combine them to form a larger image or 
so called mosaic has been demonstrated previously (149). This may be of value because it 
allows the assessment of larger and clinically more meaningful tissue areas. The 
commercial software package that can facilitate this recording mode was however not 
accessible for experimental use. The importance of standardising the fluorescence values 
that have been used in the statistical analysis of CLE image data has already been stressed 
above (4.4).  
A major issue during laparoscopic CLE imaging in the porcine model was the stabilisation of 
the CLE probe. Stability of images was hugely dependent on the area of the liver being 
visualised which meant that some liver regions may have been over-represented. 
Occasionally more pressure had to be exerted to obtain images and this may have 
influenced the local tissue perfusion and hence distribution of fluorophores. A change in this 
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distribution pattern may have influenced the quality of images. In both animal models, 
porcine and murine, normal tissue was compared to pathological tissue (ablated or cancer 
tissue) from the same animal. It could be argued that a comparison to control animals may 
have been preferable. The rationale behind comparing tissues in the same animal was that 
this approach is more relevant in a clinical context where it is important to delineate areas of 
diseased form non-diseased tissue (134). 
A clinical evaluation of CLE imaging of liver pathology and an attempt to verify the predictive 
algorithm developed for the murine and porcine model in this context would have been 
desirable. It was however not possible to obtain ethical approval in the required time frame. 
Furthermore it was felt that more data was needed on different forms of cancer and that in 
addition a better stabilisation method for laparoscopic CLE imaging was required to make a 
clinical evaluation beneficial. More recent CLE platforms enable simultaneous dual 
wavelength visualisation. If this technology would have been available for experiments, a 
better direct correlation between CLE images in the red and blue light spectrum could have 
been achieved.  
Studies into multispectral imaging were only conducted on ex-vivo liver tissue. Examination 
of in-vivo tissue may have provided a better estimate of the impact of perfusion and bile 
content on tissue spectra. On the other hand, the range of the spectral imaging was 1100-
1700nm which does not include absorption peaks that are relevant for haemoglobin or 
bilirubin (256). This means that theoretically only the water content could have been different 
in an in-vivo experiment as the content of fat is unlikely to be influenced by blood flow. 
Naturally it would have been preferable to conduct MSI employing a wider spectral range, 
perhaps between 600-1700nm (155,240). This was however not possible due to the 
technical restrictions of the excitation laser source and the InGaAs NIR camera.  
The number of studied animals and ex-vivo specimen was small across studies, but 
comparable to previous reports from other groups (225,241,248,336,377). In the murine 
model some animals were lost before they could be studied and for some of the studied 
animals data was insufficient to allow comparison between healthy and cancerous liver 
(4.3.1).  
In the porcine model the main issues were the high costs for each experiment and the fact 
that several different imaging modalities were tested on each animal which meant that the 
time that could be spared for each modality was limited. The findings from murine and 
porcine experiments however were sufficiently congruent (i.e. decreased fluorescence form 
pathological areas) to support the intended analysis strategies. The main restrictions of 
obtaining more ex-vivo tissue for MSI experiments on liver steatosis were related to the 
difficulty in obtaining discarded donor livers. A larger number of live cancer specimen could 
not be obtained because no tissue could be taken from the vicinity of the resection margin 
because this would have impacted negatively on the clinical decision making process. 
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During histopathological evaluation it is crucial to ensure that the resection margin is clear 
from cancer. This would potentially be compromised if tissue for experiments were to be 
taken from this margin. This essentially means that only very large resection specimen that 
had cancer lesions distant from the resection margin could be used. Given this limitation it 
was fortunate that tissue from two different patients with HCC could be retrieved because, 
HCC is a rare indication for surgical excision in the UK (378). The time frame in which 
specimen could be retrieved was also limited (<8 months) because it took a significant 
amount of time to develop and test the MSI platform used for experiments in this thesis. 
During analysis of video magnification experiments, a striking discrepancy between initial 
results and results form later experiments was found (7.4). This difference related to visibly 
less enhanced pulsation in the latter experiments which correlated with a decrease in the 
measured VM signal strength as expressed by GLCM stats. It is unclear whether this 
discrepancy was due to a variation in the perfusion circuit itself i.e. related to pressure and 
flow although this was monitored continuously. It is also possible that the change was 
related to the use of a different flow phantom construction, because initial experiments used 
a clear phantom with two perfusion catheters whereas later recordings were made 
employing a clear phantom with three perfusion catheters and a brown phantom with two 
perfusion catheters. More concerning than this discrepancy however was the inability to 
replicate the enhancement of vessel pulsation in laparoscopic video that was reported by 
other authors (244,245). A potential explanation could be that other groups preferred the use 
of video sequences recorded with a surgical robot whereas the video material in this thesis 
was derived from laparoscopic video. The significance of this is that robotically recorded 
video is not influenced by hand tremor which would usually affect laparoscopic video 
recordings (350).  
It is however more likely that hand tremor played a minor role. The dominant VM signals 
observed in the laparoscopic video had a similar frequency to the respiratory motion. It is 
therefore hypothesised that respiratory motion of the liver prevented acquisition of more 
subtle pulsatile motion signals (7.4). Another possible problem with the video sequences 
recorded for VM processing may be related to ambient light conditions. These were not 
controlled for and hence differing amounts of light and shade were present in some of the 
sequences. Standard ceiling lighting was used for illumination and as the flow phantom was 
placed in the same position on the lab table, this factor should not have varied to a great 
extent. Because of the negative results from the porcine laparoscopy no attempts were 
made to study laparoscopic video data from patients.  
Due to time constraints during surgery, intraoperative registration was only carried out in two 
out of 9 patients who underwent image guided surgery. As highlighted above it was not 
justifiable to significantly prolong surgical procedures to optimise the accuracy of 
registration. A retrospective registration was carried out for the remaining patients. This 
mode of evaluation was not originally intended but it nevertheless provided valuable data 
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and helped in making improvements to the SmartLiver IGS. The accuracy of the system was 
objectively assessed with a validation method that has been previously verified in a porcine 
model (172). The validation method utilises visual assessment of anatomical landmarks as 
gold standard but it could perhaps be argued that an additional marker of registration 
accuracy would have been desirable. One alternative method of assessing accuracy is (141) 
to measure the distance of cancer lesions to the resection margin based on IGS data and 
then to compare this metric with a distance measurement taken from the pathological 
resection specimen. The disadvantage of this method though is that it relies solely on one 
measured dimension whereas the method used in this thesis combines metrics form two 
dimensions. In addition tumour growth in the period between preoperative image acquisition 
and time of surgery may decrease the distance between lesion and resection margin on 
histopathological evaluation. There is some indication that electromagnetic tracking of the 
laparoscope may be advantageous to optical tracking (267) and it would have been useful to 
elucidate this in a clinical setting. It was not possible to test this though because no safe 
means of integrating the electromagnetic tracker into the laparoscope could be established. 
Because of this shortcoming no attempt was made to gain ethical permission for the clinical 
use of an electromagnetic tracker. Finally the use of retrospective registration meant that 
any potential clinical impact of using an IGS could not be assessed. This however was not 
intended in the original study protocol as the main objective was to assess performance 
metrics (e.g. accuracy) and device safety. 
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9.4. Areas of future work 
9.4.1 Microscopy 
As a microscopic imaging modality, the main advantage of CLE, its detailed view of cellular 
architecture could perhaps also be regarded as its Achilles heel, because by focusing on a 
small field of view it is difficult to put images into a larger and clinically meaningful context. 
An important step would therefore be to enhance the field of view so that an area >1 cm² 
can be viewed. The capability of combining several smaller fields of view together has 
already been implemented by one commercial system (149). A crucial hurdle for making this 
‘mosaicing’ approach viable during laparoscopy, is the need for a stable point of view. To 
provide this sort of stability it is essential to have the ability to control the position of a CLE 
probe with millimetre precision. The ability to achieve this is no trivial matter because the 
probe motion needs to be coordinated with the respiratory motion of the liver. It has 
previously proposed to use a robotic arm for this purpose and this method has been 
evaluated via a natural orifice transluminal endoscopic surgery and a standard laparoscopic 
approach in a porcine model (149,150). This group’s proposed methodology addresses the 
issue of precise control but it does not allow adaptation to organ motion and furthermore 
robotic liver resection is not practiced widely at present (118). 
The liver largely consists of smooth and featureless surfaces on the outside. Theoretically a 
frame attached to several suction cups or fine atraumatic graspers could be applied to the 
liver surface. This frame could provide a steady point of reference. A motorised device 
attached to this frame could then be used to move the CLE probe smoothly across the 
underlying liver surface while ensuring that the surface is covered in its entirety. The fine 
control for this motorised movement could either be carried out manually or automatically. 
To create such a device it is proposed to aim for a spider or crab- like design with several 
arms centrally arranged around the motorised manipulator of the CLE probe in the middle. 
Such a device however would have to overcome many hurdles with the biggest probably 
being the issue of miniaturising it to such a degree where its introduction through a 12mm 
laparoscopic port is possible. If such an undertaking is considered, it is suggested to design 
it for open surgery first and then expand on this design later to apply it to minimal invasive 
surgery. 
A more sophisticated and practical solution would perhaps be a combination of CLE, robotic 
(379) and image guided surgery. In essence the robotic control provides precise 
manoeuvring of the CLE probe whereas the IGS is used to guide the robotic movements 
(221). Should future IGS gain the ability to adjust for liver deformation and motion then it 
would be possible to alter the movement of robotic arms accordingly. Combination of these 
technologies would potentially permit precise mosaicing of large patches of liver surface. As 
an added bonus the recorded CLE images could be integrated into the 3D liver model and 
hence be viewed within the correct macroscopic context (Figure 9.1).  
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A further aid in providing visualisation of greater surface areas would be a CLE probe that is 
customised to the specific requirements of laparoscopy. The CLE device tested in this thesis 
is licensed for use in luminal endoscopy and hence has been miniaturised to fit through an 
endoscopic working channel of <3mm. During laparoscopy however it would be feasible to 
used devices with a diameter of up to 12mm. Greater circumferential size would not only aid 
in covering a greater surface area but it would also likely have a positive impact on image 
quality (380). 
 
Figure 9.1 Integration of CLE images into a 3D liver model. 
 
It was demonstrated in this thesis that the relative fluorescence values (RFU) measured with 
CLE can be used to predict the presence of malignancy in a mouse model and of ablated 
tissue in a porcine model. Due to the nature of the underlying methodology no fluorescence 
threshold values that are indicative of pathological liver tissue states could be determined. 
To create a predictive clinical tool based on this method though, comparable threshold 
values are required. Creation of a system with such capabilities would require a novel and 
reproducible method of using a reference standard to calibrate the optical fibres within a 
CLE probe (299). It is proposed that a light source that emits light at a constant power 
through a narrow band filter could be used to calibrate such a system. The consistency of 
the calibration signal could be verified with the aid of a spectrometer and a photometer. The 
system used in this thesis utilises a chemical calibration standard that undergoes 
degradation over time and therefore it is unlikely to form a useful basis for producing 
calibration norms that are comparable between different users. 
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9.4.2 Multispectral imaging 
Tissue evaluation with MIS depends on the interpretation of absorption characteristics that 
are inherent to different biological substances. Some substances such as lipids have more 
than one absorption peak at different wavelengths (app. 900nm and 1200nm) whereas 
others such as oxygenated haemoglobin possess only one absorption peak (256). To extract 
a maximum of spectral data from tissue it is therefore essential to cover a broad wavelength 
range. Based on previous in-vivo studies into MSI of the liver, it is purported that a desirable 
range would include wavelengths from 600-1700nm hence covering absorption peaks for 
bile at the lower end and water and collagen at the upper end (240,256). No single system 
capable of covering this spectral range in its entirety has been described in the literature so 
far. It is believed that it should be feasible to combine existing systems to cover the desired 
spectrum. The construction of such a broad spectrum MSI system would be the first 
important hurdle towards the accelerating clinical translation of MSI of the liver.  
Once the foundation is formed to interrogate liver tissue at the most relevant wavelengths 
the following step should be the formation of an extensive database, correlating spectral 
response curves (SRC) with pathological and healthy liver tissue. It is presently unclear how 
ex-vivo and in-vivo analysis will compare but it is hypothesised that the main differences will 
be related to the absorption characteristics of haemoglobin and perhaps to a lesser extent 
water. The rationale behind this theory is that blood perfusion present in in-vivo studies will 
likely have an impact on the concentration of the main components of blood namely 
haemoglobin (163) and possibly also on water. Nevertheless studies from ex-vivo human 
liver specimen have the advantage of mirroring the histological composition of clinical 
disease (e.g. cancer) more closely than would be the case for animal disease models. The 
latter model however would provide a valuable insight into how blood flow will affect the 
spectral signature of disease. An integral approach to analysing findings from both 
experimental models in context will likely yield a close approximation of what can be 
expected from intraoperative MSI of the liver. 
To facilitate clinical studies, it will likely be most efficient to focus on spectral responses in 
certain narrowly defined wavebands as opposed to requiring a full acquisition of SRC in 
small wavelength steps (381), because this is heavily time and resource dependent. Once 
the relevant spectral ranges have been established from a SRC database, it should be 
possible to fit a spectral response curve to normal liver tissue and a variety of liver 
pathologies, respectively (161,256). Instead of measuring a full spectral response in clinical 
studies, MSI could focus on obtaining spectra from specific wavebands only and this data 
could then be processed to compare its fit to the pre-established pathological and healthy 
“signature” spectra. If this approach is shown to be feasible it would mean that technical 
solutions to laparoscopic MSI could be based on multiple bandpass filters instead of 
tuneable laser excitation. The former approach would be much less complicated as it avoids 
concerns about laser safety, costs and theatre space (382).  
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A recently established method of MSI completely dispenses with the need for interrogating 
tissue at specific wavelengths. In parallel to video magnification this methodology has the 
advantage that no specific hardware adaptations are required. The authors describe how 
they employ radiometric colour calibration of the endoscopic camera’s sensor in conjunction 
with a Bayesian framework to analyse blood volume and oxygen saturation in the observed 
tissues (383). 
9.4.3 Video magnification 
Experiments into video magnification in this thesis have corroborated findings from other 
groups which found that imperceptible motion can be enhanced and made visible in a variety 
of settings (136,244,245). A major drawback of Eulerian video magnification however is an 
increase in image background noise which correlates with the magnitude of the 
magnification factor and the quality of the original video (7.3.1.4.1). For this reason much of 
the future work into this computer vision modality will likely be directed at improving image 
noise (244,342,384,385). Although primarily investigated as a method to improve 
laparoscopic vision, VM has also been applied to standard video cameras utilised for a 
number of clinical diagnostics. One group has proposed VM as a method of monitoring 
viability of skin flaps after reconstructive surgery (386). Other authors have suggested to 
utilise VM for the diagnosis of fasciculation in patients with amyotrophic lateral sclerosis. The 
fact that VM technology can be utilised in conjunction with standard video cameras that are 
nowadays ubiquitously available is one of its main advantages. A further step towards 
implementing VM as a methodology for the remote monitoring of vital signs in a large 
number of subjects has been its incorporation into mobile app technology (341). In addition 
to using standard RGB video signals as input for VM, thermal video data has also been 
successfully utilised to assess microvascular health in diabetic feet.   
Based on the reports from a number of authors groups it is clear that utilisation of VM in 
laparoscopic surgery has led to some promising results (244,245,385). Despite this there is 
a significant requirement for further improvements and clinical evaluation before this 
computer vision modality can be employed to enhance surgical sensing of physiological 
motion. Based on the results in this thesis it is purported that considerable efforts should go 
into standardising the evaluation of VM processed video scenes. Extraneous motion such as 
respiratory and cardiac motion, may also prove an important obstacle to the implementation 
of VM in laparoscopy. A potential solution that has not been evaluated here may be to track 
a region of interest on the liver surface and transform it into a virtual “still image” to facilitate 
consequent VM processing without the interference of extraneous motion. 
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9.4.4 Image guided surgery 
The results from the SmartLiver clinical feasibility study presented in this thesis indicate that 
two key areas requiring more development work in image guided surgery are accuracy and 
usability. Quite simply an improved accuracy will increase surgical confidence in the 
reliability of the displayed augmented reality environment. Accuracy as reflected by target 
registration errors (TRE) in the range of 5-20mm RMS did vary significantly between cases 
and at this stage it is justifiable to regard the system as an aid to intraoperative orientation. 
To achieve the sub-centimetre accuracy required to carry out precise intraoperative 
navigation more improvements are required. 
Most efforts of improving accuracy are directed towards creation of a deformable 3D liver 
model that can simulate changes in liver shape in real time. Many groups are working 
towards this goal but due to the scientific complexity and immense computational demands 
the realisation of a real-time deformable liver model remains elusive so far 
(174,228,348,387). It was highlighted in chapter 8 (8.3) that a rigid 3D model that adjusts for 
liver motion would be less complex and hence may be a more realistic short to medium-term 
solution. Refinement of the 3D liver model is not the only area where accuracy may be 
enhanced. Based on preclinical experiments with the SmartLiver system it was estimated 
that a TRE of 1-2mm RMS is caused by inaccuracies of the optical tracking method. Utilising 
electromagnetic tracking instead of optical tracking was consequently shown to convey an 
improved accuracy (267). An entirely novel approach to tracking has been proposed by a 
group that employs stereoscopic surface reconstruction to estimate the laparoscopic pose. 
Initial results were promising although the best accuracy was achieved when combining the 
stereoscopic surface reconstruction method with conventional optical tracking (129).  
The second key component of IGS is usability and integration within the surgical workflow. 
This is dependent on performance of different technical aspects such as time needed for 
registration and calibration (66,67) but also on the human-to-machine interface ergonomics 
of operating the system. At the later development stages of the SmartLiver system a graphic 
user interface that is controllable via a touch screen display was implemented. Subjectively 
this was felt to be a palpable improvement over the mouse and keyboard directed controls in 
the earlier development stages of the system. A novel way of addressing IGS control during 
surgery is the utilisation of natural user interfaces, namely gesture control sensors in the 
form of wristbands and voice control. This method circumvents sterility issues that are 
encountered during surgery. A reported disadvantage is that one hand needs to be freed up 
for performing gestures, but this is also true for any other form of interacting with machines, 
systems and the surgical environment in general (388). 
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9.5. Conclusion 
The major conclusions drawn from this study with regards to the stated objectives were: 
1) Confocal laser endomicroscopy can be utilised to discriminate between normal and 
pathological liver tissue in experimental mouse and porcine models. Reduction of 
fluorescence intensity increases the likelihood for the presence of colorectal cancer 
liver metastasis or ablated liver tissue. 
2) Characteristics of liver tissue absorption spectra reconstructed from multispectral 
images, are related to the nature of the underlying tissue composition. Within the 
limitations of the available data, there is some indication that tissue absorption at 
particular wavelengths may independently predict the presence of malignant tissue. 
3) Texture based analysis of video magnification signals can be used to verify the 
presence of subtle signals. This analysis method however does not enable a 
quantification of the underlying signal strength. 
4) The feasibility of using an augmented reality based image guidance system for 
laparoscopic liver surgery has been demonstrated. The average accuracy of the 
system suggests that it will be useful in enhancing intraoperative orientation. 
The above conclusions support the hypothesis of this thesis that optical imaging and 
computer vision technologies have the ability to extract sensory information from the liver 
that is useful for guiding laparoscopic liver surgery. 
  
252 
 
References 
1.  Sherlock S, Dooley J. Diseases of the liver and biliary system. 2008.  
2.  Rouiller C. The liver : morphology, biochemistry, physiology. Volume II. 674 p.  
3.  Jarido V, Kennedy L, Hargrove L, Demieville J, Thomson J, Stephenson K, et al. The 
emerging role of mast cells in liver disease. Am J Physiol - Gastrointest Liver Physiol. 
2017 Aug 1;313(2):G89–101.  
4.  Brandl K, Kumar V, Eckmann L. Gut-liver axis at the frontier of host-microbial 
interactions. Am J Physiol - Gastrointest Liver Physiol. 2017 May 1;312(5):G413–9.  
5.  Aspinall R, Taylor-Robinson S. Mosby’s color atlas and text of gastroenterology and 
liver disease. 2002;  
6.  Blumgart L. Surgery of the liver, biliary tract, and pancreas. 2007.  
7.  Couinaud C. Le foie: études anatomiques et chirurgicales. Masson & Cie; 1957.  
8.  Clavien PA, Strasberg SM. Terminology of liver anatomy and resections: The 
Brisbane 2000 terminology. Atlas Up Gastrointest Hepato-Pancreato-Biliary Surg. 
Elsevier Masson SAS; 2007;2(3):313–7.  
9.  Glenn F. Biliary tract disease since antiquity. Bull N Y Acad Med. New York Academy 
of Medicine; 1971 Apr;47(4):329–50.  
10.  Hand BH. An anatomical study of the choledochoduodenal area. Br J Surg. John 
Wiley & Sons, Ltd.; 1963 Mar 1;50(223):486–94.  
11.  Wolff H. Geschichte der hepatobiliären Tumorchirurgie. In: Hepatobiliäre und 
Pankreastumoren. Berlin, Heidelberg: Springer Berlin Heidelberg; 2010. p. 108–15.  
12.  Bryan PJ, Martin Dinn W, Grossman ZD, Wistow BW, McAfee JG, Kieffer SA. 
Correlation of Computed Tomography, Gray Scale Ultrasonography, and 
Radionuclide Imaging of the Liver in Detecting Space-Occupying Processes. 
Radiology. 1977 Aug;124(2):387–93.  
13.  Damadian R. Tumor detection by nuclear magnetic resonance. Science. 1971 Mar 
19;171(3976):1151–3.  
14.  Allison DJ, Modlin IM, Jenkins WJ. Treatment of carcinoid liver metastases by 
hepatic-artery embolisation. Lancet (London, England). 2(8052–8053):1323–5.  
15.  Elliot JW. IV. Surgical Treatment of Tumor of the Liver, with the Report of a Case. 
Ann Surg. Lippincott, Williams, and Wilkins; 1897 Jul;26(1):83–95.  
253 
 
16.  Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer 
incidence and mortality worldwide : Sources , methods and major patterns in 
GLOBOCAN 2012. 2015;386.  
17.  El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. 
Gastroenterology. 2012 May;142(6):1264–1273.e1.  
18.  Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver 
Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients 
with Cirrhosis. N Engl J Med.  Massachusetts Medical Society ; 1996 Mar 
14;334(11):693–700.  
19.  Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of 
cholangiocarcinoma. Gastroenterology. 2013 Dec;145(6):1215–29.  
20.  Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP, et al. Guidelines 
for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012 Dec 
1;61(12):1657–69.  
21.  Poston GJ. Surgical strategies for colorectal liver metastases. Surg Oncol. 
2004;13(2–3):125–36.  
22.  Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier A-M. Epidemiology 
and management of liver metastases from colorectal cancer. Ann Surg. Lippincott, 
Williams, and Wilkins; 2006 Aug;244(2):254–9.  
23.  Jones RP, Kokudo N, Folprecht G, Mise Y, Unno M, Malik HZ, et al. Colorectal Liver 
Metastases: A Critical Review of State of the Art. Liver cancer. Karger Publishers; 
2016 Nov;6(1):66–71.  
24.  Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey J-N, Mahvi D. Improving 
Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement. Ann 
Surg Oncol. 2006 Oct 6;13(10):1271–80.  
25.  Van Cutsem E, Nordlinger B, Adam R, Köhne C-H, Pozzo C, Poston G, et al. 
Towards a pan-European consensus on the treatment of patients with colorectal liver 
metastases. Eur J Cancer. 2006 Sep;42(14):2212–21.  
26.  Ziff O, Rajput I, Adair R, Toogood GJ, Prasad KR, Lodge JPA. Repeat liver resection 
after a hepatic or extended hepatic trisectionectomy for colorectal liver metastasis. 
HPB. 2014 Mar;16(3):212–9.  
27.  Yao KA, Talamonti MS, Nemcek A, Angelos P, Chrisman H, Skarda J, et al. 
Indications and results of liver resection and hepatic chemoembolization for 
metastatic gastrointestinal neuroendocrine tumors. Surgery. 2001 Oct;130(4):677–
254 
 
85.  
28.  Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC. Update on the management of 
neuroendocrine hepatic metastases. J Vasc Interv Radiol. 2006 Aug;17(8):1235–49; 
quiz 1250.  
29.  Naik R, Nordin A, Cross PA, Hemming D, de Barros Lopes A, Monaghan JM. 
Optimal Cytoreductive Surgery Is an Independent Prognostic Indicator in Stage IV 
Epithelial Ovarian Cancer with Hepatic Metastases. Gynecol Oncol. 2000 
Aug;78(2):171–5.  
30.  Takemura N, Saiura A. Role of surgical resection for non-colorectal non-
neuroendocrine liver metastases. World J Hepatol. Baishideng Publishing Group Inc; 
2017 Feb 18;9(5):242–51.  
31.  Belghiti J, Cauchy F, Paradis V, Vilgrain V. Diagnosis and management of solid 
benign liver lesions. Nat Rev Gastroenterol Hepatol. Nature Publishing Group; 2014 
Dec 2;11(12):737–49.  
32.  Foster JH. Survival after liver resection for cancer. Cancer. Wiley Subscription 
Services, Inc., A Wiley Company; 1970 Sep 1;26(3):493–502.  
33.  Frankel TL, D’Angelica MI. Hepatic resection for colorectal metastases. J Surg 
Oncol. 2014;109(1):2–7.  
34.  Rahbari NN, Mehrabi A, Mollberg NM, Müller S a, Koch M, Büchler MW, et al. 
Hepatocellular carcinoma: current management and perspectives for the future. Ann 
Surg. 2011;253(3):453–69.  
35.  Lin TY. A simplified technique for hepatic resection: the crush method. Ann Surg. 
Lippincott, Williams, and Wilkins; 1974 Sep;180(3):285–90.  
36.  Schwarz C, Klaus DA, Tudor B, Fleischmann E, Wekerle T, Roth G, et al. 
Transection Speed and Impact on Perioperative Inflammatory Response - A 
Randomized Controlled Trial Comparing Stapler Hepatectomy and CUSA Resection. 
PLoS One. Public Library of Science; 2015;10(10):e0140314.  
37.  Fritzmann J, Kirchberg J, Sturm D, Ulrich AB, Knebel P, Mehrabi A, et al. 
Randomized clinical trial of stapler hepatectomy versus LigaSureTM transection in 
elective hepatic resection. Br J Surg. 2018;105(9):1119–27.  
38.  Moggia E, Rouse B, Simillis C, Li T, Vaughan J, Davidson BR, et al. Methods to 
decrease blood loss during liver resection: a network meta-analysis. Cochrane 
Database Syst Rev. John Wiley & Sons, Ltd; 2016 Oct 31;(10).  
255 
 
39.  Chen JM, Geng W, Zhang S, Liu FB, Zhao HC, Zhao YJ, et al. Randomized clinical 
trial of BiClamp forceps versus clamp-crushing technique in open liver resection. J 
Hepatobiliary Pancreat Sci. 2017;24(3):137–42.  
40.  Chang C-M, Yin W-Y, Wei C-K, Lee C-H, Lee C-C. The combined effects of hospital 
and surgeon volume on short-term survival after hepatic resection in a population-
based study. PLoS One. Public Library of Science; 2014;9(1):e86444.  
41.  Chapman BC, Paniccia A, Hosokawa PW, Henderson WG, Overbey DM, 
Messersmith W, et al. Impact of Facility Type and Surgical Volume on 10-Year 
Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma. J 
Am Coll Surg. American College of Surgeons; 2017;224(3):362–72.  
42.  Moggia E, Rouse B, Simillis C, Li T, Vaughan J, Davidson BR, et al. Methods to 
decrease blood loss during liver resection: a network meta-analysis. In: Gurusamy 
KS, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley 
& Sons, Ltd; 2016. p. CD010683.  
43.  Lochan R, Ansari I, Coates R, Robinson SM, White SA. Methods of Haemostasis 
During Liver Resection - A UK National Survey. Dig Surg. 2013;30(4–6):375–82.  
44.  Huang G, Chen X, Lau WY, Shen F, Wang RY, Yuan SX, et al. Quality of life after 
surgical resection compared with radiofrequency ablation for small hepatocellular 
carcinomas. Br J Surg. 2014;101(8):1006–15.  
45.  Abdalla EK, Vauthey J-N, Ellis LM, Ellis V, Pollock R, Broglio KR, et al. Recurrence 
and outcomes following hepatic resection, radiofrequency ablation, and combined 
resection/ablation for colorectal liver metastases. Ann Surg. 2004 Jun;239(6):818-25; 
discussion 825-7.  
46.  Velez E, Goldberg SN, Kumar G, Wang Y, Gourevitch S, Sosna J, et al. Hepatic 
Thermal Ablation: Effect of Device and Heating Parameters on Local Tissue 
Reactions and Distant Tumor Growth. Radiology. Radiological Society of North 
America; 2016 Dec;281(3):782–92.  
47.  Frühling P, Nilsson A, Duraj F, Haglund U, Norén A. Single-center nonrandomized 
clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) 
ablation of liver tumors in humans: Short to mid-term results. Eur J Surg Oncol. 
2017;43(4):751–7.  
48.  Mauer K, O’Kelley R, Podda N, Flanagan S, Gadani S. New Treatment Modalities for 
Hepatocellular Cancer. Curr Gastroenterol Rep. 2015;17(5).  
49.  Vroomen LGPH, Petre EN, Cornelis FH, Solomon SB, Srimathveeravalli G. 
256 
 
Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney 
and bone: What are the differences? Diagn Interv Imaging. Editions françaises de 
radiologie; 2017;98(9):609–17.  
50.  Chen M-S, Li J-Q, Zheng Y, Guo R-P, Liang H-H, Zhang Y-Q, et al. A prospective 
randomized trial comparing percutaneous local ablative therapy and partial 
hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006 Mar;243(3):321–8.  
51.  Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative 
portal vein embolization for hepatocellular carcinoma. World J Surg. 1986 
Oct;10(5):803–8.  
52.  Pandanaboyana S, Bell R, Hidalgo E, Toogood G, Prasad KR, Bartlett A, et al. A 
systematic review and meta-analysis of portal vein ligation versus portal vein 
embolization for elective liver resection. Surgery. 2015 Apr;157(4):690–8.  
53.  Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber J-C, Bachellier P. A two-
stage hepatectomy procedure combined with portal vein embolization to achieve 
curative resection for initially unresectable multiple and bilobar colorectal liver 
metastases. Ann Surg. Lippincott, Williams, and Wilkins; 2004 Dec;240(6):1037-49; 
discussion 1049-51.  
54.  Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-
Alejandro R, et al. Early Survival and Safety of ALPPS. Ann Surg. 2014;260(5):829–
38.  
55.  Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. 
Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral 
Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in 
Small-for-Size Settings. Ann Surg. 2012 Mar;255(3):405–14.  
56.  Peng SY, Wang XA, Huang CY, Zhang YY, Li JT, Hong DF, et al. Evolution of 
associating liver partition and portal vein ligation for staged hepatectomy: Simpler, 
safer and equally effective methods. World J Gastroenterol. 2017;23(23):4140–5.  
57.  de Santibañes E, Alvarez FA, Ardiles V, Pekolj J, de Santibañes M. Inverting the 
ALPPS paradigm by minimizing first stage impact: the Mini-ALPPS technique. 
Langenbeck’s Arch Surg. Langenbeck’s Archives of Surgery; 2016;401(4):557–63.  
58.  Pichlmayr R, Grosse H, Hauss J, Gubernatis G, Lamesch P, Bretschneider HJ. 
Technique and preliminary results of extracorporeal liver surgery (bench procedure) 
and of surgery on the in situ perfused liver. Br J Surg. 1990;77(1):21–6.  
59.  Lodge JP, Ammori BJ, Prasad KR, Bellamy MC. Ex vivo and in situ resection of 
257 
 
inferior vena cava with hepatectomy for colorectal metastases. Ann Surg. Lippincott, 
Williams, and Wilkins; 2000 Apr;231(4):471–9.  
60.  Azoulay D, Lim C, Salloum C, Andreani P, Maggi U, Bartelmaos T, et al. Complex 
Liver Resection Using Standard Total Vascular Exclusion, Venovenous Bypass, and 
In Situ Hypothermic Portal Perfusion. Ann Surg. 2015;262(1):93–104.  
61.  Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, et al. 
Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg. 
Lippincott, Williams, and Wilkins; 2005 Aug;242(2):252–9.  
62.  Gold JS, Are C, Kornprat P, Jarnagin WR, Gonen M, Fong Y, et al. Increased use of 
parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is 
associated with improved mortality without change in oncologic outcome: trends in 
treatment over time in 440 patients. Ann Surg. 2007/12/25. 2008;247(1):109–17.  
63.  Torzilli G, Montorsi M, Donadon M, Palmisano A, Del Fabbro D, Gambetti A, et al. 
“Radical but conservative” is the main goal for ultrasonography-guided liver 
resection: Prospective validation of this approach. J Am Coll Surg. 2005;201(4):517–
28.  
64.  Donadon M, Torzilli G. Intraoperative Ultrasound in Patients with Hepatocellular 
Carcinoma: From Daily Practice to Future Trends. Liver Cancer. 2013/10/26. 
2013;2(1):16–24.  
65.  Gotra A, Sivakumaran L, Chartrand G, Vu K-N, Vandenbroucke-Menu F, Kauffmann 
C, et al. Liver segmentation: indications, techniques and future directions. Insights 
Imaging. Springer; 2017 Aug;8(4):377–92.  
66.  Cash DM, Miga MI, Glasgow SC, Dawant BM, Clements LW, Cao Z, et al. Concepts 
and preliminary data toward the realization of image-guided liver surgery. J 
Gastrointest Surg. 2007 Jul;11(7):844–59.  
67.  Peterhans M, Vom Berg A, Dagon B, Inderbitzin D, Baur C, Candinas D, et al. A 
navigation system for open liver surgery: Design, workflow and first clinical 
applications. Int J Med Robot Comput Assist Surg. 2011 Mar;7(1):7–16.  
68.  Zaraca F, Catarci M, Gossetti F, Carboni M. Senior versus proctored young and 
resident surgeons’ experience in laparoscopic cholecystectomy: is there any need of 
previous exposure to open biliary surgery? J Laparoendosc Surg. 1995 
Oct;5(5):303–7.  
69.  Sussenbach SP, Silva EN, Pufal MA, Casagrande DS, Padoin AV, Mottin CC. 
Systematic review of economic evaluation of laparotomy versus laparoscopy for 
258 
 
patients submitted to Roux-en-Y gastric bypass. PLoS One. Public Library of 
Science; 2014;9(6):e99976.  
70.  Suh S-W, Lee K-W, Lee J-M, Choi Y, Yi N-J, Suh K-S. Clinical outcomes of and 
patient satisfaction with different incision methods for donor hepatectomy in living 
donor liver transplantation. Liver Transpl. 2015 Jan;21(1):72–8.  
71.  Costa SRP, Araújo SLM, Teixeira OA, Pereira AC. Setorectomia posterior direita 
laparoscópica no tratamento dos tumores hepáticos. ABCD Arq Bras Cir Dig (São 
Paulo). Colégio Brasileiro de Cirurgia Digestiva - CBCD; 2010 Dec;23(4):275–9.  
72.  Zand B, T. P. Robotic Surgery in Gynecologic Oncology. In: Advanced Gynecologic 
Endoscopy. InTech; 2011.  
73.  Ishizawa T, Gumbs AA, Kokudo N, Gayet B. Laparoscopic segmentectomy of the 
liver: from segment I to VIII. Ann Surg. 2012 Dec;256(6):959–64.  
74.  Wakabayashi G, Cherqui D, Geller D a., Buell JF, Kaneko H, Han HS, et al. 
Recommendations for Laparoscopic Liver Resection. Ann Surg. 2015;261(4):619–29.  
75.  Topal B, Fieuws S, Aerts R, Vandeweyer H, Penninckx F. Laparoscopic versus open 
liver resection of hepatic neoplasms: comparative analysis of short-term results. Surg 
Endosc. 2008;22(10):2208–13.  
76.  Koffron AJ, Auffenberg G, Kung R, Abecassis M. Evaluation of 300 minimally 
invasive liver resections at a single institution: less is more. Ann Surg. Lippincott, 
Williams, and Wilkins; 2007 Sep;246(3):385-92; discussion 392-4.  
77.  Hasegawa Y, Nitta H, Takahara T, Katagiri H, Baba S, Takeda D, et al. Safely 
extending the indications of laparoscopic liver resection: When should we start 
laparoscopic major hepatectomy? Surg Endosc Other Interv Tech. Springer US; 
2017;31(1):309–16.  
78.  Mühe E. Long-Term Follow-Up after Laparoscopic Cholecystectomy. Endoscopy. © 
Georg Thieme Verlag KG Stuttgart · New York; 1992 Nov 17;24(09):754–8.  
79.  Dubois F, Berthelot G, Levard H. [Cholecystectomy by coelioscopy]. Presse Med. 
1989 May 13;18(19):980–2.  
80.  Gagner M. Laparoscopic partial hepatectomy for liver tumor. Surg Endosc. 1992;  
81.  Wayand W, Woisetschläger R. [Laparoscopic resection of liver metastasis]. Chirurg. 
1993 Mar;64(3):195–7.  
82.  Croce E, Azzola M, Russo R, Golia M, Angelini S, Olmi S. Laparoscopic liver tumour 
resection with the argon beam. Endosc Surg Allied Technol. 1994;2(3–4):186–8.  
259 
 
83.  Hüscher CG, Lirici MM, Chiodini S, Recher A. Current position of advanced 
laparoscopic surgery of the liver. J R Coll Surg Edinb. 1997 Aug;42(4):219–25.  
84.  Yamanaka N, Tanaka T, Tanaka W, Yamanaka J, Yasui C, Ando T, et al. 
Laparoscopic partial hepatectomy. Hepatogastroenterology. 1998;45(19):29–33.  
85.  Katkhouda N, Hurwitz M, Gugenheim J, Mavor E, Mason RJ, Waldrep DJ, et al. 
Laparoscopic management of benign solid and cystic lesions of the liver. Ann Surg. 
Lippincott, Williams, and Wilkins; 1999 Apr;229(4):460–6.  
86.  Huscher CG, Lirici MM, Chiodini S. Laparoscopic liver resections. Semin Laparosc 
Surg. 1998;5(3):204–10.  
87.  Rau HG, Meyer G, Cohnert TU, Schardey HM, Jauch K, Schildberg FW. 
Laparoscopic liver resection with the water-jet dissector. Surg Endosc. 
1995;9(9):1009–12.  
88.  Ker CG, Chen HY, Juan CC, Chang WS, Tsai CY, Lo HW, et al. Laparoscopic 
subsegmentectomy for hepatocellular carcinoma with cirrhosis. 
Hepatogastroenterology. 47(35):1260–3.  
89.  Dagher I, O’Rourke N, Geller DA, Cherqui D, Belli G, Gamblin TC, et al. 
Laparoscopic major hepatectomy: an evolution in standard of care. Ann Surg. 
2009/10/07. 2009;250(5):856–60.  
90.  Rehman S, John SKP, French JJ, Manas DM, White SA. A single centre experience 
of first “one hundred laparoscopic liver resections”. HPB Surg. 2014 
Jan;2014:930953.  
91.  Dulucq J-L, Wintringer P, Stabilini C, Mahajna A. Isolated laparoscopic resection of 
the hepatic caudate lobe: surgical technique and a report of 2 cases. Surg Laparosc 
Endosc Percutan Tech. 2006;16(1):32–5.  
92.  Yoon Y-S, Han H-S, Choi YS, Jang J-Y, Suh K-S, Kim S-W, et al. Total Laparoscopic 
Right Posterior Sectionectomy for Hepatocellular Carcinoma. J Laparoendosc Adv 
Surg Tech. 2006 Jun;16(3):274–7.  
93.  Soubrane O, Cherqui D, Scatton O, Stenard F, Bernard D, Branchereau S, et al. 
Laparoscopic left lateral sectionectomy in living donors: safety and reproducibility of 
the technique in a single center. Ann Surg. Lippincott, Williams, and Wilkins; 2006 
Nov;244(5):815–20.  
94.  Buell JF, Cherqui D, Geller D a, O’Rourke N, Iannitti D, Dagher I, et al. The 
international position on laparoscopic liver surgery: The Louisville Statement, 2008. 
Ann Surg. 2009;250(5):825–30.  
260 
 
95.  Topal H, Tiek J, Aerts R, Topal B. Outcome of laparoscopic major liver resection for 
colorectal metastases. Surg Endosc. 2012;26(9):2451–5.  
96.  Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection-
2,804 patients. Ann Surg. 2009/10/06. 2009 Nov;250(5):831–41.  
97.  Troisi R, Montalti R, Smeets P, Van Huysse J, Van Vlierberghe H, Colle I, et al. The 
value of laparoscopic liver surgery for solid benign hepatic tumors. Surg Endosc 
Other Interv Tech. 2008;22(1):38–44.  
98.  Fuks D, Cauchy F, Ftériche S, Nomi T, Schwarz L, Dokmak S, et al. Laparoscopy 
Decreases Pulmonary Complications in Patients Undergoing Major Liver Resection. 
Ann Surg. 2015;00(00):1.  
99.  Cipriani F, Rawashdeh M, Stanton L, Armstrong T, Takhar A, Pearce NW, et al. 
Propensity score-based analysis of outcomes of laparoscopic versus open liver 
resection for colorectal metastases. Br J Surg. 2016;103(11):1504–12.  
100.  Vibert E, Perniceni T, Levard H, Denet C, Shahri NK, Gayet B. Laparoscopic liver 
resection. Br J Surg. 2006;93(1):67–72.  
101.  Gigot J-F, Glineur D, Santiago Azagra J, Goergen M, Ceuterick M, Morino M, et al. 
Laparoscopic liver resection for malignant liver tumors: preliminary results of a 
multicenter European study. Ann Surg. 2002;236(1):90–7.  
102.  Ciria R, Cherqui D, Geller D a., Briceno J, Wakabayashi G. Comparative Short-term 
Benefits of Laparoscopic Liver Resection. Ann Surg. 2015 Apr;XX(X):1.  
103.  Yu H, Wu SD, Chen DX, Zhu G. Laparoscopic resection of bismuth type I and II hilar 
cholangiocarcinoma: An audit of 14 cases from two institutions. Dig Surg. 
2011;28(1):44–9.  
104.  Aoki T, Murakami M, Fujimori A, Koizumi T, Enami Y, Kusano T, et al. Routes for 
virtually guided endoscopic liver resection of subdiaphragmatic liver tumors. 
Langenbeck’s Arch Surg. 2016;263–73.  
105.  Aoki T, Murakami M, Koizumi T, Fujimori A, Gareer H, Enami Y, et al. Three-
Dimensional Virtual Endoscopy for Laparoscopic and Thoracoscopic Liver Resection. 
J Am Coll Surg. United States: American College of Surgeons; 2015 
Aug;221(2):e21–6.  
106.  MacHado M a., Surjan RC, Makdissi FF. Intrahepatic Glissonian approach for pure 
laparoscopic right hemihepatectomy. Surg Endosc Other Interv Tech. 2011;25:3930–
3.  
261 
 
107.  Soubrane O, Perdigao Cotta F, Scatton O. Pure laparoscopic right hepatectomy in a 
living donor. Am J Transplant. 2013;13(9):2467–71.  
108.  Wong-Lun-Hing EM, van Dam RM, van Breukelen GJP, Tanis PJ, Ratti F, van 
Hillegersberg R, et al. Randomized clinical trial of open versus laparoscopic left 
lateral hepatic sectionectomy within an enhanced recovery after surgery programme 
(ORANGE II study). Br J Surg. 2017;104(5):525–35.  
109.  Fretland ÅA, Dagenborg VJ, Bjørnelv GMW, Kazaryan AM, Kristiansen R, Fagerland 
MW, et al. Laparoscopic Versus Open Resection for Colorectal Liver Metastases. 
Ann Surg. 2017;XX(Xx):1.  
110.  Lewin JW, O’Rourke NA, Chiow AKH, Bryant R, Martin I, Nathanson LK, et al. Long-
term survival in laparoscopic vs open resection for colorectal liver metastases: 
inverse probability of treatment weighting using propensity scores. HPB (Oxford). 
Elsevier; 2016 Feb;18(2):183–91.  
111.  Montalti R, Berardi G, Laurent S, Sebastiani S, Ferdinande L, Libbrecht LJ, et al. 
Laparoscopic liver resection compared to open approach in patients with colorectal 
liver metastases improves further resectability: Oncological outcomes of a case-
control matched-pairs analysis. Eur J Surg Oncol. Elsevier Ltd; 2014;40(5):536–44.  
112.  Himpens J, Leman G, Cadiere GB. Telesurgical laparoscopic cholecystectomy. Surg 
Endosc. 1998 Aug;12(8):1091.  
113.  Kitisin K, Packiam V, Bartlett DL, Tsung A. A current update on the evolution of 
robotic liver surgery. Minerva Chir. 2011 Aug;66(4):281–93.  
114.  Ho CM, Wakabayashi G, Nitta H, Ito N, Hasegawa Y, Takahara T. Systematic review 
of robotic liver resection. Surg Endosc Other Interv Tech. Germany: Springer; 2013 
Mar;27(3):732–9.  
115.  Antoniou SA, Antoniou GA, Koch OO, Pointner R, Granderath FA. Robot-assisted 
laparoscopic surgery of the colon and rectum. Surg Endosc. 2012 Jan 20;26(1):1–11.  
116.  Brody F, Richards NG. Review of robotic versus conventional laparoscopic surgery. 
Surg Endosc. 2014 May 20;28(5):1413–24.  
117.  Huang X, Wang L, Zheng X, Wang X. Comparison of perioperative, functional, and 
oncologic outcomes between standard laparoscopic and robotic-assisted radical 
prostatectomy: a systemic review and meta-analysis. Surg Endosc. 2017 Mar 
21;31(3):1045–60.  
118.  Spampinato MG, Coratti A, Bianco L, Caniglia F, Laurenzi A, Puleo F, et al. 
Perioperative outcomes of laparoscopic and robot-assisted major hepatectomies: an 
262 
 
Italian multi-institutional comparative study. Surg Endosc Other Interv Tech. 
Germany; 2014 Oct;28(10):2973–9.  
119.  Tsung A, Geller D a, Sukato DC, Sabbaghian S, Tohme S, Steel J, et al. Robotic 
versus laparoscopic hepatectomy: a matched comparison. Ann Surg. United States; 
2014 Mar;259(3):549–55.  
120.  Wu YM, Hu RH, Lai HS, Lee PH. Robotic-assisted minimally invasive liver resection. 
Asian J Surg. China; 2014 Apr;37(2):53–7.  
121.  Montalti R, Berardi G, Patriti A, Vivarelli M, Troisi RI. Outcomes of robotic vs 
laparoscopic hepatectomy: A systematic review and meta-analysis. World J 
Gastroenterol. United States; 2015 Jul;21(27):8441–51.  
122.  Kirchberg J, Reißfelder C, Weitz J, Koch M. Laparoscopic surgery of liver tumors. 
Langenbecks Arch Surg. 2013;398:931–8.  
123.  Nomi T, Fuks D, Kawaguchi Y, Mal F, Nakajima Y, Gayet B. Learning curve for 
laparoscopic major hepatectomy. Br J Surg. 2015 Jun;102(7):796–804.  
124.  Cai X, Li Z, Zhang Y, Yu H, Liang X, Jin R, et al. Laparoscopic liver resection and the 
learning curve: a 14-year, single-center experience. Surg Endosc. 2014;1–8.  
125.  Vigano L, Laurent A, Tayar C, Tomatis M, Ponti A, Cherqui D. The learning curve in 
laparoscopic liver resection: improved feasibility and reproducibility. Ann Surg. 2009 
Nov;250(5):772–82.  
126.  Robinson SM, Hui KY, Amer A, Manas DM, White SA. Laparoscopic liver resection: 
is there a learning curve? Dig Surg. 2012 Jan;29(1):62–9.  
127.  Fusaglia M, Hess H, Schwalbe M, Peterhans M, Tinguely P, Weber S, et al. A 
clinically applicable laser-based image-guided system for laparoscopic liver 
procedures. Int J Comput Assist Radiol Surg. 2015 Oct;  
128.  Nicolau S, Soler L, Mutter D, Marescaux J. Augmented reality in laparoscopic 
surgical oncology. Surg Oncol. Elsevier Ltd; 2011;20(3):189–201.  
129.  Reichard D, Bodenstedt S, Suwelack S, Mayer B, Preukschas A, Wagner M, et al. 
Intraoperative on-the-fly organ-mosaicking for laparoscopic surgery. J Med Imaging. 
2015 Oct 10;2(4):045001.  
130.  Wagner OJ, Hagen M, Kurmann A, Horgan S, Candinas D, Vorburger SA. Three-
dimensional vision enhances task performance independently of the surgical method. 
Surg Endosc. 2012 Oct;26(10):2961–8.  
131.  Hayashi Y, Misawa K, Oda M, Hawkes DJ, Mori K. Clinical application of a surgical 
263 
 
navigation system based on virtual laparoscopy in laparoscopic gastrectomy for 
gastric cancer. Int J Comput Assist Radiol Surg. 2015 Oct 1;  
132.  Alleblas CCJ, Vleugels MPH, Coppus SFPJ, Nieboer TE. The effects of laparoscopic 
graspers with enhanced haptic feedback on applied forces: a randomized 
comparison with conventional graspers. Surg Endosc Other Interv Tech. Springer 
US; 2017;(791):1–7.  
133.  Kawaguchi Y, Nagai M, Nomura Y, Kokudo N, Tanaka N. Usefulness of indocyanine 
green-fluorescence imaging during laparoscopic hepatectomy to visualize 
subcapsular hard-to-identify hepatic malignancy. J Surg Oncol. United States; 2015 
Oct;112(5):514–6.  
134.  Vigano L, Ferrero A, Amisano M, Russolillo N, Capussotti L. Comparison of 
laparoscopic and open intraoperative ultrasonography for staging liver tumours. Br J 
Surg. 2013/01/23. 2013;100(4):535–42.  
135.  Stoyanov D. Surgical vision. Ann Biomed Eng. 2012 Feb;40(2):332–45.  
136.  Wu H-Y, Rubinstein M, Shih E, Guttag J, Durand F, Freeman W. Eulerian video 
magnification for revealing subtle changes in the world. ACM Trans Graph. 
2012;31:1–8.  
137.  Maier-Hein L, Mountney P, Bartoli  a., Elhawary H, Elson D, Groch  a., et al. Optical 
techniques for 3D surface reconstruction in computer-assisted laparoscopic surgery. 
Med Image Anal. Elsevier B.V.; 2013;17(8):974–96.  
138.  Goetz M, Deris I, Vieth M, Delaney PM, Murr ER, Galle PR, et al. Near infrared 
confocal imaging of the human liver during ongoing mini-laparoscopy: A newly 
developed rigid endomicroscope with increased imaging plane depth. Gastrointest 
Endosc (conference DDW). 2009;69(5):AB373-.  
139.  Ishizawa T, Gumbs A a., Kokudo N, Gayet B. Laparoscopic segmentectomy of the 
liver: from segment I to VIII. Ann Surg. 2012 Dec;256(6):959–64.  
140.  Abu Hilal M, Di Fabio F, Abu Salameh M, Pearce NW. Oncological efficiency analysis 
of laparoscopic liver resection for primary and metastatic cancer: a single-center UK 
experience. Arch Surg. 2012 Jan;147(1):42–8.  
141.  Kingham TP, Jayaraman S, Clements LW, Scherer MA, Stefansic JD, Jarnagin WR, 
et al. Evolution of image-guided liver surgery: transition from open to laparoscopic 
procedures. J Gastrointest Surg. United States; 2013 Jul;17(7):1274–82.  
142.  Kingham TP, Scherer MA, Neese BW, Clements LW, Stefansic JD, Jarnagin WR. 
Image-guided liver surgery: intraoperative projection of computed tomography 
264 
 
images utilizing tracked ultrasound. HPB (Oxford). 2012 Sep;14(9):594–603.  
143.  Buchs NC, Volonte F, Pugin F, Toso C, Fusaglia M, Gavaghan K, et al. Augmented 
environments for the targeting of hepatic lesions during image-guided robotic liver 
surgery. J Surg Res. United States; 2013 Oct;184(2):825–31.  
144.  Tummers QRJG, Verbeek FPR, Prevoo H a JM, Braat AE, Baeten CIM, Frangioni J 
V, et al. First Experience on Laparoscopic Near-Infrared Fluorescence Imaging of 
Hepatic Uveal Melanoma Metastases Using Indocyanine Green. Surg Innov. United 
States; 2014 Feb;22(1):20–5.  
145.  Schols RM, Bouvy ND, Van Dam RM, Stassen LPS. Advanced intraoperative 
imaging methods for laparoscopic anatomy navigation: An overview. Surg Endosc 
Other Interv Tech. 2013;27(6):1851–9.  
146.  Goetz M, Kiesslich R. Advances of endomicroscopy for gastrointestinal physiology 
and diseases. Am J Physiol Gastrointest Liver Physiol. 2010/02/27. 
2010;298(6):G797-806.  
147.  Goetz M, Deris I, Vieth M, Murr E, Hoffman A, Delaney P, et al. Near-infrared 
confocal imaging during mini-laparoscopy: A novel rigid endomicroscope with 
increased imaging plane depth. J Hepatol. England; 2010 Jul;53(1):84–90.  
148.  Becker V, Wallace MB, Fockens P, von Delius S, Woodward TA, Raimondo M, et al. 
Needle-based confocal endomicroscopy for in vivo histology of intra-abdominal 
organs: first results in a porcine model (with videos). Gastrointest Endosc. 
2010/04/28. United States; 2010 Jun;71(7):1260–6.  
149.  Newton RC, Noonan DP, Vitiello V, Clark J, Payne CJ, Shang J, et al. Robot-assisted 
transvaginal peritoneoscopy using confocal endomicroscopy: a feasibility study in a 
porcine model. Surg Endosc. 2012 Sep;26(9):2532–40.  
150.  Gayet B, Validire P, Pierangelo A, Benali A, Fuks D, Takahashi H, et al. Technical 
feasibility of confocal laser endomicroscopy in laparoscopic surgery: The persee 
project. Gastroenterol (conference Abstr. AGA Institute; 2015;148(4):S-1160.  
151.  Holzinger F, Krähenbühl L, Schteingart CD, Ton-Nu HT, Hofmann AF, Demling L. 
Use of a fluorescent bile acid to enhance visualization of the biliary tract and bile 
leaks during laparoscopic surgery in rabbits. Surg Endosc. 2001;15(2):209–12.  
152.  Kudo H, Ishizawa T, Tani K, Harada N, Ichida A, Shimizu A, et al. Visualization of 
subcapsular hepatic malignancy by indocyanine-green fluorescence imaging during 
laparoscopic hepatectomy. Surg Endosc Other Interv Tech. Germany; 2014 
Aug;28(8):2504–8.  
265 
 
153.  Nambu M, Namihisa T. Hepatic transport of serum bilirubin, bromsulfophthalein, and 
indocyanine green in patients with congenital non-hemolytic hyperbilirubinemia and 
patients with constitutional indocyanine green excretory defect. J Gastroenterol. 1996 
Apr;31(2):228–36.  
154.  Matsui A, Tanaka E, Choi HS, Winer JH, Kianzad V, Gioux S, et al. Real-time intra-
operative near-infrared fluorescence identification of the extrahepatic bile ducts using 
clinically available contrast agents. Surgery. United States; 2010 Jul;148(1):87–95.  
155.  Zuzak KJ, Naik SC, Alexandrakis G, Hawkins D, Behbehani K, Livingston E. 
Intraoperative bile duct visualization using near-infrared hyperspectral video imaging. 
Am J Surg. 2008;195(4):491–7.  
156.  Minagawa M, Kurosaki I, Ogawa H, Hatakeyama K. Navigation surgery with 
autofluorescence imaging for small hepatocellular carcinomas invisible to 
ultrasonography. Surgery. 2011;149(6):848–50.  
157.  Guyon L, Lesage JC, Mordon S, Betrouni N, Mordon S, Claude Lesage J, et al. 
Development of a new illumination procedure for photodynamic therapy of the 
abdominal cavity. J Biomed Opt. United States; 2012 Mar;17(3):038001.  
158.  Yserbyt J, Dooms C, Decramer M, Verleden GM, Thiberville L, Salaün M, et al. 
Probe-based confocal laser endomicroscopy of the respiratory tract: A data 
consistency analysis. Respir Med. Elsevier; 2013 Aug;107(8):1234–40.  
159.  Ishizawa T, Zucker NB, Kokudo N, Gayet B. Positive and Negative Staining of 
Hepatic Segments By Use of Fluorescent Imaging Techniques During Laparoscopic 
Hepatectomy. Arch Surg. United States; 2012 Apr;147(4):393–4.  
160.  Fabila D, de la Rosa JM, Stolik S, Moreno E, Su??rez-??lvarez K, L??pez-Navarrete 
G, et al. In vivo assessment of liver fibrosis using diffuse reflectance and 
fluorescence spectroscopy: A proof of concept. Photodiagnosis Photodyn Ther. 
Netherlands; 2012 Dec;9(4):376–82.  
161.  Nachabé R, Hendriks BHW, Desjardins AE, van der Voort M, van der Mark MB, 
Sterenborg HJCM. Estimation of lipid and water concentrations in scattering media 
with diffuse optical spectroscopy from 900 to 1,600 nm. J Biomed Opt. 2010/07/10. 
2010;15(3):37015.  
162.  Evers DJ, Nachabé R, Hompes D, van Coevorden F, Lucassen GW, Hendriks BHW, 
et al. Optical sensing for tumor detection in the liver. Eur J Surg Oncol. 2013 
Jan;39(1):68–75.  
163.  Clancy NT, Stoyanov D, James DRC, Di Marco A, Sauvage V, Clark J, et al. 
266 
 
Multispectral image alignment using a three channel endoscope in vivo during 
minimally invasive surgery. Biomed Opt Express. 2012 Oct 1;3(10):2567–78.  
164.  Feng C, Rozenblit JW, Hamilton AJ. A computerized assessment to compare the 
impact of standard, stereoscopic, and high-definition laparoscopic monitor displays 
on surgical technique. Surg Endosc. 2010 Nov;24(11):2743–8.  
165.  Kobayashi E, Sakuma I, Konishi K, Hashizume M, Dohi T. A robotic wide-angle view 
endoscope using wedge prisms. Surg Endosc Other Interv Tech. Germany; 2004 
Sep;18(9):1396–8.  
166.  Terry BS, Ruppert AD, Steinhaus KR, Schoen JA, Rentschler ME. An integrated port 
camera and display system for laparoscopy. IEEE Trans Biomed Eng. United States; 
2010 May;57(5):1191–7.  
167.  Sahu D, Mathew MJ, Reddy PK. 3D Laparoscopy - Help or Hype; Initial Experience 
of A Tertiary Health Centre. J Clin Diagn Res. 2014 Jul;8(7):NC01-3.  
168.  Smith R, Day A, Rockall T, Ballard K, Bailey M, Jourdan I. Advanced stereoscopic 
projection technology significantly improves novice performance of minimally invasive 
surgical skills. Surg Endosc. 2012 Jun;26(6):1522–7.  
169.  Buchs NC, Volonte F, Pugin F, Toso C, Morel P. Three-dimensional laparoscopy: A 
step toward advanced surgical navigation. Surg Endosc Other Interv Tech. 
2013;27(2):692–3.  
170.  Azagury DE, Dua MM, Barrese JC, Henderson JM, Buchs NC, Ris F, et al. Image-
guided Surgery. Curr Probl Surg. 2015;52:476–520.  
171.  Fusaglia M, Peterhans M, Wallach D, Beldi G, Candinas D, Weber S. Validation of 
image overlay accuracy in a instrument guidance system for laparoscopic liver 
surgery. Hpb (IHPBA 2012). 2012;14:520.  
172.  Thompson S, Totz J, Song Y, Johnsen S, Stoyanov D, Gurusamy K, et al. Accuracy 
Validation of an Image Guided Laparoscopy System for Liver Resection. SPIE Proc. 
2015;9415(7).  
173.  Okamoto T, Onda S, Yanaga K, Suzuki N, Hattori A. Clinical application of navigation 
surgery using augmented reality in hepatobiliary pancreatic surgery. Surg Today. 
2015;45(4):397–406.  
174.  Plantefève R, Peterlik I, Haouchine N, Cotin S. Patient-Specific Biomechanical 
Modeling for Guidance During Minimally-Invasive Hepatic Surgery. Ann Biomed Eng. 
United States; 2016 Jan 22;44(1):139–53.  
267 
 
175.  Newton RC, Noonan DP, Vitiello V, Clark J, Payne CJ, Shang J, et al. Robot-assisted 
transvaginal peritoneoscopy using confocal endomicroscopy: A feasibility study in a 
porcine model. Surg Endosc Other Interv Tech. Germany; 2012 Sep;26(9):2532–40.  
176.  Goetz M, Ansems J V, Galle PR, Schuchmann M, Kiesslich R. In vivo real-time 
imaging of the liver with confocal endomicroscopy permits visualization of the 
temporospatial patterns of hepatocyte apoptosis. Am J Physiol Gastrointest Liver 
Physiol. 2011/07/23. 2011;301(5):G764-72.  
177.  Goetz M, Deris I, Vieth M, Murr E, Hoffman A, Delaney P, et al. Near-infrared 
confocal imaging during mini-laparoscopy: a novel rigid endomicroscope with 
increased imaging plane depth. J Hepatol. European Association for the Study of the 
Liver; 2010 Jul;53(1):84–90.  
178.  Goetz M, Kiesslich R, Dienes H-PP, Drebber U, Murr E, Hoffman A, et al. In vivo 
confocal laser endomicroscopy of the human liver: a novel method for assessing liver 
microarchitecture in real time. Endoscopy. 2008/07/09. Germany; 2008 
Jul;40(7):554–62.  
179.  Meining A, Shah RJ, Slivka A, Pleskow D, Chuttani R, Stevens PD, et al. 
Classification of probe-based confocal laser endomicroscopy findings in 
pancreaticobiliary strictures. Endoscopy. © Georg Thieme Verlag KG; 2012 Mar 
19;44(3):251–7.  
180.  Pierangelo A, Fuks D, Validire P, Benali A, Gayet B. Diagnostic accuracy of confocal 
laser endomicroscopy for the characterization of liver nodules. Eur J Gastroenterol 
Hepatol. 2017;29(1):42–7.  
181.  Gayet B, Pierangelo A, Fuks D, Validire P, Benali A, B. G, et al. Accuracy of confocal 
laser endomicroscopy for the characterization of peritoneal carcinosis and liver 
nodules. In: Gastroenterology. AGA Institute; 2016. p. S1199.  
182.  Latt WT, Newton RC, Visentini-Scarzanella M, Payne CJ, Noonan DP, Shang J, et al. 
A hand-held instrument to maintain steady tissue contact during probe-based 
confocal laser endomicroscopy. IEEE Trans Biomed Eng. 2011;58(9):2694–703.  
183.  Pierangelo A, Fuks D, Benali A, Validire P, Gayet B. Role of intraoperative confocal 
endomicroscopy for the realtime characterization of tissues during laparoscopic 
procedures. Surg Endosc (016 Sci Sess Soc Am Gastrointest Endosc Surg 
(SAGES), Boston, Massachusetts, USA, 16-19 March 2016). 2016;30:S431.  
184.  Ashitate Y, Stockdale A, Choi HS, Laurence RG, Frangioni J V. Real-time 
simultaneous near-infrared fluorescence imaging of bile duct and arterial anatomy. J 
Surg Res. United States; 2012 Jul;176(1):7–13.  
268 
 
185.  European Association For The Study Of The Liver EOFRATOC. EASL-EORTC 
clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 
2012 Apr;56(4):908–43.  
186.  Sakoda M, Ueno S, Iino S, Hiwatashi K, Minami K, Kawasaki Y, et al. Anatomical 
Laparoscopic Hepatectomy for Hepatocellular Carcinoma Using Indocyanine Green 
Fluorescence Imaging. J Laparoendosc Adv Surg Tech A. 2014 Dec;24(12):878–82.  
187.  Kawaguchi Y, Nomi T, Fuks D, Kokudo N, Gayet B. Visualization of the biliary ducts 
and anatomical segments using indocyanine green-fluorescence imaging. Surg 
Endosc Other Interv Tech. 2015;29:279 (supplement).  
188.  Ishizawa T, Masuda K, Urano Y, Kawaguchi Y, Satou S, Kaneko J, et al. Mechanistic 
background and clinical applications of indocyanine green fluorescence imaging of 
hepatocellular carcinoma. Ann Surg Oncol. 2014;21(2):440–8.  
189.  Ishizawa T, Fukushima N, Shibahara J, Masuda K, Tamura S, Aoki T, et al. Real-
time identification of liver cancers by using indocyanine green fluorescent imaging. 
Cancer. 2009;115(11):2491–504.  
190.  Boogerd L, Handgraaf H, Lam H, Van De Velde C, Braat A, Vahrmeijer A. 
Fluorescence-guided laparoscopic hepatectomies. HPB Conf 12th World Congr Int 
Hepato-Pancreato-Biliary Assoc Sao Paulo Brazil. 2016;18:e124.  
191.  Kawaguchi Y, Velayutham V, Fuks D, Christidis C, Kokudo N, Gayet B. Usefulness of 
Indocyanine Green-Fluorescence Imaging for Visualization of the Bile Duct during 
Laparoscopic Liver Resection. J Am Coll Surg. United States; 2015 
Dec;221(6):e113–7.  
192.  Fan YF, Xiang F, Cai W, Yang J, Xiang N, Zeng N, et al. [Analysis of intrahepatic 
Glisson’s sheath vascular disconnection approach for anatomical hepatectomy by 
three-dimensional laparoscope]. Zhonghua Wai Ke Za Zhi. China; 2016 
Mar;54(3):191–5.  
193.  Tanaka M, Inoue Y, Mise Y, Ishizawa T, Arita J, Takahashi Y, et al. Laparoscopic 
deroofing for polycystic liver disease using laparoscopic fusion indocyanine green 
fluorescence imaging. Surg Endosc. Germany; 2016 Jun;30(6):2620–3.  
194.  Kitajima T, Fujimoto Y, Hatano E, Mitsunori Y, Tomiyama K, Taura K, et al. 
Intraoperative fluorescent cholangiography using indocyanine green for laparoscopic 
fenestration of nonparasitic huge liver cysts. Asian J Endosc Surg. Japan; 2015 
Feb;8(1):71–4.  
195.  Diana M, Usmaan H, Legner A, Yu-Yin L, D’Urso A, Halvax P, et al. Novel 
269 
 
laparoscopic narrow band imaging for real-time detection of bile leak during 
hepatectomy: proof of the concept in a porcine model. Surg Endosc. Germany; 2016 
Jul;30(7):3128–32.  
196.  Iida H, Kaibori Kwon M, Ishizaki M, Matsui K, Kaibori Kwon M, Kudo M. 
Intraoperative navigation by ICG fluorescence imaging in patients with laparoscopic 
hepatic resection. Liver Cancer. 2015;(Apple):1–257.  
197.  Otsuka Y, Katagiri T, Kubota Y, Maeda T, Ishii J, Tsuchiya M, et al. Usefulness of 
ICG fluorescence imaging system in laparoscopic liver resection for liver tumors. 
HPB. 2016;18:e275.  
198.  Diana M, Liu Y, Pop R, Kong S, Legner A, Beaujeux R, et al. Super-selective intra-
arterial indocyanine green injection for positive fluorescence image guided hepatic 
segments staining: Proof of the concept in the porcine model. Surg Endosc. 
2016;30:325–500.  
199.  Aoki T, Murakami M, Fujimori A, Kusano T, Matsuda K, Yamada K, et al. 
Laparoscopic image-guided liver surgery with a color near-infrared light overlay of 
imaging system. J Am Coll Surg Laparosc image-guided liver Surg with a Color near-
infrared Light overlay imaging Syst. 2015;4(Supplement 1):221.  
200.  Zuzak KJ, Naik SC, Alexandrakis G, Hawkins D, Behbehani K, Livingston E. 
Intraoperative bile duct visualization using near-infrared hyperspectral video imaging. 
Am J Surg. 2008 Apr;195(4):491–7.  
201.  Starkov Y, Dzhantukhanova S, Vyborniy M. 3D laparoscopic liver cyst surgery. Surg 
Endosc (EAES suppl). 2016;27:1–52.  
202.  Suh K-S, Hong SK, Yi N-J, Lee K-W, Kim H-S, Yoon KC, et al. Pure 3D Laparoscopic 
Extended Right Hepatectomy in a Living Donor. Liver Transpl. 2016 Jun;  
203.  Velayutham V, Fuks D, Nomi T, Kawaguchi Y, Gayet B, V. V, et al. 3D visualization 
reduces operating time when compared to high-definition 2D in laparoscopic liver 
resection: a case-matched study. Surg Endosc Other Interv Tech. V. Velayutham, 
Department of Digestive Diseases, Institut Mutualiste Montsouris, 42 Boulevard 
Jourdan, Paris 75014, France. E-mail: drvimmi@gmail.com, Germany: Springer New 
York LLC; 2016 Jan;30(1):147–53.  
204.  Nakamura Y, Hayashibe M. Laser-Pointing Endoscope System for Intra-Operative. 
Stud Health Technol Inform. Netherlands; 2001;81:1543–8.  
205.  Hayashibe M, Suzuki N, Nakamura Y, Hattori A. Real-time 3D deformation imaging 
of abdominal organs in laparoscopy. Stud Health Technol Inform. Netherlands; 
270 
 
2003;94:117–23.  
206.  Hayashibe M, Suzuki N, Nakamura Y. Laser-scan endoscope system for 
intraoperative geometry acquisition and surgical robot safety management. Med 
Image Anal. Netherlands; 2006 Aug;10(4):509–19.  
207.  Yi B, Wang G, Li J, Jiang J, Son Z, Su H, et al. The first clinical use of domestically 
produced Chinese minimally invasive surgical robot system “Micro Hand S”. Surg 
Endosc. Germany; 2016 Jun;30(6):2649–55.  
208.  Stoyanov D, Scarzanella MV, Pratt P, Yang G-Z. Real-time stereo reconstruction in 
robotically assisted minimally invasive surgery. Med Image Comput Comput Assist 
Interv. 2010 Jan;13(Pt 1):275–82.  
209.  Haouchine N, Dequidt J, Berger MO, Cotin S. Deformation-based augmented reality 
for hepatic surgery. Stud Health Technol Inform. 2013 Jan;184:182–8.  
210.  Kang X, Azizian M, Wilson E, Wu K, Martin AD, Kane TD, et al. Stereoscopic 
augmented reality for laparoscopic surgery. Surg Endosc. Germany; 2014 
Jul;28(7):2227–35.  
211.  López-Mir F, Naranjo V, Fuertes JJ, Alcañiz M, Bueno J, Pareja E. Design and 
validation of an augmented reality system for laparoscopic surgery in a real 
environment. Biomed Res Int. 2013;2013.  
212.  Satou S, Mitsui T, Ninomiya R, Komagome M, Akamatsu N, Ozawa F, et al. Image 
overlay navigation of laparoscopic liver resection. Hepatol Int. 2014;8:1–405.  
213.  Mbah NA, Scoggins C, McMasters K, Martin R. Impact of hepatectomy margin on 
survival following resection of colorectal metastasis: the role of adjuvant therapy and 
its effects. Eur J Surg Oncol. 2013/10/03. 2013;39(12):1394–9.  
214.  Are C, Gonen M, Zazzali K, Dematteo RP, Jarnagin WR, Fong Y, et al. The impact of 
margins on outcome after hepatic resection for colorectal metastasis. Ann Surg. 
2007/08/02. 2007;246(2):295–300.  
215.  Peterhans M, Oliveira T, Banz V, Candinas D, Weber S. Computer-assisted liver 
surgery: clinical applications and technological trends. Crit Rev Biomed Eng. 
2012;40(3):199–220.  
216.  Haouchine N, Cotin S, Peterlik I, Dequidt J, Kerrien E, Berger M, et al. Impact of Soft 
Tissue Heterogeneity on Augmented Reality for Liver Surgery. IEEE Trans Vis 
Comput Graph. 2015 May 1;21(5):584–97.  
217.  Pua EC, Light ED, Wolf PD, Smith SW, Von Allmen D. 3-D ultrasound guidance of 
271 
 
surgical robotics: A feasibility study. Proc - IEEE Ultrason Symp. United States; 2006 
Nov;1(11):993–6.  
218.  Hammill CW, Clements LW, Stefansic JD, Wolf RF, Hansen PD, Gerber DA. 
Evaluation of a minimally invasive image-guided surgery system for hepatic ablation 
procedures. Surg Innov. United States; 2014 Aug;21(4):419–26.  
219.  Suwelack S, Röhl S, Bodenstedt S, Reichard D, Dillmann R, dos Santos T, et al. 
Physics-based shape matching for intraoperative image guidance. Med Phys. 
American Association of Physicists in Medicine; 2014 Nov 8;41(11):111901.  
220.  Schneider C, Thompson S, Song Y, Totz J, Desjardins A, Gurusamy K, et al. 
Preliminary results from a clinical study evaluating a novel image guidance system 
for laparoscopic liver surgery. HPB. Elsevier; 2017 Jun 7;18(Conference 
Publication):e99.  
221.  Pessaux P, Diana M, Soler L, Piardi T, Mutter D, Marescaux J. Towards cybernetic 
surgery: robotic and augmented reality-assisted liver segmentectomy. Langenbeck’s 
Arch Surg. Germany; 2014 Apr;400(3):381–5.  
222.  Huber T, Baumgart J, Peterhans M, Weber S, Heinrich S, Lang H, et al. [Computer-
assisted 3D-navigated laparoscopic resection of a vanished colorectal liver 
metastasis after chemotherapy]. Zeitschrift für Gastroenterol. Germany; 2016 
Jan;54(1):40–3.  
223.  Volonté F, Pugin F, Bucher P, Sugimoto M, Ratib O, Morel P. Augmented reality and 
image overlay navigation with OsiriX in laparoscopic and robotic surgery: Not only a 
matter of fashion. J Hepatobiliary Pancreat Sci. Japan; 2011 Jul;18(4):506–9.  
224.  Nachabe R, Hendriks BH, van der Voort M, Desjardins AE, Sterenborg HJ. 
Estimation of biological chromophores using diffuse optical spectroscopy: benefit of 
extending the UV-VIS wavelength range to include 1000 to 1600 nm. Biomed Opt 
Express. 2011/01/25. 2010;1(5):1432–42.  
225.  Nachabé R, Hendriks BHW, Schierling R, Hales J, Racadio JM, Rottenberg S, et al. 
Real-Time In Vivo Characterization of Primary Liver Tumors With Diffuse Optical 
Spectroscopy During Percutaneous Needle Interventions: Feasibility Study in 
Woodchucks. Invest Radiol. 2015 Mar 16;  
226.  Clements LW, Dumpuri P, Chapman WC, Dawant BM, Galloway RL, Miga MI. Organ 
surface deformation measurement and analysis in open hepatic surgery: method and 
preliminary results from 12 clinical cases. IEEE Trans Biomed Eng. 2011 Aug;58(8).  
227.  Schneider C, Thompson S, Clarkson MJ, Hawkes DJ, Davidson BR. A novel 
272 
 
approach to image guidance in laparoscopic liver surgery. Surg Endosc. 2015;20 
Suppl 1.  
228.  Zijlmans M, Langø T, Hofstad EF, Van Swol CFP, Rethy A. Navigated laparoscopy – 
liver shift and deformation due to pneumoperitoneum in an animal model. Minim 
Invasive Ther Allied Technol. England; 2012 May;21(3):241–8.  
229.  Kenngott HG, Wagner M, Gondan M, Nickel F, Nolden M, Fetzer A, et al. Real-time 
image guidance in laparoscopic liver surgery: first clinical experience with a guidance 
system based on intraoperative CT imaging. Surg Endosc. Germany; 2014 
Mar;28(3):933–40.  
230.  Chopra SS, Schmidt SC, Eisele R, Teichgräber U, Van Der Voort I, Seebauer C, et 
al. Initial results of MR-guided liver resection in a high-field open MRI. Surg Endosc 
Other Interv Tech. Germany; 2010 Oct;24(10):2506–12.  
231.  Yasunaga T, Konishi K, Yamaguchi S, Okazaki K, Hong JS, Ieiri S, et al. MR-
compatible laparoscope with a distally mounted CCD for MR image-guided surgery. 
Int J Comput Assist Radiol Surg. 2007;2(1):11–8.  
232.  Beard P. Biomedical photoacoustic imaging. Interface Focus. 2012/08/07. 
2011;1(4):602–31.  
233.  Solberg O V, Langø T, Tangen G a, Mårvik R, Ystgaard B, Rethy  a, et al. Navigated 
ultrasound in laparoscopic surgery. Minim Invasive Ther Allied Technol. 
2009;18(1):36–53.  
234.  Konishi K, Nakamoto M, Kakeji Y, Tanoue K, Kawanaka H, Yamaguchi S, et al. A 
real-time navigation system for laparoscopic surgery based on three-dimensional 
ultrasound using magneto-optic hybrid tracking configuration. Int J Comput Assist 
Radiol Surg. 2007;2(1):1–10.  
235.  Hildebrand P, Schlichting S, Martens V, Besirevic A, Kleemann M, Roblick U, et al. 
Prototype of an intraoperative navigation and documentation system for laparoscopic 
radiofrequency ablation: First experiences. Eur J Surg Oncol. England; 2008 
Apr;34(4):418–21.  
236.  Song Y, Totz J, Thompson S, Johnsen S, Barratt D, Schneider C, et al. Locally rigid, 
vessel-based registration for laparoscopic liver surgery. Int J Comput Assist Radiol 
Surg. Germany; 2015 Dec;10(12):1951–61.  
237.  Tao K, Liu X, Deng M, Shi W, Gao J. Three-Dimensional Against 2-Dimensional 
Laparoscopic Colectomy for Right-sided Colon Cancer. Surg Laparosc Endosc 
Percutan Tech. 2016 Aug;26(4):324–7.  
273 
 
238.  Fanfani F, Rossitto C, Restaino S, Ercoli A, Chiantera V, Monterossi G, et al. How 
Technology Can Impact Surgeon Performance: A Randomized Trial Comparing 3-
Dimensional versus 2-Dimensional Laparoscopy in Gynecology Oncology. J Minim 
Invasive Gynecol. 23(5):810–7.  
239.  Aykan S, Singhal P, Nguyen DP, Yigit A, Tuken M, Yakut E, et al. Perioperative, 
pathologic, and early continence outcomes comparing three-dimensional and two-
dimensional display systems for laparoscopic radical prostatectomy--a retrospective, 
single-surgeon study. J Endourol. 2014 May;28(5):539–43.  
240.  Xu G, Meng Z-X, Lin J-D, Deng CX, Carson PL, Fowlkes JB, et al. High resolution 
Physio-chemical Tissue Analysis: Towards Non-invasive In Vivo Biopsy. Sci Rep. 
2016;6:16937.  
241.  Miyata A, Ishizawa T, Kamiya M, Shimizu A, Kaneko J, Ijichi H, et al. Photoacoustic 
tomography of human hepatic malignancies using Intraoperative indocyanine green 
fluorescence imaging. PLoS One. 2014;9(11).  
242.  Hill ER, Xia W, Nikitichev DI, Gurusamy K, Beard PC, Hawkes DJ, et al. 
Interventional multi-spectral photoacoustic imaging in laparoscopic surgery. Proc 
SPIE. 2016;9708:97080B.  
243.  Rubins U, Spigulis J, Miscuks A. Application of Colour Magnification Technique for 
Revealing Skin Microcirculation Changes under Regional Anaesthetic Input. Spigulis 
J, Kuzmina I, editors. International Society for Optics and Photonics; 2013 Nov 
18;9032:2–6.  
244.  Amir-Khalili A, Hamarneh G, Peyrat J-M, Abinahed J, Al-Alao O, Al-Ansari A, et al. 
Automatic Segmentation of Occluded Vasculature via Pulsatile Motion Analysis in 
Endoscopic Robot-Assisted Partial Nephrectomy Video. Med Image Anal. Elsevier 
Ltd.; 2015;25(1):103–10.  
245.  McLeod  a. J, Baxter JSH, de Ribaupierre S, Peters TM. Motion magnification for 
endoscopic surgery. Yaniv ZR, Holmes DR, editors. SPIE Proc. 2014 Mar 
12;9036(1):90360C.  
246.  Jones G, Clancy NT, Arridge S, Elson DS, Stoyanov D. Inference of Tissue 
Haemoglobin Concentration from Stereo RGB. Springer International Publishing; 
2016;1:50–8.  
247.  Becker V, van den Broek FJ, Buchner AM, Dekker E, Wallace MB, von Delius S, et 
al. Optimal fluorescein dose for intravenous application in miniprobe-based confocal 
laser scanning microscopy in pigs. J Biophotonics. 2011 Jan;4(1–2):108–13.  
274 
 
248.  von Delius S, Feussner H, Wilhelm D, Karagianni A, Henke J, Schmid RM, et al. 
Transgastric in vivo histology in the peritoneal cavity using miniprobe-based confocal 
fluorescence microscopy in an acute porcine model. Endoscopy. 2007/05/23. 
2007;39(5):407–11.  
249.  Giovannini M, Bories E, Monges G, Pesenti C, Caillol F, Delpero JR. Results of a 
phase I-II study on intraductal confocal microscopy (IDCM) in patients with common 
bile duct (CBD) stenosis. Surg Endosc. 2011 Jul;25(7):2247–53.  
250.  Rajkumar V, Goh V, Siddique M, Robson M, Boxer G, Pedley RB, et al. Texture 
analysis of (125)I-A5B7 anti-CEA antibody SPECT differentiates metastatic colorectal 
cancer model phenotypes and anti-vascular therapy response. Br J Cancer. 2015 
Jun 9;112(12):1882–7.  
251.  Le Goualher G, Perchant A, Genet M, Cave C, Viellerobe B, Berier R, et al. Towards 
optical biopsies with an integrated fibered confocal fluorescence microscope. Lect-
Notes-Comput-Sci. 2004;3217:761–8.  
252.  Lewandowski D, Barroca V, Ducongé F, Bayer J, Van Nhieu JT, Pestourie C, et al. In 
vivo cellular imaging pinpoints the role of reactive oxygen species in the early steps 
of adult hematopoietic reconstitution. Blood. American Society of Hematology; 2010 
Jan 21;115(3):443–52.  
253.  Li X, Zhou X, Guan Y, Wang Y-XJ, Scutt D, Gong Q-Y. N-nitrosodiethylamine-
induced pig liver hepatocellular carcinoma model: radiological and histopathological 
studies. Cardiovasc Intervent Radiol. 2006;29(3):420–8.  
254.  Schneider C, Desjardins AE, Gurusamy K, Hawkes DJ, Davidson BR. Laparoscopic 
manipulation of a probe-based confocal laser endomicroscope using a steerable 
intravascular catheter. Surg Laparosc Endosc Percutan Tech. United States; 2015 
Apr;25(2):e83-5.  
255.  Jahne B. Digital Image Processing. Berlin/Heidelberg: Springer-Verlag; 2005.  
256.  Nachabé R, Evers DJ, Hendriks BHW, Lucassen GW, van der Voort M, Wesseling J, 
et al. Effect of bile absorption coefficients on the estimation of liver tissue optical 
properties and related implications in discriminating healthy and tumorous samples. 
Biomed Opt Express. 2011 Jan;2(3):600–14.  
257.  Nachabé R, Hendriks BHW, Schierling R, Hales J, Racadio JM, Rottenberg S, et al. 
Real-Time In Vivo Characterization of Primary Liver Tumors With Diffuse Optical 
Spectroscopy During Percutaneous Needle Interventions Feasibility Study in 
Woodchucks. 2015;00(00):1–6.  
275 
 
258.  Greaby R, Zderic V, Vaezy S, Manuscript A. Pulsatile flow phantom for ultrasound 
image-guided HIFU treatment of vascular injuries. Ultrasound Med Biol. 2007 
Aug;33(8):1269–76.  
259.  Hoskins PR. Simulation and Validation of Arterial Ultrasound Imaging and Blood 
Flow. Ultrasound Med Biol. 2008;34(5):693–717.  
260.  Nikitichev DI, Barburas A, McPherson K, Mari J-M, West SJ, Desjardins AE. 
Construction of 3-Dimensional Printed Ultrasound Phantoms With Wall-less Vessels. 
J Ultrasound Med. 2016;35(6):1333–9.  
261.  Srivastava S, Ng KK, Delp EJ. Crowd flow estimation using multiple visual features 
for scenes with changing crowd densities. 2011 8th IEEE Int Conf Adv Video Signal 
Based Surveill. IEEE; 2011 Aug;60–5.  
262.  Beura S, Majhi B, Dash R. Mammogram classification using two dimensional discrete 
wavelet transform and gray-level co-occurrence matrix for detection of breast cancer. 
Neurocomputing. Elsevier; 2015;154:1–14.  
263.  Clarkson MJ, Zombori G, Thompson S, Totz J, Song Y, Espak M, et al. The NifTK 
software platform for image-guided interventions: platform overview and NiftyLink 
messaging. Int J Comput Assist Radiol Surg. 2015 Mar;10(3):301–16.  
264.  Totz J, Thompson S, Stoyanov D, Gurusamy K, Davidson BR, Hawkes DJ, et al. Fast 
Semi-dense Surface Reconstruction from Stereoscopic Video in Laparoscopic 
Surgery. 5th Int Conf IPCAI 2014. 2014;8498:206–15.  
265.  Soler L, Nicolau S, Pessaux P, Mutter D, Marescaux J. Real-time 3D image 
reconstruction guidance in liver resection surgery. Hepatobiliary Surg Nutr. 2014 
Apr;3(2):73–81.  
266.  Zhang Z. A flexible new technique for camera calibration. IEEE Trans Pattern Anal 
Mach Intell. 2000;22(11):1330–4.  
267.  Thompson S, Stoyanov D, Schneider C, Gurusamy K, Ourselin S, Davidson B, et al. 
Hand–eye calibration for rigid laparoscopes using an invariant point. Int J Comput 
Assist Radiol Surg. Germany; 2016 Jun;11(6):1–10.  
268.  Van Cutsem E, Nordlinger B, Cervantes A. Advanced colorectal cancer: ESMO 
Clinical Practice Guidelines for treatment. Ann Oncol. 2010 May;21 Suppl 5:v93-7.  
269.  Helling TS, Martin M. Cause of death from liver metastases in colorectal cancer. Ann 
Surg Oncol. 2014 Feb;21(2):501–6.  
270.  Page AJ, Cosgrove DC, Herman JM, Pawlik TM. Advances in understanding of 
276 
 
colorectal liver metastasis and implications for the clinic. Expert Rev Gastroenterol 
Hepatol. 2015;9(2):245–59.  
271.  Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal 
liver metastases. Oncologist. 2008 Jan;13(1):51–64.  
272.  Antoniou A, Lovegrove RE, Tilney HS, Heriot AG, John TG, Rees M, et al. Meta-
analysis of clinical outcome after first and second liver resection for colorectal 
metastases. Surgery. 2006/12/26. 2007;141(1):9–18.  
273.  de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, et al. Rates and 
patterns of recurrence following curative intent surgery for colorectal liver metastasis: 
an international multi-institutional analysis of 1669 patients. Ann Surg. 2009 
Sep;250(3):440–8.  
274.  Welsh FK, Tekkis PP, O’Rourke T, John TG, Rees M. Quantification of risk of a 
positive (R1) resection margin following hepatic resection for metastatic colorectal 
cancer: an aid to clinical decision-making. Surg Oncol. 2008/01/29. 2008;17(1):3–13.  
275.  Torzilli G, Del Fabbro D, Palmisano A, Donadon M, Bianchi P, Roncalli M, et al. 
Contrast-enhanced intraoperative ultrasonography during hepatectomies for 
colorectal cancer liver metastases. J Gastrointest Surg. 2005 Nov;9(8):1148-53; 
discussion 1153-4.  
276.  Conlon R, Jacobs M, Dasgupta D, Lodge JPA. The value of intraoperative ultrasound 
during hepatic resection compared with improved preoperative magnetic resonance 
imaging. Eur J Ultrasound. 2003 Feb;16(3):211–6.  
277.  Kishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, Wallace MJ, et al. Three hundred 
and one consecutive extended right hepatectomies: evaluation of outcome based on 
systematic liver volumetry. Ann Surg. 2009/09/05. 2009;250(4):540–8.  
278.  Chopra SS, Schmidt SC, Eisele R, Teichgräber U, Van Der Voort I, Seebauer C, et 
al. Initial results of MR-guided liver resection in a high-field open MRI. Surg Endosc 
Other Interv Tech. 2010;24(10):2506–12.  
279.  Peloso A, Franchi E, Canepa MC, Barbieri L, Briani L, Ferrario J, et al. Combined 
use of intraoperative ultrasound and indocyanine green fluorescence imaging to 
detect liver metastases from colorectal cancer. HPB. 2013/03/06. 2013;15(12):928–
34.  
280.  Zhu Y, Gao W, Zhou Y, Guo Y, Guo F, He Y. Rapid and high-resolution imaging of 
human liver specimens by full-field optical coherence tomography. J Biomed Opt. 
2015;20(11):116010.  
277 
 
281.  Goetz M, Fottner C, Schirrmacher E, Delaney P, Gregor S, Schneider C, et al. In-vivo 
confocal real-time mini-microscopy in animal models of human inflammatory and 
neoplastic diseases. Endoscopy. 2007/04/12. © Georg Thieme Verlag KG Stuttgart · 
New York; 2007 Apr;39(4):350–6.  
282.  Goetz M, Deris I, Vieth M, Murr E, Hoffman A, Delaney P, et al. Near-infrared 
confocal imaging during mini-laparoscopy: a novel rigid endomicroscope with 
increased imaging plane depth. J Hepatol. 2010/05/11. 2010;53(1):84–90.  
283.  Leggett CL, Gorospe EC, Chan DK, Muppa P, Owens V, Smyrk TC, et al. 
Comparative diagnostic performance of volumetric laser endomicroscopy and 
confocal laser endomicroscopy in the detection of dysplasia associated with Barrett’s 
esophagus. Gastrointest Endosc. 2016 May;83(5):880–888.e2.  
284.  Goetz M, Hoetker MS, Diken M, Galle PR, Kiesslich R. In vivo molecular imaging 
with cetuximab, an anti-EGFR antibody, for prediction of response in xenograft 
models of human colorectal cancer. Endoscopy. 2013 Jun;45(6):469–77.  
285.  Bok GH, Jeon SR, Cho JY, Cho JH, Lee WC, Jin SY, et al. The accuracy of probe-
based confocal endomicroscopy versus conventional endoscopic biopsies for the 
diagnosis of superficial gastric neoplasia (with videos). Gastrointest Endosc. 
2013/03/12. 2013;77(6):899–908.  
286.  Chang TC, Liu JJ, Liao JC. Probe-based confocal laser endomicroscopy of the 
urinary tract: the technique. J Vis Exp. 2013/01/29. 2013;(71):e4409.  
287.  Fuchs FS, Zirlik S, Hildner K, Schubert J, Vieth M, Neurath MF. Confocal laser 
endomicroscopy for diagnosing lung cancer in vivo. Eur Respir J. 2012/09/22. 
2013;41(6):1401–8.  
288.  De Palma GD, Esposito D, Luglio G, Limite G, Accurso A, Sollazzo V, et al. Confocal 
laser endomicroscopy in breast surgery: a pilot study. BMC Cancer. 2015 
Jan;15:252.  
289.  Nathan C-AO, Kaskas NM, Ma X, Chaudhery S, Lian T, Moore-Medlin T, et al. 
Confocal Laser Endomicroscopy in the Detection of Head and Neck Precancerous 
Lesions. Otolaryngol Head Neck Surg. 2014 Apr 3;151(1):73–80.  
290.  Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic 
therapy. Science. 2005 Jan 7;307(5706):58–62.  
291.  Alander JT, Kaartinen I, Laakso A, Pätilä T, Spillmann T, Tuchin V V, et al. A review 
of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging. 2012 
Jan;2012:940585.  
278 
 
292.  Rubbia-Brandt L, Giostra E, Brezault C, Roth AD, Andres A, Audard V, et al. 
Importance of histological tumor response assessment in predicting the outcome in 
patients with colorectal liver metastases treated with neo-adjuvant chemotherapy 
followed by liver surgery. Ann Oncol. 2007 Feb 1;18(2):299–304.  
293.  Vermeulen PB, Colpaert C, Salgado R, Royers R, Hellemans H, Van Den Heuvel E, 
et al. Liver metastases from colorectal adenocarcinomas grow in three patterns with 
different angiogenesis and desmoplasia. J Pathol. 2001/10/24. 2001;195(3):336–42.  
294.  Fukumura D, Jain RK. Tumor microvasculature and microenvironment: targets for 
anti-angiogenesis and normalization. Microvasc Res. 2007 Jan;74(2–3):72–84.  
295.  Stoeltzing O, Liu W, Reinmuth N, Parikh A, Ahmad SA, Jung YD, et al. Angiogenesis 
and antiangiogenic therapy of colon cancer liver metastasis. Ann Surg Oncol. 2003 
Aug;10(7):722–33.  
296.  Martirosyan NL, Cavalcanti DD, Eschbacher JM, Delaney PM, Scheck AC, 
Abdelwahab MG, et al. Use of in vivo near-infrared laser confocal endomicroscopy 
with indocyanine green to detect the boundary of infiltrative tumor. J Neurosurg. 2011 
Dec;115(6):1131–8.  
297.  Schindl MJ, Redhead DN, Fearon KCH, Garden OJ, Wigmore SJ. The value of 
residual liver volume as a predictor of hepatic dysfunction and infection after major 
liver resection. Gut. 2005 Feb;54(2):289–96.  
298.  Kulaylat MN, Gibbs JF. Thermoablation of colorectal liver metastasis. J Surg Oncol. 
2010 Jun 15;101(8):699–705.  
299.  Schulz P, Dierkes C, Wiedenmann B, Grötzinger C. Near-Infrared Confocal Laser 
Endomicroscopy Detects Colorectal Cancer via an Integrin αvβ3 Optical Probe. Mol 
Imaging Biol. 2015;17(4):450–60.  
300.  Eser S, Messer M, Eser P, von Werder A, Seidler B, Bajbouj M, et al. In vivo 
diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic 
cancer by molecular imaging. Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9945–
50.  
301.  Meining A, Frimberger E, Becker V, Von Delius S, Von Weyhern CH, Schmid RM, et 
al. Detection of cholangiocarcinoma in vivo using miniprobe-based confocal 
fluorescence microscopy. Clin Gastroenterol Hepatol. 2008 Sep;6(9):1057–60.  
302.  Liu H, Li Y-Q, Yu T, Zhao Y-A, Zhang J-P, Zhang J-N, et al. Confocal 
endomicroscopy for in vivo detection of microvascular architecture in normal and 
malignant lesions of upper gastrointestinal tract. J Gastroenterol Hepatol. 2008 
279 
 
Jan;23(1):56–61.  
303.  Hurlstone DP, Baraza W, Brown S, Thomson M, Tiffin N, Cross SS. In vivo real-time 
confocal laser scanning endomicroscopic colonoscopy for the detection and 
characterization of colorectal neoplasia. Br J Surg. 2008 May;95(5):636–45.  
304.  Goetz M, Fottner C, Schirrmacher E, Delaney P, Gregor S, Schneider C, et al. In-vivo 
confocal real-time mini-microscopy in animal models of human inflammatory and 
neoplastic diseases. Endoscopy. 2007/04/12. 2007;39(4):350–6.  
305.  Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells 
in metastatic sites. Nat Rev Cancer. 2002 Aug;2(8):563–72.  
306.  Frese KK, Tuveson DA. Maximizing mouse cancer models. Nat Rev Cancer. Nature 
Publishing Group; 2007 Sep 1;7(9):645–58.  
307.  Johnson SP, Ogunlade O, Zhang E, Laufer J, Rajkumar V, Pedley RB, et al. 
Photoacoustic tomography of vascular therapy in a preclinical mouse model of 
colorectal carcinoma. In: Oraevsky AA, Wang L V., editors. SPIE BiOS. International 
Society for Optics and Photonics; 2014. p. 89431R.  
308.  Rees M, Tekkis PP, Welsh FK, O’Rourke T, John TG. Evaluation of long-term 
survival after hepatic resection for metastatic colorectal cancer: a multifactorial model 
of 929 patients. Ann Surg. 2007/12/25. 2008;247(1):125–35.  
309.  Abo T, Nanashima A, Tobinaga S, Hidaka S, Taura N, Takagi K, et al. Usefulness of 
intraoperative diagnosis of hepatic tumors located at the liver surface and hepatic 
segmental visualization using indocyanine green-photodynamic eye imaging. Eur J 
Surg Oncol. 2014 Oct 18;  
310.  Allen PJ, Ronald P, Kingham TP, Kemeny N, Blumgart LH, Jarnagin WR, et al. 
Resection Margin and Survival in 2368 Patients Undergoing Hepatic Resection for 
Metastatic Colorectal Cancer. 2015;262(3).  
311.  Knavel EM, Brace CL. Tumor ablation: common modalities and general practices. 
Tech Vasc Interv Radiol. 2013 Dec;16(4):192–200.  
312.  Herbold T, Wahba R, Bangard C, Demir M, Drebber U, Stippel DL. The laparoscopic 
approach for radiofrequency ablation of hepatocellular carcinoma--indication, 
technique and results. Langenbecks Arch Surg. 2013 Jan;398(1):47–53.  
313.  Frich L. Non-invasive thermometry for monitoring hepatic radiofrequency ablation. 
Minim Invasive Ther Allied Technol. 2006 Jan;15(1):18–25.  
314.  Goldberg SN, Dupuy DE. Image-guided Radiofrequency Tumor Ablation: Challenges 
280 
 
and Opportunities—Part I. J Vasc Interv Radiol. 2001 Sep;12(9):1021–32.  
315.  Chen W, Zhuang H, Cheng G, Torigian DA, Alavi A. Comparison of FDG-PET, MRI 
and CT for post radiofrequency ablation evaluation of hepatic tumors. Ann Nucl Med. 
2013 Jan;27(1):58–64.  
316.  Kuehl H, Antoch G, Stergar H, Veit-Haibach P, Rosenbaum-Krumme S, Vogt F, et al. 
Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver 
metastases treated with radiofrequency ablation: initial results. Eur J Radiol. 2008 
Aug;67(2):362–71.  
317.  Mariani  a, Kwiecinski W, Pernot M, Balvay D, Tanter M, Clement O, et al. Real time 
shear waves elastography monitoring of thermal ablation: in vivo evaluation in pig 
livers. J Surg Res. Elsevier Inc; 2014 May 1;188(1):37–43.  
318.  Wang C-P, Wang H, Qu J-H, Lu Y-Y, Bai W-L, Dong Z, et al. Tumour seeding after 
percutaneous cryoablation for hepatocellular carcinoma. World J Gastroenterol. 2012 
Dec 7;18(45):6587–96.  
319.  Bruners P, Pandeya GD, Levit E, Roesch E, Penzkofer T, Isfort P, et al. CT-based 
temperature monitoring during hepatic RF ablation: feasibility in an animal model. Int 
J Hyperthermia. 2012 Jan;28(1):55–61.  
320.  Nikfarjam M, Muralidharan V, Malcontenti-Wilson C, McLaren W, Christophi C. 
Impact of blood flow occlusion on liver necrosis following thermal ablation. ANZ J 
Surg. 2006;76(1–2):84–91.  
321.  Nakazawa T, Kokubu S, Shibuya A, Ono K, Watanabe M, Hidaka H, et al. 
Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor 
progression after ablation and ablative margin. AJR Am J Roentgenol. American 
Roentgen Ray Society; 2007 Feb 23;188(2):480–8.  
322.  Rhim H, Lim HK. Radiofrequency ablation of hepatocellular carcinoma: pros and 
cons. Gut Liver. 2010 Sep;4 Suppl 1:S113-8.  
323.  Becker V, von Delius S, Bajbouj M, Karagianni A, Schmid RM, Meining A. 
Intravenous application of fluorescein for confocal laser scanning microscopy: 
evaluation of contrast dynamics and image quality with increasing injection-to-
imaging time. Gastrointest Endosc. 2008 Aug;68(2):319–23.  
324.  Demura Y, Ishikawa N, Hirano Y, Inaki N, Matsunoki A, Watanabe G. Transrectal 
robotic natural orifice translumenal endoscopic surgery (NOTES) applied to intestinal 
anastomosis in a porcine intestine model. Surg Endosc. 2013 Dec;27(12):4693–701.  
325.  Flora E Della, Wilson TG, Martin IJ, O’Rourke N a, Maddern GJ. A review of natural 
281 
 
orifice translumenal endoscopic surgery (NOTES) for intra-abdominal surgery: 
experimental models, techniques, and applicability to the clinical setting. Ann Surg. 
2008 Apr;247(4):583–602.  
326.  Schols RM, Lodewick TM, Bouvy ND, van Dam GM, Dejong CHC, Stassen LPS. 
Application of a new dye for near-infrared fluorescence laparoscopy of the ureters: 
demonstration in a pig model. Dis Colon Rectum. 2014 Mar;57(3):407–11.  
327.  Evers DJ, Westerkamp AC, Spliethoff JW, Pully V V, Hompes D, Hendriks BHW, et 
al. Diffuse reflectance spectroscopy: toward real-time quantification of steatosis in 
liver. Transpl Int. 2015 Apr;28(4):465–74.  
328.  Yoon WJ, Daglilar ES, Fernández-del Castillo C, Mino-Kenudson M, Pitman MB, 
Brugge WR. Peritoneal seeding in intraductal papillary mucinous neoplasm of the 
pancreas patients who underwent endoscopic ultrasound-guided fine-needle 
aspiration: the PIPE Study. Endoscopy. 2014 May;46(5):382–7.  
329.  Fong ZV, Tanabe KK. The clinical management of hepatocellular carcinoma in the 
United States, Europe, and Asia: A comprehensive and evidence-based comparison 
and review. Cancer. 2014;(617).  
330.  Martin RCG, Kwon D, Chalikonda S, Sellers M, Kotz E, Scoggins C, et al. Treatment 
of 200 Locally Advanced (Stage III) Pancreatic Adenocarcinoma Patients With 
Irreversible Electroporation. Ann Surg. 2015;262(3):486–94.  
331.  Macchi EG, Tosi D, Braschi G, Gallati M, Cigada A, Busca G, et al. Optical fiber 
sensors-based temperature distribution measurement in ex vivo radiofrequency 
ablation with submillimeter resolution. J Biomed Opt. International Society for Optics 
and Photonics; 2014 Jan 1;19(11):117004.  
332.  Clancy NT, Arya S, Qi J, Stoyanov D, Hanna GB, Elson DS. Polarised stereo 
endoscope and narrowband detection for minimal access surgery. Biomed Opt 
Express. 2014 Nov 3;5(12):4108.  
333.  Howell DC, Howell, C. D. Median Absolute Deviation. In: Wiley StatsRef: Statistics 
Reference Online. Chichester, UK: John Wiley & Sons, Ltd; 2014.  
334.  Martin Bland J, Altman D. STATISTICAL METHODS FOR ASSESSING 
AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT. Lancet. 
1986 Feb;327(8476):307–10.  
335.  Hall AR, Dhillon AP, Green AC, Ferrell L, Crawford JM, Alves V, et al. Hepatic 
steatosis estimated microscopically versus digital image analysis. Liver Int. 2013 
Jul;33(6):926–35.  
282 
 
336.  Mari JM, Xia W, West SJ, Desjardins AE. Interventional multispectral photoacoustic 
imaging with a clinical ultrasound probe for discriminating nerves and tendons: an ex 
vivo pilot study. J Biomed Opt. 2015;20(11):110503.  
337.  Wang L V, Hu S. Photoacoustic tomography: in vivo imaging from organelles to 
organs. Science. 2012 Mar 23;335(6075):1458–62.  
338.  Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. Elsevier Ltd; 
2012;379(9822):1245–55.  
339.  Athanasopoulos P, Mastoraki A, Papalois A, Nastos C, Kondi-Pafiti A, 
Kostopanagiotou G, et al. Expression of Inflammatory and Regenerative Genes in a 
Model of Liver Ischemia/Reperfusion and Partial Hepatectomy. J Investig Surg. 
2016;29(2):67–73.  
340.  Aoki T, Murakami M, Yasuda D, Shimizu Y, Kusano T, Matsuda K, et al. 
Intraoperative fluorescent imaging using indocyanine green for liver mapping and 
cholangiography. J Hepatobiliary Pancreat Sci. Japan; 2010 Sep;17(5):590–4.  
341.  Aubakir B, Nurimbetov B, Tursynbek I, Varol HA. Vital sign monitoring utilizing 
Eulerian video magnification and thermography. Proc Annu Int Conf IEEE Eng Med 
Biol Soc EMBS. 2016;2016–Octob:3527–30.  
342.  Wadhwa N, Rubinstein M, Durand F, Freeman WT. Phase-based video motion 
processing. ACM Trans Graph. ACM; 2013 Jul 1;32(4):1.  
343.  Haralick RM. Statistical and structural approaches to texture. Proc IEEE. 
1979;67(5):786–804.  
344.  Marana ANN, Valestin SA, Costa LF, Lotufo RA. Estimation of crowd density using 
image processing. IEEE Colloq Image Process Secur Appl. IEE; 1997;1997:11–11.  
345.  Arfken. Discrete Orthogonality -- Discrete Fourier Transform. 1985;  
346.  Simonoff JS. Smoothing Methods in Statistics. Springer New York; 1996. 356 p.  
347.  Barron JL, Fleet DJ, Beauchemin SS. Performance of optical flow techniques. Int J 
Comput Vis. Kluwer Academic Publishers; 1994 Feb;12(1):43–77.  
348.  Clements LW, Collins JA, Weis JA, Simpson AL, Kingham TP, Jarnagin WR, et al. 
Deformation correction for image-guided liver surgery: An intraoperative assessment 
of fidelity. Surgery. 2017 Sep;162(3):1–11.  
349.  Aoki T, Murakami M, Koizumi T, Kusano T, Fujimori A, Enami Y, et al. Preoperative 
Tattooing for Precise and Expedient Localization of Landmark in Laparoscopic Liver 
Resection. J Am Coll Surg. 2015 Nov;221(5):e97–101.  
283 
 
350.  Chandra S, Hayashibe M, Thondiyath A. Dominant component in muscle fatigue 
induced hand tremor during laparoscopic surgical manipulation. In: 2014 36th Annual 
International Conference of the IEEE Engineering in Medicine and Biology Society. 
IEEE; 2014. p. 6539–42.  
351.  Amir-khalili A, Peyrat J, Abinahed J, Al-alao O. Auto Localization and Segmentation 
of Occluded Vessels in Robot-Assisted Partial Nephrectomy. Med Image Comput 
Comput Interv – MICCAI 2014. 2014;  
352.  Muller A, Petrusca L, Auboiroux V, Valette PJ, Salomir R, Cotton F. Management of 
respiratory motion in extracorporeal high-intensity focused ultrasound treatment in 
upper abdominal organs: Current status and perspectives. Cardiovasc Intervent 
Radiol. 2013;36(6):1464–76.  
353.  Rickey DW, Picot PA, Christopher DA, Fenster A. A wall-less vessel phantom for 
Doppler ultrasound studies. Ultrasound Med Biol. 1995 Jan;21(9):1163–76.  
354.  Machado MAC, Surjan RC, Basseres T. The laparoscopic Glissonian approach is 
safe and efficient when compared with standard laparoscopic liver resection : Results 
of an observational study over 7 years. 2016;1–9.  
355.  Ogiso S, Conrad C, Araki K, Nomi T, Anil Z, Gayet B. Laparoscopic Transabdominal 
With Transdiaphragmatic Access Improves Resection of Difficult Posterosuperior 
Liver Lesions. Ann Surg. 2015;00(00):1.  
356.  Machado MAC, Surjan RC. Intrahepatic Glissonian Approach for Single-Port. 
2014;24(8):534–7.  
357.  Soubrane O, de Rougemont O, Kim K-H, Samstein B, Mamode N, Boillot O, et al. 
Laparoscopic Living Donor Left Lateral Sectionectomy: A New Standard Practice for 
Donor Hepatectomy. Ann Surg. 2015 Nov;262(5):757-61; discussion 761-3.  
358.  Cauchy F, Fuks D, Nomi T, Schwarz L, Barbier L, Dokmak S, et al. Risk factors and 
consequences of conversion in laparoscopic major liver resection. Br J Surg. 
2015;n/a-n/a.  
359.  Peterhans M, vom Berg A, Dagon B, Inderbitzin D, Baur C, Candinas D, et al. A 
navigation system for open liver surgery: design, workflow and first clinical 
applications. Int J Med Robot. 2011 Mar;7(1):7–16.  
360.  Polignano FM, Quyn AJ, De Figueiredo RSM, Henderson N a., Kulli C, Tait IS. 
Laparoscopic versus open liver segmentectomy: Prospective, case-matched, 
intention-to-treat analysis of clinical outcomes and cost effectiveness. Surg Endosc 
Other Interv Tech. 2008;22(12):2564–70.  
284 
 
361.  Abu Hilal M, Di Fabio F, Syed S, Wiltshire R, Dimovska E, Turner D, et al. 
Assessment of the financial implications for laparoscopic liver surgery: A single-
centre UK cost analysis for minor and major hepatectomy. Surg Endosc Other Interv 
Tech. 2013;27:2542–50.  
362.  Aoki T, Murakami M, Koizumi T. Three-Dimensional Virtual Endoscopy for 
Laparoscopic and Thoracoscopic Liver Resection. J Am Coll Surg. American College 
of Surgeons; 2015;221(2):e21–6.  
363.  Mountney P, Stoyanov D, Davison A, Yang G-Z. Simultaneous stereoscope 
localization and soft-tissue mapping for minimal invasive surgery. Med Image 
Comput Comput Assist Interv. 2006;9(Pt 1):347–54.  
364.  Jia Y, Shelhamer E, Donahue J, Karayev S, Long J, Girshick R, et al. Caffe: 
Convolutional Architecture for Fast Feature Embedding. Proc ACM Int Conf Multimed 
- MM ’14. 2014;675–8.  
365.  Gibson E, Robu MR, Thompson S, Edwards PE, Schneider C, Gurusamy K, et al. 
Deep residual networks for automatic segmentation of laparoscopic videos of the 
liver. Webster RJ, Fei B, editors. International Society for Optics and Photonics; 2017 
Mar 3;10135:101351M.  
366.  Haouchine N, Dequidt J, Peterlik I. Towards an Accurate Tracking of Liver Tumors 
for Augmented Reality in Robotic Assisted Surgery. … Robot …. 2014;  
367.  Kleemann M, Deichmann S, Esnaashari H, Besirevic A, Shahin O, Bruch H-P, et al. 
Laparoscopic navigated liver resection: technical aspects and clinical practice in 
benign liver tumors. Case Rep Surg. 2012;2012:265918.  
368.  Araki K, Conrad C, Ogiso S, Kuwano H, Gayet B. Intraoperative ultrasonography of 
laparoscopic hepatectomy: Key technique for safe liver transection. J Am Coll Surg. 
American College of Surgeons; 2014;218(2):e37–41.  
369.  LIU C, FAN S, LO C, CHAN S, TSO W, NG I, et al. Hepatic resection for 
incidentaloma. J Gastrointest Surg. 2004 Nov 1;8(7):785–93.  
370.  Chen X, Chen Y, Li Q, Ma D, Shen B, Peng C. Radiofrequency ablation versus 
surgical resection for intrahepatic hepatocellular carcinoma recurrence: a meta-
analysis. J Surg Res. 2015;195(1):166–74.  
371.  Lodewick TM, Arnoldussen CWKP, Lahaye MJ, van Mierlo KMC, Neumann UP, 
Beets-Tan RG, et al. Fast and accurate liver volumetry prior to hepatectomy. HPB. 
2016 Sep;18(9):764–72.  
372.  Lang H, Radtke A, Liu C, Frühauf NR, Peitgen HO, Broelsch CE. Extended left 
285 
 
hepatectomy--modified operation planning based on three-dimensional visualization 
of liver anatomy. Langenbecks Arch Surg. 2004;389(4):306–10.  
373.  Schneider C, Johnson SP, Walker-Samuel S, Gurusamy K, Clarkson MJ, Thompson 
S, et al. Utilizing confocal laser endomicroscopy for evaluating the adequacy of 
laparoscopic liver ablation. Lasers Surg Med. United States; 2016 Mar;48(3):299–
310.  
374.  Zhu Y, Gao W, Zhou Y, Guo Y, Guo F, He Y. Rapid and high-resolution imaging of 
human liver specimens by full-field optical coherence tomography. J Biomed Opt. 
2015 Nov 30;20(11):116010.  
375.  Zhang HF, Maslov K, Stoica G, Wang L V. Functional photoacoustic microscopy for 
high-resolution and noninvasive in vivo imaging. Nat Biotechnol. 2006 Jul 
25;24(7):848–51.  
376.  Chang S, Lanctot AC, McCarter MD, Roberts KM, Glueck DH, Dodd GD. The 
prediction of radiofrequency ablation zone volume using vascular indices of 3-
dimensional volumetric colour Doppler ultrasound in an in vitro blood-perfused bovine 
liver model. Br J Radiol. 2017 Feb;90(1070):20160661.  
377.  Schols RM, Bouvy ND, Masclee AAM, Van Dam RM, Dejong CHC, Stassen LPS. 
Fluorescence imaging of the extra-hepatic bile ducts during laparoscopic 
cholecystectomy: Preliminary results of a pilot-study. Surg Endosc Other Interv Tech. 
Germany; 2013 May;27(5):S33.  
378.  Bosetti C, Turati F, La Vecchia C. Hepatocellular carcinoma epidemiology. Best Pract 
Res Clin Gastroenterol. Elsevier Ltd; 2014;28(5):753–70.  
379.  Lopez A, Zlatev D V, Mach KE, Bui D, Liu J-J, Rouse R V, et al. Intraoperative 
Optical Biopsy during Robotic Assisted Radical Prostatectomy Using Confocal 
Endomicroscopy. J Urol. NIH Public Access; 2016 Apr;195(4 Pt 1):1110–7.  
380.  Goetz M, Kiesslich R. Advances in confocal laser endomicroscopy for the diagnosis 
of gastrointestinal diseases. Expert Opin Med Diagn. 2009/09/01. 2009;3(5):493–
500.  
381.  Clancy NT, Saso S, Stoyanov D, Sauvage V, Corless DJ, Boyd M, et al. Multispectral 
imaging of organ viability during uterine transplantation surgery in rabbits and sheep. 
J Biomed Opt. International Society for Optics and Photonics; 2016 Oct 
27;21(10):106006.  
382.  Lanzafame RJ. Laser safety programs in general surgery. J Laser Appl. Laser 
Institute of America; 1994 Jun 29;6(2):111–4.  
286 
 
383.  Jones G, Clancy NT, Helo Y, Arridge S, Elson DS, Stoyanov D. Bayesian Estimation 
of Intrinsic Tissue Oxygenation and Perfusion From RGB Images. IEEE Trans Med 
Imaging. 2017 Jul;36(7):1491–501.  
384.  Wadhwa N, Rubinstein M, Durand F, Freeman WT. Riesz pyramids for fast phase-
based video magnification. 2014 IEEE Int Conf Comput Photogr ICCP 2014. 2014;  
385.  Adams F, Schoelly R, Schlager D, Schoenthaler M, Schoeb DS, Wilhelm K, et al. 
Algorithm-Based Motion Magnification for Video Processing in Urological 
Laparoscopy. J Endourol. 2017;31(6):583–7.  
386.  Liu YF, Vuong C, Walker PC, Peterson NR, Inman JC, Filho PAA, et al. Noninvasive 
Free Flap Monitoring Using Eulerian Video Magnification. Case Rep Otolaryngol. 
Hindawi Publishing Corporation; 2016;2016:9471696.  
387.  Suwelack S, Röhl S, Bodenstedt S, Reichard D, Dillmann R, dos Santos T, et al. 
Physics-based shape matching for intraoperative image guidance. Med Phys. 
2014;41(11):111901.  
388.  Sánchez-Margallo FM, Sánchez-Margallo JA, Moyano-Cuevas JL, Pérez EM, 
Maestre J. Use of natural user interfaces for image navigation during laparoscopic 
surgery: initial experience. Minim Invasive Ther Allied Technol. Informa UK Limited, 
trading as Taylor 8 Francis Group; 2017;0(0):1–9.  
 
 
